Claims for Patent: 9,089,574

Summary for Patent: 9,089,574

Title:	Antiviral JAK inhibitors useful in treating or preventing retroviral and other viral infections
Abstract:	Compounds, compositions, and methods of treatment and prevention of HIV infection are disclosed. The compounds are pyrrolo[2,3-b]pyridines and pyrrolo[2,3-b]pyrimidine JAK inhibitors. Combinations of these JAK inhibitors and additional antiretroviral compounds, such as NRTI, NNRTI, integrase inhibitors, entry inhibitors, protease inhibitors, and the like, are also disclosed. In one embodiment, the combinations include a combination of adenine, cytosine, thymidine, and guanine nucleoside antiviral agents, optionally in further combination with at least one additional antiviral agent that works via a different mechanism than a nucleoside analog. This combination has the potential to eliminate the presence of HIV in an infected patient.
Inventor(s):	Gavegnano; Christina (Decatur, GA), Schinazi; Raymond F. (Miami, FL)
Assignee:	EMORY UNIVERSITY (Atlanta, GA)
Application Number:	14/360,905
Patent Claims:	1. A method for treating an HIV infection, comprising administering to a patient in need thereof an effective antiviral amount of a compound of Formula A: ##STR00035## wherein: or the pharmaceutically acceptable salt thereof; wherein R.sup.1 is a group of the formula ##STR00036## wherein y is 0, 1 or 2; R.sup.4 is selected from the group consisting of hydrogen, (C.sub.1-C.sub.6)alkyl, (C.sub.1-C.sub.6)alkylsulfonyl, (C.sub.2-C.sub.6)alkenyl, (C.sub.2-C.sub.6)alkynyl wherein the alkyl, alkenyl and alkynyl groups are optionally substituted by deuterium, hydroxy, amino, trifluoromethyl, (C.sub.1-C.sub.4)alkoxy, (C.sub.1-C.sub.6)acyloxy, (C.sub.1-C.sub.6)alkylamino, ((C.sub.1-C.sub.6)alkyl).sub.2amino, cyano, nitro, (C.sub.2-C.sub.6)alkenyl, (C.sub.2-C.sub.6)alkynyl or (C.sub.1-C.sub.6)acylamino; or R.sup.4 is (C.sub.3-C.sub.10)cycloalkyl wherein the cycloalkyl group is optionally substituted by deuterium, hydroxy, amino, trifluoromethyl, (C.sub.1-C.sub.6)acyloxy, (C.sub.1-C.sub.6)acylamino, (C.sub.1-C.sub.6)alkylamino, ((C.sub.1-C.sub.6)alkyl).sub.2amino, cyano, cyano(C.sub.1-C.sub.6)alkyl, trifluoromethyl(C.sub.1-C.sub.6)alkyl, nitro, nitro(C.sub.1-C.sub.6)alkyl or (C.sub.1-C.sub.6)acylamino; R.sup.5 is (C.sub.2-C.sub.9)heterocycloalkyl wherein the heterocycloalkyl groups must be substituted by one to five carboxy, cyano, amino, deuterium, hydroxy, (C.sub.1-C.sub.6)alkyl, (C.sub.1-C.sub.6)alkoxy, halo, (C.sub.1-C.sub.6)acyl, (C.sub.1-C.sub.6)alkylamino, amino(C.sub.1-C.sub.6)alkyl, (C.sub.1-C.sub.6)alkoxy-CO--NH, (C.sub.1-C.sub.6)alkylamino-CO--, (C.sub.2-C.sub.6)alkenyl, (C.sub.2-C.sub.6)alkynyl, (C.sub.1-C.sub.6)alkylamino, amino(C.sub.1-C.sub.6)alkyl, hydroxy(C.sub.1-C.sub.6)alkyl, (C.sub.1-C.sub.6)alkoxy(C.sub.1-C.sub.6)alkyl, (C.sub.1-C.sub.6)acyloxy(C.sub.1-C.sub.6)alkyl, nitro, cyano(C.sub.1-C.sub.6)alkyl, halo(C.sub.1-C.sub.6)alkyl, nitro(C.sub.1-C.sub.6)alkyl, trifluoromethyl, trifluoromethyl(C.sub.1-C.sub.6)alkyl, (C.sub.1-C.sub.6)acylamino, (C.sub.1-C.sub.6)acylamino(C.sub.1-C.sub.6)alkyl, (C.sub.1-C.sub.6)alkoxy(C.sub.1-C.sub.6)acylamino, amino(C.sub.1-C.sub.6)acyl, amino(C.sub.1-C.sub.6)acyl(C.sub.1-C.sub.6)alkyl, (C.sub.1-C.sub.6)alkylamino(C.sub.1-C.sub.6)acyl, ((C.sub.1-C.sub.6)alkyl).sub.2amino(C.sub.1-C.sub.6)acyl, R.sup.15R.sup.16N--CO--O--, R.sup.15R.sup.16N--CO--(C.sub.1-C.sub.6)alkyl, (C.sub.1-C.sub.6)alkyl-S(O).sub.m, R.sup.15R.sup.16NS(O).sub.m, R.sup.15R.sup.16NS(O).sub.m(C.sub.1-C.sub.6)alkyl, R.sup.15S(O).sub.mR.sup.16N, R.sup.15S(O).sub.mR.sup.16(C.sub.1-C.sub.6)alkyl wherein m is 0, 1 or 2 and R.sup.15 and R.sup.16 are each independently selected from hydrogen or (C.sub.1-C.sub.6)alkyl; or a group of the formula ##STR00037## wherein a is 0, 1, 2, 3 or 4; b, c, e, f and g are each independently 0 or 1; d is 0, 1, 2, or 3; X is S(O).sub.n wherein n is 0, 1 or 2; oxygen, carbonyl or --C(.dbd.N-cyano)-; Y is S(O).sub.n wherein n is 0, 1 or 2; or carbonyl; and Z is carbonyl, C(O)O--, C(O)NR-- or S(O).sub.n wherein n is 0, 1 or 2; R.sup.6, R.sup.7, R.sup.8, R.sup.9, R.sup.10 and R.sup.11 are each independently selected from the group consisting of hydrogen or (C.sub.1-C.sub.6)alkyl optionally substituted by deuterium, hydroxy, amino, trifluoromethyl, (C.sub.1-C.sub.6)acyloxy, (C.sub.1-C.sub.6)acylamino, (C.sub.1-C.sub.6)alkylamino, ((C.sub.1-C.sub.6)alkyl).sub.2amino, cyano, cyano(C.sub.1-C.sub.6)alkyl, trifluoromethyl(C.sub.1-C.sub.6)alkyl, nitro, nitro(C.sub.1-C.sub.6)alkyl or (C.sub.1-C.sub.6)acylamino; R.sup.12 is carboxy, cyano, amino, oxo, deuterium, hydroxy, trifluoromethyl, (C.sub.1-C.sub.6)alkyl, trifluoromethyl(C.sub.1-C.sub.6)alkyl, (C.sub.1-C.sub.6)alkoxy, halo, (C.sub.1-C.sub.6)acyl, (C.sub.1-C.sub.6)alkylamino, ((C.sub.1-C.sub.6)alkyl).sub.2amino, amino(C.sub.1-C.sub.6)alkyl, (C.sub.1-C.sub.6)alkoxy-CO--NH, (C.sub.1-C.sub.6)alkylamino-CO--, (C.sub.2-C.sub.6)alkenyl, (C.sub.2-C.sub.6) alkynyl, (C.sub.1-C.sub.6)alkylamino, hydroxy(C.sub.1-C.sub.6)alkyl, (C.sub.1-C.sub.6)alkoxy(C.sub.1-C.sub.6)alkyl, (C.sub.1-C.sub.6)acyloxy(C.sub.1-C.sub.6)alkyl, nitro, cyano(C.sub.1-C.sub.6)alkyl, halo(C.sub.1-C.sub.6)alkyl, nitro(C.sub.1-C.sub.6)alkyl, trifluoromethyl, trifluoromethyl(C.sub.1-C.sub.6)alkyl, (C.sub.1-C.sub.6)acylamino, (C.sub.1-C.sub.6)acylamino(C.sub.1-C.sub.6)alkyl, (C.sub.1-C.sub.6)alkoxy(C.sub.1-C.sub.6)acylamino, amino(C.sub.1-C.sub.6)acyl, amino(C.sub.1-C.sub.6)acyl(C.sub.1-C.sub.6)alkyl, (C.sub.1-C.sub.6)alkylamino(C.sub.1-C.sub.6)acyl, ((C.sub.1-C.sub.6)alkyl).sub.2amino(C.sub.1-C.sub.6)acyl, R.sup.15R.sup.16N--CO--O--, R.sup.15R.sup.16N--CO--(C.sub.1-C.sub.6)alkyl, R.sup.15C(O)NH, R.sup.15OC(O)NH, R.sup.15NHC(O)NH, (C.sub.1-C.sub.6)alkyl-S(O).sub.m, (C.sub.1-C.sub.6)alkyl-S(O).sub.m--(C.sub.1-C.sub.6)alkyl, R.sup.15R.sup.16NS(O).sub.m, R.sup.15R.sup.16NS(O).sub.m(C.sub.1-C.sub.6)alkyl, R.sup.15S(O).sub.mR.sup.16N, R.sup.15S(O).sub.mR.sup.16N(C.sub.1-C.sub.6)alkyl wherein m is 0, 1 or 2 and R.sup.15 and R.sup.16 are each independently selected from hydrogen or (C.sub.1-C.sub.6)alkyl; R.sup.2 and R.sup.3 are each independently selected from the group consisting of hydrogen, deuterium, amino, halo, hydroxy, nitro, carboxy, (C.sub.2-C.sub.6)alkenyl, (C.sub.2-C.sub.6)alkynyl, trifluoromethyl, trifluoromethoxy, (C.sub.1-C.sub.6)alkyl, (C.sub.1-C.sub.6)alkoxy, (C.sub.3-C.sub.10)cycloalkyl wherein the alkyl, alkoxy or cycloalkyl groups are optionally substituted by one to three groups selected from halo, hydroxy, carboxy, amino(C.sub.1-C.sub.6)alkylthio, (C.sub.1-C.sub.6)alkylamino, ((C.sub.1-C.sub.6)alkyl).sub.2amino, (C.sub.5-C.sub.9)heteroaryl, (C.sub.2-C.sub.9)heterocycloalkyl, (C.sub.3-C.sub.9)cycloalkyl or (C.sub.6-C.sub.10)aryl; or R.sup.2 and R.sup.3 are each independently (C.sub.3-C.sub.10)cycloalkyl, (C.sub.3-C.sub.10)cycloalkoxy, (C.sub.1-C.sub.6)alkylamino, ((C.sub.1-C.sub.6)alkyl).sub.2amino, (C.sub.6-C.sub.10)arylamino, (C.sub.1-C.sub.6)alkylthio, (C.sub.6-C.sub.10)arylthio, (C.sub.1-C.sub.6)alkylsulfinyl, (C.sub.6-C.sub.10)arylsulfinyl, (C.sub.1-C.sub.6)alkylsulfonyl, (C.sub.6-C.sub.10)arylsulfonyl, (C.sub.1-C.sub.6)acyl, (C.sub.1-C.sub.6)alkoxy-CO--NH--, (C.sub.1-C.sub.6)alkylamino-CO--, (C.sub.5-C.sub.9)heteroaryl, (C.sub.2-C.sub.9)heterocycloalkyl or (C.sub.6-C.sub.10)aryl wherein the heteroaryl, heterocycloalkyl and aryl groups are optionally substituted by one to three halo, (C.sub.1-C.sub.6)alkyl, (C.sub.1-C.sub.6)alkyl-CO--NH--, (C.sub.1-C.sub.6)alkoxy-CO--NH--, (C.sub.1-C.sub.6)alkyl-CO--NH--(C.sub.1-C.sub.6)alkyl, (C.sub.1-C.sub.6)alkoxy-CO--NH--(C.sub.1-C.sub.6)alkyl, (C.sub.1-C.sub.6)alkoxy-CO--NH--(C.sub.1-C.sub.6)alkoxy, carboxy, carboxy(C.sub.1-C.sub.6)alkyl, carboxy(C.sub.1-C.sub.6)alkoxy, benzyloxycarbonyl(C.sub.1-C.sub.6)alkoxy, (C.sub.1-C.sub.6)alkoxycarbonyl(C.sub.1-C.sub.6)alkoxy, (C.sub.6-C.sub.10)aryl, amino, amino(C.sub.1-C.sub.6)alkyl, (C.sub.1-C.sub.6)alkoxycarbonylamino, (C.sub.6-C.sub.10)aryl(C.sub.1-C.sub.6)alkoxycarbonylamino, (C.sub.1-C.sub.6)alkylamino, ((C.sub.1-C.sub.6)alkyl).sub.2amino, (C.sub.1-C.sub.6)alkylamino(C.sub.1-C.sub.6)alkyl, ((C.sub.1-C.sub.6)alkyl).sub.2amino(C.sub.1-C.sub.6)alkyl, hydroxy, (C.sub.1-C.sub.6)alkoxy, carboxy, carboxy(C.sub.1-C.sub.6)alkyl, (C.sub.1-C.sub.6)alkoxycarbonyl, (C.sub.1-C.sub.6)alkoxycarbonyl(C.sub.1-C.sub.6)alkyl, (C.sub.1-C.sub.6)alkoxy-CO--NH--, (C.sub.1-C.sub.6)alkyl-CO--NH--, cyano, (C.sub.5-C.sub.9)heterocycloalkyl, amino-CO--NH--, (C.sub.1-C.sub.6)alkylamino-CO--NH--, ((C.sub.1-C.sub.6)alkyl).sub.2amino-CO--NH--, (C.sub.6-C.sub.10)arylamino-CO--NH--, (C.sub.5-C.sub.9)heteroarylamino-CO--NH--, (C.sub.1-C.sub.6)alkylamino-CO--NH--(C.sub.1-C.sub.6)alkyl, ((C.sub.1-C.sub.6)alkyl).sub.2amino-CO--NH--(C.sub.1-C.sub.6)alkyl, (C.sub.6-C.sub.10)arylamino-CO--NH--(C.sub.1-C.sub.6)alkyl, (C.sub.5-C.sub.9)heteroarylamino-CO--NH--(C.sub.1-C.sub.6)alkyl, (C.sub.1-C.sub.6)alkylsulfonyl, (C.sub.1-C.sub.6)alkylsulfonylamino, (C.sub.1-C.sub.6)alkylsulfonylamino(C.sub.1-C.sub.6)alkyl, (C.sub.6-C.sub.10)arylsulfonyl, (C.sub.6-C.sub.10)arylsulfonylamino, (C.sub.6-C.sub.10)arylsulfonylamino(C.sub.1-C.sub.6)alkyl, (C.sub.1-C.sub.6)alkylsulfonylamino, (C.sub.1-C.sub.6)alkylsulfonylamino(C.sub.1-C.sub.6)alkyl, (C.sub.5-C.sub.9)hetero aryl or (C.sub.2-C.sub.9)heterocycloalkyl, or of Formula B: ##STR00038## including pharmaceutically acceptable salt forms or prodrugs thereof, wherein: A.sup.1 and A.sup.2 are independently selected from C and N; T, U, and V are independently selected from O, S, N, CR.sup.5, and NR.sup.6; wherein the 5-membered ring formed by A.sup.1, A.sup.2, U, T, and V is aromatic; X is N or CR.sup.4; Y is C.sub.1-8 alkylene, C.sub.2-8 alkenylene, C.sub.2-8 alkynylene, (CR.sup.11R.sup.12).sub.p--(C.sub.3-10 cycloalkylene)-(CR.sup.11R.sup.12).sub.q, (CR.sup.11R.sup.12).sub.p-(arylene)-(CR.sup.11R.sup.12).sub.q, (CR.sup.11R.sup.12).sub.\p--(C.sub.1-10 heterocycloalkylene)-(CR.sup.11R.sup.12).sub.q, (CR.sup.11R.sup.12).sub.p-(heteroarylene)-(CR.sup.11R.sup.12).sub.q, (CR.sup.11R.sup.12).sub.pO(CR.sup.11R.sup.12).sub.q, (CR.sup.11R.sup.12).sub.pS(CR.sup.11R.sup.12).sub.q, (CR.sup.11R.sup.12).sub.pC(O)(CR.sup.11R.sup.12).sub.q, (CR.sup.11R.sup.12).sub.pC(O)NR.sub.c(CR.sup.11R.sup.12).sub.q, (CR.sup.11R.sup.12).sub.pC(O)O(CR.sup.11R.sup.12).sub.q, (CR.sup.11R.sup.12).sub.pOC(O)(CR.sup.11R.sup.12).sub.q, (CR.sup.11R.sup.12).sub.pOC(O)NR.sup.c(CR.sup.11R.sup.12).sub.q, (CR.sup.11R.sup.12).sub.pNR.sup.c(CR.sup.11R.sup.12).sub.q, (CR.sup.11R.sup.12).sub.pNR.sup.cC(O)NR.sup.d(CR.sup.11R.sup.12).sub.q, (CR.sup.11R.sup.12).sub.pS(O)(CR.sup.11R.sup.12).sub.q, (CR.sup.11R.sup.12).sub.pS(O)NR.sup.c(CR.sup.11R.sup.12).sub.q, (CR.sup.11R.sup.12).sub.pS(O).sub.2(CR.sup.11R.sup.12).sub.q, or (CR.sup.11R.sup.12).sub.pS(O).sub.2NR.sup.c(CR.sup.11R.sup.12).sub.q, wherein said C.sub.1-8 alkylene, C.sub.2-8 alkenylene, C.sub.2-8 alkynylene, cycloalkylene, arylene, heterocycloalkylene, or heteroarylene, is optionally substituted with 1, 2, or 3 substituents independently selected from -D.sup.1-D.sup.2-D.sup.3-D.sup.4; Z is H, halo, C.sub.1-4 alkyl, C.sub.2-4 alkenyl, C.sub.2-4 alkynyl, C.sub.1-4 haloalkyl, halosulfanyl, C.sub.1-4 hydroxyalkyl, C.sub.1-4 cyanoalkyl, .dbd.C--R.sup.i, .dbd.N--R.sup.i, Cy.sup.1, CN, NO.sub.2, OR.sup.a, SR.sup.a, C(O)R.sup.b, C(O)NR.sup.cR.sup.d, C(O)OR.sup.a, OC(O)R.sup.b, OC(O)NR.sup.cR.sup.d, NR.sup.cR.sup.d, NR.sup.cC(O)R.sup.b, NR.sup.cC(O)NR.sup.cR.sup.d, NR.sup.cC(O)OR.sup.a, C(.dbd.NR.sup.i)NR.sup.cR.sup.d, NR.sup.cC(.dbd.NR.sup.i)NR.sup.cR.sup.d, S(O)R.sup.b, S(O)NR.sup.cR.sup.d, S(O).sub.2R.sup.b, NR.sup.cS(O).sub.2R.sup.b, C(.dbd.NOH)R.sup.b, C(.dbd.NO(C.sub.1-6alkyl)R.sup.b, and S(O).sub.2NR.sup.cR.sup.d, wherein said C.sub.1-8 alkyl, C.sub.2-8 alkenyl, or C.sub.2-8 alkynyl, is optionally substituted with 1, 2, 3, 4, 5, or 6 substituents independently selected from halo, C.sub.1-4 alkyl, C.sub.2-4 alkenyl, C.sub.2-4 alkynyl, C.sub.1-4 haloalkyl, halosulfanyl, C.sub.1-4 hydroxyalkyl, C.sub.1-4 cyanoalkyl, Cy.sup.1, CN, N.sub.2, OR.sup.a, SR.sup.a, C(O)R.sup.b, C(O)NR.sup.cR.sup.d, C(O)OR.sup.a, OC(O)R.sup.b, OC(O)NR.sup.cR.sup.d, NR.sup.cR.sup.d, NR.sup.cC(O)R.sup.b, NR.sup.cC(O)NR.sup.cR.sup.d, NR.sup.cC(O)OR.sup.a, C(.dbd.NR.sup.i)NR.sup.cR.sup.d, NR.sup.cC(.dbd.NR.sup.i)NR.sup.cR.sup.d, S(O)R.sup.b, S(O)NR.sup.cR.sup.d, S(O).sub.2R.sup.b, NR.sup.cS(O).sub.2R.sup.b, C(.dbd.NOH)R.sup.b, C(.dbd.NO(C.sub.1-6 alkyl))R.sup.b, and S(O).sub.2NR.sup.cR.sup.d; wherein when Z is H, n is 1; or the --(Y).sub.n--Z moiety is taken together with i) A.sup.2 to which the moiety is attached, ii) R.sup.5 or R.sup.6 of either T or V, and iii) the C or N atom to which the R.sup.5 or R.sup.6 of either T or V is attached to form a 4- to 20-membered aryl, cycloalkyl, heteroaryl, or heterocycloalkyl ring fused to the 5-membered ring formed by A.sup.1 A.sup.2, U, T, and V, wherein said 4- to 20-membered aryl, cycloalkyl, heteroaryl, or heterocycloalkyl ring is optionally substituted by 1, 2, 3, 4, or 5 substituents independently selected from --(W).sub.m-Q; W is C.sub.1-8 alkylenyl, C.sub.2-8 alkenylenyl, C.sub.2-8 alkynylenyl, O, S, C(O), C(O)NR.sup.c', C(O)O, OC(O), OC(O)NR.sup.c', NR.sup.c', NR.sup.c'C(O)NR.sup.d', S(O), S(O)NR.sup.c', S(O).sub.2, or S(O)2NR.sup.c'; Q is H, halo, CN, NO.sub.2, C.sub.1-8 alkyl, C.sub.2-8 alkenyl, C.sub.2-8 alkynyl, C.sub.1-8 haloalkyl, halosulfanyl, aryl, cycloalkyl, heteroaryl, or heterocycloalkyl, wherein said C.sub.1-8 alkyl, C.sub.2-8 alkenyl, C.sub.2-8 alkynyl, C.sub.1-8 haloalkyl, aryl, cycloalkyl, heteroaryl, or heterocycloalkyl is optionally substituted with 1, 2, 3 or 4 substituents independently selected from halo, C.sub.1-4 alkyl, C.sub.2-4 alkenyl, C.sub.2-4 alkynyl, C.sub.1-4 haloalkyl, halosulfanyl, C.sub.1-4 hydroxyalkyl, C.sub.1-4 cyanoalkyl, Cy.sup.2, CN, NO.sub.2, OR.sup.a', SR.sup.a', C(O)R.sup.b', C(O)NR.sup.c'R.sup.d', C(O)OR.sup.a', OC(O)R.sup.b', OC(O)NR.sup.c'R.sup.d', NR.sup.c'R.sup.d', NR.sup.c'C(O)R.sup.b', NR.sup.c'C(O)N R.sup.c'R.sup.d', N R.sup.c'C(O)OR.sup.a', S(O)R.sup.b', S(O)N R.sup.c'R.sup.d', S(O).sub.2R.sup.b', NR.sup.c'S(O).sub.2R.sup.b', and S(O).sub.2N R.sup.c'R.sup.d'; Cy.sup.1 and Cy.sup.2 are independently selected from aryl, heteroaryl, cycloalkyl, and heterocycloalkyl, each optionally substituted by 1, 2, 3, 4 or 5 substituents independently selected from halo, C.sub.1-4 alkyl, C.sub.2-4 alkenyl, C.sub.2-4 alkynyl, C.sub.1-4 haloalkyl, halosulfanyl, C.sub.1-4 hydroxyalkyl, C.sub.1-4 cyanoalkyl, CN, NO.sub.2, OR.sup.a'', SR.sup.a'', C(O)R.sup.b'', C(O)NR.sup.c''R.sup.d'', C(O)OR.sup.a'', OC(O)R.sup.b'', OC(O)N R.sup.c''R.sup.d'', NR.sup.c''R.sup.d'', NR.sup.c''C(O)R.sup.b'', NR.sup.c''C(O)OR.sup.a'', NR.sup.c''S(O)R.sup.b'', NR.sup.c''S(O).sub.2R.sup.b'', S(O)R.sup.b'', S(O)NR.sup.c''R.sup.d'', S(O).sub.2R.sup.b'', and S(O).sub.2NR.sup.c''R.sup.d''; R.sup.1, R.sup.2, R.sup.3, and R.sup.4 are independently selected from H, halo, C.sub.1-4 alkyl, C.sub.2-4 alkenyl, C.sub.2-4 alkynyl, C.sub.1-4 haloalkyl, halosulfanyl, aryl, cycloalkyl, heteroaryl, heterocycloalkyl, CN, NO.sub.2, OR.sup.7, SR.sup.7, C(O)R.sup.8, C(O)NR.sup.9R.sup.10, C(O)OR.sup.7OC(O)R.sup.8, OC(O)NR.sup.9R.sup.10, NR.sup.9R.sup.10, NR.sup.9C(O)R.sup.8, NR.sup.cC(O)OR.sup.7, S(O)R.sup.8, S(O)NR.sup.9R.sup.10, S(O).sub.2R.sup.8, NR.sup.9S(O).sub.2R.sup.8, and S(O).sub.2NR.sup.9R.sup.10; R.sup.5 is H, halo, C.sub.1-4 alkyl, C.sub.2-4 alkenyl, C.sub.2-4 alkynyl, C.sub.1-4 haloalkyl, halosulfanyl, CN, NO.sub.2, OR.sup.7, SR.sup.7, C(O)R.sup.8, C(O)NR.sup.9R.sup.10, C(O)OR.sup.7, OC(O)R.sup.8, OC(O)NR.sup.9R.sup.10, NR.sup.9R.sup.10, NR.sup.9C(O)R.sup.8, NR.sup.9C(O)OR.sup.7, S(O)R.sup.8, S(O)NR.sup.9R.sup.10, S(O).sub.2R.sup.8, NR.sup.9S(O).sub.2R.sup.8, or S(O).sub.2NR.sup.9R.sup.10; R.sup.6 is H, C.sub.1-4 alkyl, C.sub.2-4 alkenyl, C.sub.2-4 alkynyl, C.sub.1-4 haloalkyl, OR.sup.7, C(O)R.sup.8, C(O)NR.sup.9R.sup.10, C(O)OR.sup.7, S(O)R.sup.8, S(O)NR.sup.9R.sup.10, S(O).sub.2R.sup.8, or S(O).sub.2NR.sup.9R.sup.10; R.sup.7 is H, C.sub.1-6 alkyl, C.sub.1-6 haloalkyl, C.sub.2-6 alkenyl, C.sub.2-6 alkynyl, aryl, cycloalkyl, heteroaryl, heterocycloalkyl, arylalkyl, heteroarylalkyl, cycloalkylalkyl or heterocycloalkylalkyl; R.sup.8 is H, C.sub.1-6 alkyl, C.sub.1-6 haloalkyl, C.sub.2-6 alkenyl, C.sub.2-6 alkynyl, aryl, cycloalkyl, heteroaryl, heterocycloalkyl, arylalkyl, heteroarylalkyl, cycloalkylalkyl or heterocycloalkylalkyl; R.sup.9 and R.sup.10 are independently selected from H, C.sub.1-10 alkyl, C.sub.1-6 haloalkyl, C.sub.2-6 alkenyl, C.sub.2-6 alkynyl, C.sub.1-6 alkylcarbonyl, arylcarbonyl, C.sub.1-6 alkylsulfonyl, arylsulfonyl, aryl, heteroaryl, cycloalkyl, heterocycloalkyl, arylalkyl, heteroarylalkyl, cycloalkylalkyl and heterocycloalkylalkyl; or R.sup.9 and R.sup.10 together with the N atom to which they are attached form a 4-, 5-, 6- or 7-membered heterocycloalkyl group; R.sup.11 and R.sup.12 are independently selected from H and -E.sup.1-E.sup.2-E.sup.3-E.sup.4; D.sup.1 and E.sup.1 are independently absent or independently selected from C.sub.1-6 alkylene, C.sub.2-6 alkenylene, C.sub.2-6 alkynylene, arylene, cycloalkylene, heteroarylene, and heterocycloalkylene, wherein each of the C.sub.1-6 alkylene, C.sub.2-6 alkenylene, C.sub.2-6 alkynylene, arylene, cycloalkylene, heteroarylene, and heterocycloalkylene is optionally substituted by 1, 2 or 3 substituents independently selected from halo, CN, NO.sub.2, N.sub.3, SCN, OH, C.sub.1-6 alkyl, C.sub.1-6 haloalkyl, C.sub.2-8 alkoxyalkyl, C.sub.1-6 alkoxy, C.sub.1-6 haloalkoxy, amino, C.sub.1-6 alkylamino, and C.sub.2-8 dialkylamino; D.sup.2 and E.sup.2 are independently absent or independently selected from C.sub.1-6 alkylene, C.sub.2-6 alkenylene, C.sub.2-6 alkynylene, (C.sub.1-6 alkylene).sub.r--O--(C.sub.1-6 alkylene).sub.s, (C.sub.1-6 alkylene).sub.r--S--(C.sub.1-6 alkylene).sub.s, (C.sub.1-6 alkylene).sub.r--NR.sup.c--(C.sub.1-6 alkylene).sub.s, (C.sub.1-6 alkylene).sub.r--CO--(C.sub.1-6 alkylene).sub.s, (C.sub.1-6 alkylene).sub.r--COO--(C.sub.1-6 alkylene).sub.s, (C.sub.1-6 alkylene).sub.r---CONR.sup.c--(C.sub.1-6 alkylene).sub.s, (C.sub.1-6 alkylene).sub.r--SO--(C.sub.1-6 alkylene).sub.s, (C.sub.1-6 alkylene).sub.r--SO.sub.2--(C.sub.1-6 alkylene).sub.s, (C.sub.1-6 alkylene).sub.r--SONR.sup.c--(C.sub.1-6 alkylene).sub.s, and (C.sub.1-6 alkylene).sub.r--NR.sup.cCONR.sup.f--(C.sub.1-6 alkylene).sub.s, wherein each of the C.sub.1-6 alkylene, C.sub.2-6 alkenylene, and C.sub.2-6 alkynylene is optionally substituted by 1, 2 or 3 substituents independently selected from halo, CN, NO.sub.2, N.sub.3, SCN, OH, C.sub.1-6 alkyl, C.sub.1-6 haloalkyl, C.sub.2-8 alkoxyalkyl, C.sub.1-6 alkoxy, C.sub.1-6 haloalkoxy, amino, C.sub.1-6 alkylamino, and C.sub.2-8 dialkylamino; D.sup.3and E.sup.3 are independently absent or independently selected from C.sub.1-6 alkylene, C.sub.2-6 alkenylene, C.sub.2-6 alkynylene, arylene, cycloalkylene, heteroarylene, and heterocycloalkylene, wherein each of the C.sub.1-6 alkylene, C.sub.2-6 alkenylene, C.sub.2-6 alkynylene, arylene, cycloalkylene, heteroarylene, and heterocycloalkylene is optionally substituted by 1, 2 or 3 substituents independently selected from halo, CN, NO.sub.2, N.sub.3, SCN, OH, C.sub.1-6 alkyl, C.sub.1-6 haloalkyl, C.sub.2-8 alkoxyalkyl, C.sub.1-6 alkoxy, C.sub.1-6 haloalkoxy, amino, C.sub.1-6 alkylamino, and C.sub.2-8 dialkylamino; E.sup.4 and E.sup.4 are independently selected from H, halo, C.sub.1-4 alkyl, C.sub.2-4 alkenyl, C.sub.2-4 alkynyl, C.sub.1-4 haloalkyl, halosulfanyl, C.sub.1-4 hydroxyalkyl, C.sub.1-4 cyanoalkyl, Cy.sup.1, CN, NO.sub.2, OR.sup.a, SR.sup.a, C(O)R.sup.b, C(O)NR.sup.cR.sup.a, C(O)OR.sup.a, OC(O)R.sup.bOC(O)NR.sup.cR.sup.d NR.sup.cR.sup.d, NR.sup.cC(O)R.sup.b, NR.sup.cC(O)NR.sup.cR.sup.d, NR.sup.cC(O)OR.sup.a, C(.dbd.NR.sup.i)NR.sup.cR.sup.d, NR.sup.cC(.dbd.NR.sup.i)NR.sup.cR.sup.d, S(O)R.sup.b, S(O)NR.sup.cR.sup.d, S(O).sub.2R.sup.b, NR.sup.cS(O).sub.2R.sup.b, C(.dbd.NOH)R.sup.b, C(.dbd.NO(C.sub.1-6 alkyl)R.sup.b, and S(O).sub.2NR.sup.cR.sup.d, wherein said C.sub.1-8 alkyl, C.sub.2-8 alkenyl, or C.sub.2-8 alkynyl, is optionally substituted with 1, 2, 3, 4, 5, or 6 substituents independently selected from halo, C.sub.1-4 alkyl, C.sub.2-4 alkenyl, C.sub.2-4 alkynyl, C.sub.1-4 haloalkyl, halosulfanyl, C.sub.1-4 hydroxyalkyl, C.sub.1-4 cyanoalkyl, Cy.sup.1, CN, NO.sub.2, OR.sup.a, SR.sup.a, C(O)R.sup.b, C(O)NR.sup.cR.sup.d, C(O)OR.sup.a, OC(O)R.sup.b, OC(O)NR.sup.cR.sup.d, NR.sup.cR.sup.d, NR.sup.cC(O)R.sup.b, NR.sup.cC(O)NR.sup.cR.sup.d, NR.sup.cC(O)OR.sup.a, C(.dbd.NR.sup.i)NR.sup.cR.sup.d, NR.sup.cC(.dbd.NR.sup.i)NR.sup.cR.sup.d, S(O)R.sup.b, S(O)NR.sup.cR.sup.d, S(O).sub.2R.sup.b, NR.sup.cS(O).sub.2R.sup.b, C(.dbd.NOH)R.sup.b, C(.dbd.NO(C.sub.1-6 alkyl))R.sup.b, and S(O).sub.2NR.sup.cR.sup.d; R.sup.a is H, Cy.sup.1, --(C.sub.1-6 alkyl)-Cy.sup.1, C.sub.1-6 alkyl, C.sub.1-6 haloalkyl, C.sub.2-6 alkenyl, C.sub.2-6 alkynyl, wherein said C.sub.1-6 alkyl, C.sub.1-6 haloalkyl, C.sub.2-6 alkenyl, or C.sub.2-6 alkynyl is optionally substituted with 1, 2, or 3 substituents independently selected from OH, CN, amino, halo, C.sub.1-6 alkyl, C.sub.1-6 haloalkyl, halosulfanyl, aryl, arylalkyl, heteroaryl, heteroarylalkyl, cycloalkyl and heterocycloalkyl; R.sup.b is H, Cy.sup.1, --(C.sub.1-6 alkyl)-Cy.sup.1, C.sub.1-6 alkyl, C.sub.1-6 haloalkyl, C.sub.2-6 alkenyl, C.sub.2-6 alkynyl, wherein said C.sub.1-6 alkyl, C.sub.1-61-6 haloalkyl, C.sub.2-6 alkenyl, or C.sub.2-6 alkynyl is optionally substituted with 1, 2, or 3 substituents independently selected from OH, CN, amino, halo, C.sub.1-6 alkyl, C.sub.1-6 haloalkyl, C.sub.1-6 haloalkyl, halosulfanyl, aryl, arylalkyl, heteroaryl, heteroarylalkyl, cycloalkyl and heterocycloalkyl; R.sup.a' and R.sup.a'' are independently selected from H, C.sub.1-6 alkyl, C.sub.1-6 haloalkyl, C.sub.2-6 alkenyl, C.sub.2-6 alkynyl, aryl, cycloalkyl, heteroaryl, heterocycloalkyl, arylalkyl, heteroarylalkyl, cycloalkylalkyl and heterocycloalkylalkyl, wherein said C.sub.1-6 alkyl, C.sub.1-6 haloalkyl, C.sub.2-6 alkenyl, C.sub.2-6 alkynyl, aryl, cycloalkyl, heteroaryl, heterocycloalkyl, arylalkyl, heteroarylalkyl, cycloalkylalkyl or heterocycloalkylalkyl is optionally substituted with 1, 2, or 3 substituents independently selected from OH, CN, amino, halo, C.sub.1-6 alkyl, C.sub.1-6 haloalkyl, halosulfanyl, aryl, arylalkyl, heteroaryl, heteroarylalkyl, cycloalkyl and heterocycloalkyl; R.sup.b' and R.sup.b'' are independently selected from H, C.sub.1-6 alkyl, C.sub.1-6 haloalkyl, C.sub.2-6 alkenyl, C.sub.2-6 alkynyl, aryl, cycloalkyl, heteroaryl, heterocycloalkyl, arylalkyl, heteroarylalkyl, cycloalkylalkyl and heterocycloalkylalkyl, wherein said C.sub.1-6 alkyl, C.sub.1-6 haloalkyl, C.sub.2-6 alkenyl, C.sub.2-6 alkynyl, aryl, cycloalkyl, heteroaryl, heterocycloalkyl, arylalkyl, heteroarylalkyl, cycloalkylalkyl or heterocycloalkylalkyl is optionally substituted with 1, 2, or 3 substituents independently selected from OH, CN, amino, halo, C.sub.1-6 alkyl, C.sub.1-6 haloalkyl, C.sub.1-6 haloalkyl, halosulfanyl, aryl, arylalkyl, heteroaryl, heteroarylalkyl, cycloalkyl and heterocycloalkyl; R.sup.c and R.sup.d are independently selected from H, Cy.sup.1, --(C.sub.1-6 alkyl)-Cy.sup.1, C.sub.1-10 alkyl, C.sub.1-6 haloalkyl, C.sub.2-6 alkenyl, C.sub.2-6 alkynyl, wherein said C.sub.1-10 alkyl, C.sub.1-6 haloalkyl, C.sub.2-6 alkenyl, or C.sub.2-6 alkynyl, is optionally substituted with 1, 2, or 3 substituents independently selected from Cy.sup.1, --(C.sub.1-6 alkyl)-Cy.sup.1, OH, CN, amino, halo, C.sub.1-6 alkyl, C.sub.1-6 haloalkyl, C.sub.1-6 haloalkyl, and halosulfanyl; or R.sup.c and R.sup.d together with the N atom to which they are attached form a 4-, 5-, 6- or 7-membered heterocycloalkyl group optionally substituted with 1, 2, or 3 substituents independently selected from Cy.sup.1, --(C.sub.1-6 alkyl)-Cy.sup.1, OH, CN, amino, halo, C.sub.1-6 alkyl, C.sub.1-6 haloalkyl, C.sub.1-6 haloalkyl, and halosulfanyl; R.sup.c' and R.sup.d' are independently selected from H, C.sub.1-10 alkyl, C.sub.1-6 haloalkyl, C.sub.2-6 alkenyl, C.sub.2-6 alkynyl, aryl, heteroaryl, cycloalkyl, heterocycloalkyl, arylalkyl, heteroarylalkyl, cycloalkylalkyl and heterocycloalkylalkyl, wherein said C.sub.1-10 alkyl, C.sub.1-6 haloalkyl, C.sub.2-6 alkenyl, C.sub.2-6 alkynyl, aryl, heteroaryl, cycloalkyl, heterocycloalkyl, arylalkyl, heteroarylalkyl, cycloalkylalkyl or heterocycloalkylalkyl is optionally substituted with 1, 2, or 3 substituents independently selected from OH, CN, amino, halo, C.sub.1-6 alkyl, C.sub.1-6 haloalkyl, C.sub.1-6 haloalkyl, halosulfanyl, aryl, arylalkyl, heteroaryl, heteroarylalkyl, cycloalkyl and heterocycloalkyl; or R.sup.c' and R.sup.d' together with the N atom to which they are attached form a 4-, 5-, 6- or 7-membered heterocycloalkyl group optionally substituted with 1, 2, or 3 substituents independently selected from OH, CN, amino, halo, C.sub.1-6 alkyl, C.sub.1-6 haloalkyl, C.sub.1-6 haloalkyl, halosulfanyl, aryl, arylalkyl, heteroaryl, heteroarylalkyl, cycloalkyl and heterocycloalkyl; R.sup.c'' and R.sup.d'' are independently selected from H, C.sub.1-10 alkyl, C.sub.1-6 haloalkyl, C.sub.2-6 alkenyl, C.sub.2-6 alkynyl, aryl, heteroaryl, cycloalkyl, heterocycloalkyl, arylalkyl, heteroarylalkyl, cycloalkylalkyl and heterocycloalkylalkyl, wherein said C.sub.1-10 alkyl, C.sub.1-6 haloalkyl, C.sub.2-6 alkenyl, C.sub.2-6 alkynyl, aryl, heteroaryl, cycloalkyl, heterocycloalkyl, arylalkyl, heteroarylalkyl, cycloalkylalkyl or heterocycloalkylalkyl is optionally substituted with 1, 2, or 3 substituents independently selected from OH, CN, amino, halo, C.sub.1-6 alkyl, C.sub.1-6 haloalkyl, halosulfanyl, C.sub.1-6 haloalkyl, aryl, arylalkyl, heteroaryl, heteroarylalkyl, cycloalkyl and heterocycloalkyl; or R.sup.c'' and R.sup.d'' together with the N atom to which they are attached form a 4-, 5-, 6- or 7-membered heterocycloalkyl group optionally substituted with 1, 2, or 3 substituents independently selected from OH, CN, amino, halo, C.sub.1-6 alkyl, C.sub.1-6 haloalkyl, C.sub.1-6 haloalkyl, halosulfanyl, aryl, arylalkyl, heteroaryl, heteroarylalkyl, cycloalkyl and heterocycloalkyl; R.sup.i is H, CN, NO.sub.2, or C.sub.1-6 alkyl; R.sup.e and R.sup.f are independently selected from H and C.sub.1-6 alkyl; R.sup.i is H, CN, or NO.sub.2; m is 0 or 1; n is 0 or 1; p is 0, 1, 2, 3, 4, 5, or 6; q is 0, 1, 2, 3, 4, 5 or 6; r is 0 or 1; and s is 0 or 1. 2. The method of claim 1, further comprising the co-administration of a) at least one each of an adenine, cytosine, thymidine, and guanine nucleoside antiviral agent, or b) at least one additional antiviral agent selected from the group consisting of non-nucleoside reverse transcriptase inhibitors (NNRTI), protease inhibitors, fusion inhibitors, entry inhibitors, attachment inhibitors, and integrase inhibitors. 3. The method of claim 1, wherein the compound of Formula A is ##STR00039## or a pharmaceutically acceptable salt or prodrug thereof, or the compound of Formula B is ##STR00040## or LY3009104/INCB28050, or a pharmaceutically acceptable salt or prodrug thereof. 4. The method of claim 1, further comprising the co-administration of a macrophage depleting agent. 5. A method of treating or eradicating an HIV infection, comprising: a) reducing viral loads in a patient by administering a combination of HAART and a JAK inhibitor of Formula A: ##STR00041## wherein: or the pharmaceutically acceptable salt thereof; wherein R.sup.1 is a group of the formula ##STR00042## wherein y is 0, 1 or 2; R.sup.4 is selected from the group consisting of hydrogen, (C.sub.1-C.sub.6)alkyl, (C.sub.1-C.sub.6)alkylsulfonyl, (C.sub.2-C.sub.6)alkenyl, (C.sub.2-C.sub.6)alkynyl wherein the alkyl, alkenyl and alkynyl groups are optionally substituted by deuterium, hydroxy, amino, trifluoromethyl,(C.sub.1-C.sub.4)alkoxy, (C.sub.1-C.sub.6)acyloxy, (C.sub.1-C.sub.6)alkylamino, ((C.sub.1-C.sub.6).sub.2amino, cyano, nitro, (C.sub.2-C.sub.6)alkenyl, (C.sub.2-C.sub.6)alkynyl or (C.sub.1-C.sub.6)acylamino; or R.sup.4 is (C.sub.3-C.sub.10)cycloalkyl wherein the cycloalkyl group optionally substituted by deuterium, hydroxy, amino, trifluoromethyl, (C.sub.1-C.sub.6)acyloxy, (C.sub.1-C.sub.6)acylamino, (C.sub.1-C.sub.6)alkylamino, ((C.sub.1-C.sub.6)alkyl).sub.2amino, cyano, cyano(C.sub.1-C.sub.6)alkyl, trifluoromethyl(C.sub.1-C.sub.6)alkyl, nitro, nitro(C.sub.1-C.sub.6)alkyl or (C.sub.1-C.sub.6)acylamino; R.sup.5 is (C.sub.2-C.sub.9)heterocycloalkyl wherein the heterocycloalkyl groups must be substituted by one to five carboxy, cyano, amino, deuterium, hydroxy, (C.sub.1-C.sub.6)alkyl, (C.sub.1-C.sub.6)alkoxy, halo, (C.sub.1-C.sub.6)acyl, (C.sub.1-C.sub.6)alkylamino, amino(C.sub.1-C.sub.6)alkyl, (C.sub.1-C.sub.6)alkoxy-CO--NH, (C.sub.1-C.sub.6)alkylamino-CO--, (C.sub.2-C.sub.6)alkenyl, (C.sub.2-C.sub.6) alkynyl, (C.sub.1-C.sub.6)alkylamino, amino(C.sub.1-C.sub.6)alkyl, hydroxy(C.sub.1-C.sub.6)alkyl, (C.sub.1-C.sub.6)alkoxy(C.sub.1-C.sub.6)alkyl, (C.sub.1-C.sub.6)acyloxy(C.sub.1-C.sub.6)alkyl, nitro, cyano(C.sub.1-C.sub.6)alkyl, halo(C.sub.1-C.sub.6)alkyl, nitro(C.sub.1-C.sub.6)alkyl, trifluoromethyl, trifluoromethyl(C.sub.1-C.sub.6)alkyl, (C.sub.1-C.sub.6)acylamino, (C.sub.1-C.sub.6)acylamino(C.sub.1-C.sub.6)alkyl, (C.sub.1-C.sub.6)alkoxy(C.sub.1-C.sub.6)acylamino, amino(C.sub.1-C.sub.6)acyl, amino(C.sub.1-C.sub.6)alkyl, (C.sub.1-C.sub.6)alkylamino(C.sub.1-C.sub.6)acyl, ((C.sub.1-C.sub.6)alkyl).sub.2amino(C.sub.1-C.sub.6)acyl, R.sup.15R.sup.16N--CO--O--, R.sup.15R.sup.16N--CO--(C.sub.1-C.sub.6)alkyl, (C.sub.1-C.sub.6)alkyl-S(O).sub.m, R.sup.15R.sup.16NS(O).sub.m, R.sup.15R.sup.16NS(O).sub.m(C.sub.1-C.sub.6)alkyl, R.sup.15S(O).sub.mR.sup.16N, R.sup.15S(O).sub.mR.sup.16(C.sub.1-C.sub.6)alkyl wherein m is 0, 1 or 2 and R.sup.15 and R.sup.16 are each independently selected from hydrogen or (C.sub.1-C.sub.6)alkyl; or a group of the formula ##STR00043## wherein a is 0, 1, 2, 3 or 4; b, c, e, f and g are each independently 0 or 1; d is 0, 1, 2, or 3; X is S(O).sub.n wherein n is 0, 1 or 2; oxygen, carbonyl or --C(.dbd.N-cyano)-; Y is S(O).sub.n wherein n is 0, 1 or 2; or carbonyl; and Z is carbonyl, C(O)O--, C(O)NR-- or S(O).sub.n wherein n is 0, 1 or 2; R.sup.6, R.sup.7, R.sup.8, R.sup.9, R.sup.10 and R.sup.11 are each independently selected from the group consisting of hydrogen or (C.sub.1-C.sub.6)alkyl optionally substituted by deuterium, hydroxy, amino, trifluoromethyl, (C.sub.1-C.sub.6)acyloxy, (C.sub.1-C.sub.6)acylamino, (C.sub.1-C.sub.6)alkylamino, ((C.sub.1-C.sub.6)alkyl).sub.2amino, cyano, cyano(C.sub.1-C.sub.6)alkyl, trifluoromethyl(C.sub.1-C.sub.6)alkyl, nitro, nitro(C.sub.1-C.sub.6)alkyl or (C.sub.1-C.sub.6)acylamino; R.sup.12 is carboxy, cyano, amino, oxo, deuterium, hydroxy, trifluoromethyl, (C.sub.1-C.sub.6)alkyl, trifluoromethyl(C.sub.1-C.sub.6)alkyl, (C.sub.1-C.sub.6)alkoxy, halo, (C.sub.1-C.sub.6)acyl, (C.sub.1-C.sub.6)alkylamino, ((C.sub.1-C.sub.6)alkyl).sub.2amino, amino(C.sub.1-C.sub.6)alkyl, (C.sub.1-C.sub.6)alkoxy-CO--NH, (C.sub.1-C.sub.6)alkylamino-CO--, (C.sub.2-C.sub.6)alkenyl, (C.sub.2-C.sub.6) alkynyl, (C.sub.1-C.sub.6)alkylamino, hydroxy(C.sub.1-C.sub.6)alkyl, (C.sub.1-C.sub.6)alkoxy(C.sub.1-C.sub.6)alkyl, (C.sub.1-C.sub.6)acyloxy(C.sub.1-C.sub.6)alkyl, nitro, cyano(C.sub.1-C.sub.6)alkyl, halo(C.sub.1-C.sub.6)alkyl, nitro(C.sub.1-C.sub.6)alkyl, trifluoromethyl, trifluoromethyl(C.sub.1-C.sub.6)alkyl, (C.sub.1-C.sub.6)acylamino, (C.sub.1-C.sub.6)acylamino(C.sub.1-C.sub.6)alkyl, (C.sub.1-C.sub.6)alkoxy(C.sub.1-C.sub.6)acylamino, amino(C.sub.1-C.sub.6)acyl, amino(C.sub.1-C.sub.6)acyl(C.sub.1-C.sub.6)alkyl, (C.sub.1-C.sub.6)alkylamino(C.sub.1-C.sub.6)acyl, ((C.sub.1-C.sub.6)alkyl).sub.2amino(C.sub.1-C.sub.6)acyl, R.sup.15R.sup.16N--CO--O--, R.sup.15R.sup.16N--CO--(C.sub.1-C.sub.6)alkyl, R.sup.15C(O)NH, R.sup.15OC(O)NH, R.sup.15NHC(O)NH, (C.sub.1-C.sub.6)alkyl-S(O).sub.m, (C.sub.1-C.sub.6)alkyl-S(O).sub.m--(C.sub.1-C.sub.6)alkyl, R.sup.15R.sup.16NS(O).sub.m, R.sup.15R.sup.16NS(O).sub.m(C.sub.1C.sub.6)alkyl, R.sup.15S(O).sub.mR.sup.16N R.sup.15S(O).sub.mR.sup.16N(C.sub.1-C.sub.6)alkyl wherein m is 0, 1 or 2 and R.sup.15 and R.sup.16 are each independently selected from hydrogen or (C.sub.1-C.sub.6)alkyl; R.sup.2 and R.sup.3 are each independently selected from the group consisting of hydrogen, deuterium, amino, halo, hydroxy, nitro, carboxy, (C.sub.2-C.sub.6)alkenyl, (C.sub.2-C.sub.6)alkynyl, trifluoromethyl, trifluoromethoxy, (C.sub.1-C.sub.6)alkyl, (C.sub.1-C.sub.6)alkoxy, (C.sub.3-C.sub.10)cycloalkyl wherein the alkyl, alkoxy or cycloalkyl groups are optionally substituted by one to three groups selected from halo, hydroxy, carboxy, amino (C.sub.1-C.sub.6)alkylthio, (C.sub.1-C.sub.6)alkylamino, ((C.sub.1-C.sub.6)alkyl).sub.2amino, (C.sub.5-C.sub.9)heteroaryl, (C.sub.2-C.sub.9)heterocycloalkyl, (C.sub.3-C.sub.9)cycloalkyl or (C.sub.6-C.sub.10)aryl; or R.sup.2 and R.sup.3 are each independently (C.sub.3-C.sub.10)cycloalkyl, (C.sub.3-C.sub.10)cycloalkoxy, (C.sub.1-C.sub.6)alkylamino, ((C.sub.1-C.sub.6)alkyl).sub.2amino, (C.sub.6-C.sub.10)arylamino,(C.sub.1-C.sub.6)alkylthio, (C.sub.6-C.sub.10)arylthio, (C.sub.1-C.sub.6)alkylsulfinyl, (C.sub.6-C.sub.10)arylsulfinyl, (C.sub.1-C.sub.6)alkylsulfonyl, (C.sub.6-C.sub.10arylsulfonl, (C.sub.1-C.sub.6)acyl, (C.sub.1-C.sub.6)alkoxy-CO--NH--, (C.sub.1-C.sub.6)alkylamino-CO--, (C.sub.5-C.sub.9)heteroaryl, (C.sub.2-C.sub.9)heterocycloalkyl or (C.sub.6-C.sub.10)aryl wherein the heteroaryl, heterocycloalkyl and aryl groups are optionally substituted by one to three halo, (C.sub.1-C.sub.6)alkyl, (C.sub.1-C.sub.6)alkyl-CO--NH--, (C.sub.1-C.sub.6)alkoxy-CO--NH--, (C.sub.1-C.sub.6)alkyl-CO--NH--(C.sub.1-C.sub.6)alkyl, (C.sub.1-C.sub.6)alkoxy-CO--NH--(C.sub.1-C.sub.6)alkyl, (C.sub.1-C.sub.6)alkoxy-CO--NH--(C.sub.1-C.sub.6)alkoxy, carboxy, carboxy(C.sub.1-C.sub.6)alkyl, carboxy(C.sub.1-C.sub.6)alkoxy, benzyloxycarbonyl(C.sub.1-C.sub.6)alkoxy, (C.sub.1-C.sub.6)alkoxycarbonyl(C.sub.1-C.sub.6)alkoxy, (C.sub.6-C.sub.10)aryl, amino, amino(C.sub.1-C.sub.6)alkyl, (C.sub.1-C.sub.6)alkoxycarbonylamino, (C.sub.6-C.sub.10)aryl(C.sub.1-C.sub.6)alkoxycarbonylamino, (C.sub.1-C.sub.6)alkylamino, ((C.sub.1-C.sub.6)alkyl).sub.2amino, (C.sub.1-C.sub.6)alkylamino(C.sub.1-C.sub.6)alkyl, ((C.sub.1-C.sub.6)alkyl).sub.2amino(C.sub.1-C.sub.6)alkyl, hydroxy, (C.sub.1-C.sub.6)alkoxy, carboxy, carboxy(C.sub.1-C.sub.6)alkyl, (C.sub.1-C.sub.6)alkoxycarbonyl, (C.sub.1-C.sub.6)alkoxycarbonyl(C.sub.1-C.sub.6)alkyl, (C.sub.1-C.sub.6)alkoxy-CO--NH--, (C.sub.1-C.sub.6)alkyl-CO--NH--, cyano, (C.sub.5-C.sub.9)heterocycloalkyl, amino-CO--NH--,(C.sub.1-C.sub.6)alkylamino-CO--NH--, ((C.sub.1-C.sub.6alkyl).sub.2amino-CO--NH--, (C.sub.6-C.sub.10)arylamino-CO--NH--, (C.sub.5-C.sub.9)heteroarylamino-CO--NH--, (C.sub.1-C.sub.6)alkylamino-CO--NH--(C.sub.1-C.sub.6)alkyl, ((C.sub.1-C.sub.6)alkyl).sub.2amino-CO--NH--(C.sub.1-C.sub.6)alkyl, (C.sub.6-C.sub.10)arylamino-CO--NH--(C.sub.1-C.sub.6)alkyl, (C.sub.5-C.sub.9)heteroarylamino-CO--NH--(C.sub.1-C.sub.6)alkyl, (C.sub.1-C.sub.6)alkylsulfonyl, (C.sub.1-C.sub.6)alkylsulfonylamino, (C.sub.1-C.sub.6)alkylsulfonylamino(C.sub.1-C.sub.6)alkyl, (C.sub.6-C.sub.10)arylsulfonyl, (C.sub.6-C.sub.10)arylsulfonylamino, (C.sub.6-C.sub.10)arylsulfonylamino(C.sub.1-C.sub.6)alkyl, (C.sub.1-C.sub.6)alkylsulfonylamino, (C.sub.1-C.sub.6)alkylsulfonylamino(C.sub.1-C.sub.6)alkyl, (C.sub.5-C.sub.9)heteroaryl or (C.sub.2-C.sub.9)heterocycloalkyl, or of Formula B: ##STR00044## including pharmaceutically acceptable salt forms or prodrugs thereof, wherein: A.sup.1 and A.sup.2 are independently selected from C and N; T, U, and V are independently selected from O, S, N, CR.sup.5, and NR.sup.6; wherein the 5-membered ring formed by A.sup.1, A.sup.2, U, T, and V is aromatic; X is N or CR.sup.4; Y is C.sub.1-8 alkylene, C.sub.2-8 alkenylene, C.sub.2-8 alkynylene, (CR.sup.11R.sup.12).sub.p--(C.sub.3-10 cycloalkylene)-(CR.sup.11R.sup.12).sub.q, (CR.sup.11R.sup.12).sub.p-(arylene)-(CR.sup.11R.sup.12).sub.q, (CR.sup.11R.sup.12).sub.\p--(C.sub.1-10 heterocycloalkylene)-(CR.sup.11R.sup.12).sub.q, (CR.sup.11R.sup.12).sub.p-(heteroarylene)-(CR.sup.11R.sup.12).sub.q, (CR.sup.11R.sup.12).sub.pO(CR.sup.11R.sup.12).sub.q, (CR.sup.11R.sup.12).sub.pS(CR.sup.11R.sup.12).sub.q, (CR.sup.11R.sup.12).sub.pC(O)(CR.sup.11R.sup.12).sub.q, (CR.sup.11R.sup.12).sub.pC(O)NR.sub.c(CR.sup.11R.sup.12).sub.q, (CR.sup.11R.sup.12).sub.pC(O)O(CR.sup.11R.sup.12).sub.q, (CR.sup.11R.sup.12).sub.pOC(O)(CR.sup.11R.sup.12).sub.q, (CR.sup.11R.sup.12).sub.pOC(O)NR.sup.c(CR.sup.11R.sup.12).sub.q, (CR.sup.11R.sup.12).sub.pNR.sup.c(CR.sup.11R.sup.12).sub.q, (CR.sup.11R.sup.12).sub.pNR.sup.cC(O)NR.sup.d(CR.sup.11R.sup.12).sub.q, (CR.sup.11R.sup.12).sub.pS(O)(CR.sup.11R.sup.12).sub.q, (CR.sup.11R.sup.12).sub.pS(O)NR.sup.c(CR.sup.11R.sup.12).sub.q, (CR.sup.11R.sup.12).sub.pS(O).sub.2(CR.sup.11R.sup.12).sub.q, or (CR.sup.11R.sup.12).sub.pS(O).sub.2NR.sup.c(CR.sup.11R.sup.12).sub.q, wherein said C.sub.1-8 alkylene, C.sub.2-8 alkenylene, C.sub.2-8 alkynylene, cycloalkylene, arylene, heterocycloalkylene, or heteroarylene, is optionally substituted with 1, 2, or 3 substituents independently selected from -D.sup.1-D.sup.2-D.sup.3-D.sup.4; Z is H, halo, C.sub.1-4 alkyl, C.sub.2-4 alkenyl, C.sub.2-4 alkynyl, C.sub.1-4 haloalkyl, halosulfanyl, C.sub.1-4 hydroxyalkyl, C.sub.1-4 cyanoalkyl, .dbd.C--R.sup.i,.dbd.N--R.sup.i, Cy.sup.1, CN, NO.sub.2, OR.sup.a, SR.sup.a, C(O)R.sup.b, C(O)NR.sup.cR.sup.d, C(O)OR.sup.a, OC(O)R.sup.b, OC(O)NR.sup.cR.sup.d, NR.sup.cR.sup.d, NR.sup.cC(O)R.sup.b, NR.sup.cC(O)NR.sup.cR.sup.d, NR.sup.cC(O)OR.sup.a, C(.dbd.NR.sup.i)NR.sup.cR.sup.d, NR.sup.cC(.dbd.NR.sup.i)NR.sup.cR.sup.d, S(O)R.sup.b, S(O)NR.sup.cR.sup.d, S(O).sub.2R.sup.b, NR.sup.cS(O).sub.2R.sup.b, C(.dbd.NOH)R.sup.b, C(.dbd.NO(C.sub.1-6alkyl)R.sup.b, and S(O).sub.2NR.sup.cR.sup.d, wherein said C.sub.1-8 alkyl, C.sub.2-8 alkenyl, or C.sub.2-8 alkynyl, is optionally substituted with 1, 2, 3, 4, 5, or 6 substituents independently selected from halo, C.sub.1-4 alkyl, C.sub.2-4 alkenyl, C.sub.2-4 alkynyl, C.sub.1-4 haloalkyl, halosulfanyl, C.sub.1-4 hydroxyalkyl, C.sub.1-4 cyanoalkyl, Cy.sup.1, CN, N.sub.2, OR.sup.a, SR.sup.a, C(O)R.sup.b, C(O)NR.sup.cR.sup.d, C(O)OR.sup.a, OC(O)R.sup.b, OC(O)NR.sup.cR.sup.d, NR.sup.cR.sup.d, NR.sup.cC(O)R.sup.b, NR.sup.cC(O)NR.sup.cR.sup.d, NR.sup.cC(O)OR.sup.a, C(.dbd.NR.sup.i)NR.sup.cR.sup.d, NR.sup.cC(.dbd.NR.sup.i)NR.sup.cR.sup.d, S(O)R.sup.b, S(O)NR.sup.cR.sup.d, S(O).sub.2R.sup.b, NR.sup.cS(O).sub.2R.sup.b, C(.dbd.NOH)R.sup.b, C(.dbd.NO(C.sub.1-6 alkyl))R.sup.b, and S(O).sub.2NR.sup.cR.sup.d; wherein when Z is H, n is 1; or the --(Y).sub.n--Z moiety is taken together with i) A.sup.2 to which the moiety is attached, ii) R.sup.5 or R.sup.6 of either T or V, and iii) the C or N atom to which the R.sup.5 or R.sup.6 of either T or V is attached to form a 4- to 20-membered aryl, cycloalkyl, heteroaryl, or heterocycloalkyl ring fused to the 5-membered ring formed by A.sup.1 A.sup.2, U, T, and V, wherein said 4- to 20-membered aryl, cycloalkyl, heteroaryl, or heterocycloalkyl ring is optionally substituted by 1, 2, 3, 4 or 5 substituents independently selected from --(W).sub.m-Q; W is C.sub.1-8 alkylenyl, C.sub.2-8 alkenylenyl, C.sub.2-8 alkynylenyl, O, S, C(O), C(O)NR.sup.c', C(O)O, OC(O), OC(O)NR.sup.c', NR.sup.c', NR.sup.c'C(O)NR.sup.d', S(O), S(O)NR.sup.c', S(O).sub.2, or S(O)2NR.sup.c'; Q is H, halo, CN, NO.sub.2, C.sub.1-8alkyl, C.sub.2-8 alkenyl, C.sub.2-8 alkynyl, C.sub.1-8 haloalkyl, halosulfanyl, aryl, cycloalkyl, heteroaryl, or heterocycloalkyl, wherein said C.sub.1-8alkyl, C.sub.2-8 alkenyl, C.sub.2-8 alkynyl, C.sub.1-8 haloalkyl, aryl, cycloalkyl, heteroaryl, or heterocycloalkyl is optionally substituted with 1, 2, 3 or 4 substituents independently selected from halo, C.sub.1-4 alkyl, C.sub.2-4 alkenyl, C.sub.2-4 alkynyl, C.sub.1-4 haloalkyl, halosulfanyl, C.sub.1-4 hydroxyalkyl, C.sub.1-4 cyanoalkyl, Cy.sup.2, CN, NO.sub.2, OR.sup.a', SR.sup.a', C(O)R.sup.b', C(O)NR.sup.c'R.sup.d', C(O)OR.sup.a', OC(O)R.sup.b', OC(O)NR.sup.c'R.sup.d', NR.sup.c'R.sup.d', NR.sup.c'C(O)R.sup.b', NR.sup.c'C(O)N R.sup.c'R.sup.d', N R.sup.c'C(O)OR.sup.a', S(O)R.sup.b', S(O)N R.sup.c'R.sup.d', S(O).sub.2R.sup.b', NR.sup.c'S(O).sub.2R.sup.b', and S(O).sub.2N R.sup.c'R.sup.d'; Cy.sup.1 and Cy.sup.2 are independently selected from aryl, heteroaryl, cycloalkyl, and heterocycloalkyl, each optionally substituted by 1, 2, 3, 4 or 5 substituents independently selected from halo, C.sub.1-4 alkyl, C.sub.2-4 alkenyl, C.sub.2-4 alkynyl, C.sub.1-4 haloalkyl, halosulfanyl, C.sub.1-4 hydroxyalkyl, C.sub.1-4 cyanoalkyl, CN, NO.sub.2, OR.sup.a'', SR.sup.a'', C(O)R.sup.b'', C(O)NR.sup.c''R.sup.d'', C(O)OR.sup.a'', OC(O)R.sup.b'', OC(O)N R.sup.c''R.sup.d'', NR.sup.c''R.sup.d'', NR.sup.c''C(O)R.sup.b'', NR.sup.c''C(O)OR.sup.a'', NR.sup.c''S(O)R.sup.b'', NR.sup.c''S(O).sub.2R.sup.b'', S(O)R.sup.b'', S(O)NR.sup.c''R.sup.d'', S(O).sub.2R.sup.b'', and S(O).sub.2NR.sup.c''R.sup.d''; R.sup.1, R.sup.2, R.sup.3, and R.sup.4 are independently selected from H, halo, C.sub.1-4 alkyl, C.sub.2-4 alkenyl, C.sub.2-4 alkynyl, C.sub.1-4 haloalkyl, halosulfanyl, aryl, cycloalkyl, heteroaryl, heterocycloalkyl, CN, NO.sub.2, OR.sup.7, SR.sup.7, C(O)R.sup.8, C(O)NR.sup.9R.sup.10, C(O)OR.sup.7OC(O)R.sup.8, OC(O)NR.sup.9R.sup.10, NR.sup.9R.sup.10, NR.sup.9 C(O)R.sup.8, NR.sup.cC(O)OR.sup.7, S(O)R.sup.8, S(O)NR.sup.9R.sup.10, S(O).sub.2R.sup.8, NR.sup.9S(O).sub.2R.sup.8, and S(O).sub.2NR.sup.9R.sup.10; R.sup.5 is H, halo, C.sub.1-4 alkyl, C.sub.2-4alkenyl,C.sub.2-4 alkynyl, C.sub.1-4 haloalkyl, halosulfanyl, CN, NO.sub.2, OR.sup.7, SR.sup.7, C(O)R.sup.8, C(O)NR.sup.9R.sup.10, C(O)OR.sup.7, OC(O)R.sup.8, OC(O)NR.sup.9R.sup.10, NR.sup.9R.sup.10, NR.sup.9C(O)R.sup.8, NR.sup.9C(O)OR.sup.7, S(O)R.sup.8, S(O)NR.sup.9R.sup.10, S(O).sub.2R.sup.8, NR.sup.9S(O).sub.2R.sup.8, or S(O).sub.2NR.sup.9R.sup.10; R.sup.6 is H, C.sub.1-4 alkyl, C.sub.2-4 alkenyl, C.sub.2-4 alkynyl, C.sub.1-4 haloalkyl, OR.sup.7, C(O)R.sup.8, C(O)NR.sup.9R.sup.10, C(O)OR.sup.7, S(O)R.sup.8, S(O)NR.sup.9R.sup.10, S(O).sub.2R.sup.8, or S(O).sub.2NR.sup.9R.sup.10; R.sup.7 is H, C.sub.1-6 alkyl, C.sub.1-6 haloalkyl, C.sub.2-6 alkenyl, C.sub.2-6 alkynyl, aryl, cycloalkyl, heteroaryl, heterocycloalkyl, arylalkyl, heteroarylalkyl, cycloalkylalkyl or heterocycloalkylalkyl; R.sup.8 is H, C.sub.1-6 alkyl, C.sub.1-6 haloalkyl, C.sub.2-6 alkenyl, C.sub.2-6 alknyl, aryl, cycloalkyl, heteroaryl, heterocycloalkyl, arylalkyl, heteroarylalkyl, cycloalkylalkyl or heterocycloalkylalkyl: R.sup.9 and R.sup.10 are independently selected from H, C.sub.1-10 alkyl, C.sub.1-6 haloalkyl, C.sub.2-6 alkenyl, C.sub.2-6 alkynyl, C.sub.1-6 alkylcarbonyl, arylcarbonyl, C.sub.1-6 alkylsulfonyl, arylsulfonyl, aryl, heteroaryl, cycloalkyl, heterocycloalkyl, arylalkyl, heteroarylalkyl, cycloalkylalkyl and heterocycloalkylalkyl; or R.sup.9 and R.sup.10 together with the N atom to which they are attached form a 4-, 5-, 6- or 7-membered heterocycloalkyl group; R.sup.11 and R.sup.12 are independently selected from H and -E.sup.1-E.sup.2-E.sup.3E.sup.4; D.sup.1 and E.sup.1 are independently absent or independently selected from C.sub.1-6 alkylene, C.sub.2-6 alkenylene, C.sub.2-6 alkynylene, arylene, cycloalkylene, heteroarylene, and heterocycloalkylene, wherein each of the C.sub.1-6 alkylene, C.sub.2-6 alkenylene, C.sub.2-6 alkynylene, arylene, cycloalkylene, heteroarylene, and heterocycloalkylene is optionally substituted by 1, 2 or 3 substituents independently selected from halo, CN, NO.sub.2, N.sub.3, SCN, OH, C.sub.1-6 alkyl, C.sub.1-6 haloalkyl, C.sub.2-8 alkoxyalkyl, C.sub.1-6 alkoxy, C.sub.1-6 haloalkoxy, amino, C.sub.1-6 alkylamino, and C.sub.2-8 dialkylamino; D.sup.2 and E.sup.2 are independently absent or independently selected from C.sub.1-6 alkylene, C.sub.2-6 alkenylene, C.sub.2-6 alkynylene, (C.sub.1-6 alkylene).sub.r--O--(C.sub.1-6 alkylene).sub.s, (C.sub.1-6 alkylene).sub.r--S--(C.sub.1-6 alkylene).sub.s, (C.sub.1-6 alkylene).sub.r--NR.sup.c--(C.sub.1-6 alkylene).sub.s, (C.sub.1-6 alkylene).sub.r--CO--(C.sub.1-6 alkylene).sub.s, (C.sub.1-6 alkylene).sub.r--COO--(C.sub.1-6 alkylene).sub.s, (C.sub.1-6 alkylene).sub.r--CONR.sup.c--(C.sub.1-6 alkylene).sub.s, (C.sub.1-6 alkylene).sub.r--SO--(C.sub.1-6 alkylene).sub.s, (C.sub.1-6 alkylene).sub.r--SO.sub.2--(C.sub.1-6 alkylene).sub.s, (C.sub.1-6 alkylene).sub.r--SONR.sup.c--(C.sub.1-6 alkylene).sub.s, and (C.sub.1-6 alkylene).sub.r--NR.sup.cCONR.sup.f--(C.sub.1-6 alkylene).sub.s, wherein each of the C.sub.1-6 alkylene, C.sub.2-6 alkenylene, and C.sub.2-6 alkynylene is optionally substituted by 1, 2 or 3 substituents independently selected from halo, CN, NO.sub.2, N.sub.3, SCN, OH, C.sub.1-6 alkyl, C.sub.1-6 haloalkyl, C.sub.2-8 alkoxyalkyl, C.sub.1-6 alkoxy, C.sub.1-6 haloalkoxy, amino, C.sub.1-6 alkylamino, and C.sub.2-8 dialkylamino; D.sup.3and E.sup.3 are independently absent or independently selected from C.sub.1-6 alkylene, C.sub.2-6 alkenylene, C.sub.2-6 alkynylene, arylene, cycloalkylene, heteroarylene, and heterocycloalkylene, wherein each of the C.sub.1-6 alkylene, C.sub.2-6 alkenylene, C.sub.2-6 alkynylene, arylene, cycloalkylene, heteroarylene, and heterocycloalkylene is optionally substituted by 1, 2 or 3 substituents independently selected from halo, CN, NO.sub.2, N.sub.3, SCN, OH, C.sub.1-6 alkyl, C.sub.1-6 haloalkyl, C.sub.2-8 alkoxyalkyl, C.sub.1-6 alkoxy, C.sub.1-6 haloalkoxy, amino, C.sub.1-6 alkylamino, and C.sub.2-8 dialklamino; E.sup.4 and E.sup.4 are independently selected from H, halo, C.sub.1-4 alkyl, C.sub.2-4 alkenyl, C.sub.2-4 alkynyl, C.sub.1-4 haloalkyl, halosulfanyl, C.sub.1-4 hydroxyalkyl, C.sub.1-4 cyanoalkyl, Cy.sup.1, CN, NO.sub.2, OR.sup.a, SR.sup.a, C(O)R.sup.b, C(O)NR.sup.cR.sup.a, C(O)OR.sup.a, OC(O)R.sup.bOC(O)NR.sup.cR.sup.d NR.sup.cR.sup.d, NR.sup.cC(O)R.sup.b, NR.sup.cC(O)NR.sup.cR.sup.d, NR.sup.cC(O)OR.sup.a,C(.dbd.NR.sup.i)NR.sup.cR.sup.d, NR.sup.cC(.dbd.NR.sup.i)NR.sup.cR.sup.d, S(O)R.sup.b, S(O)NR.sup.cR.sup.d, S(O).sub.2R.sup.b, NR.sup.cS(O).sub.2R.sup.b, C(.dbd.NOH)R.sup.b, C(.dbd.NO(C.sub.1-6 alkyl)R.sup.b, and S(O).sub.2NR.sup.cR.sup.d, wherein said C.sub.1-8 alkyl, C.sub.2-8 alkenyl, or C.sub.2-8 alkynyl, is optionally substituted with 1, 2, 3, 4, 5, or 6 substituents independently selected from halo, C.sub.1-4 alkyl, C.sub.2-4 alkenyl, C.sub.2-4 alkynyl, C.sub.1-4 haloalkyl, halosulfanyl, C.sub.1-4 hydroxyalkyl, C.sub.1-4 cyanoalkyl, Cy.sup.1, CN, NO.sub.2, OR.sup.a, SR.sup.a, C(O)R.sup.b, C(O)NR.sup.cR.sup.d, C(O)OR.sup.a, OC(O)R.sup.b, OC(O)NR.sup.cR.sup.d, NR.sup.cR.sup.d, NR.sup.cC(O)R.sup.b, NR.sup.cC(O)NR.sup.cR.sup.d, NR.sup.cC(O)OR.sup.a, C(.dbd.NR.sup.i)NR.sup.cR.sup.d, NR.sup.cC(.dbd.NR.sup.i)NR.sup.cR.sup.d, S(O)R.sup.b, S(O)NR.sup.cR.sup.d, S(O).sub.2R.sup.b, NR.sup.cS(O).sub.2R.sup.b, C(.dbd.NOH)R.sup.b, C(.dbd.NO(C.sub.1-6 alkyl))R.sup.b, and S(O).sub.2NR.sup.cR.sup.d; R.sup.a is H, Cy.sup.1, --(C.sub.1-6 alkyl)-Cy.sup.1, C.sub.1-6 alkyl, C.sub.1-6 haloalkyl, C.sub.2-6 alkenyl, C.sub.2-6 alkynyl, wherein said C.sub.1-6 alkyl, C.sub.1-6 haloalkyl, C.sub.2-6 alkenyl, or C.sub.2-6 alkynyl is optionally substituted with 1, 2, or 3 substituents independently selected from OH, CN, amino, halo, C.sub.1-6 alkyl, C.sub.1-6 haloalkyl, halosulfanyl, aryl, arylalkyl, heteroaryl, heteroarylalkyl, cycloalkyl and heterocycloalkyl; R.sup.b is H, Cy.sup.1, --(C.sub.1-6 alkyl)-Cy.sup.1, C.sub.1-6 alkyl, C.sub.1-6 haloalkyl, C.sub.2-6 alkenyl, C.sub.2-6 alkynyl, wherein said C.sub.1-6 alkyl, C.sub.1-61-6 haloalkyl, C.sub.2-6 alkenyl, or C.sub.2-6 alkynyl is optionally substituted with 1, 2, or 3 substituents independently selected from OH, CN, amino, halo, C.sub.1-6 alkyl, C.sub.1-6 haloalkyl, C.sub.1-6 haloalkyl, halosulfanyl, aryl, arylalkyl, heteroaryl, heteroarylalkyl, cycloalkyl and heterocycloalkyl; R.sup.a' and R.sup.a'' are independently selected from H, C.sub.1-6 alkyl, C.sub.1-6haloalkyl, (C.sub.2-6 alkenyl, C.sub.2-6 alkynyl, aryl, cycloalkyl, heteroaryl, heterocycloalkyl, arylalkyl, heteroarylalkyl, cycloalkylalkyl and heterocycloalkylalkyl, wherein said C.sub.1-6 alkyl, C.sub.1-6 haloalkyl, C.sub.2-6 alkenyl, C.sub.2-6 alkynyl, aryl, cycloalkyl, heteroaryl, heterocycloalkyl, arylalkyl, heteroarylalkyl, cycloalkylalkyl or heterocycloalkylalkyl is optionally substituted with 1, 2, or 3 substituents independently selected from OH, CN, amino, halo, C.sub.1-6 alkyl, C.sub.1-6 haloalkyl, halosulfanyl, aryl, arylalkyl, heteroaryl, heteroarylalkyl, cycloalkyl and heterocycloalkyl; R.sup.b' and R.sup.b'' are independently selected from H, C.sub.1-6 alkyl, C.sub.1-6 haloalkyl, C.sub.2-6 alkenyl, C.sub.2-6 alkynyl, aryl, cycloalkyl, heteroaryl, heterocycloalkyl, arylalkyl, heteroarylalkyl, cycloalkylalkyl and heterocycloalkylalkyl, wherein said C.sub.1-6 alkyl, C.sub.1-6 haloalkyl, C.sub.2-6 alkenyl, C.sub.2-6 alkynyl, aryl, cycloalkyl, heteroaryl, heterocycloalkyl, arylalkyl, heteroarylalkyl, cycloalkylalkyl or heterocycloalkylalkyl is optionally substituted with 1, 2, or 3 substituents independently selected from OH, CN, amino, halo, C.sub.1-6 alkyl, C.sub.1-6 haloalkyl, C.sub.1-6 haloalkyl, halosulfanyl, aryl, arylalkyl, heteroaryl, heteroarylalkyl, cycloalkyl and heterocycloalkyl; R.sup.c and R.sup.d are independently selected from H, Cy.sup.1, --(C.sub.1-6 alkyl)-Cy.sup.1, C.sub.1-10 alkyl, C.sub.1-6 haloalkyl, C.sub.2-6 alkenyl, C.sub.2-6 alkynyl, wherein said C.sub.1-10 alkyl, C.sub.1-6 haloalkyl, C.sub.2-6 alkenyl, or C.sub.2-6alkynyl, is optionally substituted with 1, 2, or 3 substituents independently selected from Cy.sup.1, --(C.sub.1-6 alkyl)-Cy.sup.1, OH, CN, amino, halo, C.sub.1-6 alkyl, C.sub.1-6 haloalkyl, C.sub.1-6 haloalkyl, and halosulfanyl; or R.sup.c and R.sup.d together with the N atom to which they are attached form a 4-, 5-, 6- or 7-membered heterocycloalkyl group optionally substituted with 1, 2, or 3 substituents independently selected from Cy.sup.1, --(C.sub.1-6 alkyl)-Cy.sup.1, OH, CN, amino, halo, C.sub.1-6 alkyl, C.sub.1-6 haloalkyl, C.sub.1-6 haloalkyl, and halosulfanyl; R.sup.C' and R.sup.d' are independently selected from H, C.sub.1-10 alkyl, C.sub.1-6 haloalkyl, C.sub.2-6 alkenyl, C.sub.2-6 alkynyl, aryl, heteroaryl, cycloalkyl, heterocycloalkyl, arylalkyl, heteroarylalkyl, cycloalkylalkyl and heterocycloalkylalkyl, wherein said C.sub.1-10 alkyl, C.sub.1-6 haloalkyl, C.sub.2-6 alkenyl, C.sub.2-6 alkynyl, aryl, heteroaryl, cycloalkyl, heterocycloalkyl, arylalkyl, heteroarylalkyl, cycloalkylalkyl or heterocycloalkylalkyl is optionally substituted with 1, 2, or 3 substituents independently selected from OH, CN, amino, halo, C.sub.1-6 alkyl, C.sub.1-6 haloalkyl, C.sub.1-6 haloalkyl, halosulfanyl, aryl, arylalkyl, heteroaryl, heteroarylalkyl, cycloalkyl and heterocycloalkyl; or R.sup.c' and R.sup.d' together with the N atom to which they are attached form a 4-, 5-, 6- or 7-membered heterocycloalkyl group optionally substituted with 1, 2, or 3 substituents independently selected from OH, CN, amino, halo, C.sub.1-6 alkyl, C.sub.1-6 haloalkyl, C.sub.1-6 haloalkyl, halosulfanyl, aryl, arylalkyl, heteroaryl, heteroarylalkyl, cycloalkyl and heterocycloalkyl; R.sup.c'' and R.sup.d'' are independently selected from H, C.sub.1-10 alkyl, C.sub.1-6 haloalkyl, C-.sub.2-6 alkenyl, C.sub.2-6 alkynyl, aryl, heteroaryl, cycloalkyl, heterocycloalkyl, arylalkyl, heteroarylalkyl, cycloalkylalkyl and heterocycloalkylalkyl, wherein said C.sub.1-10 alkyl, C.sub.1-6 haloalkyl, C.sub.2-6 alkenyl, C.sub.2-6 alkynyl, aryl, heteroaryl, cycloalkyl, heterocycloalkyl, arylalkyl, heteroarylalkyl, cycloalkylalkyl or heterocycloalkylalkyl is optionally substituted with 1, 2, or 3 substituents independently selected from OH, CN, amino, halo, C.sub.1-6 alkyl, C.sub.1-6 haloalkyl, halosulfanyl, C.sub.1-6 haloalkyl, aryl, arylalkyl, heteroaryl, heteroarylalkyl, cycloalkyl and heterocycloalkyl; or R.sup.c'' and R.sup.d'' together with the N atom to which they are attached form a 4-, 5-, 6- or 7-membered heterocycloalkyl group optionally substituted with 1, 2, or 3 substituents independently selected from OH, CN, amino, halo, C.sub.1-6 alkyl, C.sub.1-6 haloalkyl, C.sub.1-6 haloalkyl, halosulfanyl, aryl, arylalkyl, heteroaryl, heteroarylalkyl, cycloalkyl and heterocycloalkyl; R.sup.i is H, CN, NO.sub.2, or C.sub.1-6 alkyl; R.sup.e and R.sup.f are independently selected from H and C.sub.1-6 alkyl; R.sup.i is H, CN, or NO.sub.2 m is 0 or 1; n is 0 or 1; p is 0, 1, 2, 3, 4, 5, or 6; q is 0, 1, 2, 3, 4, 5 or 6; r is 0 or 1; and s is 0 or 1, b) systemically depleting macrophages with a macrophage depleting agent while maintaining HAART and JAK inhibitor therapy until a sufficient amount of macrophages are depleted, as determined, for example, by flow cytometry that a low level or no macrophages are present in the circulating periphery upon blood draw, c) withdrawing treatment with the macrophage depleting agent, while maintaining treatment with HAART and the JAK inhibitor, where withdrawal of HAART and/or JAK inhibitor is executed upon sustained low level or absent viremia, and d) either withdrawing HAART while JAK inhibitor therapy is maintained, or withdrawing both HAART and JAK inhibitor therapy, optionally while monitoring viral rebound. 6. The method of claim 5, wherein the macrophage depleting agent is Boniva or Fosamax. 7. The method of claim 5, wherein the JAK inhibitor is ##STR00045## LY3009104/INCB28050, or ##STR00046## or a pharmaceutically acceptable salt or prodrug thereof. 8. A method of treating or eradicating an HIV infection, comprising: a) reducing viral loads in a patient by administering a combination of HAART and a JAK inhibitor of Formula A: ##STR00047## wherein: or the pharmaceutically acceptable salt thereof; wherein R.sup.1 is a group of the formula ##STR00048## wherein y is 0, 1 or 2; R.sup.4 is selected from the group consisting of hydrogen, (C.sub.1-C.sub.6)alkyl, (C.sub.1-C.sub.6)alkylsulfonyl, (C.sub.2-C.sub.6)alkenyl, (C.sub.2-C.sub.6)alkynyl wherein the alkyl, alkenyl and alkynyl groups are optionally substituted by deuterium, hydroxy, amino, trifluoromethyl, (C.sub.1-C.sub.4)alkoxy, (C.sub.1-C.sub.6)acyloxy, C.sub.1-C.sub.6)alkylamino , ((C.sub.1-C.sub.6)alkyl).sub.2amino, cyano, nitro, (C.sub.2-C.sub.6)alkenyl, (C.sub.2-C.sub.6)alkynyl or (C.sub.1-C.sub.6)acylamino; or R.sup.4 is (C.sub.3-C.sub.10)cycloalkyl wherein the cycloalkyl group is optionally substituted by deuterium, hydroxy, amino, trifluoromethyl, (C.sub.1-C.sub.6)acyloxy, (C.sub.1-C.sub.6)acylamino, (C.sub.1-C.sub.6)alkylamino, ((C.sub.1-C.sub.6)alkyl).sub.2amino, cyano, cyano(C.sub.1-C.sub.6)alkyl, trifluoromethyl(C.sub.1-C.sub.6)alkyl, nitro, nitro(C.sub.1-C.sub.6)alkyl or (C.sub.1-C.sub.6)acylamino; R.sup.5 is (C.sub.2-C.sub.9)heterocycloalkyl wherein the heterocycloalkyl groups must be substituted by one to five carboxy, cyano, amino, deuterium, hydroxy, (C.sub.1-C.sub.6)alkyl, (C.sub.1-C.sub.6)alkoxy, halo, (C.sub.1-C.sub.6)acyl, (C.sub.1-C.sub.6)alkylamino, amino(C.sub.1-C.sub.6)alkyl, (C.sub.1-C.sub.6)alkoxy-CO--NH, (C.sub.1-C.sub.6)alkylamino-CO--, (C.sub.2-C.sub.6)alkenyl, (C.sub.2-C.sub.6) alkynyl, (C.sub.1-C.sub.6)alkylamino, amino(C.sub.1-C.sub.6)alkyl, hydroxy(C.sub.1-C.sub.6)alkyl, (C.sub.1-C.sub.6)alkoxy(C.sub.1-C.sub.6)alkyl, (C.sub.1-C.sub.6)acyloxy C.sub.1-C.sub.6)alkyl, nitro, cyano(C.sub.1-C.sub.6)alkyl, halo(C.sub.1-C.sub.6)alkyl, nitro(C.sub.1-C.sub.6)alkyl, trifluoromethyl, trifluoromethyl(C.sub.1-C.sub.6)alkyl, (C.sub.1-C.sub.6)acylamino, (C.sub.1-C.sub.6)acylamino(C.sub.1-C.sub.6)alkyl, (C.sub.1-C.sub.6)alkoxy(C.sub.1-C.sub.6)acylamino, amino(C.sub.1-C.sub.6)acyl, amino(C.sub.1-C.sub.6)acyl(C.sub.1-C.sub.6)alkyl, (C.sub.1-C.sub.6)alkylamino(C.sub.1-C.sub.6)acyl, ((C.sub.1-C.sub.6)alkyl).sub.2amino(C.sub.1-C.sub.6)acyl, R.sup.15R.sup.16N--CO--O--, R.sup.15R.sup.16N--CO--(C.sub.1-C.sub.6)alkyl, (C.sub.1-C.sub.6)alkyl-S(O).sub.m, R.sup.15R.sup.16NS(O).sub.m, R.sup.15R.sup.16NS(O).sub.m(C.sub.1-C.sub.6)alkyl, R.sup.15S(O).sub.mR.sup.16N, R.sup.15S(O).sub.mR.sup.16(C.sub.1-C.sub.6)alkyl wherein m is 0, 1 or 2 and R.sup.15 and R.sup.16 are each independently selected from hydrogen or (C.sub.1-C.sub.6)alkyl; or a group of the formula ##STR00049## wherein a is 0, 1, 2, 3 or 4; b, c, e, f and g are each independently 0 or 1; d is 0, 1, 2, or 3; X is S(O).sub.n wherein n is 0, 1 or 2; oxygen, carbonyl or --C(.dbd.N-cyano)-; Y is S(O).sub.n wherein n is 0, 1 or 2; or carbonyl; and Z is carbonyl, C(O)O--, C(O)NR-- or S(O).sub.n wherein n is 0, 1 or 2; R.sup.6, R.sup.7, R.sup.8, R.sup.9, R.sup.10 and R.sup.11 are each independently selected from the group consisting of hydrogen or (C.sub.1-C.sub.6)alkyl optionally substituted by deuterium, hydroxy, amino, trifluoromethyl, C.sub.1-C.sub.6)acyloxy, (C.sub.1-C.sub.6)acylamino, (C.sub.1-C.sub.6)alkylamino, ((C.sub.1-C.sub.6)alkyl).sub.2amino, cyano, cyano(C.sub.1-C.sub.6)alkyl, trifluoromethyl(C.sub.1-C.sub.6)alkyl, nitro, nitro(C.sub.1-C.sub.6)alkyl or (C.sub.1-C.sub.6)acylamino; R.sup.12 is carboxy, cyano, amino, oxo, deuterium, hydroxy, trifluoromethyl, (C.sub.1-C.sub.6)alkyl, trifluoromethyl (C.sub.1-C.sub.6)alkyl, (C.sub.1-C.sub.6)alkoxy, halo, (C.sub.1-C.sub.6)acyl, (C.sub.1-C.sub.6)alkylamino, ((C.sub.1-C.sub.6)alkyl).sub.2amino, amino(C.sub.1-C.sub.6)alkyl, (C.sub.1-C.sub.6)alkoxy-CO--NH, (C.sub.1-C.sub.6)alkylamino-CO--, (C.sub.2-C.sub.6)alkenyl, (C.sub.2-C.sub.6)alkynyl, (C.sub.1-C.sub.6)alkylamino, hydroxy(C.sub.1-C.sub.6)alkyl, (C.sub.1-C.sub.6)alkoxy(C.sub.1-C.sub.6)alkyl, (C.sub.1-C.sub.6)acyloxy(C.sub.1-C.sub.6)alkyl, nitro, cyano(C.sub.1-C.sub.6)alkyl, halo(C.sub.1-C.sub.6)alkyl, nitro(C.sub.1-C.sub.6)alkyl, trifluoromethyl, trifluoromethyl(C.sub.1-C.sub.6)alkyl, (C.sub.1-C.sub.6)acylamino, (C.sub.1-C.sub.6)acylamino(C.sub.1-C.sub.6)alkyl, (C.sub.1-C.sub.6)alkoxy(C.sub.1-C.sub.6)acylamino, amino(C.sub.1-C.sub.6)acyl, amino(C.sub.1-C.sub.6)acyl(C.sub.1-C.sub.6)alkyl, (C.sub.1-C.sub.6)alkylamino(C.sub.1-C.sub.6)acyl, ((C.sub.1-C.sub.6)alkyl).sub.2amino(C.sub.1-C.sub.6)acyl, R.sup.15R.sup.16N--CO--O--, R.sup.15R.sup.16N--CO--(C.sub.1-C.sub.6)alkyl, R.sup.15C(O)NH, R.sup.15OC(O)NH, R.sup.15NHC(O)NH, (C.sub.1-C.sub.6)alkyl-S(O).sub.m, (C.sub.1-C.sub.6)alkyl-S(O).sub.m--(C.sub.1-C.sub.6)alkyl, R.sup.15R.sup.16NS(O).sub.m, R.sup.15R.sup.16NS(O).sub.m(C.sub.1-C.sub.6)alkyl, R.sup.15S(O).sub.mR.sup.16N, R.sup.15S(O).sub.mR.sup.16N (C.sub.1-C.sub.6)alkyl wherein m is 0, 1 or 2 and R.sup.15 and R.sup.16 are each independently selected from hydrogen or (C.sub.1-C.sub.6)alkyl; R.sup.2 and R.sup.3 are each independently selected from the group consisting of hydrogen, deuterium, amino, halo, hydroxy, nitro, carboxy, (C.sub.2-C.sub.6)alkenyl, (C.sub.2-C.sub.6)alkynyl, trifluoromethyl, trifluoromethoxy, (C.sub.1-C.sub.6)alkyl, (C.sub.1-C.sub.6)alkoxy, (C.sub.3-C.sub.10)cycloalkyl wherein the alkyl, alkoxy or cycloalkyl groups are optionally substituted by one to three groups selected from halo, hydroxy, carboxy, amino (C.sub.1-C.sub.6)alkylthio, (C.sub.1-C.sub.6)alkylamino, ((C.sub.1-C.sub.6)alkyl).sub.2amino, (C.sub.5-C.sub.9)heteroaryl, (C.sub.2-C.sub.9)heterocycloalkyl, (C.sub.3-C.sub.9)cycloalkyl or (C.sub.6-C.sub.10)aryl; or R.sup.2 and R.sup.3 are each independently (C.sub.3-C.sub.10)cycloalkyl, (C.sub.3-C.sub.10)cycloalkoxy, (C.sub.1-C.sub.6)alkylamino, ((C.sub.1-C.sub.6)alkyl).sub.2amino, (C.sub.6-C.sub.10)arylamino, (C.sub.1-C.sub.6)alkylthio, (C.sub.6-C.sub.10)arylthio, (C.sub.1-C.sub.6)alkylsulfinyl, (C.sub.6-C.sub.10)arylsulfinyl, (C.sub.1-C.sub.6)alklysulfonyl, (C.sub.6-C.sub.10)arylsulfonyl, (C.sub.1-C.sub.6)acyl, (C.sub.1-C.sub.6)alkoxy-CO--NH--, (C.sub.1-C.sub.6)alkylamino-CO--, (C.sub.5-C.sub.9)heteroaryl, (C.sub.2-C.sub.9)heterocycloalkyl or (C.sub.6-C.sub.10)aryl wherein the heteroaryl, heterocycloalkyl and aryl groups are optionally substituted by one to three halo, (C.sub.1-C.sub.6)alkyl, (C.sub.1-C.sub.6)alkyl-CO--NH--, (C.sub.1-C.sub.6)alkoxy-CO--NH--, (C.sub.1-C.sub.6)alkyl-CO--NH--(C.sub.1-C.sub.6)alkyl, (C.sub.1-C.sub.6)alkoxy-CO--NH--(C.sub.1-C.sub.6)alkyl, (C.sub.1-C.sub.6)alkoxy-CO--NH--(C.sub.1-C.sub.6)alkoxy, carboxy, carboxy(C.sub.1-C.sub.6)alkyl, carboxy(C.sub.1-C.sub.6)alkoxy, benzyloxycarbonyl(C.sub.1-C.sub.6)alkoxy, (C.sub.1-C.sub.6)alkoxycarbonyl(C.sub.1-C.sub.6)alkoxy, (C.sub.6-C.sub.10)aryl, amino, amino(C.sub.1-C.sub.6)alkyl, (C.sub.1-C.sub.6)alkoxycarbonylamino, (C.sub.6-C.sub.10)aryl(C.sub.1-C.sub.6)alkoxycarbonylamino, (C.sub.1-C.sub.6)alkylamino, ((C.sub.1-C.sub.6)alkyl).sub.2 amino, (C.sub.1-C.sub.6)alkylamino(C.sub.1-C.sub.6)alkyl, ((C.sub.1-C.sub.6)alkyl).sub.2amino(C.sub.1-C.sub.6)alkyl, hydroxy, (C.sub.1-C.sub.6)alkoxy, carboxy, carboxy(C.sub.1-C.sub.6)alkyl, (C.sub.1-C.sub.6)alkoxycarbonyl, (C.sub.1-C.sub.6)alkoxycarbonyl(C.sub.1-C.sub.6)alkyl, (C.sub.1-C.sub.6)alkoxy-CO--NH--, (C.sub.1-C.sub.6)alkyl-CO--NH--, cyano, (C.sub.5-C.sub.9)heterocycloalkyl, amino-CO--NH--, (C.sub.1-C.sub.6)alkylamino-CO--NH--, ((C.sub.1-C.sub.6)alkyl).sub.2amino-CO--NH--, (C.sub.6-C.sub.10)arylamino-CO--NH--, (C.sub.5-C.sub.9)heteroarylamino-CO--NH--, (C.sub.1C.sub.6)alkylamino-CO--NH--(C.sub.1-C.sub.6)alkyl, ((C.sub.1-C.sub.6)alkyl).sub.2amino-CO--NH--(C.sub.1-C.sub.6)alkyl, (C.sub.6-C.sub.10)arylamino-CO--NH--(C.sub.1-C.sub.6)alkyl, (C.sub.5-C.sub.9)heteroarylamino-CO--NH--(C.sub.1-C.sub.6)alkyl, (C.sub.1-C.sub.6)alkylsulfonyl, (C.sub.1-C.sub.6)alkylsulfonylamino, (C.sub.1-C.sub.6)alkylsulfonylamino (C.sub.1-C.sub.6)alkyl, (C.sub.6-C.sub.10)arylsulfonyl, (C.sub.6-C.sub.10)aryllsulfonylamino, (C.sub.6-C.sub.10)arylsulfonylamino(C.sub.1-C.sub.6)alkyl, (C.sub.1-C.sub.6)alkylsulfonylamino, (C.sub.1-C.sub.6)alkylsulfonylamino(C.sub.1-C.sub.6)alkyl, (C.sub.5-C.sub.9)heteroaryl or (C.sub.2-C.sub.9)heterocycloalkyl, or of Formula B: ##STR00050## including pharmaceutically acceptable salt forms or prodrugs thereof, wherein: A.sup.1 and A.sup.2 are independently selected from C and N; T, U, and V are independently selected from O, S, N, CR.sup.5, and NR.sup.6; wherein the 5-membered ring formed by A.sup.1, A.sup.2, U, T, and V is aromatic; X is N or CR.sup.4; Y is C.sub.1-8 alkylene, C.sub.2-8 alkenylene, C.sub.2-8 alkynylene, (CR.sup.11R.sup.12).sub.p--(C.sub.3-10 cycloalkylene)-(CR.sup.11R.sup.12).sub.q, (CR.sup.11R.sup.12).sub.p-(arylene)-(CR.sup.11R.sup.12).sub.q, (CR.sup.11R.sup.12).sub.\p--(C.sub.1-10 heterocycloalkylene)-(CR.sup.11R.sup.12).sub.q, (CR.sup.11R.sup.12).sub.p-(heteroarylene)-(CR.sup.11R.sup.12).sub.q, (CR.sup.11R.sup.12).sub.pO(CR.sup.11R.sup.12).sub.q, (CR.sup.11R.sup.12).sub.pS(CR.sup.11R.sup.12).sub.q, (CR.sup.11R.sup.12).sub.pC(O)(CR.sup.11R.sup.12).sub.q, (CR.sup.11R.sup.12).sub.pC(O)NR.sub.c(CR.sup.11R.sup.12).sub.q, (CR.sup.11R.sup.12).sub.pC(O)O(CR.sup.11R.sup.12).sub.q, (CR.sup.11R.sup.12).sub.pOC(O)(CR.sup.11R.sup.12).sub.q, (CR.sup.11R.sup.12).sub.pOC(O)NR.sup.c(CR.sup.11R.sup.12).sub.q, (CR.sup.11R.sup.12).sub.pNR.sup.c(CR.sup.11R.sup.12).sub.q, (CR.sup.11R.sup.12).sub.pNR.sup.cC(O)NR.sup.d(CR.sup.11R.sup.12).sub.q, (CR.sup.11R.sup.12).sub.pS(O)(CR.sup.11R.sup.12).sub.q, (CR.sup.11R.sup.12).sub.pS(O)NR.sup.c(CR.sup.11R.sup.12).sub.q, (CR.sup.11R.sup.12).sub.pS(O).sub.2(CR.sup.11R.sup.12).sub.q, or (CR.sup.11R.sup.12).sub.pS(O).sub.2NR.sup.c(CR.sup.11R.sup.12).sub.q, wherein said C.sub.1-8 alkylene, C.sub.2-8 alkenylene, C.sub.2-8 alkynylene, cycloalkylene, arylene, heterocycloalkylene, or heteroarylene, is optionally substituted with 1, 2, or 3 substituents independently selected from -D.sup.1-D.sup.2-D.sup.3-D.sup.4; Z is H, halo, C.sub.1-4 alkyl, C.sub.2-4 alkenyl, C.sub.2-4 alkynyl, C.sub.1-4 haloalkyl, halosulfanyl, C.sub.1-4 hydroxyalkyl, C.sub.1-4 cyanoalkyl, .dbd.C--R.sup.i, .dbd.N--R.sup.i, Cy.sup.1, CN, NO.sub.2, OR.sup.a, SR.sup.a, C(O)R.sup.b, C(O)NR.sup.cR.sup.d, C(O)OR.sup.a, OC(O)R.sup.b, OC(O)NR.sup.cR.sup.d, NR.sup.cR.sup.d, NR.sup.cC(O)R.sup.b, NR.sup.cC(O)NR.sup.cR.sup.d, NR.sup.cC(O)OR.sup.a, C(.dbd.NR.sup.i)NR.sup.cR.sup.d, NR.sup.cC(.dbd.NR.sup.i)NR.sup.cR.sup.d, S(O)R.sup.b, S(O)NR.sup.cR.sup.d, S(O).sub.2R.sup.b, NR.sup.cS(O).sub.2R.sup.b, C(.dbd.NOH)R.sup.b, C(.dbd.NO(C.sub.1-6alkyl)R.sup.b, and S(O).sub.2NR.sup.cR.sup.d, wherein said C.sub.1-8 alkyl, C.sub.2-8 alkenyl, or C.sub.2-8 alkynyl, is optionally substituted with 1, 2, 3, 4, 5, or 6 substituents independently selected from halo, C.sub.1-4 alkyl, C.sub.2-4 alkenyl, C.sub.2-4 alkynyl, C.sub.1-4 haloalkyl, halosulfanyl, C.sub.1-4 hydroxyalkyl, C.sub.1-4 cyanoalkyl, Cy.sup.1, CN, N.sub.2, OR.sup.a, SR.sup.a, C(O)R.sup.b, C(O)NR.sup.cR.sup.d, C(O)OR.sup.a, OC(O)R.sup.b, OC(O)NR.sup.cR.sup.d, NR.sup.cR.sup.d, NR.sup.cC(O)R.sup.b, NR.sup.cC(O)NR.sup.cR.sup.d, NR.sup.cC(O)OR.sup.a, C(.dbd.NR.sup.i)NR.sup.cR.sup.d, NR.sup.cC(.dbd.NR.sup.i)NR.sup.cR.sup.d, S(O)R.sup.b, S(O)NR.sup.cR.sup.d, S(O).sub.2R.sup.b, NR.sup.cS(O).sub.2R.sup.b, C(.dbd.NOH)R.sup.b, C(.dbd.NO(C.sub.1-6 alkyl))R.sup.b, and S(O).sub.2NR.sup.cR.sup.d; wherein when Z is H, n is 1; or the --(Y).sub.n--Z moiety is taken together with i) A.sup.2 to which the moiety is attached, ii) R.sup.5 or R.sup.6 of either T or V, and iii) the C or N atom to which the R.sup.5 or R.sup.6 of either T or V is attached to form a 4- to 20-membered aryl, cycloalkyl, heteroaryl, or heterocycloalkyl ring fused to the 5-membered ring formed by A.sup.1 A.sup.2, U, T, and V, wherein said 4- to 20-membered aryl, cycloalkyl, heteroaryl, or heterocycloalkyl ring is optionally substituted by 1, 2, 3, 4, or 5 substituents independently selected from --(W).sub.m-Q; W is C.sub.1-8 alkylenyl, C.sub.2-8 alkenylenyl, C.sub.2-8 alkynylenyl, O, S, C(O), C(O)NR.sup.c', C(O)O, OC(O), OC(O)NR.sup.c', NR.sup.c', NR.sup.c'C(O)NR.sup.d', S(O), S(O)NR.sup.c', S(O).sub.2, or S(O)2NR.sup.c'; Q is H, halo, CN, NO.sub.2, C.sub.1-8 alkyl, C.sub.2-8 alkenyl, C.sub.2-8 alkynyl, C.sub.1-8 haloalkyl, halosulfanyl, aryl, cycloalkyl, heteroaryl, or heterocycloalkyl, wherein said C.sub.1-8 alkyl, C.sub.2-8 alkenyl, C.sub.2-8 alkynyl, C.sub.1-8 haloalkyl, aryl, cycloalkyl, heteroaryl, or heterocycloalkyl is optionally substituted with 1, 2, 3 or 4 substituents independently selected from halo, C.sub.1-4 alkyl, C.sub.2-4 alkenyl, C.sub.2-4 alkynyl, C.sub.1-4 haloalkyl, halosulfanyl, C.sub.1-4 hydroxyalkyl, C.sub.1-4 cyanoalkyl, Cy.sup.2, CN, NO.sub.2, OR.sup.a', SR.sup.a', C(O)R.sup.b', C(O)NR.sup.c'R.sup.d', C(O)OR.sup.a', OC(O)R.sup.b', OC(O)NR.sup.c'R.sup.d', NR.sup.c'R.sup.d', NR.sup.c'C(O)R.sup.b', NR.sup.c'C(O)N R.sup.c'R.sup.d', N R.sup.c'C(O)OR.sup.a', S(O)R.sup.b', S(O)N R.sup.c'R.sup.d', S(O).sub.2R.sup.b', NR.sup.c'S(O).sub.2R.sup.b', and S(O).sub.2N R.sup.c'R.sup.d'; Cy.sup.1 and Cy.sup.2 are independently selected from aryl, heteroaryl, cycloalkyl, and heterocycloalkyl, each optionally substituted by 1, 2, 3, 4 or 5 substituents independently selected from halo, C.sub.1-4 alkyl, C.sub.2-4 alkenyl, C.sub.2-4 alkynyl, C.sub.1-4 haloalkyl, halosulfanyl, C.sub.1-4 hydroxyalkyl, C.sub.1-4 cyanoalkyl, CN, NO.sub.2, OR.sup.a'', SR.sup.a'', C(O)R.sup.b'', C(O)NR.sup.c''R.sup.d'', C(O)OR.sup.a'', OC(O)R.sup.b'', OC(O)N R.sup.c''R.sup.d'', NR.sup.c''R.sup.d'', NR.sup.c''C(O)R.sup.b'', NR.sup.c''C(O)OR.sup.a'', NR.sup.c''S(O)R.sup.b'', NR.sup.c''S(O).sub.2R.sup.b'', S(O)R.sup.b'', S(O)NR.sup.c''R.sup.d'', S(O).sub.2R.sup.b'', and S(O).sub.2NR.sup.c''R.sup.d''; R.sup.1, R.sup.2, R.sup.3, and R.sup.4 are independently selected from H, halo, C.sub.1-4 alkyl, C.sub.2-4 alkenyl, C.sub.2-4 alkynyl, C.sub.1-4 haloalkyl, halosulfanyl, aryl, cycloalkyl, heteroaryl, heterocycloalkyl, CN, NO.sub.2, OR.sup.7, SR.sup.7, C(O)R.sup.8, C(O)NR.sup.9R.sup.10, C(O)OR.sup.7OC(O)R.sup.8, OC(O)NR.sup.9R.sup.10, NR.sup.9R.sup.10, NR.sup.9C(O)R.sup.8, NR.sup.cC(O)OR.sup.7, S(O)R.sup.8, S(O)NR.sup.9R.sup.10, S(O).sub.2R.sup.8, NR.sup.9S(O).sub.2R.sup.8, and S(O).sub.2NR.sup.9R.sup.10; R.sup.5 is H, halo, C.sub.1-4 alkyl, C.sub.2-4 alkenyl, C.sub.2-4 alkynyl, C.sub.1-4 haloalkyl, halosulfanyl, CN, NO.sub.2, OR.sup.7, SR.sup.7, C(O)R.sup.8, C(O)NR.sup.9R.sup.10, C(O)OR.sup.7, OC(O)R.sup.8, OC(O)NR.sup.9R.sup.10, NR.sup.9R.sup.10, NR.sup.9C(O)R.sup.8, NR.sup.9C(O)OR.sup.7, S(O)R.sup.8, S(O)NR.sup.9R.sup.10, S(O).sub.2R.sup.8, NR.sup.9S(O).sub.2R.sup.8, or S(O).sub.2NR.sup.9R.sup.10; R.sup.6 is H, C.sub.1-4 alkyl, C.sub.2-4 alkenyl, C.sub.2-4 alkynyl, C.sub.1-4 haloalkyl, OR.sup.7, C(O)R.sup.8, C(O)NR.sup.9R.sup.10, C(O)OR.sup.7, S(O)R.sup.8, S(O)NR.sup.9R.sup.10, S(O).sub.2R.sup.8, or S(O).sub.2NR.sup.9R.sup.10; R.sup.7 is H, C.sub.1-6 alkyl, C.sub.1-6 haloalkyl, C.sub.2-6 alkenyl, C.sub.2-6 alkynyl, aryl, cycloalkyl, heteroaryl, heterocycloalkyl, arylalkyl, heteroarylalkyl, cycloalkylalkyl or heterocycloalkylalkyl; R.sup.8 is H, C.sub.1-6 alkyl, C.sub.1-6 haloalkyl, C.sub.2-6 alkenyl, C.sub.2-6 alkynyl, aryl, cycloalkyl, heteroaryl, heterocycloalkyl, arylalkyl, heteroarylalkyl, cycloalkylalkyl or heterocycloalkylalkyl; R.sup.9 and R.sup.10 are independently selected from H, C.sub.1-10 alkyl, C.sub.1-6 haloalkyl, C.sub.2-6 alkenyl, C.sub.2-6 alkynyl, C.sub.1-6 alkylcarbonyl, arylcarbonyl, C.sub.1-6 alkylsulfonyl, arylsulfonyl, aryl, heteroaryl, cycloalkyl, heterocycloalkyl, arylalkyl, heteroarylalkyl, cycloalkylalkyl and heterocycloalkylalkyl. or R.sup.9 and R.sup.10 together with the N atom to which they are attached form a 4-, 5-, 6- or 7-membered heterocycloalkyl group; R.sup.11 and R.sup.12 are independently selected from H and -E.sup.1-E.sup.2-E.sup.3-E.sup.4; D.sup.1 and E.sup.1 are independently absent or independently selected from C.sub.1-6 alkylene, C.sub.2-6 alkenylene, C.sub.2-6 alkynylene, arylene, cycloalkylene, heteroarylene, and heterocycloalkylene, wherein each of the C.sub.1-6 alkylene, C.sub.2-6 alkenylene, C.sub.2-6 alkynylene, arylene, cycloalkylene, heteroarylene, and heterocycloalkylene is optionally substituted by 1, 2 or 3 substituents independently selected from halo, CN, NO.sub.2, N.sub.3, SCN, OH, C.sub.1-6 alkyl, C.sub.1-6 haloalkyl, C.sub.2-8 alkoxyalkyl, C.sub.1-6 alkoxy, C.sub.1-6 haloalkoxy, amino, C.sub.1-6 alkylamino, and C.sub.2-8 dialkylamino; D.sup.2 and E.sup.2 are independently absent or independently selected from C.sub.1-6 alkylene, C.sub.2-6 alkenylene, C.sub.2-6 alkynylene, (C.sub.1-6 alkylene).sub.r--O--(C.sub.1-6 alkylene).sub.s, (C.sub.1-6 alkylene).sub.r--S--(C.sub.1-6 alkylene).sub.s, (C.sub.1-6 alkylene).sub.r--NR.sup.c--(C.sub.1-6 alkylene).sub.s, (C.sub.1-6 alkylene).sub.r--CO--(C.sub.1-6 alkylene).sub.s, (C.sub.1-6 alkylene).sub.r--COO--(C.sub.1-6 alkylene).sub.s, (C.sub.1-6 alkylene).sub.r--CONR.sup.c--(C.sub.1-6 alkylene).sub.s, (C.sub.1-6 alkylene).sub.r--SO--(C.sub.1-6 alkylene).sub.s, (C.sub.1-6 alkylene).sub.r--SO.sub.2--(C.sub.1-6 alkylene).sub.s, (C.sub.1-6 alkylene).sub.r--SONR.sup.c--(C.sub.1-6 alkylene).sub.s, and (C.sub.1-6 alkylene).sub.r--NR.sup.cCONR.sup.f--(C.sub.1-6 alkylene).sub.s, wherein each of the C.sub.1-6 alkylene, C.sub.2-6 alkenylene, and C.sub.2-6 alkynylene is optionally substituted by 1, 2 or 3 substituents independently selected from halo, CN, NO.sub.2, N.sub.3, SCN, OH, C.sub.1-6 alkyl, C.sub.1-6 haloalkyl, C.sub.2-8 alkoxyalkyl, C.sub.1-6 alkoxy, C.sub.1-6 haloalkoxy, amino, C.sub.1-6 alkylamino, and C.sub.2-8 dialkylamino; D.sup.3 and E.sup.3 are independently absent or independently selected from C.sub.1-6 alkylene, C.sub.2-6 alkenylene, C.sub.2-6 alkynylene, arylene, cycloalkylene, heteroarylene, and heterocycloalkylene, wherein each of the C.sub.1-6 alkylene, C.sub.2-6 alkenylene, C.sub.2-6 alkynylene, arylene, cycloalkylene, heteroarylene, and heterocycloalkylene is optionally substituted by 1, 2 or 3 substituents independently selected from halo, CN, NO.sub.2, N.sub.3, SCN, OH, C.sub.1-6 alkyl, C.sub.1-6 haloalkyl, C.sub.2-8 alkoxyalkyl, C.sub.1-6 alkoxy, C.sub.1-6 haloalkoxy, amino, C.sub.1-6 alkylamino, and C.sub.2-8 dialkylamino; E.sup.4 and E.sup.4 are independently selected from H, halo, C.sub.1-4 alkyl, C.sub.2-4 alkenyl, C.sub.2-4 alkynyl, C.sub.1-4 haloalkyl, halosulfanyl, C.sub.1-4 hydroxyalkyl, C.sub.1-4 cyanoalkyl, Cy.sup.1, CN, NO.sub.2, OR.sup.a, SR.sup.a, C(O)R.sup.b, C(O)NR.sup.cR.sup.a, C(O)OR.sup.a, OC(O)R.sup.bOC(O)NR.sup.cR.sup.d NR.sup.cR.sup.d, NR.sup.cC(O)R.sup.b, NR.sup.cC(O)NR.sup.cR.sup.d, NR.sup.cC(O)OR.sup.a, C(.dbd.NR.sup.i)NR.sup.cR.sup.d, NR.sup.cC(.dbd.NR.sup.i)NR.sup.cR.sup.d, S(O)R.sup.b, S(O)NR.sup.cR.sup.d, S(O).sub.2R.sup.b, NR.sup.cS(O).sub.2R.sup.b, C(.dbd.NOH)R.sup.b, C(.dbd.NO(C.sub.1-6 alkyl)R.sup.b, and S(O).sub.2NR.sup.cR.sup.d, wherein said C.sub.1-8 alkyl, C.sub.2-8 alkenyl, or C.sub.2-8 alkynyl, is optionally substituted with 1, 2, 3, 4, 5, or 6 substituents independently selected from halo, C.sub.1-4 alkyl, C.sub.2-4 alkenyl, C.sub.2-4 alkynyl, C.sub.1-4 haloalkyl, halosulfanyl, C.sub.1-4 hydroxyalkyl, C.sub.1-4 cyanoalkyl, Cy.sup.1, CN, NO.sub.2, OR.sup.a, SR.sup.a, C(O)R.sup.b, C(O)NR.sup.cR.sup.d, C(O)OR.sup.a, OC(O)R.sup.b, OC(O)NR.sup.cR.sup.d, NR.sup.cR.sup.d, NR.sup.cC(O)R.sup.b, NR.sup.cC(O)NR.sup.cR.sup.d, NR.sup.cC(O)OR.sup.a, C(.dbd.NR.sup.i)NR.sup.cR.sup.d, NR.sup.cC(.dbd.NR.sup.i)NR.sup.cR.sup.d, S(O)R.sup.b, S(O)NR.sup.cR.sup.d, S(O).sub.2R.sup.b , NR.sup.cS(O).sub.2R.sup.b, C(.dbd.NOH)R.sup.b, C(.dbd.NO(C.sub.1-6 alkyl))R.sup.b, and S(O).sub.2NR.sup.cR.sup.d; R.sup.a is H, Cy.sup.1, --(C.sub.1-6 alkyl)-Cy.sup.1, C.sub.1-6 alkyl, C.sub.1-6 haloalkyl, C.sub.2-6 alkenyl, C.sub.2-6 alkynyl, wherein said C.sub.1-6 alkyl, C.sub.1-6 haloalkyl, C.sub.2-6 alkenyl, or C.sub.2-6 alkynyl is optionally substituted with 1, 2, or 3 substituents independently selected from OH, CN, amino, halo, C.sub.1-6 alkyl, C.sub.1-6 haloalkyl, halosulfanyl, aryl, arylalkyl, heteroaryl, heteroarylalkyl, cycloalkyl and heterocycloalkyl; R.sup.b is H, Cy.sup.1,--(C.sub.1-6 alkyl)-Cy.sup.1, C.sub.1-6 alkyl, C.sub.1-6 haloalkyl, C.sub.2-6 alkenyl, C.sub.2-6 alkynyl, wherein said C.sub.1-6 alkyl, C.sub.1-61-6 haloalkyl, C.sub.2-6 alkenyl, or C.sub.2-6 alkynyl is optionally substituted with 1, 2, or 3 substituents independently selected from OH, CN, amino, halo, C.sub.1-6 alkyl, C.sub.1-6 haloalkyl, C.sub.1-6 haloalkyl, halosulfanyl, aryl, arylalkyl, heteroaryl, heteroarylalkyl, cycloalkyl and heterocycloalkyl; R.sup.a' and R.sup.a'' are independently selected from H, C.sub.1-6 alkyl, C.sub.1-6 haloalkyl, C.sub.2-6 alkenyl, C.sub.2-6 alkynyl, aryl, cycloalkyl, heteroaryl, heterocycloalkyl, arylalkyl, heteroarylalkyl, cycloalkylalkyl and heterocycloalkylalkyl, wherein said C.sub.1-6 alkyl, C.sub.1-6 haloalkyl, C.sub.2-6 alkenyl, C.sub.2-6 alkynyl, aryl, cycloalkyl, heteroaryl, heterocycloalkyl, arylalkyl, heteroarylalkyl, cycloalkylalkyl or heterocycloalkylalkyl is optionally substituted with 1, 2, or 3 substituents independently selected from OH, CN, amino, halo, C.sub.1-6 alkyl, C.sub.1-6 haloalkyl, halosulfanyl, aryl, arylalkyl, heteroaryl, heteroarylalkyl, cycloalkyl and heterocycloalkyl; R.sup.b' and R.sup.b'' are independently selected from H, C.sub.1-6 alkyl, C.sub.1-6 haloalkyl, C.sub.2-6 alkenyl, C.sub.2-6 alkynyl, aryl, cycloalkyl, heteroaryl, heterocycloalkyl, arylalkyl, heteroarylalkyl, cycloalkylalkyl and heterocycloalkylalkyl, wherein said C.sub.1-6 alkyl, C.sub.1-6 haloalkyl, C.sub.2-6 alkenyl, C.sub.2-6 alkynyl, aryl, cycloalkyl, heteroaryl, heterocycloalkyl, arylalkyl, heteroarylalkyl, cycloalkylalkyl or heterocycloalkylalkyl is optionally substituted with 1, 2, or 3 substituents independently selected from OH, CN, amino, halo, C.sub.1-6 alkyl, C.sub.1-6 haloalkyl, C.sub.1-6 haloalkyl, halosulfanyl, aryl, arylalkyl, heteroaryl, heteroarylalkyl, cycloalkyl and heterocycloalkyl; R.sup.c and R.sup.d are independently selected from H, Cy.sup.1, --(C.sub.1-6 alkyl)-Cy.sup.1, C.sup.1-10 alkyl, C.sub.1-6 haloalkyl, C.sub.2-6 alkenyl, C.sub.2-6 alkynyl, wherein said C.sub.1-10 alkyl, C.sub.1-6 haloalkyl, C.sub.2-6 alkenyl, C.sub.2-6 alkynyl, is optionally substituted with 1, 2, or 3 substituents independently selected from Cy.sup.1, --(C.sub.1-6 alkyl)-Cy.sup.1, OH, CN, amino, halo, C.sub.1-6 alkyl, C.sub.1-6 haloalkyl, C.sub.1-6 haloalkyl, and halosulfanyl; or R.sup.c and R.sup.d together with the N atom to which they are attached form a 4-, 5-, 6- or 7-membered heterocycloalkyl group optionally substituted with 1, 2, or 3 substituents independently selected from Cy.sup.1, --(C.sub.1-6 alkyl)-Cy.sup.1, OH, CN, amino, halo, C.sub.1-6 alkyl, C.sub.1-6 haloalkyl, C.sub.1-6 haloalkyl, and halosulfanyl; R.sup.c' and R.sup.d' are independently selected from H, C.sub.1-10 alkyl, C.sub.1-6 haloalkyl, C.sub.2-6 alkenyl, C.sub.2-6 alknyl, aryl, heteroaryl, cycloalkyl, heterocycloalkyl, arylalkyl, heteroarylalkyl, cycloalkylalkyl and heterocycloalkylalkyl, wherein said C.sub.1-10 alkyl, C.sub.1-6 haloalkyl, C.sub.2-6 alkenyl, C.sub.2-6 alkynyl, aryl, heteroaryl, cycloalkyl, heterocycloalkyl, arylalkyl, heteroarylalkyl, cycloalkylalkyl or heterocycloalkylalkyl is optionally substituted with 1, 2, or 3 substituents independently selected from OH, CN, amino, halo, C.sub.1-6 alkyl, C.sub.1-6 haloalkyl, C.sub.1-6 haloalkyl, halosulfanyl, aryl, arylalkyl, heteroaryl, heteroarylalkyl, cycloalkyl and heterocycloalkyl; or R.sup.c' and R.sup.d' together with the N atom to which they are attached form a 4-, 5-, 6- or 7-membered heterocycloalkyl group optionally substituted with 1, 2, or 3 substituents independently selected from OH, CN, amino, halo, C.sub.1-6 alkyl, C.sub.1-6 haloalkyl, C.sub.1-6 haloalkyl, halosulfanyl, aryl, arylalkyl, heteroaryl, heteroarylalkyl, cycloalkyl and heterocycloalkyl; R.sup.c'' and R.sup.d'' are independently selected from H, C.sub.1-10 alkyl, C.sub.1-6 haloalkyl, C.sub.2-6 alkenyl, C.sub.2-6 alkynyl, aryl, heteroaryl, cycloalkyl, heterocycloalkyl, arylalkyl, heteroarylalkyl, cycloalkylalkyl and heterocycloalkylalkyl, wherein said C.sub.1-10 alkyl, C.sub.1-6 haloalkyl, C.sub.2-6 alkenyl, C.sub.2-6 alkynyl, aryl, heteroaryl, cycloalkyl, heterocycloalkyl, arylalkyl, heteroarylalkyl, cycloalkylalkyl or heterocycloalkylalkyl is optionally substituted with 1, 2, or 3 substituents independently selected from OH, CN, amino, halo, C.sub.1-6 alkyl, C.sub.1-6 haloalkyl, halosulfanyl, C.sub.1-6 haloalkyl, aryl, arylalkyl, heteroaryl, heteroarylalkyl, cycloalkyl and heterocycloalkyl; or R.sup.c'' and R.sup.d'' together with the N atom to which they are attached form a 4-, 5-, 6- or 7-membered heterocycloalkyl group optionally substituted with 1, 2, or 3 substituents independently selected from OH, CN, amino, halo, C.sub.1-6 alkyl, C.sub.1-6 haloalkyl, C.sub.1-6 haloalkyl, halosulfanyl, aryl, arylalkyl, heteroaryl, heteroarylalkyl, cycloalkyl and heterocycloalkyl; R.sup.i is H, CN, NO.sub.2 or C.sub.1-6 alkyl; R.sup.e and R.sup.f are independently selected from H and C.sub.1-6 alkyl, R.sup.i is H, CN, or NO.sub.2; m is 0 or 1; n is 0 or 1; p is 0, 1, 2, 3, 4, 5, or 6; q is 0, 1, 2, 3, 4, 5 or 6; r is 0 or 1; and s is 0 or 1, b) administering a reactivation agent, while maintaining one or both of HAART and JAK inhibitor therapy, c) withdrawing treatment with the reactivation agent, upon assessment of increased viral loads in the periphery that may be coupled with but not limited to assessment of diminished or absent memory lymphocytes with flow cytometry, while continuing treatment with HAART and one or more JAK inhibitors, until low level or absent viremia is maintained, d) withdrawing HAART, while JAK inhibitor therapy is maintained, or withdrawing both HAART and JAK inhibitor therapy, optionally while monitoring viral rebound. 9. The method of claim 8, wherein the reactivation agent is panobinostat. 10. The method of claim 8, wherein the JAK inhibitor is ##STR00051## LY3009104/INCB28050, ##STR00052## or a pharmaceutically acceptable salt or prodrug thereof. 11. A method of treating a viral disease in a patient in need of treatment thereof, comprising administering an effective, antiviral amount of a JAK inhibitor compound of Formula A: ##STR00053## wherein: or the pharmaceutially acceptable salt thereof; wherein R.sup.1 is a group of the formula ##STR00054## wherein y is 0, 1 or 2; R.sup.4 is selected from the group consisting of hydrogen, (C.sub.1-C.sub.6)alkyl, (C.sub.1-C.sub.6)alkylsulfonyl, (C.sub.2-C.sub.6)alkenyl, (C.sub.2-C.sub.6)alkynyl wherein the alkyl, alkenyl and alkynyl groups are optionally substituted by deuterium hydroxy, amino, trifluoromethyl, (C.sub.1-C.sub.4)alkoxy,(C.sub.1-C.sub.6)acyloxy, (C.sub.1-C.sub.6)alkylamino, ((C.sub.1-C.sub.6)alkyl).sub.2amino, cyano, nitro, (C.sub.2-C.sub.6)alkenyl, (C.sub.2-C.sub.6)alkynyl or (C.sub.1-C.sub.6)acylamino; or R.sup.4 is (C.sub.3-C.sub.10)cycloalkyl wherein the cycloalkyl group is optionally substituted by deuterium, hydroxy, amino, trifluoromethyl, (C.sub.1-C.sub.6)acyloxy, (C.sub.1-C.sub.6)acylamino, (C.sub.1-C.sub.6)alkylamino, ((C.sub.1-C.sub.6)alkyl).sub.2amino, cyano, cyano(C.sub.1-C.sub.6)alkyl, trifluoromethyl(C.sub.1-C.sub.6)alkyl, nitro, nitro(C.sub.1-C.sub.6)alkyl or (C.sub.1-C.sub.6)acylamino; R.sup.5 is (C.sub.2-C.sub.9)heterocycloalkyl wherein the heterocycloalkyl groups must be substituted by one to five carboxy, cyano, amino, deuterium, hydroxy, (C.sub.1-C.sub.6)alkyl, (C.sub.1-C.sub.6)alkoxy, halo, (C.sub.1-C.sub.6)acyl, (C.sub.1-C.sub.6)alkylamino, amino(C.sub.1-C.sub.6)alkyl, (C.sub.1-C.sub.6)alkoxy-CO--NH, (C.sub.1-C.sub.6)alkylamino-CO--, (C.sub.2-C.sub.6)alkenyl, (C.sub.2-C.sub.6) alkynyl, (C.sub.1-C.sub.6)alkylamino, amino(C.sub.1-C.sub.6)alkyl, hydroxy(C.sub.1-C.sub.6)alkyl, (C.sub.1-C.sub.6)alkoxy(C.sub.1-C.sub.6)alkyl, (C.sub.1-C.sub.6)acyloxy(C.sub.1-C.sub.6)alkyl, nitro, cyano(C.sub.1-C.sub.6)alkyl, halo(C.sub.1-C.sub.6)alkyl, nitro(C.sub.1-C.sub.6)alkyl, trifluoromethyl, trifluoromethyl(C.sub.1-C.sub.6)alkyl, (C.sub.1-C.sub.6)acylamino, (C.sub.1-C.sub.6)acylamino(C.sub.1-C.sub.6)alkyl, (C.sub.1-C.sub.6)alkoxy(C.sub.1-C.sub.6)acylamino, amino(C.sub.1-C.sub.6)acyl, amino(C.sub.1-C.sub.6)acyl(C.sub.1-C.sub.6)alkyl, (C.sub.1-C.sub.6)alkylamino(C.sub.1-C.sub.6)acyl, ((C.sub.1-C.sub.6)alkyl).sub.2amino(C.sub.1-C.sub.6)acyl, R.sup.15R.sup.16N--CO--O--, R.sup.15R.sup.16N--CO--(C.sub.1-C.sub.6)alkyl, (C.sub.1-C.sub.6)alkyl-S(O).sub.m, R.sup.15R.sup.16NS(O).sub.m, R.sup.15R.sup.16NS(O).sub.m(C.sub.1-C.sub.6)alkyl, R.sup.15S(O).sub.mR.sup.16N, R.sup.15S(O).sub.mR.sup.16(C.sub.1-C.sub.6)alkyl wherein m is 0, 1 or 2 and R.sup.15 and R.sup.16 are each independently selected from hydrogen or (C.sub.1-C.sub.6)alkyl; or a group of the formula ##STR00055## wherein a is 0, 1, 2, 3 or 4; b, c, e, f and g are each independently 0 or 1; d is 0, 1, 2, or 3; X is S(O).sub.n wherein n is 0, 1 or 2; oxygen, carbon or --C(.dbd.N-cyano)-; Y is S(O).sub.n wherein n is 0, 1 or 2; or carbonyl; and Z is carbonyl, C(O)O--, C(O)NR-- or S(O).sub.n wherein n is 0, 1 or 2; R.sup.6, R.sup.7, R.sup.8, R.sup.9, R.sup.10 and R.sup.11 are each independently selected from the group consisting of hydrogen or (C.sub.1-C.sub.6)alkyl optionally substituted by deuterium, hydroxy, amino, trifluoromethyl, (C.sub.1-C.sub.6)acyloxy, (C.sub.1-C.sub.6)acylamino , (C.sub.1-C.sub.6)alkylamino, ((C.sub.1-C.sub.6)alkyl).sub.2amino, cyano, cyano(C.sub.1-C.sub.6)alkyl, trifluoromethyl(C.sub.1-C.sub.6)alkyl, nitro, nitro(C.sub.1-C.sub.6)alkyl or (C.sub.1-C.sub.6)acylamino; R.sup.12 is carboxy, cyano, amino, oxo, deuterium, hydroxy, trifluoromethyl, (C.sub.1-C.sub.6)alkyl, trifluoromethyl(C.sub.1-C.sub.6)alkyl, (C.sub.1-C.sub.6)alkoxy, halo, (C.sub.1-C.sub.6)acyl, (C.sub.1-C.sub.6)alkylamino, ((C.sub.1-C.sub.6)alkyl).sub.2amino, amino(C.sub.1-C.sub.6)alkyl, (C.sub.1-C.sub.6)alkoxy-CO--NH, (C.sub.1-C.sub.6)alkylamino-CO--, (C.sub.2-C.sub.6)alkenyl, (C.sub.2-C.sub.6) alkynyl, (C.sub.1-C.sub.6)alkylamino, hydroxy(C.sub.1-C.sub.6)alkyl, (C.sub.1-C.sub.6)alkoxy(C.sub.1-C.sub.6)alkyl, (C.sub.1-C.sub.6)acyloxy(C.sub.1-C.sub.6)alkyl, nitro, cyano(C.sub.1-C.sub.6)alkyl, halo(C.sub.1-C.sub.6)alkyl, nitro(C.sub.1-C.sub.6)alkyl, trifluoromethyl, trifluoromethyl(C.sub.1-C.sub.6)alkyl, (C.sub.1-C.sub.6)acylamino (C.sub.1-C.sub.6)acylamino(C.sub.1-C.sub.6)alkyl, (C.sub.1-C.sub.6)alkoxy(C.sub.1-C.sub.6)acylamino, amino(C.sub.1-C.sub.6)acyl, amino(C.sub.1-C.sub.6)acyl(C.sub.1-C.sub.6)alkyl, (C.sub.1-C.sub.6)alkylamino(C.sub.1-C.sub.6)acyl, ((C.sub.1-C.sub.6)alkyl).sub.2amino(C.sub.1-C.sub.6)acyl, R.sup.15R.sup.16N--CO--O--, R.sup.15R.sup.16N--CO--(C.sub.1-C.sub.6)alkyl, R.sup.15C(O)NH, R.sup.15C(O)NH, R.sup.15NHC(O)NH, (C.sub.1-C.sub.6)alkyl-S(O).sub.m, (C.sub.1-C.sub.6)alkyl-S(O).sub.m--(C.sub.1-C.sub.6)alkyl, R.sup.15R.sup.16NS(O).sub.m, R.sup.15R.sup.16NS(O).sub.m(C.sub.1-C.sub.6)alkyl, R.sup.15S(O).sub.mR.sup.16N, R.sup.15S(O).sub.mR.sup.16N(C.sub.1-C.sub.6)alkyl wherein m is 0, 1 or 2 and R.sup.15 and R.sup.16 are each independently selected from hydrogen or (C.sub.1-C.sub.6)alkyl; R.sup.2 and R.sup.3 are each independently selected from the group consisting of hydrogen, deuterium, amino, halo, hydroxy, nitro, carboxy, (C.sub.2-C.sub.6)alkenyl, (C.sub.2-C.sub.6)alkynyl, trifluoromethyl, trifluoromethoxy, (C.sub.1-C.sub.6)alkyl, (C.sub.1-C.sub.6)alkoxy, (C.sub.3-C.sub.10)cycloalkyl wherein the alkyl, alkoxy or cycloalkyl groups are optionally substituted by one to three groups selected from halo, hydroxy, carboxy, amino (C.sub.1-C.sub.6)alkylthio, (C.sub.1-C.sub.6)alkylamino, ((C.sub.1-C.sub.6)alkyl).sub.2amino, (C.sub.5-C.sub.9)heteroaryl, (C.sub.2-C.sub.9)heterocycloalkyl, (C.sub.3-C.sub.9)cycloalkyl or (C.sub.6-C.sub.10)aryl; or R.sup.2 and R.sup.3 are each independently (C.sub.3-C.sub.10)cycloalkyl, (C.sub.3-C.sub.10)cycloalkoxy, (C.sub.1-C.sub.6)alkylamino, ((C.sub.1-C.sub.6)alkyl).sub.2amino, (C.sub.6-C.sub.10)arylamino, (C.sub.1-C.sub.6)alkylthio, (C.sub.6-C.sub.10)arylthio, (C.sub.1-C.sub.6)alkylsulfinyl, (C.sub.6-C.sub.10)arylsulfinyl, (C.sub.1-C.sub.6)alkylsulfonyl, (C.sub.6-C.sub.10)arylsulfonyl, (C.sub.1-C.sub.6)acyl, (C.sub.1-C.sub.6)alkoxy-CO--NH--, (C.sub.1-C.sub.6)alkylamino-CO--, (C.sub.5-C.sub.9)heteroaryl, (C.sub.2-C.sub.9)heterocycloalkyl or (C.sub.6-C.sub.10)aryl wherein the heteroaryl, heterocycloalkyl and aryl groups are optionally substituted by one to three halo, (C.sub.1-C.sub.6)alkyl, (C.sub.1-C.sub.6)alkyl-CO--NH--, (C.sub.1-C.sub.6)alkoxy-CO--NH--, (C.sub.1-C.sub.6)alkyl-CO--NH--(C.sub.1-C.sub.6)alkyl, (C.sub.1-C.sub.6)alkoxy-CO--NH--(C.sub.1-C.sub.6)alkyl, (C.sub.1-C.sub.6)alkoxy-CO--NH--(C.sub.1-C.sub.6)alkoxy, carboxy, carboxy(C.sub.1-C.sub.6)alkyl, carboxy(C.sub.1-C.sub.6)alkoxy, benzyloxycarbonyl(C.sub.1-C.sub.6)alkoxy, (C.sub.1-C.sub.6)alkoxycarbonyl(C.sub.1-C.sub.6)alkoxy, (C.sub.6-C.sub.10)aryl, amino, amino(C.sub.1-C.sub.6)alkyl, (C.sub.1-C.sub.6)alkoxycarbonylamino, (C.sub.6-C.sub.10)aryl(C.sub.1-C.sub.6)alkoxycarbonylamino, (C.sub.1-C.sub.6)alkylamino, ((C.sub.1-C.sub.6)alkyl).sub.2amino, (C.sub.1-C.sub.6)alkylamino(C.sub.1-C.sub.6)alkyl, ((C.sub.1-C.sub.6)alkyl).sub.2amino(C.sub.1-C.sub.6)alkyl, hydroxy, (C.sub.1-C.sub.6)alkoxy, carboxy, carboxy(C.sub.1-C.sub.6)alkyl, (C.sub.1-C.sub.6)alkoxycarbonyl, (C.sub.1-C.sub.6)alkoxycarbonyl(C.sub.1-C.sub.6)alkyl, (C.sub.1-C.sub.6)alkoxy-CO--NH--, (C.sub.1-C.sub.6)alkyl-CO--NH--, cyano, (C.sub.5-C.sub.9)heterocycloalkyl, amino-CO--NH--, (C.sub.1-C.sub.6)alkylamino-CO--NH--, ((C.sub.1-C.sub.6)alkyl).sub.2amino-CO--NH--, (C.sub.6-C.sub.10)arylamino-CO--NH--, (C.sub.5-C.sub.9)heteroarylamino-CO--NH--, (C.sub.1-C.sub.6)alkylamino-CO--NH--(C.sub.1-C.sub.6)alkyl, ((C.sub.1-C.sub.6)alkyl).sub.2amino-CO--NH--(C.sub.1-C.sub.6)alkyl, (C.sub.6-C.sub.10)arylamino-CO--NH--(C.sub.1-C.sub.6)alkyl, (C.sub.5-C.sub.9)heteroarylamino-CO--NH--(C.sub.1-C.sub.6)alkyl, (C.sub.1-C.sub.6)alkylsulfonyl, (C.sub.1-C.sub.6)alkylsulfonylamino, (C.sub.1-C.sub.6)alkylsulfonylamino(C.sub.1-C.sub.6)alkyl, (C.sub.6-C.sub.10)arylsulfonyl, (C.sub.6-C.sub.10)arylsulfonylamino, (C.sub.6-C.sub.10)arylsulfonylamino(C.sub.1-C.sub.6)alkyl, (C.sub.1-C.sub.6)alkylsulfonylamino, (C.sub.1-C.sub.6)alkylsulfonylamino(C.sub.1-C.sub.6)alkyl, (C.sub.5-C.sub.9)heteroaryl or (C.sub.2-C.sub.9)heterocycloalkyl, or of Formula B: ##STR00056## including pharmaceutically acceptable salt forms or prodrugs thereof, wherein: A.sup.1 and A.sup.2 are independently selected from C and N; T, U, and V are independently selected from O, S, N, CR.sup.5, and NR.sup.6; wherein the 5-membered ring formed by A.sup.1, A.sup.2, U, T, and V is aromatic; X is N or CR.sup.4; Y is C.sub.1-8 alkylene, C.sub.2-8 alkenylene, C.sub.2-8 alkynylene, (CR.sup.11R.sup.12).sub.p--(C.sub.3-10 cycloalkylene)-(CR.sup.11R.sup.12).sub.q, (CR.sup.11R.sup.12).sub.p-(arylene)-(CR.sup.11R.sup.12).sub.q, (CR.sup.11R.sup.12).sub.\p--(C.sub.1-10 heterocycloalkylene)-(CR.sup.11R.sup.12).sub.q, (CR.sup.11R.sup.12).sub.p-(heteroarylene)-(CR.sup.11R.sup.12).sub.q, (CR.sup.11R.sup.12).sub.pO(CR.sup.11R.sup.12).sub.q, (CR.sup.11R.sup.12).sub.pS(CR.sup.11R.sup.12).sub.q, (CR.sup.11R.sup.12).sub.pC(O)(CR.sup.11R.sup.12).sub.q, (CR.sup.11R.sup.12).sub.pC(O)NR.sub.c(CR.sup.11R.sup.12).sub.q,(CR.sup.11- R.sup.12).sub.pC(O)O(CR.sup.11R.sup.12).sub.q, (CR.sup.11R.sup.12).sub.pOC(O)(CR.sup.11R.sup.12).sub.q, (CR.sup.11R.sup.12).sub.pOC(O)NR.sup.c(CR.sup.11R.sup.12).sub.q, (CR.sup.11R.sup.12).sub.pNR.sup.c(CR.sup.11R.sup.12).sub.q, (CR.sup.11R.sup.12).sub.pNR.sup.cC(O)NR.sup.d(CR.sup.11R.sup.12).sub.q, (CR.sup.11R.sup.12).sub.pS(O)(CR.sup.11R.sup.12).sub.q, (CR.sup.11R.sup.12).sub.pS(O)NR.sup.c(CR.sup.11R.sup.12).sub.q, (CR.sup.11R.sup.12).sub.pS(O).sub.2(CR.sup.11R.sup.12).sub.q, or (CR.sup.11R.sup.12).sub.pS(O).sub.2NR.sup.c(CR.sup.11R.sup.12).sub.q, wherein said C.sub.1-8 alkylene, C.sub.2-8 alkenylene, C.sub.2-8 alkynylene, cycloalkylene, arylene, heterocycloalkylene, or heteroarylene, is optionally substituted with 1, 2, or 3 substituents independently selected from -D.sup.1-D.sup.2-D.sup.3-D.sup.4; Z is H, halo, C.sub.1-4 alkyl, C.sub.2-4 alkenyl, C.sub.2-4 alkynyl, C.sub.1-4 haloalkyl, halosulfanyl, C.sub.1-4 hydroxyalkyl, C.sub.1-4 cyanoalkyl, .dbd.C--R.sup.i, .dbd.N--R.sup.i, Cy.sup.1, CN, NO.sub.2, OR.sup.a, SR.sup.a, C(O)R.sup.b, C(O)NR.sup.cR.sup.d, C(O)OR.sup.a, OC(O)R.sup.b, OC(O)NR.sup.cR.sup.d, NR.sup.cR.sup.d, NR.sup.cC(O)R.sup.b, NR.sup.cC(O)NR.sup.cR.sup.d, NR.sup.cC(O)OR.sup.a, C(.dbd.NR.sup.i)NR.sup.cR.sup.d, NR.sup.cC(.dbd.NR.sup.i)NR.sup.cR.sup.d, S(O)R.sup.b, S(O)NR.sup.cR.sup.d, S(O).sub.2R.sup.b, NR.sup.cS(O).sub.2R.sup.b, C(.dbd.NOH)R.sup.b, C(.dbd.NO(C.sub.1-6alkyl)R.sup.b, and S(O).sub.2NR.sup.cR.sup.d, wherein said C.sub.1-8 alkyl, C.sub.2-8 alkenyl, or C.sub.2-8 alkynyl, is optionally substituted with 1, 2, 3, 4, 5, or 6 substituents independently selected from halo, C.sub.1-4 alkyl, C.sub.2-4 alkenyl, C.sub.2-4 alkynyl, C.sub.1-4 haloalkyl, halosulfanyl, C.sub.1-4 hydroxyalkyl, C.sub.1-4 cyanoalkyl, Cy.sup.1, CN, N.sub.2, OR.sup.a, SR.sup.a, C(O)R.sup.b, C(O)NR.sup.cR.sup.d, C(O)OR.sup.a, OC(O)R.sup.b, OC(O)NR.sup.cR.sup.d, NR.sup.cR.sup.d, NR.sup.cC(O)R.sup.b, NR.sup.cC(O)NR.sup.cR.sup.d, NR.sup.cC(O)OR.sup.a, C(.dbd.NR.sup.i)NR.sup.cR.sup.d, NR.sup.cC(.dbd.NR.sup.i)NR.sup.cR.sup.d, S(O)R.sup.b, S( hu d, S(O).sub.2R.sup.b, NR.sup.cS(O).sub.2R.sup.b, C(.dbd.NOH)R.sup.b, C(.dbd.NO(C.sub.1-6 alkyl))R.sup.b, and S(O).sub.2NR.sup.cR.sup.d; wherein when Z is H, n is 1; or the --(Y)--Z moiety is taken together with i) A.sup.2 to which the moiety is attached, ii) R.sup.5 or R.sup.6 of either T or V, and iii) the C or N atom to which the R.sup.5 or R.sup.6 of either T or V is attached to form a 4- to 20-membered aryl, cycloalkyl, heteroaryl, or heterocycloalkyl ring fused to the 5-membered ring formed by A.sup.1 A.sup.2, U, T, and V, wherein said 4- to 20-membered aryl, cycloalkyl, heteroaryl, or heterocycloalkyl ring is optionally substituted by 1, 2, 3, 4, or 5 substituents independently selected from --(W).sub.m-Q; W is C.sub.1-8 alkylenyl, C.sub.2-8 alkenylenyl, C.sub.2-8 alkynylenyl, O, S, C(O), C(O)NR.sup.c', C(O)O, OC(O), OC(O)NR.sup.c', NR.sup.c', NR.sup.c'C(O)NR.sup.d', S(O), S(O)NR.sup.c', S(O).sub.2, or S(O)2NR.sup.c'; Q is H, halo, CN, NO.sub.2, C.sub.1-8 alkyl, C.sub.2-8 alkenyl, C.sub.2-8 alkynyl, C.sub.1-8 haloalkyl, halosulfanyl, aryl, cycloalkyl, heteroaryl, or heterocycloalkyl, wherein said C.sub.1-8 alkyl, C.sub.2-8 alkenyl, C.sub.2-8 alkynyl, C.sub.1-8 haloalkyl, aryl, cycloalkyl, heteroaryl, or heterocycloalkyl is optionally substituted with 1, 2, 3 or 4 substituents independently selected from halo, C.sub.1-4 alkyl, C.sub.2-4 alkenyl, C.sub.2-4 alkynyl, C.sub.1-4 haloalkyl, halosulfanyl, C.sub.1-4 hydroxyalkyl, C.sub.1-4 cyanoalkyl, Cy.sup.2, CN, NO.sub.2, OR.sup.a', SR.sup.a', C(O)R.sup.b', C(O)NR.sup.c'R.sup.d', C(O)OR.sup.a', OC(O)R.sup.b', OC(O)NR.sup.c'R.sup.d', NR.sup.c'R.sup.d', NR.sup.c'C(O)R.sup.b', NR.sup.c'C(O)N R.sup.c'R.sup.d', N R.sup.c'C(O)OR.sup.a', S(O)R.sup.b', S(O)N R.sup.c'R.sup.d', S(O).sub.2R.sup.b', NR.sup.c'S(O).sub.2R.sup.b', and S(O).sub.2N R.sup.c'R.sup.d'; Cy.sup.1 and Cy.sup.2 are independently selected from aryl, heteroaryl, cycloalkyl, and heterocycloalkyl, each optionally substituted by 1, 2, 3, 4 or 5 substituents independently selected from halo, C.sub.1-4 alkyl, C.sub.2-4 alkenyl, C.sub.2-4 alkynyl, C.sub.1-4 haloalkyl, halosulfanyl, C.sub.1-4 hydroxyalkyl, C.sub.1-4 cyanoalkyl, CN, NO.sub.2, OR.sup.a'', SR.sup.a'', C(O)R.sup.b'', C(O)NR.sup.c''R.sup.d'', C(O)OR.sup.a'', OC(O)R.sup.b'', OC(O)N R.sup.c''R.sup.d'', NR.sup.c''R.sup.d'', NR.sup.c''C(O)R.sup.b'', NR.sup.c''C(O)OR.sup.a'', NR.sup.c''S(O)R.sup.b'', NR.sup.c''S(O).sub.2R.sup.b'', S(O)R.sup.b'', S(O)NR.sup.c''R.sup.d'', S(O).sub.2R.sup.b'', and S(O).sub.2NR.sup.c''R.sup.d''; R.sup.1, R.sup.2, R.sup.3, and R.sup.4 are independently selected from H, halo, C.sub.1-4 alkyl, C.sub.2-4 alkenyl, C.sub.2-4 alkynyl, C.sub.1-4 haloalkyl, halosulfanyl, aryl, cycloalkyl, heteroaryl, heterocycloalkyl, CN, NO.sub.2, OR.sup.7, SR.sup.7, C(O)R.sup.8, C(O)NR.sup.9R.sup.10, C(O)OR.sup.7OC(O)R.sup.8, OC(O)NR.sup.9R.sup.10, NR.sup.9R.sup.10, NR.sup.9C(O)R.sup.8, NR.sup.cC(O)OR.sup.7, S(O)R.sup.8, S(O)NR.sup.9R.sup.10, S(O).sub.2R.sup.8, NR.sup.9S(O).sub.2R.sup.8, and S(O).sub.2NR.sup.9R.sup.10; R.sup.5 is H, halo, C.sub.1-4 alkyl, C.sub.2-4 alkenyl, C.sub.2-4 alkynyl, C.sub.1-4 haloalkyl, halosulfanyl, CN, NO.sub.2, OR.sup.7, SR.sup.7, C(O)R.sup.8, C(O)NR.sup.9R.sup.10, C(O)OR.sup.7, OC(O)R.sup.8, OC(O)NR.sup.9R.sup.10, NR.sup.9R.sup.10, NR.sup.9C(O)R.sup.8, NR.sup.9C(O)OR.sup.7, S(O)R.sup.8, S(O)NR.sup.9R.sup.10, S(O).sub.2R.sup.8, NR.sup.9S(O).sub.2R.sup.8, or S(O).sub.2NR.sup.9R.sup.10; R.sup.6 is H, C.sub.1-4 alkyl, C.sub.2-4 alkenyl, C.sub.2-4 alkynyl, C.sub.1-4 haloalkyl, OR.sup.7, C(O)R.sup.8, C(O)NR.sup.9R.sup.10, C(O)OR.sup.7, S(O)R.sup.8, S(O)NR.sup.9R.sup.10, S(O).sub.2R.sup.8, or S(O).sub.2NR9R.sup.10; R.sup.7 is H, C.sub.1-6 alkyl, C.sub.1-6 haloalkyl, C.sub.2-6 alkenyl, C.sub.2-6 alkynyl, aryl, cycloalkyl, heteroaryl, heterocycloalkyl, arylalkyl, heteroarylalkyl, cycloalkylalkyl or heterocycloalkylalkyl; R.sup.8 is H, C.sub.1-6 alkyl, C.sub.1-6 haloalkyl, C.sub.2-6 alkenyl, C.sub.2-6 alkynyl, aryl, cycloalkyl, heteroaryl, heterocycloalkyl, arylalkyl, heteroarylalkyl, cycloalkylalkyl or heterocycloalkylalkyl; R.sup.9 and R.sup.10 are independently selected from H, C.sub.1-10 alkyl, C.sub.1-6 haloalkyl, C.sub.2-6 alkenyl, C.sub.2-6 alkynyl, C.sub.1-6 alkylcarbonyl, arylcarbonyl, C.sub.1-6 alkylsulfonyl, arylsulfonyl, aryl, heteroaryl, cycloalkyl, heterocycloalkyl, arylalkyl, heteroarylalkyl, cycloalkylalkyl and heterocycloalkylalkyl; or R.sup.9 and R.sup.10 together with the N atom to which they are attached form a 4-, 5-, 6- or 7-membered heterocycloalkyl group; R.sup.11 and R.sup.12 are independently selected from H and -E.sup.1-E.sup.2-E.sup.3-E.sup.4; D.sup.1 and E.sup.1 are independently absent or independently selected from C.sub.1-6 alkylene, C.sub.2-6 alkenylene, C.sub.2-6 alkynylene, arylene, cycloalkylene, heteroarylene, and heterocycloalkylene, wherein each of the C.sub.1-6 alkylene, C.sub.2-6 alkenylene, C.sub.2-6 alkynylene, arylene, cycloalkylene, heteroarylene, and heterocycloalkylene is optionally substituted by 1, 2 or 3 substituents independently selected from halo, CN, NO.sub.2, N.sub.3, SCN, OH, C.sub.1-6 alkyl, C.sub.1-6 haloalkyl, C.sub.2-8 alkoxyalkyl, C.sub.1-6 alkoxy, C.sub.1-6 haloalkoxy, amino, C.sub.1-6 alkylamino, and C.sub.2-8 dialkylamino; D.sup.2 and E.sup.2 are independently absent or independently selected from C.sub.1-6 alkylene, C.sub.2-6 alkenylene, C.sub.2-6 alkynylene, (C.sub.1-6 alkylene).sub.r--O--(C.sub.1-6 alkylene).sub.s, (C.sub.1-6 alkylene).sub.r--S--(C.sub.1-6 alkylene).sub.s, (C.sub.1-6 alkylene).sub.r--NR.sup.c--(C.sub.1-6 alkylene).sub.s, (C.sub.1-6 alkylene).sub.r--CO--(C.sub.1-6 alkylene).sub.s, (C.sub.1-6 alkylene).sub.r--COO--(C.sub.1-6 alkylene).sub.s, (C.sub.1-6 alkylene).sub.r--CONR.sup.c--(C.sub.1-6 alkylene).sub.s, (C.sub.1-6 alkylene).sub.r--SO--(C.sub.1-6 alkylene).sub.s, (C.sub.1-6 alkylene).sub.r--SO.sub.2--(C.sub.1-6 alkylene).sub.s, (C.sub.1-6 alkylene).sub.r--SONR.sup.c--(C.sub.1-6 alkylene).sub.s, and (C.sub.1-6 alkylene).sub.r--NR.sup.cCONR.sup.f--(C.sub.1-6 alkylene).sub.s, wherein each of the C.sub.1-6 alkylene, C.sub.2-6 alkenylene, and C.sub.2-6 alkynylene is optionally substituted by 1, 2 or 3 substituents independently selected from halo, CN, NO.sub.2, N.sub.3, SCN, OH, C.sub.1-6 alkyl, C.sub.1-6 haloalkyl, C.sub.2-8 alkoxyalkyl, C.sub.1-6 alkoxy, C.sub.1-6 haloalkoxy, amino, C.sub.1-6 alkylamino, and C.sub.2-8 dialkylamino; D.sup.3and E.sup.3 are independently absent or independently selected from C.sub.1-6 alkylene, C.sub.2-6 alkenylene, C.sub.2-6 alkynylene, arylene, cycloalkylene, heteroarylene, and heterocycloalkylene, wherein each of the C.sub.1-6 alkylene, C.sub.2-6 alkenylene, C.sub.2-6 alkynylene, arylene, cycloalkylene, heteroarylene, and heterocycloalkylene is optionally substituted by 1, 2 or 3 substituents independently selected from halo, CN, NO.sub.2, N.sub.3, SCN, OH, C.sub.1-6 alkyl, C.sub.1-6 haloalkyl, C.sub.2-8 alkoxyalkyl, C.sub.1-6 alkoxy, C.sub.1-6 haloalkoxy, amino, C.sub.1-6 alkylamino, and C.sub.2-8 dialkylamino; E.sup.4 and E.sup.4 are independently selected from H, halo, C.sub.1-4 alkyl, C.sub.2-4 alkenyl, C.sub.2-4 alkynyl, C.sub.1-4 haloalkyl, halosulfanyl, C.sub.1-4 hydroxyalkyl, C.sub.1-4 cyanoalkyl, Cy.sup.1, CN, NO.sub.2, OR.sup.a, SR.sup.a, C(O)R.sup.b, C(O)NR.sup.cR.sup.a, C(O)OR.sup.a, OC(O)R.sup.bOC(O)NR.sup.cR.sup.d NR.sup.cR.sup.d, NR.sup.cC(O)R.sup.b, NR.sup.cC(O)NR.sup.cR.sup.d, NR.sup.cC(O)OR.sup.a, C(.dbd.NR.sup.i)NR.sup.cR.sup.d, NR.sup.cC(.dbd.NR.sup.i)NR.sup.cR.sup.d, S(O)R.sup.b, S(O)NR.sup.cR.sup.d, S(O).sub.2R.sup.b, NR.sup.cS(O).sub.2R.sup.b, C(.dbd.NOH)R.sup.b, C(.dbd.NO(C.sub.1-6 alkyl)R.sup.b, and S(O).sub.2NR.sup.cR.sup.d, wherein said C.sub.1-8 alkyl, C.sub.2-8 alkenyl, or C.sub.2-8 alkynyl, is optionally substituted with 1, 2, 3, 4, 5, or 6 substituents independently selected from halo, C.sub.1-4 alkyl, C.sub.2-4 alkenyl, C.sub.2-4 alkynyl, C.sub.1-4 haloalkyl, halosulfanyl, C.sub.1-4 hydroxyalkyl, C.sub.1-4 cyanoalkyl, Cy.sup.1, CN, NO.sub.2, OR.sup.a, SR.sup.a, C(O)R.sup.b, C(O)NR.sup.cR.sup.d, C(O)OR.sup.a, OC(O)R.sup.b, OC(O)NR.sup.cR.sup.d, NR.sup.cR.sup.d, NR.sup.cC(O)R.sup.b, NR.sup.cC(O)NR.sup.cR.sup.d, NR.sup.cC(O)OR.sup.a, C(.dbd.NR.sup.i)NR.sup.cR.sup.d, NR.sup.cC(.dbd.NR.sup.i)NR.sup.cR.sup.d, S(O)R.sup.b, S(O)NR.sup.cR.sup.d, S(O).sub.2R.sup.b, NR.sup.cS(O).sub.2R.sup.b, C(.dbd.NOH)R.sup.b, C(.dbd.NO(C.sub.1-6 alkyl))R.sup.b, and S(O).sub.2NR.sup.cR.sup.d; R.sup.a is H, Cy.sup.1, --(C.sub.1-6 alkyl)-Cy.sup.1, C.sub.1-6 alkyl, C.sub.1-6 haloalkyl, C.sub.2-6 alkenyl, C.sub.2-6 alkynyl, wherein said C.sub.1-6 alkyl, C.sub.1-6 haloalkyl, C.sub.2-6 alkenyl, or C.sub.2-6 alkynyl is optionally substituted with 1, 2, or 3 substituents independently selected from OH, CN, amino, halo, C.sub.1-6 alkyl, C.sub.1-6 haloalkyl, halosulfanyl, aryl, arylalkyl, heteroaryl, heteroarylalkyl, cycloalkyl and heterocycloalkyl; R.sup.b is H, Cy.sup.1, --(C.sub.1-6 alkyl)-Cy.sup.1, C.sub.1-6 alkyl, C.sub.1-6 haloalkyl, C.sub.2-6 alkenyl, C.sub.2-6 alkynyl, wherein said C.sub.1-6 alkyl, C.sub.1-61-6 haloalkyl, C.sub.2-6 alkenyl, or C.sub.2-6 alkynyl is optionally substituted with 1, 2, or 3 substituents independently selected from OH, CN, amino, halo, C.sub.1-6 alkyl, C.sub.1-6 haloalkyl, C.sub.1-6 haloalkyl, halosulfanyl, aryl, arylalkyl, heteroaryl, heteroarylalkyl, cycloalkyl and heterocycloalkyl; R.sup.a' and R.sup.a'' are independently selected from H, C.sub.1-6 alkyl, C.sub.1-6 haloalkyl, C.sub.2-6 alkenyl, C.sub.2-6 alkynyl, aryl, cycloalkyl, heteroaryl, heterocycloalkyl, arylalkyl, heteroarylalkyl, cycloalkylalkyl and heterocycloalkylalkyl, wherein said C.sub.1-6 alkyl, C.sub.1-6 haloalkyl, C.sub.2-6 alkenyl, C.sub.2-6 alkynyl, aryl, cycloalkyl, heteroaryl, heterocycloalkyl, arylalkyl, heteroarylalkyl, cycloalkylalkyl or heterocycloalkylalkyl is optionally substituted with 1, 2, or 3 substituents independently selected from OH, CN, amino, halo, C.sub.1-6 alkyl, C.sub.1-6 haloalkyl, halosulfanyl, aryl, arylalkyl, heteroaryl, heteroarylalkyl, cycloalkyl and heterocycloalkyl; R.sup.b' and R.sup.b'' are independently selected from H, C.sub.1-6 alkyl, C.sub.1-6 haloalkyl, C.sub.2-6 alkenyl, C.sub.2-6 alkynyl, aryl, cycloalkyl, heteroaryl, heterocycloalkyl, arylalkyl, heteroarylalkyl, cycloalkylalkyl and heterocycloalkylalkyl, wherein said C.sub.1-6 alkyl, C.sub.1-6 haloalkyl, C.sub.2-6 alkenyl, C.sub.2-6 alkynyl, aryl, cycloalkyl, heteroaryl, heterocycloalkyl, arylalkyl, heteroarylalkyl, cycloalkylalkyl or heterocycloalkylalkyl is optionally substituted with 1, 2, or 3 substituents independently selected from OH, CN, amino, halo, C.sub.1-6 alkyl, C.sub.1-6 haloalkyl, C.sub.1-6 haloalkyl, halosulfanyl, aryl, arylalkyl, heteroaryl, heteroarylalkyl, cycloalkyl and heterocycloalkyl; R.sup.c and R.sup.d are independently selected from H, Cy.sup.1, --(C.sub.1-6 alkyl)-Cy.sup.1, C.sub.1-10 alkyl, C.sub.1-6 haloalkyl, C.sub.2-6 alkenyl, C.sub.2-6 alkynyl, wherein said C.sub.1-10 alkyl, C.sub.1-6 haloalkyl, C.sub.2-6 alkenyl, or C.sub.2-6 alkynyl, is optionally substituted with 1, 2, or 3 substituents independently selected from Cy.sup.1, --(C.sub.1-6 alkyl)-Cy.sup.1, OH, CN, amino, halo, C.sub.1-6 alkyl, C.sub.1-6 haloalkyl, C.sub.1-6 haloalkyl, and halosulfanyl; or R.sup.c and R.sup.d together with the N atom to which they are attached form a 4-, 5-, 6- or 7-membered heterocycloalkyl group optionally substituted with 1, 2, or 3 substituents independently selected from Cy.sup.1, --(C.sub.1-6 alkyl)-Cy.sup.1, OH, CN, amino, halo, C.sub.1-6 alkyl, C.sub.1-6 haloalkyl, C.sub.1-6 haloalkyl, and halosulfanyl; R.sup.c' and R.sup.d' are independently selected from H, C.sub.1-10 alkyl, C.sub.1-6 haloalkyl, C.sub.2-6 alkenyl, C.sub.2-6 alkynyl, aryl, heteroaryl, cycloalkyl, heterocycloalkyl, arylalkyl, heteroarylalkyl, cycloalkylalkyl and heterocycloalkylalkyl, wherein said C.sub.1-10 alkyl, C.sub.1-6 haloalkyl, C.sub.2-6 alkenyl, C.sub.2-6 alkynyl, aryl, heteroaryl, cycloalkyl, heterocycloalkyl, arylalkyl, heteroarylalkyl, cycloalkylalkyl or heterocycloalkylalkyl is optionally substituted with 1, 2, or 3 substituents independently selected from OH, CN, amino, halo, C.sub.1-6 alkyl, C.sub.1-6 haloalkyl, C.sub.1-6 haloalkyl, halosulfanyl, aryl, arylalkyl, heteroaryl, heteroarylalkyl, cycloalkyl and heterocycloalkyl; or R.sup.c' and R.sup.d' together with the N atom to which they are attached form a 4-, 5-, 6- or 7-membered heterocycloalkyl group optionally substituted with 1, 2, or 3 substituents independently selected from OH, CN, amino, halo, C.sub.1-6 alkyl, C.sub.1-6 haloalkyl, C.sub.1-6 haloalkyl, halosulfanyl, aryl, arylalkyl, heteroaryl, heteroarylalkyl, cycloalkyl and heterocycloalkyl; R.sup.c'' and R.sup.d'' are independently selected from H, C.sub.1-10 alkyl, C.sub.1-6 haloalkyl, C.sub.2-6 alkenyl, C.sub.2-6 alkynyl, aryl, heteroaryl, cycloalkyl, heterocycloalkyl, arylalkyl, heteroarylalkyl, cycloalkylalkyl and heterocycloalkylalkyl, wherein said C.sub.1-10 alkyl, C.sub.1-6 haloalkyl, C.sub.2-6 alkenyl, C.sub.2-6 alkynyl, aryl, heteroaryl, cycloalkyl, heterocycloalkyl, arylalkyl, heteroarylalkyl, cycloalkylalkyl or heterocycloalkylalkyl is optionally substituted with 1, 2, or 3 substituents independently selected from OH, CN, amino, halo, C.sub.1-6 alkyl, C.sub.1-6 haloalkyl, halosulfanyl, C.sub.1-6 haloalkyl, aryl, arylalkyl, heteroaryl, heteroarylalkyl, cycloalkyl and heterocycloalkyl; or R.sup.c'' and R.sup.d'' together with the N atom to which they are attached form a 4-, 5-, 6- or 7-membered heterocycloalkyl group optionally substituted with 1, 2, or 3 substituents independently selected from OH, CN, amino, halo, C.sub.1-6 alkyl, C.sub.1-6 haloalkyl, C.sub.1-6 haloalkyl, halosulfanyl, aryl, arylalkyl, heteroaryl, heteroarylalkyl, cycloalkyl and heterocycloalkyl; R.sup.i is H, CN, NO.sub.2, or C.sub.1-6 alkyl; R.sup.e and R.sup.f are independently selected from H and C.sub.1-6 alkyl; R.sup.i is H, CN, or NO.sub.2; m is 0 or 1; n is 0 or 1; p is 0, 1, 2, 3, 4, 5, or 6; q is 0, 1, 2, 3, 4, 5 or 6; r is 0 or 1; and s is 0 or 1, to a patient in need of treatment thereof. 12. The method of claim 11, wherein the compound is administered in combination or alternation with a second anti-viral agent optionally selected from the group consisting of an interferon, a ribavirin, an interleukin, a NS3 protease inhibitor, a NS5A inhibitor, a cysteine protease inhibitor, a phenanthrenequinone, a thiazolidine derivative, a thiazolidine, a benzanilide, a helicase inhibitor, a polymerase inhibitor, a nucleotide analogue, a gliotoxin, a cerulenin, an antisense phosphorothioate oligodeoxynucleotide, an inhibitor of IRES-dependent translation, and a ribozyme. 13. The method of claim 12, wherein the second agent is selected from the group consisting of pegylated interferon alpha 2a, interferon alphacon-1, natural interferon, albuferon, interferon beta-la, omega interferon, interferon alpha, interferon gamma, interferon tau, interferon delta and interferon .gamma.-lb. 14. The method of claim 11, wherein the viral disease is caused by a virus selected from the group consisting of an adenovirus, an Alphaviridae, an Arbovirus, an Astro virus, a Bunyaviridae, a Coronaviridae, a Filoviridae, a Flaviviridae, a Hepadnaviridae, a Herpesviridae (such as HSV-1, HSV-2, EBV, CMV), an Alphaherpesvirinae, a Betaherpesvirinae, a Gammaherpesvirinae, a Norwalk Virus, an Astroviridae, a Caliciviridae, an Orthomyxoviridae, a Paramyxoviridae, a Paramyxoviruses, a Rubulavirus, a Morbillivirus, a Papovaviridae, a Parvoviridae, a Picornaviridae, an Aphthoviridae, a Cardioviridae, an Enteroviridae, a Coxsackie virus, a Polio Virus, a Rhinoviridae, a Phycodnaviridae, a Poxviridae, a Reoviridae, a Rotavirus, a Retroviridae, an A-Type Retrovirus, an Immunodeficiency Virus, a Leukemia Viruses, an Avian Sarcoma Viruses, a Rhabdoviruses, a Rubiviridae and a Togaviridae. 15. The method of claim 11, wherein the viral disease is caused by a Flaviviridae virus, Dengue virus, Chikungunya virus, BVDV virus, West Nile virus, hepatitis B virus, hepatitis C virus, or a combination of a hepatitis C virus with HIV and/or HBV. 16. A method of treating or eradicating an HIV infection, comprising: a) reducing viral loads in a patient by administering a JAK inhibitor of Formula A: ##STR00057## wherein: or the pharmaceutically acceptable salt thereof; wherein R.sup.1 is a group of the formula ##STR00058## wherein y is 0, 1 or 2; R.sup.4 is selected from the group consisting of hydrogen, (C.sub.1-C.sub.6)alkyl, (C.sub.1-C.sub.6)alkylsulfonyl, (C.sub.2-C.sub.6)alkenyl, (C.sub.2-C.sub.6)alkynyl wherein the alkyl, alkenyl and alkynyl groups are optionally substituted by deuterium, hydroxy, amino, trifluoromethl, C.sub.1-C.sub.4)alkoxy, (C.sub.1-C.sub.6)acyloxy, (C.sub.1-C.sub.6)alkylamino, ((C.sub.1-C.sub.6)alkyl).sub.2amino, cyano, nitro, (C.sub.2-C.sub.6)alkenyl, (C.sub.2-C.sub.6)alkynyl or (C.sub.1-C.sub.6)acylamino; or R.sup.4 is (C.sub.3-C.sub.10)cycloalkyl wherein the cycloalkyl group is optionally substituted by deuterium, hydroxy, amino, trifluoromethyl, (C.sub.1-C.sub.6)acyloxy, (C.sub.1-C.sub.6)acylamino, (C.sub.1-C.sub.6)alkylamino, ((C.sub.1-C.sub.6)alkyl).sub.2amino, cyano, cyano(C.sub.1-C.sub.6)alkyl, trifluoromethyl(C.sub.1-C.sub.6)alkyl, nitro, nitro(C.sub.1-C.sub.6)alkyl or (C.sub.1-C.sub.6)acylamino; R.sup.5 is (C.sub.2-C.sub.9)heterocycloalkyl wherein the heterocycloalkyl groups must be substituted by one to five carboxy, cyano, amino, deuterium, hydroxy, (C.sub.1-C.sub.6) alkyl, (C.sub.1-C.sub.6)alkoxy, halo, (C.sub.1-C.sub.6)acyl, (C.sub.1-C.sub.6)alkylamino, amino(C.sub.1-C.sub.6)alkyl, (C.sub.1-C.sub.6)alkoxy-CO--NH, (C.sub.1-C.sub.6)alkylamino-CO--, (C.sub.2-C.sub.6)alkenyl, (C.sub.2-C.sub.6) alkynyl, (C.sub.1-C.sub.6)alkylamino, amino(C.sub.1-C.sub.6)alkyl, hydroxy(C.sub.1-C.sub.6)alkyl, (C.sub.1-C.sub.6)alkoxy(C.sub.1-C.sub.6)alkyl, (C.sub.1-C.sub.6)acyloxy(C.sub.1-C.sub.6)alkyl, nitro, cyano(C.sub.1-C.sub.6)alkyl, halo(C.sub.1-C.sub.6)alkyl, nitro(C.sub.1-C.sub.6)alkyl, trifluoromethyl, trifluoromethyl(C.sub.1-C.sub.6)alkyl, (C.sub.1-C.sub.6)acylamino, (C.sub.1-C.sub.6)acylamino(C.sub.1-C.sub.6)alkyl, (C.sub.1-C.sub.6)alkoxy(C.sub.1-C.sub.6)acylamino, amino(C.sub.1-C.sub.6)acyl, amino(C.sub.1-C.sub.6)acyl(C.sub.1-C.sub.6)alkyl, (C.sub.1-C.sub.6)alkylamino(C.sub.1-C.sub.6)acyl, ((C.sub.1-C.sub.6)alkyl).sub.2amino(C.sub.1-C.sub.6)acyl, R.sup.15R.sup.16N--CO--O--, R.sup.15R.sup.16N--CO--(C.sub.1-C.sub.6)alkyl, (C.sub.1-C.sub.6)alkyl-S(O).sub.m, R.sup.15R.sup.16NS(O).sub.m, R.sup.15R.sup.16NS(O).sub.m(C.sub.1-C.sub.6)alkyl, R.sup.15S(O).sub.mR.sup.16N, R.sup.15S(O).sub.mR.sup.16(C.sub.1-C.sub.6)alkyl wherein m is 0, 1 or 2 and R.sup.15 and R.sup.16 are each independently selected from hydrogen or (C.sub.1-C.sub.6)alkyl; or a group of the formula ##STR00059## wherein a is 0, 1, 2, 3 or 4; b, c, e, f and g are each independently 0 or 1; d is 0, 1, 2, or 3; X is S(O).sub.n wherein n is 0, 1 or 2; oxygen carbonyl or --C(.dbd.N-cyano)-; Y is S(O).sub.n wherein n is 0, 1 or 2; or carbonyl; and Z is carbonyl, C(O)O--, C(O)NR-- or S(O).sub.n wherein n is 0, 1 or 2; R.sup.6, R.sup.7, R.sup.8, R.sup.9, R.sup.10 and R.sup.11 are each independently selected from the group consisting of hydrogen or (C.sub.1-C.sub.6)alkyl optionally substituted by deuterium, hydroxy, amino, trifluoromethyl, (C.sub.1-C.sub.6)acyloxy, (C.sub.1-C.sub.6)acylamino, (C.sub.1-C.sub.6)alklamino, ((C.sub.1-C.sub.6)alkyl).sub.2amino, cyano, cyano(C.sub.1-C.sub.6)alkyl, trifluoromethyl(C.sub.1-C.sub.6)alkyl, nitro, nitro(C.sub.1-C.sub.6)alkyl or (C.sub.1-C.sub.6)acylamino; R.sup.12 is carboxy, cyano, amino, oxo, deuterium, hydroxy, trifluoromethyl, (C.sub.1-C.sub.6) alkyl, trifluoromethyl(C.sub.1-C.sub.6)alkyl, (C.sub.1-C.sub.6)alkoxy, halo, (C.sub.1-C.sub.6)acyl, (C.sub.1-C.sub.6)alkylamino, ((C.sub.1-C.sub.6)alkyl).sub.2amino, amino(C.sub.1-C.sub.6)alkyl, (C.sub.1-C.sub.6)alkoxy-CO--NH, (C.sub.1-C.sub.6)alkylamino-CO--, (C.sub.2-C.sub.6)alkenyl, (C.sub.2-C.sub.6) alkynyl, (C.sub.1-C.sub.6)alkylamino, hydroxy(C.sub.1-C.sub.6)alkyl, (C.sub.1-C.sub.6)alkoxy(C.sub.1-C.sub.6)alkyl, (C.sub.1-C.sub.6)acyloxy(C.sub.1-C.sub.6)alkyl, nitro, cyano(C.sub.1-C.sub.6)alkyl, halo (C.sub.1-C.sub.6)alkyl, nitro(C.sub.1-C.sub.6)alkyl, trifluoromethyl, trifluoromethyl(C.sub.1-C.sub.6)alkyl, (C.sub.1-C.sub.6)acylamino, (C.sub.1-C.sub.6)acylamino(C.sub.1-C.sub.6)alkyl, (C.sub.1-C.sub.6)alkoxy(C.sub.1-C.sub.6)acylamino, amino(C.sub.1-C.sub.6)acyl, amino(C.sub.1-C.sub.6)acyl(C.sub.1-C.sub.6)alkyl, (C.sub.1-C.sub.6)alkylamino(C.sub.1-C.sub.6)acyl, ((C.sub.1-C.sub.6)alkyl).sub.2amino(C.sub.1-C.sub.6)acyl, R.sup.15R.sub.16N--CO--O--, R.sup.15R.sub.16N--CO--(C.sub.1-C.sub.6)alkyl, R.sup.15C(O)NH, R.sup.15OC(O)NH, R.sup.15NHC(O)NH, (C.sub.1-C.sub.6)alkyl-S(O).sub.m, (C.sub.1-C.sub.6)alkyl-S(O).sub.M--(C.sub.1-C.sub.6)alkyl, R.sup.15R.sup.16NS(O).sub.m, R.sup.15R.sup.16NS(O).sub.m(C.sub.1-C.sub.6)alkyl, R.sup.15S(O).sub.mR.sup.16N, R.sup.15S(O).sub.mR.sup.16N(C.sub.1-C.sub.6)alkyl wherein m is 0, 1 or 2 and R.sup.15 and R.sup.16 are each independently selected from hydrogen or (C.sub.1-C.sub.6)alkyl; R.sup.2 and R.sup.3 are each independently selected from the group consisting of hydrogen, deuterium, amino, halo, hydroxy, nitro, carboxy, (C.sub.2-C.sub.6)alkenyl, (C.sub.2-C.sub.6)alkynyl, trifluoromethyl, trifluoromethoxy, (C.sub.1-C.sub.6)alkyl, (C.sub.1-C.sub.6)alkoxy, (C.sub.3-C.sub.10)cycloalkyl wherein the alkyl, alkoxy or cycloalkyl groups are optionally substituted by one to three groups selected from halo, hydroxy, carboxy, amino (C.sub.1-C.sub.6)alkylthio, (C.sub.1-C.sub.6)alkylamino, ((C.sub.1-C.sub.6)alkyl).sub.2amino, (C.sub.5-C.sub.9)heteroaryl, (C.sub.2-C.sub.9)heterocycloalkyl, (C.sub.3C.sub.9)cycloalkyl or (C.sub.6-C.sub.10)aryl; or R.sup.2 and R.sup.3 are each independently (C.sub.3-C.sub.10)cycloalkyl, (C.sub.3-C.sub.10)cycloalkoxy, (C.sub.1-C.sub.6)alkylamino, ((C.sub.1-C.sub.6)alkyl).sub.2amino, (C.sub.6-C.sub.10)arylamino, (C.sub.1-C.sub.6)alkylthio, (C.sub.6-C.sub.10)arylthio, (C.sub.1-C.sub.6)alkylsulfinyl, (C.sub.6-C.sub.10)arylsulfinyl, (C.sub.1-C.sub.6)alkylsulfonyl, (C.sub.6-C.sub.10)arylsulfonyl, (C.sub.1-C.sub.6)acyl, (C.sub.1-C.sub.6)alkoxy-CO--NH--, (C.sub.1-C.sub.6)alkylamino-CO--, (C.sub.5-C.sub.9)heteroaryl, (C.sub.2-C.sub.9)heterocycloalkyl or (C.sub.6-C.sub.10)aryl wherein the heteroaryl, heterocycloalkyl and aryl groups are optionally substituted by one to three halo, (C.sub.1-C.sub.6)alkyl, (C.sub.1-C.sub.6)alkyl-CO--NH--, (C.sub.1-C.sub.6) alkoxy-CO--NH--, (C.sub.1-C.sub.6)alkyl-CO--NH--(C.sub.1-C.sub.6)alkyl, (C.sub.1-C.sub.6)alkoxy-CO--NH--(C.sub.1-C.sub.6)alkyl, (C.sub.1-C.sub.6)alkoxy-CO--NH--(C.sub.1-C.sub.6)alkoxy, carboxy, carboxy(C.sub.1-C.sub.6)alkoxy, carboxy(C.sub.1-C.sub.6)alkoxy, benzyloxycarbonyl (C.sub.1-C.sub.6 alkoxy, (C.sub.1-C.sub.6)alkoxycarbonyl(C.sub.1-C.sub.6)alkoxy, (C.sub.6-C.sub.10)aryl, amino, amino(C.sub.1-C.sub.6)alkyl, (C.sub.1-C.sub.6)alkoxycarbonylamino, (C.sub.6-C.sub.10)aryl(C.sub.1-C.sub.6)alkoxycarbonylamino, (C.sub.1-C.sub.6)alkylamino, ((C.sub.1-C.sub.6)alkyl).sub.2amino, (C.sub.1-C.sub.6)alkylamino(C.sub.1-C.sub.6)alkyl, ((C.sub.1-C.sub.6)alkyl).sub.2amino(C.sub.1-C.sub.6)alkyl, hydroxy, (C.sub.1-C.sub.6)alkoxy, carboxy, carboxy(C.sub.1-C.sub.6)alkyl, (C.sub.1-C.sub.6)alkoxycarbonyl, (C.sub.1-C.sub.6)alkoxycarbonyl(C.sub.1-C.sub.6)alkyl, (C.sub.1-C.sub.6)alkoxy-CO--NH--, (C.sub.1-C.sub.6)alkyl-CO--NH --, cyano, (C.sub.5-C.sub.9)heterocycloalkyl, amino-CO--NH--, (C.sub.1-C.sub.6)alkylamino-CO--NH--, ((C.sub.1-C.sub.6)alkyl).sub.2amino-CO--NH--, (C.sub.6-C.sub.10)arylamino-CO--NH--, (C.sub.5C.sub.9)heteroarylamino-CO--NH--, (C.sub.1-C.sub.6)alkylamino-CO--NH--(C.sub.1-C.sub.6)alkyl, ((C.sub.1-(C.sub.6)alkyl).sub.2amino-CO--NH--(C.sub.1-C.sub.6) alkyl, (C.sub.6-C.sub.10)arylamino-CO--NH--(C.sub.1-C.sub.6)alkyl, (C.sub.5-C.sub.9)heteroarylamino-CO--NH--(C.sub.1-C.sub.6)alkyl, (C.sub.1-C.sub.6)alkylsulfonyl, (C.sub.1-C.sub.6)alkylsulfonylamino, (C.sub.1-C.sub.6)alkylsulfonylamino(C.sub.1-C.sub.6)alkyl, (C.sub.6-C.sub.10)arylsulfonyl (C.sub.6-C.sub.10)arylsulfonylamino, (C.sub.6-C.sub.10)arylsulfonylamino(C.sub.1-C.sub.6)alkyl, (C.sub.1-C.sub.6)alkylsulfonylamino, (C.sub.1-C.sub.6)alkylsulfonylamino(C.sub.1-C.sub.6)alkyl, (C.sub.5-C.sub.9)heteroaryl or (C.sub.2-C.sub.9)heterocycloalkyl, or of Formula B: ##STR00060## including pharmaceutically acceptable salt forms or prodrugs thereof, wherein: A.sup.1 and A.sup.2 are independently selected from C and N; T, U, and V are independently selected from O, S, N, CR.sup.5, and NR.sup.6; wherein the 5-membered ring formed by A.sup.1, A.sup.2, U, T, and V is aromatic; X is N or CR.sup.4; Y is C.sub.1-8 alkylene, C.sub.2-8 alkenylene, C.sub.2-8 alkynylene, (CR.sup.11R.sup.12).sub.p--C.sub.3-10 cycloalkylene)-(CR.sup.11R.sup.12).sub.q, (CR.sup.11R.sup.12).sub.p(arylene)-(CR.sup.11R.sup.12).sub.q, (CR.sup.11R.sup.12).sub.\p--(C.sub.1-10 heterocycloalkylene)-(CR.sup.11R.sup.12).sub.q, (CR.sup.11R.sup.12).sub.p-(heteroarylene)-(CR.sup.11R.sup.12).sub.q, (CR.sup.11R.sup.12).sub.pO(CR.sup.11R.sup.12).sub.q, (CR.sup.11R.sup.12).sub.pS(CR.sup.11R.sup.12).sub.q, (CR.sup.11R.sup.12).sub.pC(O)(CR.sup.11R.sup.12).sub.q, (CR.sup.11R.sup.12).sub.pC(O)NR.sub.c(CR.sup.11R.sup.12).sub.q, (CR.sup.11R.sup.12).sub.pC(O)O(CR.sup.11R.sup.12).sub.q, (CR.sup.11R.sup.12).sub.pOC(O)(CR.sup.11R.sup.12).sub.q, (CR.sup.11R.sup.12).sub.pOC(O)NR.sup.c(CR.sup.11R.sup.12).sub.q, (CR.sup.11R.sup.12).sub.pNR.sup.c(CR.sup.11R.sup.12).sub.q, (CR.sup.11R.sup.12).sub.pNR.sup.cC(O)NR.sup.d(CR.sup.11R.sup.12).sub.q, (CR.sup.11R.sup.12).sub.pS(O)(CR.sup.11R.sup.12).sub.q, (C.sup.11R.sup.12).sub.pS(O) NR.sup.c(C.sup.11R.sup.12).sub.q, (CR.sup.11R.sup.12).sub.pS(O).sub.2(CR.sup.11R.sup.12).sub.q, or (C.sup.11R.sup.12).sub.pS(O) NR.sup.c(C.sup.11R.sup.12).sub.q, wherein said C.sub.1-8 alkylene, C.sub.2-8 alkenylene, C.sub.2-8 alkynylene, cycloalkylene, arylene, heterocycloalkylene, or heteroarylene, is optionally substituted with 1, 2, or 3 substituents independently selected from -D.sup.1-D.sup.2-D.sup.3-D.sup.4; Z is H, halo, C.sub.1-4 alkyl, C.sub.2-4 alkenyl, C.sub.2-4 alkynyl, C.sub.1-4 haloalkyl, halosulfanyl, C.sub.1-4 hydroxalkyl, C.sub.1-4 cyanoalkyl, .dbd.C--R.sup.i, .dbd.N---R.sup.i, Cy.sup.1, CN, NO.sub.2, OR.sup.a, SR.sup.a, C(O)R.sup.b, C(O)NR.sup.cR.sup.d, C(O)OR.sup.a, OC(O)R.sup.b, OC(O)NR.sup.cR.sup.d, NR.sup.cR.sup.d, NR.sup.cC(O)R.sup.b, NR.sup.cC(O)NR.sup.cR.sup.d, NR.sup.cC(O)OR.sup.a, C(.dbd.NR.sup.i)NR.sup.cR.sup.d, NR.sup.cC(.dbd.NR.sup.i)NR.sup.cR.sup.d, S(O)R.sup.b, S(O)NR.sup.cR.sup.d, S(O).sub.2R.sup.d, NR.sup.cS(O).sub.2R.sup.b, C(.dbd.NOH)R.sup.b, C(.dbd.NO(C.sub.1-6alkyl)R.sup.b, and S(O).sub.2NR.sup.cR.sup.d, wherein said C.sub.1-8 alkyl, C.sub.2-8 alkenyl, or C.sub.2-8 alkynyl, is optionally substituted with 1, 2, 3, 4, 5, or 6 substituents independently selected from halo, C.sub.1-4 alkyl, C.sub.2-4 alkenyl, C.sub.2-4 alkynyl, C.sub.1-4 haloalkyl, halosulfanyl, C.sub.1-4 hydroxyalkyl, C.sub.1-4 cyanoalkyl, Cy.sup.1, CN, N.sub.2, OR.sup.a, SR.sup.a, C(O)R.sup.b, C(O)NR.sup.cR.sup.d, C(O)OR.sup.a, OC(O)R.sup.b, OC(O)NR.sup.cR.sup.d, NR.sup.cR.sup.d, NR.sup.cC(O)R.sup.b, NR.sup.cC(O)NR.sup.cR.sup.d, NR.sup.cC(O)OR.sup.a, C(.dbd.NR.sup.i)NR.sup.cR.sup.d, NR.sup.cC(.dbd.NR.sup.i)NR.sup.cR.sup.d, S(O)R.sup.b S(O)NR.sup.cR.sup.d, S(O).sub.2R.sup.b, NR.sup.cS(O).sub.2R.sup.b, C(.dbd.NOH)R.sup.b, C(.dbd.NO(C.sub.1-6 alkyl))R.sup.b, and S(O).sub.2NR.sup.cR.sup.d; wherein when Z is H, n is 1; or the --(Y).sub.n--Z moiety is taken, together with i) A.sup.2 to which the moiety is attached, ii) R.sup.5 or R.sup.6 of either T or V, and iii) the C or N atom to which the R.sup.5 or R.sup.6 of either T or V is attached to form a 4- to 20-membered aryl, cycloalkyl, heteroaryl, or heterocycloalkyl ring fused to the 5-membered ring formed by A.sup.1 A.sup.2, U, T, and V, wherein said 4- to 20-membered aryl, cycloalkyl, heteroaryl, or heterocycloalkyl ring is optionally substituted by 1, 2, 3, 4, or 5 substituents independently selected from --(W).sub.m-Q; W is C.sub.1-8 alkylenyl, C.sub.2-8 alkenylenyl, C.sub.2-8 alkynylenyl, O, S, C(O), C(O)NR.sup.c', C(O)O, OC(O), OC(O)NR.sup.c', NR.sup.c', NR.sup.c'C(O)NR.sup.d', S(O), S(O)NR.sup.c', S(O).sub.2, or S(O)2NR.sup.c'; Q is H, halo, CN, NO.sub.2, C.sub.1-8 alkyl, C.sub.2-8 alkenyl, C.sub.2-8 alkynyl, C.sub.1-8 haloalkyl, halosulfanyl, aryl, cycloalkyl, heteroaryl, or heterocycloalkyl, wherein said C.sub.1-8 alkyl, C.sub.2-8 alkenyl, C.sub.2-8 alkynyl, C.sub.1-8 haloalkyl, aryl, cycloalkyl, heteroaryl, or heterocycloalkyl is optionally substituted with 1, 2, 3 or 4 substituents independently selected from halo, C.sub.1-4 alkyl, C.sub.2-4 alkenyl, C.sub.2-4 alkynyl, C.sub.1-4 haloalkyl, halosulfanyl, C.sub.1-4 hydroxyalkyl, C.sub.1-4 cyanoalkyl, Cy.sup.2, CN, NO.sub.2, OR.sup.a', SR.sup.a', C(O)R.sup.b', C(O)NR.sup.c'R.sup.d', C(O)OR.sup.a', OC(O)R.sup.b', OC(O)NR.sup.c'R.sup.d', NR.sup.c'R.sup.d', NR.sup.c'C(O)R.sup.b', NR.sup.c'C(O)N R.sup.c'R.sup.d', N R.sup.c'C(O)OR.sup.a', S(O)R.sup.b', S(O)N R.sup.c'R.sup.d', S(O).sub.2R.sup.b', NR.sup.c'S(O).sub.2R.sup.b', and S(O).sub.2N R.sup.c'R.sup.d'; Cy.sup.1 and Cy.sup.2 are independently selected from aryl, heteroaryl, cycloalkyl, and heterocycloalkyl, each optionally substituted by 1, 2, 3, 4 or 5 substituents independently selected from halo, C.sub.1-4 alkyl, C.sub.2-4 alkenyl, C.sub.2-4 alkynyl, C.sub.1-4 haloalkyl, halosulfanyl, C.sub.1-4 hydroxyalkyl, C.sub.1-4 cyanoalkyl, CN, NO.sub.2, OR.sup.a'', SR.sup.a'', C(O)R.sup.b'', C(O)NR.sup.c''R.sup.d'', C(O)OR.sup.a'', OC(O)R.sup.b'', OC(O)N R.sup.c''R.sup.d'', NR.sup.c''R.sup.d'', NR.sup.c''C(O)R.sup.b'', NR.sup.c''C(O)OR.sup.a'', NR.sup.c''S(O)R.sup.b'', NR.sup.c''S(O).sub.2R.sup.b'', S(O)R.sup.b'', S(O)NR.sup.c''R.sup.d'', S(O).sub.2R.sup.b'', and S(O).sub.2NR.sup.c''R.sup.d''; R.sup.1, R.sup.2, R.sup.3, and R.sup.4 are independently selected from H, halo, C.sub.1-4 alkyl, C.sub.2-4 alkenyl, C.sub.2-4 alkynyl, C.sub.1-4 haloalkyl, halosulfanyl, aryl, cycloalkyl, heteroaryl, heterocycloalkyl, CN, NO.sub.2, OR.sup.7, SR.sup.7, C(O)R.sup.8, C(O)NR.sup.9R.sup.10, C(O)OR.sup.7OC(O)R.sup.8, OC(O)NR.sup.9R.sup.10, NR.sup.9R.sup.10, NR.sup.9C(O)R.sup.8, NR.sup.cC(O)OR.sup.7, S(O)R.sup.8, S(O)NR.sup.9R.sup.10, S(O).sub.2R.sup.8, NR.sup.9S(O).sub.2R.sup.8, and S(O).sub.2NR.sup.9R.sup.10; R.sup.5 is H, halo, C.sub.1-4 alkyl, C.sub.2-4 alkenyl, C.sub.2-4 alkynyl, C.sub.1-4 haloalkyl, halosulfanyl, CN, NO.sub.2, OR.sup.7, SR.sup.7, C(O)R.sup.8, C(O)NR.sup.9R.sup.10, C(O)OR.sup.7, OC(O)R.sup.8, OC(O)NR.sup.9R.sup.10, NR.sup.9R.sup.10, NR.sup.9C(O)R.sup.8, NR.sup.9C(O)OR.sup.7, S(O)R.sup.8, S(O)NR.sup.9R.sup.10, S(O).sub.2R.sup.8, NR.sup.9S(O).sub.2R.sup.8, or S(O).sub.2NR.sup.9R.sup.10; R.sup.6 is H, C.sub.1-4 alkyl, C.sub.2-4 alkenyl, C.sub.2-4 alkynyl, C.sub.1-4 haloalkyl, OR.sup.7, C(O)R.sup.8, C(O)NR.sup.9R.sup.10, C(O)OR.sup.7, S(O)R.sup.8, S(O)NR.sup.9R.sup.10, S(O).sub.2R.sup.8, or S(O).sub.2NR.sup.9R.sup.10; R.sup.7 is H, C.sub.1-6 alkyl, C.sub.1-6 haloalkyl, C.sub.2-6 alkenyl, C.sub.2-6 alkynyl, aryl, cycloalkyl, heteroaryl, heterocycloalkyl, arylalkyl, heteroarylalkyl, cycloalkylalkyl or heterocycloalkylalkyl; R.sup.8 is H, C.sub.1-6 alkyl, C.sub.1-6 haloalkyl, C.sub.2-6 alkenyl, C.sub.2-6 alkynyl, aryl, cycloalkyl, heteroaryl, heterocycloalkyl, arylalkyl, heteroarylalkyl, cycloalkylalkyl or heterocycloalkylalkyl; R.sup.9 and R.sup.10 are independently selected from H, C.sub.1-10 alkyl, C.sub.1-6 haloalkyl, C.sub.2-6 alkenyl, C.sub.2-6 alkynyl, C.sub.1-6 alkylcarbonyl, arylcarbonyl, C.sub.1-6 alkylsulfonyl, arylsulfonyl, aryl, heteroaryl, cycloalkyl, heterocycloalkyl, arylalkyl, heteroarylalkyl, cycloalkylalkyl and heterocycloalkylalkyl; or R.sup.9 and R.sup.10 together with the N atom to which they are attached form a 4-, 5-, 6- or 7-membered heterocycloalkyl group; R.sup.11 and R.sup.12 are independently selected from H and -E.sup.1-E.sup.2-E.sup.3-E.sup.4; D.sup.1 and E.sup.1 are independently absent or independently selected from C.sub.1-6 alkylene, C.sub.2-6 alkenylene, C.sub.2-6 alkynylene, arylene, cycloalkylene, heteroarylene, and heterocycloalkylene, wherein each of the C.sub.1-6 alkylene, C.sub.2-6 alkenylene, C.sub.2-6 alkynylene, arylene, cycloalkylene, heteroarylene, and heterocycloalkylene is optionally substituted by 1, 2 or 3 substituents independently selected from halo, CN, NO.sub.2, N.sub.3, SCN, OH, C.sub.1-6 alkyl, C.sub.1-6 haloalkyl, C.sub.2-8 alkoxyalkyl, C.sub.1-6 alkoxy, C.sub.1-6 haloalkoxy, amino, C.sub.1-6 alkylamino, and C.sub.2-8 dialkylamino; D.sup.2 and E.sup.2 are independently absent or independently selected from C.sub.1-6 alkylene, C.sub.2-6 alkenlene, C.sub.2-6 alkylene, (C.sub.1-6 alkylene).sub.r--O--(C.sub.1-6 alkylene).sub.s, (C.sub.1-6 alkylene).sub.r--S--(C.sub.1-6 alkylene).sub.s, (C.sub.1-6 alkylene).sub.r--NR.sup.c--(C.sub.1-6 alkylene).sub.s, (C.sub.1-6 alkylene).sub.r--CO--(C.sub.1-6 alkylene).sub.s, (C.sub.1-6 alkylene).sub.r--COO--(C.sub.1-6 alkylene).sub.s, (C.sub.1-6 alkylene).sub.r--CONR.sup.c--(C.sub.1-6 alkylene).sub.s, (C.sub.1-6 alkylene).sub.r--SO--(C.sub.1-6 alkylene).sub.s, (C.sub.1-6 alkylene).sub.r--SO.sub.2--(C.sub.1-6alkylene).sub.s, (C.sub.1-6 alkylene).sub.r--SONR.sup.c--(C.sub.1-6 alkylene).sub.s, and (C.sub.1-6 alkylene).sub.r--NR.sup.cCONR.sup.f--(C.sub.1-6 alkylene).sub.s, wherein each of the C.sub.1-6 alkylene, C.sub.2-6 alkenylene, and C.sub.2-6 alkynylene is optionally substituted by 1, 2 or 3 substituents independently selected from halo, CN, NO.sub.2, N.sub.3, SCN, OH, C.sub.1-6 alkyl, C.sub.1-6 haloalkyl, C.sub.2-8 alkoxyalkyl, C.sub.1-6 alkoxy, C.sub.1-6 haloalkoxy, amino, C.sub.1-6 alkylamino, and C.sub.2-8 dialkylamino; D.sup.3and E.sup.3 are independently absent or independently selected from C.sub.1-6 alkylene, C.sub.2-6 alkenylene, C.sub.2-6 alkynylene, arylene, cycloalkylene, heteroarylene, and heterocycloalkylene, wherein each of the C.sub.1-6 alkylene, C.sub.2-6 alkenylene, C.sub.2-6 alkynylene, arylene, cycloalkylene, heteroarylene, and heterocycloalkylene is optionally substituted by 1, 2 or 3 substituents independently selected from halo, CN, NO.sub.2, N.sub.3, SCN, OH, C.sub.1-6 alkyl, C.sub.1-6 haloalkyl, C.sub.2-8 alkoxyalkyl, C.sub.1-6 alkoxy, C.sub.1-6 haloalkoxy, amino, C.sub.1-6 alkylamino, and C.sub.2-8 dialkylamino; E.sup.4 and E.sup.4 are independently selected from H, halo, C.sub.1-4 alkyl, C.sub.2-4 alkenyl, C.sub.2-4 alkynyl, C.sub.1-4 haloalkyl, halosulfanyl, C.sub.1-4 hydroxyalkyl, C.sub.1-4 cyanoalkyl, Cy.sup.1, CN, NO.sub.2, OR.sup.a, SR.sup.a, C(O)R.sup.b, C(O)NR.sup.cR.sup.a, C(O)OR.sup.a, OC(O)R.sup.bOC(O)NR.sup.cR.sup.d NR.sup.cR.sup.d, NR.sup.cC(O)R.sup.b, NR.sup.cC(O)NR.sup.cR.sup.d, NR.sup.cC(O)OR.sup.a, C(.dbd.NR.sup.i)NR.sup.cR.sup.d, NR.sup.cC(.dbd.NR.sup.i)NR.sup.cR.sup.d, S(O)R.sup.b, S(O)NR.sup.cR.sup.d, S(O).sub.2R.sup.b, NR.sup.cS(O).sub.2R.sup.b, C(.dbd.NOH)R.sup.b, C(.dbd.NO(C.sub.1-6 alkyl)R.sup.b, and S(O).sub.2NR.sup.cR.sup.d, wherein said C.sub.1-8 alkyl, C.sub.2-8 alkenyl, or C.sub.2-8 alkynyl, is optionally substituted with 1, 2, 3, 4, 5, or 6 substituents independently selected from halo, C.sub.1-4 alkyl, C.sub.2-4 alkenyl, C.sub.2-4 alkynyl, C.sub.1-4 haloalkyl, halosulfanyl, C.sub.1-4 hydroxyalkyl, C.sub.1-4 cyanoalkyl, Cy.sup.1, CN, NO.sub.2, OR.sup.a, SR.sup.a, C(O)R.sup.b, C(O)NR.sup.cR.sup.d, C(O)OR.sup.a, OC(O)R.sup.b, OC(O)NR.sup.cR.sup.d, NR.sup.cR.sup.d, NR.sup.cC(O)R.sup.b, NR.sup.cC(O)NR.sup.cR.sup.d, NR.sup.cC(O)OR.sup.a, C(.dbd.NR.sup.i)NR.sup.cR.sup.d, NR.sup.cC(.dbd.NR.sup.i)NR.sup.cR.sup.d, S(O)R.sup.b, S(O)NR.sup.cR.sup.d, S(O).sub.2R.sup.b, NR.sup.cS(O).sub.2R.sup.b, C(.dbd.NOH)R.sup.b, C(.dbd.NO(C.sub.1-6 alkyl))R.sup.b, and S(O).sub.2NR.sup.cR.sup.d; R.sup.a is H, Cy.sup.1, --(C.sub.1-6 alkyl)-Cy.sup.1, C.sub.1-6 alkyl, C.sub.1-6 haloalkyl, C.sub.2-6 alkenyl, C.sub.2-6 alkynyl, wherein said C.sub.1-6 alkyl, C.sub.1-6 haloalkyl, C.sub.2-6 alkenyl, or C.sub.2-6 alkynyl is optionally substituted with 1, 2, or 3 substituents independently selected from OH, CN, amino, halo, C.sub.1-6 alkyl, C.sub.1-6 haloalkyl, halosulfanyl, aryl, arylalkyl, heteroaryl, heteroarylalkyl, cycloalkyl and heterocycloalkyl; R.sup.b is H, Cy.sup.1, --(C.sub.1-6 alkyl)-Cy.sup.1, C.sub.1-6 alkyl, C.sub.1-6 haloalkyl, C.sub.2-6 alkenyl, C.sub.2-6 alkynyl, wherein said C.sub.1-6 alkyl, C.sub.1-61-6 haloalkyl, C.sub.2-6 alkenyl, or C.sub.2-6 alkynyl is optionally substituted with 1, 2, or 3 substituents independently selected from OH, CN, amino, halo, C.sub.1-6 alkyl, C.sub.1-6 haloalkyl, C.sub.1-6 haloalkyl, halosulfanyl, aryl, arylalkyl, heteroaryl, heteroarylalkyl, cycloalkyl and heterocycloalkyl; R.sup.a' and R.sup.a'' are independently selected from H, C.sub.1-6 alkyl, C.sub.1-6 haloalkyl, C.sub.2-6 alkenyl, C.sub.2-6 alkynyl, aryl, cycloalkyl, heteroaryl, heterocycloalkyl, arylalkyl, heteroarylalkyl, cycloalkylalkyl_and heterocycloalkylalkyl, wherein said C.sub.1-6 alkyl, C.sub.1-6 haloalkyl, C.sub.2-6 alkenyl, C.sub.2-6 alkynyl, aryl, cycloalkyl, heteroaryl, heterocycloalkyl, arylalkyl, heteroarylalkyl, cycloalkylalkyl or heterocycloalkylalkyl is optionally substituted with 1, 2, or 3 substituents independently selected from OH, CN, amino, halo, C.sub.1-6 alkyl, C.sub.1-6 haloalkyl, halosulfanyl, aryl, arylalkyl, heteroaryl, heteroarylalkyl, cycloalkyl and heterocycloalkyl; R.sup.b' and R.sup.b'' are independently selected from H, C.sub.1-6 alkyl, C.sub.1-6 haloalkyl, C.sub.2-6 alkenyl, C.sub.2-6 alkynyl, aryl, cycloalkyl, heteroaryl, heterocycloalkyl, arylalkyl, heteroarylalkyl, cycloalkylalkyl and heterocycloalkylalkyl, wherein said C.sub.1-6 alkyl, C.sub.1-6 haloalkyl, C.sub.2-6 alkenyl, C.sub.2-6 alkynyl, aryl, cycloalkyl, heteroaryl, heterocycloalkyl, arylalkyl, heteroarylalkyl, cycloalkylalkyl or heterocycloalkylalkyl is optionally substituted with 1, 2, or 3 substituents independently selected from OH, CN, amino, halo, C.sub.1-6 alkyl, C.sub.1-6 haloalkyl, C.sub.1-6 haloalkyl, halosulfanyl, aryl, arylalkyl, heteroaryl, heteroarylalkyl, cycloalkyl and heterocycloalkyl; R.sup.c and R.sup.d are independently selected from H, Cy.sup.1, --(C.sub.1-6 alkyl)-Cy.sup.1, C.sub.1-10 alkyl, C.sub.1-6 haloalkyl, C.sub.2-6 alkenyl, C.sub.2-6 alkynyl, wherein said C.sub.1-10 alkyl, C.sub.1-6 haloalkyl, C.sub.2-6 alkenyl, or C.sub.2-6 alkynyl, is optionally substituted with 1, 2, or 3 substituents independently selected from Cy.sup.1, --(C.sub.1-6 alkyl)-Cy.sup.1, OH, CN, amino, halo, C.sub.1-6 alkyl, C.sub.1-6 haloalkyl, C.sub.1-6 haloalkyl, and halosulfanyl; or R.sup.c and R.sup.d together with the N atom to which they are attached form a 4-, 5-, 6- or 7-membered heterocycloalkyl group optionally substituted with 1, 2, or 3 substituents independently selected from Cy.sup.1, --(C.sub.1-6 alkyl)-Cy.sup.1, OH, CN, amino, halo, C.sub.1-6 alkyl, C.sub.1-6 haloalkyl, C.sub.1-6 haloalkyl, and halosulfanyl; R.sup.c' and R.sup.d' are independently selected from H, C.sub.1-10 alkyl, C.sub.1-6 haloalkyl, C.sub.2-6 alkenyl, C.sub.2-6 alkynyl, aryl, heteroaryl, cycloalkyl, heterocycloalkyl, arylalkyl, heteroarylalkyl, cycloalkylalkyl and heterocycloalkylalkyl, wherein said C.sub.1-10 alkyl, C.sub.1-6 haloalkyl, C.sub.2-6 alkenyl, C.sub.2-6 alkynyl, aryl, heteroaryl, cycloalkyl, heterocycloalkyl, arylalkyl, heteroarylalkyl, cycloalkylalkyl or heterocycloalkylalkyl is optionally substituted with 1, 2, or 3 substituents independently selected from OH, CN, amino, halo, C.sub.1-6 alkyl, C.sub.1-6 haloalkyl, C.sub.1-6 haloalkyl, halosulfanyl, aryl, arylalkyl, heteroaryl, heteroarylalkyl, cycloalkyl and heterocycloalkyl; or R.sup.c' and R.sup.d' together with the N atom to which they are attached form a 4-, 5-, 6- or 7-membered heterocycloalkyl group optionally substituted with 1, 2, or 3 substituents independently selected from OH, CN, amino, halo, C.sub.1-6 alkyl, C.sub.1-6 haloalkyl, C.sub.1-6 haloalkyl, halosulfanyl, aryl, arylalkyl, heteroaryl, heteroarylalkyl, cycloalkyl and heterocycloalkyl; R.sup.c'' and R.sup.d'' are independently selected from H, C.sub.1-10 alkyl, C.sub.1-6 haloalkyl, C.sub.2-6 alkenyl, C.sub.2-6 alkynyl, aryl, heteroaryl, cycloalkyl, heterocycloalkyl, arylalkyl, heteroarylalkyl, cycloalkylalkyl and heterocycloalkylalkyl, wherein said C.sub.1-10 alkyl, C.sub.1-6 haloalkyl, C.sub.2-6 alkenyl, C.sub.2-6 alkynyl, aryl, heteroaryl, cycloalkyl, heterocycloalkyl, arylalkyl, heteroarylalkyl, cycloalkylalkyl or heterocycloalkylalkyl is optionally substituted with 1, 2, or 3 substituents independently selected from OH, CN, amino, halo, C.sub.1-6 alkyl, C.sub.1-6 haloalkyl, halosulfanyl, C.sub.1-6 haloalkyl, aryl, arylalkyl, heteroaryl, heteroarylalkyl, cycloalkyl and heterocycloalkyl; or R.sup.c'' and R.sup.d'' together with the N atom to which they are attached form a 4-, 5-, 6- or 7-membered heterocycloalkyl group optionally substituted with 1, 2, or 3 substituents independently selected from OH, CN, amino, halo, C.sub.1-6 alkyl, C.sub.1-6 haloalkyl, C.sub.1-6 haloalkyl, halosulfanyl, aryl, arylalkyl, heteroaryl, heteroarylalkyl, cycloalkyl and heterocycloalkyl; R.sup.i is H, CN, NO.sub.2 or C.sub.1-6 alkyl; R.sup.e and R.sup.f are independently selected from H and C.sub.1-6 alkyl; R.sup.i is H, CN, or NO.sub.2; m is 0 or 1; n is 0 or 1; p is 0, 1, 2, 3, 4, 5, or 6; q is 0, 1, 2, 3, 4, 5 or 6; r is 0 or 1; and s is 0 or 1, and b) administering an anti-HIV vaccine and/or an immunostimulatory agent before, during, or after the JAK inhibitor is administered. 17. The method of claim 16, further comprising administration of HAART along with the JAK inhibitor. 18. The method of claim 17, wherein the HAART comprises the co-administration of a) at least one each of an adenine, cytosine, thymidine, and guanine nucleoside antiviral agent, or b) at least one additional antiviral agent selected from the group consisting of non-nucleoside reverse transcriptase inhibitors (NNRTI), protease inhibitors, fusion inhibitors, entry inhibitors, attachment inhibitors, and integrase inhibitors. 19. The method of claim 17, wherein the JAK inhibitor, HAART, and vaccine or immunostimulatory compound are administered in combination. 20. The method of claim 17, wherein the JAK inhibitor, HAART, and vaccine or immunostimulatory compound are administered in alternation. 21. A pharmaceutical composition comprising a compound of Formula A: ##STR00061## or the pharmaceutically acceptable salt thereof; wherein R.sup.1 is a group of the formula ##STR00062## wherein y is 0, 1 or 2; R.sup.4 is selected from the group consisting of hydrogen, (C.sub.1-C.sub.6)alkyl, (C.sub.1-C.sub.6)alkylsulfonyl, (C.sub.2-C.sub.6)alkenyl, (C.sub.2-C.sub.6)alkynyl wherein the alkyl, alkenyl and alkynyl groups are optionally substituted by deuterium, hydroxy, amino, trifluoromethyl, (C.sub.1-C.sub.4)alkoxy, (C.sub.1-C.sub.6)acyloxy, (C.sub.1-C.sub.6)alkylamino, ((C.sub.1-C.sub.6)alkyl).sub.2amino, cyano, nitro, (C.sub.2-C.sub.6)alkenyl, (C.sub.2-C.sub.6)alkynyl or (C.sub.1-C.sub.6)acylamino; or R.sup.4 is (C.sub.3-C.sub.10)cycloalkyl wherein the cycloalkyl group is optionally substituted by deuterium, hydroxy, amino, trifluoromethyl, (C.sub.1-C.sub.6)acyloxy, (C.sub.1-C.sub.6)acylamino, (C.sub.1-C.sub.6)alkylamino, ((C.sub.1-C.sub.6)alkyl).sub.2amino, cyano, cyano(C.sub.1-C.sub.6)alkyl, trifluoromethyl(C.sub.1-C.sub.6)alkyl, nitro, nitro(C.sub.1-C.sub.6)alkyl or (C.sub.1-C.sub.6)acylamino; R.sup.5 is (C.sub.2-C.sub.9)heterocycloalkyl wherein the heterocycloalkyl groups must be substituted by one to five carboxy, cyano, amino, deuterium, hydroxy, (C.sub.1-C.sub.6)alkyl, (C.sub.1-C.sub.6)alkoxy, halo, (C.sub.1-C.sub.6)acyl, (C.sub.1-C.sub.6)alkylamino, amino(C.sub.1-C.sub.6)alkyl, (C.sub.1-C.sub.6)alkoxy-CO--NH, (C.sub.1-C.sub.6)alkylamino-CO--, (C.sub.2-C.sub.6)alkenyl, (C.sub.2-C.sub.6)alkynyl, (C.sub.1-C.sub.6)alkylamino, amino(C.sub.1-C.sub.6)alkyl, hydroxy(C.sub.1-C.sub.6)alkyl, (C.sub.1-C.sub.6)alkoxy(C.sub.1-C.sub.6)alkyl, (C.sub.1-C.sub.6)acyloxy(C.sub.1-C.sub.6)alkyl, nitro, cyano(C.sub.1-C.sub.6)alkyl, halo(C.sub.1-C.sub.6)alkyl, nitro(C.sub.1-C.sub.6)alkyl, trifluoromethyl, trifluoromethyl(C.sub.1-C.sub.6)alkyl, (C.sub.1-C.sub.6)acylamino, (C.sub.1-C.sub.6)acylamino(C.sub.1-C.sub.6)alkyl, (C.sub.1-C.sub.6)alkoxy(C.sub.1-C.sub.6)acylamino, amino(C.sub.1-C.sub.6)acyl, amino(C.sub.1-C.sub.6)acyl(C.sub.1-C.sub.6)alkyl, (C.sub.1-C.sub.6)alkylamino(C.sub.1-C.sub.6)acyl, ((C.sub.1-C.sub.6)alkyl).sub.2amino(C.sub.1-C.sub.6)acyl, R.sup.15R.sup.16N--CO--O--, R.sup.15R.sup.16N--CO--(C.sub.1-C.sub.6)alkyl, (C.sub.1-C.sub.6)alkyl-S(O).sub.m, R.sup.15R.sup.16NS(O).sub.m, R.sup.15R.sup.16NS(O).sub.m(C.sub.1-C.sub.6)alkyl, R.sup.15S(O).sub.mR.sup.16N, R.sup.15S(O).sub.mR.sup.16(C.sub.1-C.sub.6)alkyl wherein m is 0, 1 or 2 and R.sup.15 and R.sup.16 are each independently selected from hydrogen or (C.sub.1-C.sub.6)alkyl; or a group of the formula ##STR00063## wherein a is 0, 1, 2, 3 or 4; b, c, e, f and g are each independently 0 or 1; d is 0, 1, 2, or 3; X is S(O).sub.n wherein n is 0, 1 or 2; oxygen, carbonyl or --C(.dbd.N-cyano)-; Y is S(O).sub.n wherein n is 0, 1 or 2; or carbonyl; and Z is carbonyl, C(O)O--, C(O)NR-- or S(O).sub.n wherein n is 0, 1 or 2; R.sup.6, R.sup.7, R.sup.8, R.sup.9, R.sup.10 and R.sup.11 are each independently selected from the group consisting of hydrogen or (C.sub.1-C.sub.6)alkyl optionally substituted by deuterium, hydroxy, amino, trifluoromethyl, (C.sub.1-C.sub.6)acyloxy, (C.sub.1-C.sub.6)acylamino, (C.sub.1-C.sub.6)alkylamino, ((C.sub.1-C.sub.6)alkyl).sub.2amino, cyano, cyano(C.sub.1-C.sub.6)alkyl, trifluoromethyl(C.sub.1-C.sub.6)alkyl, nitro, nitro(C.sub.1-C.sub.6)alkyl or (C.sub.1-C.sub.6)acylamino; R.sup.12 is carboxy, cyano, amino, oxo, deuterium, hydroxy, trifluoromethyl, (C.sub.1-C.sub.6)alkyl, trifluoromethyl(C.sub.1-C.sub.6)alkyl, (C.sub.1-C.sub.6)alkoxy, halo, (C.sub.1-C.sub.6)acyl, (C.sub.1-C.sub.6)alkylamino, ((C.sub.1-C.sub.6)alkyl).sub.2amino, amino(C.sub.1-C.sub.6)alkyl, (C.sub.1-C.sub.6)alkoxy-CO--NH, (C.sub.1-C.sub.6)alkylamino-CO--, (C.sub.2-C.sub.6)alkenyl, (C.sub.2-C.sub.6)alkynyl, (C.sub.1-C.sub.6)alkylamino, hydroxy(C.sub.1-C.sub.6)alkyl, (C.sub.1-C.sub.6)alkoxy(C.sub.1-C.sub.6)alkyl, (C.sub.1-C.sub.6)acyloxy(C.sub.1-C.sub.6)alkyl, nitro, cyano(C.sub.1-C.sub.6)alkyl, halo(C.sub.1-C.sub.6)alkyl, nitro(C.sub.1-C.sub.6)alkyl, trifluoromethyl, trifluoromethyl(C.sub.1-C.sub.6)alkyl, (C.sub.1-C.sub.6)acylamino, (C.sub.1-C.sub.6)acylamino(C.sub.1-C.sub.6)alkyl, (C.sub.1-C.sub.6)alkoxy(C.sub.1-C.sub.6)acylamino, amino(C.sub.1-C.sub.6)acyl, amino(C.sub.1-C.sub.6)acyl(C.sub.1-C.sub.6)alkyl, (C.sub.1-C.sub.6)alkylamino(C.sub.1-C.sub.6)acyl, ((C.sub.1-C.sub.6)alkyl).sub.2amino(C.sub.1-C.sub.6)acyl, R.sup.15R.sup.16N--CO--O--, R.sup.15R.sup.16N--CO--(C.sub.1-C.sub.6)alkyl, R.sup.15C(O)NH, R.sup.15OC(O)NH, R.sup.15NHC(O)NH, (C.sub.1-C.sub.6)alkyl-S(O).sub.m, (C.sub.1-C.sub.6)alkyl-S(O).sub.m--(C.sub.1-C.sub.6)alkyl, R.sup.15R.sup.16NS(O).sub.m, R.sup.15R.sup.16NS(O).sub.m(C.sub.1-C.sub.6)alkyl, R.sup.15S(O).sub.mR.sup.16N, R.sup.15S(O).sub.mR.sup.16N(C.sub.1-C.sub.6)alkyl wherein m is 0, 1 or 2 and R.sup.15 and R.sup.16 are each independently selected from hydrogen or (C.sub.1-C.sub.6)alkyl; R.sup.2 and R.sup.3 are each independently selected from the group consisting of hydrogen, deuterium, amino, halo, hydroxy, nitro, carboxy, (C.sub.2-C.sub.6)alkenyl, (C.sub.2-C.sub.6)alkynyl, trifluoromethyl, trifluoromethoxy, (C.sub.1-C.sub.6)alkyl, (C.sub.1-C.sub.6)alkoxy, (C.sub.3-C.sub.10)cycloalkyl wherein the alkyl, alkoxy or cycloalkyl groups are optionally substituted by one to three groups selected from halo, hydroxy, carboxy, amino(C.sub.1-C.sub.6)alkylthio, (C.sub.1-C.sub.6)alkylamino, ((C.sub.1-C.sub.6)alkyl).sub.2amino, (C.sub.5-C.sub.9)heteroaryl, (C.sub.2-C.sub.9)heterocycloalkyl, (C.sub.3-C.sub.9)cycloalkyl or (C.sub.6-C.sub.10)aryl; or R.sup.2 and R.sup.3 are each independently (C.sub.3-C.sub.10)cycloalkyl, (C.sub.3-C.sub.10)cycloalkoxy, (C.sub.1-C.sub.6)alkylamino, ((C.sub.1-C.sub.6)alkyl).sub.2amino, (C.sub.6-C.sub.10)arylamino, (C.sub.1-C.sub.6)alkylthio, (C.sub.6-C.sub.10)arylthio, (C.sub.1-C.sub.6)alkylsulfinyl, (C.sub.6-C.sub.10)arylsulfinyl, (C.sub.1-C.sub.6)alkylsulfonyl, (C.sub.6-C.sub.10)arylsulfonyl, (C.sub.1-C.sub.6)acyl, (C.sub.1-C.sub.6)alkoxy-CO--NH--, (C.sub.1-C.sub.6)alkylamino-CO--, (C.sub.5-C.sub.9)heteroaryl, (C.sub.2-C.sub.9)heterocycloalkyl or (C.sub.6-C.sub.10)aryl wherein the heteroaryl, heterocycloalkyl and aryl groups are optionally substituted by one to three halo, (C.sub.1-C.sub.6)alkyl, (C.sub.1-C.sub.6)alkyl-CO--NH--, (C.sub.1-C.sub.6)alkoxy-CO--NH--, (C.sub.1-C.sub.6)alkyl-CO--NH--(C.sub.1-C.sub.6)alkyl, (C.sub.1-C.sub.6)alkoxy-CO--NH--(C.sub.1-C.sub.6)alkyl, (C.sub.1-C.sub.6)alkoxy-CO--NH--(C.sub.1-C.sub.6)alkoxy, carboxy, carboxy(C.sub.1-C.sub.6)alkyl, carboxy(C.sub.1-C.sub.6)alkoxy, benzyloxycarbonyl(C.sub.1-C.sub.6)alkoxy, (C.sub.1-C.sub.6)alkoxycarbonyl(C.sub.1-C.sub.6)alkoxy, (C.sub.6-C.sub.10)aryl, amino, amino(C.sub.1-C.sub.6)alkyl, (C.sub.1-C.sub.6)alkoxycarbonylamino, (C.sub.6-C.sub.10)aryl(C.sub.1-C.sub.6)alkoxycarbonylamino, (C.sub.1-C.sub.6)alkylamino, ((C.sub.1-C.sub.6)alkyl).sub.2amino, (C.sub.1-C.sub.6)alkylamino(C.sub.1-C.sub.6)alkyl, ((C.sub.1-C.sub.6)alkyl).sub.2amino(C.sub.1-C.sub.6)alkyl, hydroxy, (C.sub.1-C.sub.6)alkoxy, carboxy, carboxy(C.sub.1-C.sub.6)alkyl, (C.sub.1-C.sub.6)alkoxycarbonyl, (C.sub.1-C.sub.6)alkoxycarbonyl(C.sub.1-C.sub.6)alkyl, (C.sub.1-C.sub.6)alkoxy-CO--NH--, (C.sub.1-C.sub.6)alkyl-CO--NH--, cyano, (C.sub.5-C.sub.9)heterocycloalkyl, amino-CO--NH--, (C.sub.1-C.sub.6)alkylamino-CO--NH--, ((C.sub.1-C.sub.6)alkyl).sub.2amino-CO--NH--, (C.sub.6-C.sub.10)arylamino-CO--NH--, (C.sub.5-C.sub.9)heteroarylamino-CO--NH--, (C.sub.1-C.sub.6)alkylamino-CO--NH--(C.sub.1-C.sub.6)alkyl, ((C.sub.1-C.sub.6)alkyl).sub.2amino-CO--NH--(C.sub.1-C.sub.6)alkyl, (C.sub.6-C.sub.10)arylamino-CO--NH--(C.sub.1-C.sub.6)alkyl, (C.sub.5-C.sub.9)heteroarylamino-CO--NH-(C.sub.1-C.sub.6)alkyl, (C.sub.1-C.sub.6)alkylsulfonyl, (C.sub.1-C.sub.6)alkylsulfonylamino, (C.sub.1-C.sub.6)alkylsulfonylamino(C.sub.1-C.sub.6)alkyl, (C.sub.6-C.sub.10)arylsulfonyl, (C.sub.6-C.sub.10)arylsulfonylamino, (C.sub.6-C.sub.10)arylsulfonylamino(C.sub.1-C.sub.6)alkyl, (C.sub.1-C.sub.6)alkylsulfonylamino, (C.sub.1-C.sub.6)alkylsulfonylamino(C.sub.1-C.sub.6)alkyl, (C.sub.5-C.sub.9)heteroaryl or (C.sub.2-C.sub.9)heterocycloalkyl, or of Formula B: ##STR00064## including pharmaceutically acceptable salt forms or prodrugs thereof, wherein: A.sup.1 and A.sup.2 are independently selected from C and N; T, U, and V are independently selected from O, S, N, CR.sup.5, and NR.sup.6; wherein the 5-membered ring formed by A.sup.1, A.sup.2, U, T, and V is aromatic; X is N or CR.sup.4; Y is C.sub.1-8 alkylene, C.sub.2-8 alkenylene, C.sub.2-8 alkynylene, (CR.sup.11R.sup.12).sub.p--(C.sub.3-10 cycloalkylene)-(CR.sup.11R.sup.12).sub.q, (CR.sup.11R.sup.12).sub.p-(arylene)-(CR.sup.11R.sup.12).sub.q, (CR.sup.11R.sup.12).sub.\p--(C.sub.1-10 heterocycloalkylene)-(CR.sup.11R.sup.12).sub.q, (CR.sup.11R.sup.12).sub.p-(heteroarylene)-(CR.sup.11R.sup.12).sub.q, (CR.sup.11R.sup.12).sub.pO(CR.sup.11R.sup.12).sub.q, (CR.sup.11R.sup.12).sub.pS(CR.sup.11R.sup.12).sub.q, (CR.sup.11R.sup.12).sub.pC(O)(CR.sup.11R.sup.12).sub.q, (CR.sup.11R.sup.12).sub.pC(O)NR.sub.c(CR.sup.11R.sup.12).sub.q, (CR.sup.11R.sup.12).sub.pC(O)O(CR.sup.11R.sup.12).sub.q, (CR.sup.11R.sup.12).sub.pOC(O)(CR.sup.11R.sup.12).sub.q, (CR.sup.11R.sup.12).sub.pOC(O)NR.sup.c(CR.sup.11R.sup.12).sub.q, (CR.sup.11R.sup.12).sub.pNR.sup.c(CR.sup.11R.sup.12).sub.q, (CR.sup.11R.sup.12).sub.pNR.sup.cC(O)NR.sup.d(CR.sup.11R.sup.12).sub.q, (CR.sup.11R.sup.12).sub.pS(O)(CR.sup.11R.sup.12).sub.q, (CR.sup.11R.sup.12).sub.pS(O)NR.sup.c(CR.sup.11R.sup.12).sub.q, (CR.sup.11R.sup.12).sub.pS(O).sub.2(CR.sup.11R.sup.12).sub.q, or (CR.sup.11R.sup.12).sub.pS(O).sub.2NR.sup.c(CR.sup.11R.sup.12).sub.q, wherein said C.sub.1-8 alkylene, C.sub.2-8 alkenylene, C.sub.2-8 alkynylene, cycloalkylene, arylene, heterocycloalkylene, or heteroarylene, is optionally substituted with 1, 2, or 3 substituents independently selected from -D.sup.1-D.sup.2-D.sup.3-D.sup.4; Z is H, halo, C.sub.1-4 alkyl, C.sub.2-4 alkenyl, C.sub.2-4 alkynyl, C.sub.1-4 haloalkyl, halosulfanyl, C.sub.1-4 hydroxyalkyl, C.sub.1-4 cyanoalkyl, .dbd.C--R.sup.i, .dbd.N--R.sup.i, Cy.sup.1, CN, NO.sub.2, OR.sup.a, SR.sup.a, C(O)R.sup.b, C(O)NR.sup.cR.sup.d, C(O)OR.sup.a, OC(O)R.sup.b, OC(O)NR.sup.cR.sup.d, NR.sup.cR.sup.d, NR.sup.cC(O)R.sup.b, NR.sup.cC(O)NR.sup.cR.sup.d, NR.sup.cC(O)OR.sup.a, C(.dbd.NR.sup.i)NR.sup.cR.sup.d, NR.sup.cC(.dbd.NR.sup.i)NR.sup.cR.sup.d, S(O)R.sup.b, S(O)NR.sup.cR.sup.d, S(O).sub.2R.sup.b, NR.sup.cS(O).sub.2R.sup.b, C(.dbd.NOH)R.sup.b, C(.dbd.NO(C.sub.1-6alkyl)R.sup.b, and S(O).sub.2NR.sup.cR.sup.d, wherein said C.sub.1-8 alkyl, C.sub.2-8 alkenyl, or C.sub.2-8 alkynyl, is optionally substituted with 1, 2, 3, 4, 5, or 6 substituents independently selected from halo, C.sub.1-4 alkyl, C.sub.2-4 alkenyl, C.sub.2-4 alkynyl, C.sub.1-4 haloalkyl, halosulfanyl, C.sub.1-4 hydroxyalkyl, C.sub.1-4 cyanoalkyl, Cy.sup.1, CN, N.sub.2, OR.sup.a, SR.sup.a, C(O)R.sup.b, C(O)NR.sup.cR.sup.d, C(O)OR.sup.a, OC(O)R.sup.b, OC(O)NR.sup.cR.sup.d, NR.sup.cR.sup.d, NR.sup.cC(O)R.sup.b, NR.sup.cC(O)NR.sup.cR.sup.d, NR.sup.cC(O)OR.sup.a, C(.dbd.NR.sup.i)NR.sup.cR.sup.d, NR.sup.cC(.dbd.NR.sup.i)NR.sup.cR.sup.d, S(O)R.sup.b, S(O)NR.sup.cR.sup.d, S(O).sub.2R.sup.b, NR.sup.cS(O).sub.2R.sup.b, C(.dbd.NOH)R.sup.b, C(.dbd.NO(C.sub.1-6 alkyl))R.sup.b, and S(O).sub.2NR.sup.cR.sup.d; wherein when Z is H, n is 1; or the --(Y)--Z moiety is taken together with i) A.sup.2 to which the moiety is attached, ii) R.sup.5 or R.sup.6 of either T or V, and iii) the C or N atom to which the R.sup.5 or R.sup.6 of either T or V is attached to form a 4- to 20-membered aryl, cycloalkyl, heteroaryl, or heterocycloalkyl ring fused to the 5-membered ring formed by A.sup.1 A.sup.2, U, T, and V, wherein said 4- to 20-membered aryl, cycloalkyl, heteroaryl, or heterocycloalkyl ring is optionally substituted by 1, 2, 3, 4, or 5 substituents independently selected from --(W).sub.m-Q; W is C.sub.1-8 alkylenyl, C.sub.2-8 alkenylenyl, C.sub.2-8 alkynylenyl, O, S, C(O), C(O)NR.sup.c', C(O)O, OC(O), OC(O)NR.sup.c', NR.sup.c', NR.sup.c'C(O)NR.sup.d', S(O), S(O)NR.sup.c', S(O).sub.2, or S(O)2NR.sup.c'; Q is H, halo, CN, NO.sub.2, C.sub.1-8 alkyl, C.sub.2-8 alkenyl, C.sub.2-8 alkynyl, C.sub.1-8 haloalkyl, halosulfanyl, aryl, cycloalkyl, heteroaryl, or heterocycloalkyl, wherein said C.sub.1-8 alkyl, C.sub.2-8 alkenyl, C.sub.2-8 alkynyl, C.sub.1-8 haloalkyl, aryl, cycloalkyl, heteroaryl, or heterocycloalkyl is optionally substituted with 1, 2, 3 or 4 substituents independently selected from halo, C.sub.1-4 alkyl, C.sub.2-4 alkenyl, C.sub.2-4 alkynyl, C.sub.1-4 haloalkyl, halosulfanyl, C.sub.1-4 hydroxyalkyl, C.sub.1-4 cyanoalkyl, Cy.sup.2, CN, NO.sub.2, OR.sup.a', SR.sup.a', C(O)R.sup.b', C(O)NR.sup.c'R.sup.d', C(O)OR.sup.a', OC(O)R.sup.b', OC(O)NR.sup.c'R.sup.d', NR.sup.c'R.sup.d', NR.sup.c'C(O)R.sup.b', NR.sup.c'(O)N R.sup.c'R.sup.d', R.sup.c'C(O)OR.sup.a', S(O)R.sup.b', S(O)N R.sup.c'R.sup.d', S(O).sub.2R.sup.b', NR.sup.c'S(O).sub.2R.sup.b', and S(O).sub.2N R.sup.c'R.sup.d'; Cy.sup.1 and Cy.sup.2 are independently selected from aryl, heteroaryl, cycloalkyl, and heterocycloalkyl, each optionally substituted by 1, 2, 3, 4 or 5 substituents independently selected from halo, C.sub.1-4 alkyl, C.sub.2-4 alkenyl, C.sub.2-4 alkynyl, C.sub.1-4 haloalkyl, halosulfanyl, C.sub.1-4 hydroxyalkyl, C.sub.1-4 cyanoalkyl, CN, NO.sub.2, OR.sup.a'', SR.sup.a'', C(O)R.sup.b'', C(O)NR.sup.c''R.sup.d'', C(O)OR.sup.a'', OC(O)R.sup.b', OC(O)N R.sup.c''R.sup.d'', NR.sup.c''R.sup.d'', NR.sup.c''C(O)R.sup.b', NR.sup.c''C(O)OR.sup.a'', NR.sup.c''S(O)R.sup.b', NR.sup.c''S(O).sub.2R.sup.b'', S(O)R.sup.b'', S(O)NR.sup.c''R.sup.d'', S(O).sub.2R.sup.b'', and S(O).sub.2NR.sup.c''R.sup.d''; R.sup.1, R.sup.2, R.sup.3, and R.sup.4 are independently selected from H, halo, C.sub.1-4 alkyl, C.sub.2-4 alkenyl, C.sub.2-4 alkynyl, C.sub.1-4 haloalkyl, halosulfanyl, aryl, cycloalkyl, heteroaryl, heterocycloalkyl, CN, NO.sub.2, OR.sup.7, SR.sup.7, C(O)R.sup.8, C(O)NR.sup.9R.sup.10, C(O)OR.sup.7OC(O)R.sup.8, OC(O)NR.sup.9R.sup.10, NR.sup.9R.sup.10, NR.sup.9C(O)R.sup.8, NR.sup.cC(O)OR.sup.7, S(O)R.sup.8, S(O)NR.sup.9R.sup.10, S(O).sub.2R.sup.8, NR.sup.9S(O).sub.2R.sup.8, and S(O).sub.2NR.sup.9R.sup.10; R.sup.5 is H, halo, C.sub.1-4 alkyl, C.sub.2-4 alkenyl, C.sub.2-4 alkynyl, C.sub.1-4 haloalkyl, halosulfanyl, CN, NO.sub.2, OR.sup.7, SR.sup.7, C(O)R.sup.8, C(O)NR.sup.9R.sup.10, C(O)OR.sup.7, OC(O)R.sup.8, OC(O)NR.sup.9R.sup.10, NR.sup.9R.sup.10, NR.sup.9C(O)R.sup.8, NR.sup.9C(O)OR.sup.7, S(O)R.sup.8, S(O)NR.sup.9R.sup.10, S(O).sub.2R.sup.8, NR.sup.9S(O).sub.2R.sup.8, or S(O).sub.2NR.sup.9R.sup.10; R.sup.6 is H, C.sub.1-4 alkyl, C.sub.2-4 alkenyl, C.sub.2-4 alkynyl, C.sub.1-4 haloalkyl, OR.sup.7, C(O)R.sup.8, C(O)NR.sup.9R.sup.10, C(O)OR.sup.7, S(O)R.sup.8, S(O)NR.sup.9R.sup.10, S(O).sub.2R.sup.8, or S(O).sub.2NR.sup.9R.sup.10; R.sup.7 is H, C.sub.1-6 alkyl, C.sub.1-6 haloalkyl, C.sub.2-6 alkenyl, C.sub.2-6 alkynyl, aryl, cycloalkyl, heteroaryl, heterocycloalkyl, arylalkyl, heteroarylalkyl, cycloalkylalkyl or heterocycloalkylalkyl; R.sup.8 is H, C.sub.1-6 alkyl, C.sub.1-6 haloalkyl, C.sub.2-6 alkenyl, C.sub.2-6 alkynyl, aryl, cycloalkyl, heteroaryl, heterocycloalkyl, arylalkyl, heteroarylalkyl, cycloalkylalkyl or heterocycloalkylalkyl; R.sup.9 and R.sup.10 are independently selected from H, C.sub.1-10 alkyl, C.sub.1-6 haloalkyl, C.sub.2-6 alkenyl, C.sub.2-6 alkynyl, C.sub.1-6 alkylcarbonyl, arylcarbonyl, C.sub.1-6 alkylsulfonyl, arylsulfonyl, aryl, heteroaryl, cycloalkyl, heterocycloalkyl, arylalkyl, heteroarylalkyl, cycloalkylalkyl and heterocycloalkylalkyl; or R.sup.9 and R.sup.10 together with the N atom to which they are attached form a 4-, 5-, 6- or 7-membered heterocycloalkyl group; R.sup.11 and R.sup.12 are independently selected from H and -E.sup.1-E.sup.2-E.sup.3-E.sup.4; D.sup.1 and E.sup.1 are independently absent or independently selected from C.sub.1-6 alkylene, C.sub.2-6 alkenylene, C.sub.2-6 alkynylene, arylene, cycloalkylene, heteroarylene, and heterocycloalkylene, wherein each of the C.sub.1-6 alkylene, C.sub.2-6 alkenylene, C.sub.2-6 alkynylene, arylene, cycloalkylene, heteroarylene, and heterocycloalkylene is optionally substituted by 1, 2 or 3 substituents independently selected from halo, CN, NO.sub.2, N.sub.3, SCN, OH, C.sub.1-6 alkyl, C.sub.1-6 haloalkyl, C.sub.2-8 alkoxyalkyl, C.sub.1-6 alkoxy, C.sub.1-6 haloalkoxy, amino, C.sub.1-6 alkylamino, and C.sub.2-8 dialkylamino; D.sup.2 and E.sup.2 are independently absent or independently selected from C.sub.1-6 alkylene, C.sub.2-6 alkenylene, C.sub.2-6 alkynylene, (C.sub.1-6 alkylene).sub.r--O--(C.sub.1-6 alkylene).sub.s, (C.sub.1-6 alkylene).sub.r--S--(C.sub.1-6 alkylene).sub.s, (C.sub.1-6 alkylene).sub.r--NR.sup.c--(C.sub.1-6 alkylene).sub.s, (C.sub.1-6 alkylene).sub.r--CO--(C.sub.1-6 alkylene).sub.s, (C.sub.1-6 alkylene).sub.r--COO--(C.sub.1-6 alkylene).sub.s, (C.sub.1-6 alkylene).sub.r--CONR.sup.c--(C.sub.1-6 alkylene).sub.s, (C.sub.1-6 alkylene).sub.r--SO--(C.sub.1-6 alkylene).sub.s, (C.sub.1-6 alkylene).sub.r--SO.sub.2--(C.sub.1-6 alkylene).sub.s, (C.sub.1-6 alkylene).sub.r--SONR.sup.c--(C.sub.1-6 alkylene).sub.s, and (C.sub.1-6 alkylene).sub.r--NR.sup.cCONR.sup.f--(C.sub.1-6 alkylene).sub.s, wherein each of the C.sub.1-6 alkylene, C.sub.2-6 alkenylene, and C.sub.2-6 alkynylene is optionally substituted by 1, 2 or 3 substituents independently selected from halo, CN, NO.sub.2, N.sub.3, SCN, OH, C.sub.1-6 alkyl, C.sub.1-6 haloalkyl, C.sub.2-8 alkoxyalkyl, C.sub.1-6 alkoxy, C.sub.1-6 haloalkoxy, amino, C.sub.1-6 alkylamino, and C.sub.2-8 dialkylamino; D.sup.3and E.sup.3 are independently absent or independently selected from C.sub.1-6 alkylene, C.sub.2-6 alkenylene, C.sub.2-6 alkynylene, arylene, cycloalkylene, heteroarylene, and heterocycloalkylene, wherein each of the C.sub.1-6 alkylene, C.sub.2-6 alkenylene, C.sub.2-6 alkynylene, arylene, cycloalkylene, heteroarylene, and heterocycloalkylene is optionally substituted by 1, 2 or 3 substituents independently selected from halo, CN, NO.sub.2, N.sub.3, SCN, OH, C.sub.1-6 alkyl, C.sub.1-6 haloalkyl, C.sub.2-8 alkoxyalkyl, C.sub.1-6 alkoxy, C.sub.1-6 haloalkoxy, amino, C.sub.1-6 alkylamino, and C.sub.2-8 dialkylamino; E.sup.4 and E.sup.4 are independently selected from H, halo, C.sub.1-4 alkyl, C.sub.2-4 alkenyl, C.sub.2-4 alkynyl, C.sub.1-4 haloalkyl, halosulfanyl, C.sub.1-4 hydroxyalkyl, C.sub.1-4 cyanoalkyl, Cy.sup.1, CN, NO.sub.2, OR.sup.a, SR.sup.a, C(O)R.sup.b, C(O)NR.sup.cR.sup.a, C(O)OR.sup.a, OC(O)R.sup.bOC(O)NR.sup.cR.sup.d NR.sup.cR.sup.d, NR.sup.cC(O)R.sup.b, NR.sup.cC(O)NR.sup.cR.sup.d, NR.sup.cC(O)OR.sup.a, C(.dbd.NR.sup.i)NR.sup.cR.sup.d, NR.sup.cC(.dbd.NR.sup.i)NR.sup.cR.sup.d, S(O)R.sup.b, S(O)NR.sup.cR.sup.d, S(O).sub.2R.sup.b, NR.sup.cS(O).sub.2R.sup.b, C(.dbd.NOH)R.sup.b, C(.dbd.NO(C.sub.1-6 alkyl)R.sup.b, and S(O).sub.2NR.sup.cR.sup.d, wherein said C.sub.1-8 alkyl, C.sub.2-8 alkenyl, or C.sub.2-8 alkynyl, is optionally substituted with 1, 2, 3, 4, 5, or 6 substituents independently selected from halo, C.sub.1-4 alkyl, C.sub.2-4 alkenyl, C.sub.2-4 alkynyl, C.sub.1-4 haloalkyl, halosulfanyl, C.sub.1-4 hydroxyalkyl, C.sub.1-4 cyanoalkyl, Cy.sup.1, CN, NO.sub.2, OR.sup.a, SR.sup.a, C(O)R.sup.b, C(O)NR.sup.cR.sup.d, C(O)OR.sup.a, OC(O)R.sup.b, OC(O)NR.sup.cR.sup.d, NR.sup.cR.sup.d, NR.sup.cC(O)R.sup.b, NR.sup.cC(O)NR.sup.cR.sup.d, NR.sup.cC(O)OR.sup.a, C(.dbd.NR.sup.i)NR.sup.cR.sup.d, NR.sup.cC(.dbd.NR.sup.i)NR.sup.cR.sup.d, S(O)R.sup.b, S(O)NR.sup.cR.sup.d, S(O).sub.2R.sup.b, NR.sup.cS(O).sub.2R.sup.b, C(.dbd.NOH)R.sup.b, C(.dbd.NO(C.sub.1-6 alkyl))R.sup.b, and S(O).sub.2NR.sup.cR.sup.d; R.sup.a is H, Cy.sup.1, --(C.sub.1-6 alkyl)-Cy.sup.1, C.sub.1-6 alkyl, C.sub.1-6 haloalkyl, C.sub.2-6 alkenyl, C.sub.2-6 alkynyl, wherein said C.sub.1-6 alkyl, C.sub.1-6 haloalkyl, C.sub.2-6 alkenyl, or C.sub.2-6 alkynyl is optionally substituted with 1, 2, or 3 substituents independently selected from OH, CN, amino, halo, C.sub.1-6 alkyl, C.sub.1-6 haloalkyl, halosulfanyl, aryl, arylalkyl, heteroaryl, heteroarylalkyl, cycloalkyl and heterocycloalkyl; R.sup.b is H, Cy.sup.1, --(C.sub.1-6 alkyl)-Cy.sup.1, C.sub.1-6 alkyl, C.sub.1-6 haloalkyl, C.sub.2-6 alkenyl, C.sub.2-6 alkynyl, wherein said C.sub.1-6 alkyl, C.sub.1-61-6 haloalkyl, C.sub.2-6 alkenyl, or C.sub.2-6 alkynyl is optionally substituted with 1, 2, or 3 substituents independently selected from OH, CN, amino, halo, C.sub.1-6 alkyl, C.sub.1-6 haloalkyl, C.sub.1-6 haloalkyl, halosulfanyl, aryl, arylalkyl, heteroaryl, heteroarylalkyl, cycloalkyl and heterocycloalkyl; R.sup.a' and R.sup.a'' are independently selected from H, C.sub.1-6 alkyl, C.sub.1-6 haloalkyl, C.sub.2-6 alkenyl, C.sub.2-6 alkynyl, aryl, cycloalkyl, heteroaryl, heterocycloalkyl, arylalkyl, heteroarylalkyl, cycloalkylalkyl and heterocycloalkylalkyl, wherein said C.sub.1-6 alkyl, C.sub.1-6 haloalkyl, C.sub.2-6 alkenyl, C.sub.2-6 alkynyl, aryl, cycloalkyl, heteroaryl, heterocycloalkyl, arylalkyl, heteroarylalkyl, cycloalkylalkyl or heterocycloalkylalkyl is optionally substituted with 1, 2, or 3 substituents independently selected from OH, CN, amino, halo, C.sub.1-6 alkyl, C.sub.1-6 haloalkyl, halosulfanyl, aryl, arylalkyl, heteroaryl, heteroarylalkyl, cycloalkyl and heterocycloalkyl; R.sup.b' and R.sup.b'' are independently selected from H, C.sub.1-6 alkyl, C.sub.1-6 haloalkyl, C.sub.2-6 alkenyl, C.sub.2-6 alkynyl, aryl, cycloalkyl, heteroaryl, heterocycloalkyl, arylalkyl, heteroarylalkyl, cycloalkylalkyl and heterocycloalkylalkyl, wherein said C.sub.1-6 alkyl, C.sub.1-6 haloalkyl, C.sub.2-6 alkenyl, C.sub.2-6 alkynyl, aryl, cycloalkyl, heteroaryl, heterocycloalkyl, arylalkyl, heteroarylalkyl, cycloalkylalkyl or heterocycloalkylalkyl is optionally substituted with 1, 2, or 3 substituents independently selected from OH, CN, amino, halo, C.sub.1-6 alkyl, C.sub.1-6 haloalkyl, C.sub.1-6 haloalkyl, halosulfanyl, aryl, arylalkyl, heteroaryl, heteroarylalkyl, cycloalkyl and heterocycloalkyl; R.sup.c and R.sup.d are independently selected from H, Cy.sup.1, --(C.sub.1-6 alkyl)-Cy.sup.1, C.sub.1-10 alkyl, C.sub.1-6 haloalkyl, C.sub.2-6 alkenyl, C.sub.2-6 alkynyl, wherein said C.sub.1-10 alkyl, C.sub.1-6 haloalkyl, C.sub.2-6 alkenyl, or C.sub.2-6 alkynyl, is optionally substituted with 1, 2, or 3 substituents independently selected from Cy.sup.1, --(C.sub.1-6 alkyl)-Cy.sup.1, OH, CN, amino, halo, C.sub.1-6 alkyl, C.sub.1-6 haloalkyl, C.sub.1-6 haloalkyl, and halosulfanyl; or R.sup.c and R.sup.d together with the N atom to which they are attached form a 4-, 5-, 6- or 7-membered heterocycloalkyl group optionally substituted with 1, 2, or 3 substituents independently selected from Cy.sup.1, --(C.sub.1-6 alkyl)-Cy.sup.1, OH, CN, amino, halo, C.sub.1-6 alkyl, C.sub.1-6 haloalkyl, C.sub.1-6 haloalkyl, and halosulfanyl; R.sup.c' and R.sup.d' are independently selected from H, C.sub.1-10 alkyl, C.sub.1-6 haloalkyl, C.sub.2-6 alkenyl, C.sub.2-6 alkynyl, aryl, heteroaryl, cycloalkyl, heterocycloalkyl, arylalkyl, heteroarylalkyl, cycloalkylalkyl and heterocycloalkylalkyl, wherein said C.sub.1-10 alkyl, C.sub.1-6 haloalkyl, C.sub.2-6 alkenyl, C.sub.2-6 alkynyl, aryl, heteroaryl, cycloalkyl, heterocycloalkyl, arylalkyl, heteroarylalkyl, cycloalkylalkyl or heterocycloalkylalkyl is optionally substituted with 1, 2, or 3 substituents independently selected from OH, CN, amino, halo, C.sub.1-6 alkyl, C.sub.1-6 haloalkyl, C.sub.1-6 haloalkyl, halosulfanyl, aryl, arylalkyl, heteroaryl, heteroarylalkyl, cycloalkyl and heterocycloalkyl; or R.sup.c' and R.sup.d' together with the N atom to which they are attached form a 4-, 5-, 6- or 7-membered heterocycloalkyl group optionally substituted with 1, 2, or 3 substituents independently selected from OH, CN, amino, halo, C.sub.1-6 alkyl, C.sub.1-6 haloalkyl, C.sub.1-6 haloalkyl, halosulfanyl, aryl, arylalkyl, heteroaryl, heteroarylalkyl, cycloalkyl and heterocycloalkyl; R.sup.c'' and R.sup.d'' are independently selected from H, C.sub.1-10 alkyl, C.sub.1-6 haloalkyl, C.sub.2-6 alkenyl, C.sub.2-6 alkynyl, aryl, heteroaryl, cycloalkyl, heterocycloalkyl, arylalkyl, heteroarylalkyl, cycloalkylalkyl and heterocycloalkylalkyl, wherein said C.sub.1-10 alkyl, C.sub.1-6 haloalkyl, C.sub.2-6 alkenyl, C.sub.2-6 alkynyl, aryl, heteroaryl, cycloalkyl, heterocycloalkyl, arylalkyl, heteroarylalkyl, cycloalkylalkyl or heterocycloalkylalkyl is optionally substituted with 1, 2, or 3 substituents independently selected from OH, CN, amino, halo, C.sub.1-6 alkyl, C.sub.1-6 haloalkyl, halosulfanyl, C.sub.1-6 haloalkyl, aryl, arylalkyl, heteroaryl, heteroarylalkyl, cycloalkyl and heterocycloalkyl; or R.sup.c'' and R.sup.d'' together with the N atom to which they are attached form a 4-, 5-, 6- or 7-membered heterocycloalkyl group optionally substituted with 1, 2, or 3 substituents independently selected from OH, CN, amino, halo, C.sub.1-6 alkyl, C.sub.1-6 haloalkyl, C.sub.1-6 haloalkyl, halosulfanyl, aryl, arylalkyl, heteroaryl, heteroarylalkyl, cycloalkyl and heterocycloalkyl; R.sup.i is H, CN, NO.sub.2, or C.sub.1-6 alkyl; R.sup.e and R.sup.f are independently selected from H and C.sub.1-6 alkyl; R.sup.i is H, CN, or NO.sub.2; m is 0 or 1; n is 0 or 1; p is 0, 1, 2, 3, 4, 5, or 6; q is 0, 1, 2, 3, 4, 5 or 6; r is 0 or 1; and s is 0 or 1, a pharmaceutically acceptable carrier or excipient, and an additional anti-HIV compound. 22. The pharmaceutical composition of claim 21, wherein the composition further comprises: a) at least one each of an adenine, cytosine, thymidine, and guanine nucleoside antiviral agent, or b) at least one additional antiviral agent selected from the group consisting of non-nucleoside reverse transcriptase inhibitors (NNRTI), protease inhibitors, fusion inhibitors, entry inhibitors, attachment inhibitors, and integrase inhibitors. 23. The pharmaceutical composition of claim 22, wherein the thymidine nucleoside antiretroviral agent is zidovudine (AZT). 24. The pharmaceutical composition of claim 22, wherein the NNRTI is Sustiva, the protease inhibitor is Kaletra, or the integrase inhibitor is Raltegravir or Elvitegravir. 25. The pharmaceutical composition of claim 22, wherein the compound of Formula A or B, and the at least one each of an adenine, cytosine, thymidine, and guanine nucleoside antiviral agent, or at least one additional antiviral agent selected from the group consisting of non-nucleoside reverse transcriptase inhibitors (NNRTI), protease inhibitors, fusion inhibitors, entry inhibitors, attachment inhibitors, and integrase inhibitors, are administered in combination. 26. The pharmaceutical composition of claim 22, wherein the compound of Formula A or B, and the at least one each of an adenine, cytosine, thymidine, and guanine nucleoside antiviral agent, or at least one additional antiviral agent selected from the group consisting of non-nucleoside reverse transcriptase inhibitors (NNRTI), protease inhibitors, fusion inhibitors, entry inhibitors, attachment inhibitors, and integrase inhibitors, are administered in alternation. 27. The pharmaceutical composition of claim 21, wherein the compound of Formula A is ##STR00065## or a pharmaceutically acceptable salt or prodrug thereof, or wherein the compound of Formula B is LY3009104/INCB28050or ##STR00066## or a pharmaceutically acceptable salt or prodrug thereof. 28. The pharmaceutical composition of claim 21, further comprising a macrophage depleting agent. 29. The pharmaceutical composition of claim 28, wherein the macrophage depleting agent is Boniva or Fosamax. 30. A pharmaceutical composition for treating or eradicating an HIV infection comprising a combination of HAART, a JAK inhibitor, and a macrophage depleting agent or reactivation agent, wherein the JAK inhibitor is a compound of Formula A: ##STR00067## wherein: or the pharmaceutically acceptable salt thereof; wherein R.sup.1 is a group of the formula ##STR00068## wherein y is 0, 1 or 2; R.sup.4 is selected from the group consisting of hydrogen, (C.sub.1-C.sub.6)alkyl, (C.sub.1-C.sub.6)alkylsulfonyl, (C.sub.2-C.sub.6)alkenyl, (C.sub.2-C.sub.6)alkynyl wherein the alkyl, alkenyl and alkynyl groups are optionally substituted by deuterium, hydroxy, amino, trifluoromethyl, (C.sub.1-C.sub.4)alkoxy, (C.sub.1-C.sub.6)acyloxy, (C.sub.1-C.sub.6)alkylamino, ((C.sub.1-C.sub.6)alkyl).sub.2amino, cyano, nitro, (C.sub.2-C.sub.6)alkenyl, (C.sub.2-C.sub.6)alkynyl or (C.sub.1-C.sub.6)acylamino; or R.sup.4 is (C.sub.3-C.sub.10)cycloalkyl wherein the cycloalkyl group is optionally substituted by deuterium, hydroxy, amino, trifluoromethyl, (C.sub.1-C.sub.6)acyloxy, (C.sub.1-C.sub.6)acylamino, (C.sub.1-C.sub.6)alkylamino, ((C.sub.1-C.sub.6)alkyl).sub.2amino, cyano, cyano(C.sub.1-C.sub.6)alkyl, trifluoromethyl(C.sub.1-C.sub.6)alkyl, nitro, nitro(C.sub.1-C.sub.6)alkyl or (C.sub.1-C.sub.6)acylamino; R.sup.5 is (C.sub.2-C.sub.9)heterocycloalkyl wherein the heterocycloalkyl groups must be substituted by one to five carboxy, cyano, amino, deuterium, hydroxy, (C.sub.1-C.sub.6)alkyl, (C.sub.1-C.sub.6)alkoxy, halo, (C.sub.1-C.sub.6)acyl, (C.sub.1-C.sub.6)alkylamino, amino(C.sub.1-C.sub.6)alkyl, (C.sub.1-C.sub.6)alkoxy-CO--NH, (C.sub.1-C.sub.6)alkylamino-CO--, (C.sub.2-C.sub.6)alkenyl, (C.sub.2-C.sub.6)alkynyl, (C.sub.1-C.sub.6)alkylamino, amino(C.sub.1-C.sub.6)alkyl, hydroxy(C.sub.1-C.sub.6)alkyl, (C.sub.1-C.sub.6)alkoxy(C.sub.1-C.sub.6)alkyl, (C.sub.1-C.sub.6)acyloxy(C.sub.1-C.sub.6)alkyl, nitro, cyano(C.sub.1-C.sub.6)alkyl, halo(C.sub.1-C.sub.6)alkyl, nitro(C.sub.1-C.sub.6)alkyl, trifluoromethyl, trifluoromethyl(C.sub.1-C.sub.6)alkyl, (C.sub.1-C.sub.6)acylamino, (C.sub.1-C.sub.6)acylamino(C.sub.1-C.sub.6)alkyl, (C.sub.1-C.sub.6)alkoxy(C.sub.1-C.sub.6)acylamino, amino(C.sub.1-C.sub.6)acyl, amino(C.sub.1-C.sub.6)acyl(C.sub.1-C.sub.6)alkyl, (C.sub.1C.sub.6)alkylamino(C.sub.1-C.sub.6)acyl, ((C.sub.1-C.sub.6)alkyl).sub.2 amino(C.sub.1-C.sub.6)acyl, R.sup.15R.sup.16N--CO--O--, R.sup.15R.sup.16N--CO--(C.sub.1-C.sub.6)alkyl, (C.sub.1-C.sub.6)alkyl-S(O).sub.m, R.sup.15R.sup.16NS(O).sub.m, R.sup.15R.sup.16NS(O).sub.m(C.sub.1C.sub.6)alkyl, R.sup.15S(O).sub.mR.sup.16N, R.sup.15S(O).sub.mR.sup.16(C.sub.1-C.sub.6)alkyl wherein m is 0, 1 or 2 and R.sup.15 and R.sup.16 are each independently selected from hydrogen or (C.sub.1-C.sub.6)alkyl; or a group of the formula ##STR00069## wherein a is 0, 1, 2, 3 or 4; b, c, e, f and g are each independently 0 or 1; d is 0, 1, 2, or 3; X is S(O).sub.n wherein n is 0, 1 or 2; oxygen, carbonyl or --C(.dbd.N-cyano)-; Y is S(O).sub.n wherein n is 0, 1 or 2; or carbonyl; and Z is carbonyl, C(O)O--, C(O)NR-- or S(O).sub.n wherein n is 0, 1 or 2; R.sup.6, R.sup.7, R.sup.8, R.sup.9, R.sup.10 and R.sup.11 are each independently selected from the group consisting of hydrogen or (C.sub.1-C.sub.6)alkyl optionally substituted by deuterium, hydroxy, amino, trifluoromethyl, (C.sub.1-C.sub.6)acyloxy, (C.sub.1-C.sub.6)acylamino, (C.sub.1-C.sub.6)alkylamino, ((C.sub.1-C.sub.6)alkyl).sub.2amino, cyano, cyano(C.sub.1-C.sub.6)alkyl, trifluoromethyl(C.sub.1-C.sub.6)alkyl, nitro, nitro(C.sub.1-C.sub.6)alkyl or (C.sub.1-C.sub.6)acylamino; R.sup.12 is carboxy, cyano, amino, oxo, deuterium, hydroxy, trifluoromethyl, (C.sub.1-C.sub.6)alkyl, trifluoromethyl(C.sub.1-C.sub.6)alkyl, (C.sub.1-C.sub.6)alkoxy, halo, (C.sub.1-C.sub.6)acyl, (C.sub.1-C.sub.6)alkylamino, ((C.sub.1-C.sub.6)alkyl).sub.2amino, amino(C.sub.1-C.sub.6)alkyl, (C.sub.1-C.sub.6)alkoxy-CO--NH (C.sub.1-C.sub.6)alkylamino-CO--, (C.sub.1-C.sub.6)alkenyl, (C.sub.2-C.sub.6)alkynyl, (C.sub.1-C.sub.6)alkylamino, hydroxy(C.sub.1-C.sub.6)alkyl, (C.sub.1-C.sub.6)alkoxy(C.sub.1-C.sub.6)alkyl, (C.sub.1-C.sub.6) acyloxy(C.sub.1-C.sub.6)alkyl, nitro, cyano(C.sub.1-C.sub.6)alkyl, halo(C.sub.1-C.sub.6)alkyl, nitro(C.sub.1-C.sub.6)alkyl, trifluoromethyl, trifluoromethyl(C.sub.1-C.sub.6)alkyl, (C.sub.1-C.sub.6)acylamino, (C.sub.1-C.sub.6)acylamino(C.sub.1-C.sub.6)alkyl, (C.sub.1-C.sub.6)alkoxy(C.sub.1-C.sub.6)acylamino, amino(C.sub.1-C.sub.6)acyl, amino(C.sub.1-C.sub.6)acyl(C.sub.1-C.sub.6)alkyl, (C.sub.1-C.sub.6)alkylamino(C.sub.1-C.sub.6)acyl, ((C.sub.1-C.sub.6)alkyl).sub.2amino(C.sub.1-C.sub.6)acyl, R.sup.15R.sup.16N--CO--O--, R.sup.15R.sup.16N--CO--(C.sub.1-C.sub.6)alkyl, R.sup.15C(O)NH, R.sup.15OC(O)NH, R.sup.15NHC(O)NH, (C.sub.1-C.sub.6)alkyl-S(O).sub.m, (C.sub.1-C.sub.6)alkyl-S(O).sub.m--(C.sub.1-C.sub.6)alkyl, R.sup.15R.sup.16NS(O).sub.m, R.sup.15R.sup.16NS(O).sub.m(C.sub.1-C.sub.6)alkyl, R.sup.15S(O).sub.mR.sup.16N, R.sup.15S(O).sub.mR.sup.16N(C.sub.1-C.sub.6)alkyl wherein m is 0, 1 or 2 and R.sup.15 and R.sup.16 are each independently selected from hydrogen or (C.sub.1-C.sub.6)alkyl; R.sup.2 and R.sup.3 are each independently selected from the group consisting of hydrogen, deuterium, amino, halo, hydroxy, nitro, carboxy, (C.sub.2-C.sub.6)alkenyl, (C.sub.2-C.sub.6)alkynyl, trifluoromethyl, trifluoromethoxy, (C.sub.1-C.sub.6)alkyl, (C.sub.1-C.sub.6)alkoxy, (C.sub.3C.sub.10)cycloalkyl wherein the alkyl, alkoxy or cycloalkyl groups are optionally substituted by one to three groups selected from halo, hydroxy, carboxy, amino (C.sub.1-C.sub.6)alkylthio, (C.sub.1-C.sub.6)alkylamino, ((C.sub.1-C.sub.6)alkyl).sub.2amino, (C.sub.5-C.sub.9)heteroaryl, (C.sub.2C.sub.9)heterocycloalkyl, (C.sub.3-C.sub.9)cycloalkyl or (.sub.6-C.sub.10)aryl; or R.sup.2 and R.sup.3 are each independently (C.sub.3-C.sub.10)cycloalkyl, (C.sub.3-C.sub.10)cycloalkoxy, (C.sub.1-C.sub.6)alkylamino, ((C.sub.1-C.sub.6)alkyl).sub.2amino, (C.sub.6-C.sub.10)arylamino, (C.sub.1-C.sub.6)alkylthio, (C.sub.6-C.sub.10)arylthio, (C.sub.1-C.sub.6)alkylsulfinyl, (C.sub.6-C.sub.10)arylsulfinyl, (C.sub.1-C.sub.6)alkylsulfinyl, (C.sub.6-C.sub.10)arylsulfonyl, (C.sub.1-C.sub.6)acyl, (C.sub.1-C.sub.6)alkoxy-CO--NH--, (C.sub.1-C.sub.6)alkylamino-CO--, (C.sub.5-C.sub.9)heteroaryl, (C.sub.2-C.sub.9)heterocycloalkyl or (C.sub.6-C.sub.10)aryl wherein the heteroaryl, heterocycloalkyl and aryl groups are optionally substituted by one to three halo, (C.sub.1-C.sub.6)alkyl, (C.sub.1-C.sub.6)alkyl-CO--NH--, (C.sub.1-C.sub.6)alkoxy-CO--NH--, (C.sub.1-C.sub.6)alkyl-CO--NH--(C.sub.1-C.sub.6)alkyl, (C.sub.1-C.sub.6)alkoxy-CO--NH--(C.sub.1-C.sub.6)alkyl, (C.sub.1-C.sub.6)alkoxy-CO--NH--(C.sub.1-C.sub.6)alkoxy, carboxy, carboxy(C.sub.1-C.sub.6)alkyl, carboxy(C.sub.1-C.sub.6)alkoxy, benzyloxycarbonyl(C.sub.1-C.sub.6)alkoxy, (C.sub.1-C.sub.6)alkoxycarbonyl(C.sub.1-C.sub.6)alkoxy, (C.sub.6-C.sub.10)aryl, amino, amino(C.sub.1-C.sub.6)alkyl, (C.sub.1-C.sub.6)alkoxycarbonylamino, (C.sub.6-C.sub.10)aryl(C.sub.1-C.sub.6)alkoxycarbonylamino, (C.sub.1-C.sub.6)alkylamino, ((C.sub.1-C.sub.6)alkyl).sub.2amino, (C.sub.1-C.sub.6)alkylamino(C.sub.1-C.sub.6)alkyl, ((C.sub.1-C.sub.6)alkyl).sub.2amino(C.sub.1-C.sub.6)alkyl, hydroxy, (C.sub.1-C.sub.6)alkoxy, carboxy, carboxy(C.sub.1-C.sub.6)alkyl, (C.sub.1-C.sub.6)alkoxycarbonyl, (C.sub.1-C.sub.6)alkoxycarbonyl(C.sub.1-C.sub.6)alkyl, (C.sub.1-C.sub.6)alkoxy-CO--NH--, (C.sub.1-C.sub.6)alkyl-CO--NH--, cyano, (C.sub.5-C.sub.9)heterocycloalkyl, amino-CO--NH--, (C.sub.1-C.sub.6)alkylamino-CO--NH--, ((C.sub.1-C.sub.6)alkyl).sub.2amino-CO--NH--, (C.sub.6-C.sub.10)arylamino-CO--NH--, (C.sub.5-C.sub.9)heteroarylamino-CO--NH--, (C.sub.1-C.sub.6)alkylamino-CO--NH--(C.sub.1-C.sub.6)alkyl, ((C.sub.1-C.sub.6)alkyl).sub.2amino-CO--NH--(C.sub.1-C.sub.6)alkyl, (C.sub.6-C.sub.10)arylamino-CO--NH--(C.sub.1-C.sub.6)alkyl, (C.sub.5-C.sub.9)heteroarylamino-CO--NH--(C.sub.1-C.sub.6)alkyl, (C.sub.1-C.sub.6)alkylsulfonyl (C.sub.1-C.sub.6)alkylsulfonylamino, (C.sub.1-C.sub.6)alksulfonylamino(C.sub.1-C.sub.6)alkyl, (C.sub.6-C.sub.10)arylsulfonyl, (C.sub.6-C.sub.10)arylsulfonylamino, (C.sub.6-C.sub.10)arylsulfonylamino(C.sub.1-C.sub.6)alkyl, (C.sub.1-C.sub.6)alkylsulfonylamino, (C.sub.1-C.sub.6)alkylsulfonylamino(C.sub.1-C.sub.6)alkyl, (C.sub.5-C.sub.9)heteroaryl or (C.sub.2-C.sub.9)heterocycloalkyl, or of Formula B: ##STR00070## including pharmaceutically acceptable salt forms or prodrugs thereof, wherein: A.sup.1 and A.sup.2 are independently selected from C and N; T, U, and V are independently selected from O, S, N, CR.sup.5, and NR.sup.6; wherein the 5-membered ring formed by A.sup.1, A.sup.2, U, T, and V is aromatic; X is N or CR.sup.4; Y is C.sub.1-8 alkylene, C.sub.2-8 alkenylene, C.sub.2-8 alkynylene, (CR.sup.11R.sup.12).sub.p--(C.sub.3-10 cycloalkylene)-(CR.sup.11R.sup.12).sub.q, (CR.sup.11R.sup.12).sub.R-(arylene)-(CR.sup.11R.sup.12).sub.q, (CR.sup.11R.sup.12).sub.544 p--(C.sub.1-10 heterocycloalkylene)-(CR.sup.11R.sup.12).sub.q, (CR.sup.11R.sup.12).sub.p-(heteroarylene)-(CR.sup.11R.sup.12).sub.q, (CR.sup.11R.sup.12).sub.pO(CR.sup.11R.sup.12).sub.q, (CR.sup.11R.sup.12).sub.pS(CR.sup.11R.sup.12).sub.q, (CR.sup.11R.sup.12).sub.pC(O)(CR.sup.11R.sup.12).sub.q, (CR.sup.11R.sup.12).sub.pC(O)NR.sub.c(CR.sup.11R.sup.12).sup.q, (CR.sup.11R.sup.12).sub.pC(O)O(CR.sup.11R.sup.12).sub.q, (CR.sup.11R.sup.12).sub.pOC(O)(CR.sup.11R.sup.12).sub.q, (CR.sup.11R.sup.12).sub.pOC(O)NR.sup.c(CR.sup.11R.sup.12).sub.q, (CR.sup.11R.sup.12).sub.pNR.sup.c(CR.sup.11R.sup.12).sub.q, (CR.sup.11R.sup.12).sub.pNR.sup.cC(O)NR.sup.d(CR.sup.11R.sup.12).sub.q, (CR.sup.11R.sup.12).sub.pS(O)(CR.sup.11R.sup.12).sub.q, (CR.sup.11R.sup.12).sub.pS(O)NR.sup.c(CR.sup.11R.sup.12).sub.q, (CR.sup.11R.sup.12).sub.pS(O).sub.2(CR.sup.11R.sup.12).sub.q, or (CR.sup.11R.sup.12).sub.pS(O).sub.2NR.sup.c(CR.sup.11R.sup.12).sub.q, wherein said C.sub.1-8 alkylene, C.sub.2-8 alkenylene, C.sub.2-8 alkynylene, cycloalkylene, arylene, heterocycloalkylene, or heteroarylene, is optionally substituted with 1, 2, or 3 substituents independently selected from -D.sup.1-D.sup.2-D.sup.3-D.sup.4; Z is H, halo, C.sub.1-4 alkyl, C.sub.2-4 alkenyl, C.sub.2-4 alkynyl, C.sub.1-4 haloalkyl, halosulfanyl, C.sub.1-4 hydroxyalkyl, C.sub.1-4 cyanoalkyl, .dbd.C--R.sup.i, .dbd.N--R.sup.i, Cy.sup.1, CN, NO.sub.2, OR.sup.a, SR.sup.a, C(O)R.sup.b, C(O)NR.sup.cR.sup.d, C(O)OR.sup.a, OC(O)R.sup.b, OC(O)NR.sup.cR.sup.d, NR.sup.cR.sup.d, NR.sup.cC(O)R.sup.b, NR.sup.cC(O)NR.sup.cR.sup.d, NR.sup.cC(O)OR.sup.a, C(.dbd.NR.sup.i)NR.sup.cR.sup.d, NR.sup.cC(.dbd.NR.sup.i)NR.sup.cR.sup.d, S(O)R.sup.b, S(O)NR.sup.cR.sup.d, S(O).sub.2R.sup.b, NR.sup.cS(O).sub.2R.sup.b, C(.dbd.NOH)R.sup.b, C(.dbd.NO(C.sub.1-6 alkyl)R.sup.b, and S(O).sub.2NR.sup.cR.sup.d, wherein said C.sub.1-8 alkyl, C.sub.2-8 alkenyl, or C.sub.2-4 alkynyl, is optionally substituted with 1, 2, 3, 4, 5, or 6 substituents independently selected from halo, C.sub.1-4 alkyl, C.sub.2-4 alkenyl, C.sub.2-4 alkynyl, C.sub.1-4 haloalkyl, halosulfanyl, C.sub.1-4 hydroxyalkyl, C.sub.1-4 cyanoalkyl, Cy.sup.1, CN, N.sub.2, OR.sup.a, SR.sup.a, C(O)R.sup.b, C(O)NR.sup.cR.sup.d, C(O)OR.sup.a, OC(O)R.sup.b, OC(O)NR.sup.cR.sup.d, NR.sup.cR.sup.d, NR.sup.cC(O)R.sup.b, NR.sup.cC(O)NR.sup.cR.sup.d, NR.sup.cC(O)OR.sup.a, C(.dbd.NR.sup.i)NR.sup.cR.sup.d, NR.sup.cC(.dbd.NR.sup.i)NR.sup.cR.sup.d, S(O)R.sup.b, S(O)NR.sup.cR.sup.d, S(O).sub.2R.sup.b, NR.sup.cS(O).sub.2R.sup.b, C(.dbd.NOH)R.sup.b, C(.dbd.NO(C.sub.1-6 alkyl))R.sup.b, and S(O).sub.2NR.sup.cR.sup.d; wherein when Z is H, n is 1; or the --(Y).sub.n--Z moiety is taken together i) A.sup.2 to which moiety is attached, ii) R.sup.5 or R.sup.6 of either T or V, and iii) the C or N atom to which the R.sup.5 or R.sup.6 of either T or V is attached to form a 4- to 20-membered aryl, cycloalkyl, heteroaryl, or heterocycloalkyl ring fused to the 5-membered ring formed by A.sup.1 A.sup.2, U, T, and V, wherein said 4- to 20-membered aryl, cycloalkyl, heteroaryl, or heterocycloalkyl ring is optionally substituted by 1, 2, 3, 4, or 5 substituents independently selected from --(W).sub.m-Q; W is C.sub.1-8 alkylenyl, C.sub.2-8 alkenylenyl, C.sub.2-8 alkynylenyl, O, S, C(O), C(O)NR.sup.c', C(O)O, OC(O), OC(O)NR.sup.c', NR.sup.c', NR.sup.c'C(O)NR.sup.d', S(O), S(O)NR.sup.c', S(O).sub.2, or S(O)2NR.sup.c'; Q is H, halo, CN, NO.sub.2, C.sub.1-8 alkyl, C.sub.2-8 alkenyl, C.sub.2-8 alkynyl, C.sub.1-8 haloalkyl, halosulfanyl, aryl, cycloalkyl, heteroaryl, or heterocycloalkyl, wherein said C.sub.1-8 alkyl, C.sub.2-8 alkenyl, C.sub.2-8 alkynyl, C.sub.1-8 haloalkyl, aryl, cycloalkyl, heteroaryl, or heterocycloalkyl is optionally substituted with 1, 2, 3 or 4 substituents independently selected from halo, C.sub.1-4 alkyl, C.sub.2-4 alkenyl, C.sub.2-4 alkynyl, C.sub.1-4 haloalkyl, halosulfanyl, C.sub.1-4 hydroxyalkyl, C.sub.1-4 cyanoalkyl, Cy.sup.2, CN, NO.sub.2, OR.sup.a', SR.sup.a', C(O)R.sup.b', C(O)NR.sup.c'R.sup.d', C(O)OR.sup.a', OC(O)R.sup.b', OC(O)NR.sup.c'R.sup.d', NR.sup.c'R.sup.d', NR.sup.c'C(O)R.sup.b', NR.sup.c'C(O)N R.sup.c'R.sup.d', N R.sup.c'C(O)OR.sup.a', S(O)R.sup.b', S(O)N R.sup.c'R.sup.d', S(O).sub.2R.sup.b', NR.sup.c'S(O).sub.2R.sup.b', and S(O).sub.2N R.sup.c'R.sup.d'; Cy.sup.1 and Cy.sup.2 are independently selected from aryl, heteroaryl, cycloalkyl, and heterocycloalkyl, each optionally substituted by 1, 2, 3, 4 or 5 substituents independently selected from halo, C.sub.1-4 alkyl, C.sub.2-4 alkenyl, C.sub.2-4 alkynyl, C.sub.1-4 haloalkyl, halosulfanyl, C.sub.1-4 hydroxyalkyl, C.sub.1-4 cyanoalkyl, CN, NO.sub.2, OR.sup.a'', SR.sup.a'', C(O)R.sup.b', C(O)NR.sup.c''R.sup.d'', C(O)OR.sup.a'', OC(O)R.sup.b'', OC(O)N R.sup.c''R.sup.d'', NR.sup.c''R.sup.d'', NR.sup.c''C(O)R.sup.b'', NR.sup.c''C(O)OR.sup.a'', NR.sup.c''S(O)R.sup.b'', NR.sup.c''S(O).sub.2R.sup.b'', S(O)R.sup.b'', S(O)NR.sup.c''R.sup.d'', S(O).sub.2R.sup.b'', and S(O).sub.2NR.sup.c''R.sup.d''; R.sup.1, R.sup.2, R.sup.3, and R.sup.4 are independently selected from H, halo, C.sub.1-4 alkyl, C.sub.2-4 alkenyl, C.sub.2-4 alkynyl, C.sub.1-4 haloalkyl, halosulfanyl, aryl, cycloalkyl, heteroaryl, heterocycloalkyl, CN, NO.sub.2, OR.sup.7, SR.sup.7, C(O)R.sup.8, C(O)NR.sup.9R.sup.10, C(O)OR.sup.7OC(O)R.sup.8, OC(O)NR.sup.9R.sup.10, NR.sup.9R.sup.10, NR.sup.9C(O)R.sup.8, NR.sup.cC(O)OR.sup.7, S(O)R.sup.8, S(O)NR.sup.9R.sup.10, S(O).sub.2R.sup.8, NR.sup.9S(O).sub.2R.sup.8, and S(O).sub.2NR.sup.9R.sup.10; R.sup.5 is H, halo, C.sub.1-4 alkyl, C.sub.2-4 alkenyl, C.sub.2-4 alkynyl, C.sub.1-4 haloalkyl, halosulfanyl, CN, NO.sub.2, OR.sup.7, SR.sup.7, C(O)R.sup.8, C(O)NR.sup.9R.sup.10, C(O)OR.sup.7, OC(O)R.sup.8, OC(O)NR.sup.9R.sup.10, NR.sup.9R.sup.10, NR.sup.9C(O)R.sup.8, NR.sup.9C(O)OR.sup.7, S(O)R.sup.8, S(O)NR.sup.9R.sup.10, S(O).sub.2R.sup.8, NR.sup.9S(O).sub.2R.sup.8, or S(O).sub.2NR.sup.9R.sup.10; R.sup.6 is H, C.sub.1-4 alkyl, C.sub.2-4 alkenyl, C.sub.2-4 alkenyl, C.sub.1-4 haloalkyl, OR.sup.7, C(O)R.sup.8, C(O)NR.sup.9R.sup.10, C(O)OR.sup.7, S(O)R.sup.8, S(O)NR.sup.9R.sup.10, S(O).sub.2R.sup.8, or S(O).sub.2NR.sup.9R.sup.10; R.sup.7 is H, C.sub.1-6 alkyl, C.sub.1-6 haloalkyl, C.sub.2-6 alkenyl, C.sub.2-6 alkynyl, aryl, cycloalkyl, heteroaryl, heterocycloalkyl, arylalkyl, heteroarylalkyl, cycloalkylalkyl or heterocycloalkylalkyl; R.sup.8 is H, C.sub.1-6 alkyl, C.sub.1-6 haloalkyl, C.sub.2-6 alkenyl, C.sub.2-6 alkynyl, aryl, cycloalkyl, heteroaryl, heterocycloalkyl, arylalkyl, heteroarylalkyl, cycloalkylalkyl or heterocycloalkylalkyl; R.sup.9 and R.sup.10 are independently from H, C.sub.1-10 alkyl, C.sub.1-6 haloalkyl, C.sub.2-6 alkenyl, C.sub.2-6 alkynyl, C.sub.1-6 alkylcarbonyl, arylcarbonyl, C.sub.1-6 alkylsulfonyl, arylsulfonyl, aryl, heteroaryl, cycloalkyl, heterocycloalkyl, arylalkyl, heteroarylalkyl, cycloalkylalkyl and heterocycloalkylalkyl; or R.sup.9 and R.sup.10 together with the N atom to which they are attached form a 4-, 5-, 6- or 7-membered heterocycloalkyl group; R.sup.11 and R.sup.12 are independently selected from H and -E.sup.1-E.sup.2-E.sup.3-E.sup.4; D.sup.1 and E.sup.1 are independently absent or independently selected from C.sub.1-6 alkylene, C.sub.2-6 alkenylene, C.sub.2-6 alkynylene, arylene, cycloalkylene, heteroarylene, and heterocycloalkylene, wherein each of the C.sub.1-6 alkylene, C.sub.2-6 alkenylene, C.sub.2-6 alkynylene, arylene, cycloalkylene, heteroarylene, and heterocycloalkylene is optionally substituted by 1, 2 or 3 substituents independently selected from halo, CN, NO.sub.2, N.sub.3, SCN, OH, C.sub.1-6 alkyl, C.sub.1-6 haloalkyl, C.sub.2-8 alkoxyalkyl, C.sub.1-6 alkoxy, C.sub.1-6 haloalkoxy, amino, C.sub.1-6 alkylamino, and C.sub.2-8 dialkylamino; D.sup.2 and E.sup.2 are independently absent or independently selected from C.sub.1-6 alkylene, C.sub.2-6 alkenylene, C.sub.2-6 alkynylene, (C.sub.1-6 alkylene).sub.r--O--(C.sub.1-6 alkylene).sub.s, (C.sub.1-6 alkylene).sub.r--S--(C.sub.1-6 alkylene).sub.s, (C.sub.1-6 alkylene).sub.r--NR.sup.c--(C.sub.1-6 alkylene).sub.s, (C.sub.1-6 alkylene).sub.r--CO--(C.sub.1-6 alkylene).sub.s, (C.sub.1-6 alkylene).sub.r--COO--(C.sub.1-6 alkylene).sub.s, (C.sub.1-6 alkylene).sub.r--CONR.sup.c--(C.sub.1-6 alkylene).sub.s, (C.sub.1-6 alkylene).sub.r--SO--(C.sub.1-6 alkylene).sub.s, (C.sub.1-6 alkylene).sub.r--SO.sub.2--(C.sub.1-6 alkylene).sub.s, (C.sub.1-6 alkylene).sub.r--SONR.sup.c--(C.sub.1-6 alkylene).sub.s, and (C.sub.1-6 alkylene).sub.r--NR.sup.cCONR.sup.f--(C.sub.1-6 alkylene).sub.s, wherein each of the C.sub.1-6 alkylene, C.sub.2-6 alkenylene, and C.sub.2-6 alkynylene is optionally substituted by 1, 2 or 3 substituents independently selected from halo, CN, NO.sub.2, N.sub.3, SCN, OH, C.sub.1-6 alkyl, C.sub.1-6 haloalkyl, C.sub.2-8 alkoxyalkyl, C.sub.1-6 alkoxy, C.sub.1-6 haloalkoxy, amino, C.sub.1-6 alkylamino, and C.sub.2-8 dialkylamino; D.sup.3and E.sup.3 are independently absent or independently selected from C.sub.1-6 alkylene, C.sub.2-6 alkenylene, C.sub.2-6 alkynylene, arylene, cycloalkylene, heteroarylene, and heterocycloalkylene, wherein each of the C.sub.1-6 alkylene, C.sub.2-6 alkenylene, C.sub.2-6 alkynylene, arylene, cycloalkylene, heteroarylene, and heterocycloalkylene is optionally substituted by 1, 2 or 3 substituents independently selected from halo, CN, NO.sub.2, N.sub.3, SCN, OH, C.sub.1-6 alkyl, C.sub.1-6 haloalkyl, C.sub.2-8 alkoxyalkyl, C.sub.1-6 alkoxy, C.sub.1-6 haloalkoxy, amino, C.sub.1-6 alkylamino, and C.sub.2-8 dialkylamino; E.sup.4 and E.sup.4 are inde endentl selected from H halo C.sub.1-4 alkyl, C.sub.2-4 alkenyl, C.sub.2-4 alkynyl, C.sub.1-4 haloalkyl halosulfanyl C.sub.1-4 hydroxyalkyl, C.sub.1-4 cyanoalkyl, Cy.sup.1, CN, NO.sub.2, OR.sup.a, SR.sup.a, C(O)R.sup.b, C(O)NR.sup.cR.sup.a, C(O)OR.sup.a, OC(O)R.sup.bOC(O)NR.sup.cR.sup.d NR.sup.cR.sup.d, NR.sup.cC(O)R.sup.b, NR.sup.cC(O)NR.sup.cR.sup.d, NR.sup.cC(O)OR.sup.a, C(.dbd.NR.sup.i)NR.sup.cR.sup.d, NR.sup.cC(.dbd.NR.sup.i)NR.sup.cR.sup.d, S(O)R.sup.b, S(O)NR.sup.cR.sup.d, S(O).sub.2R.sup.b, NR.sup.cS(O).sub.2R.sup.b, C(.dbd.NOH)R.sup.b, C(.dbd.NO(C.sub.1-6 alkyl)R.sup.b, and S(O).sub.2NR.sup.cR.sup.d, wherein said C.sub.1-8 alkyl, C.sub.2-8 alkenyl, or C.sub.2-8 alkynyl, is optionally substituted with 1, 2, 3, 4, 5, or 6 substituents independently selected from halo, C.sub.1-4 alkyl, C.sub.2-4 alkenyl, C.sub.2-4 alkynyl, C.sub.1-4 haloalkyl, halosulfanyl, C.sub.1-4 hydroxyalkyl, C.sub.1-4 cyanoalkyl, Cy.sup.1, CN, NO.sub.2, OR.sup.a, SR.sup.a, C(O)R.sup.b, C(O)NR.sup.cR.sup.d, C(O)OR.sup.a, OC(O)R.sup.b, OC(O)NR.sup.cR.sup.d, NR.sup.cR.sup.d, NR.sup.cC(O)R.sup.b, NR.sup.cC(O)NR.sup.cR.sup.d, NR.sup.cC(O)OR.sup.a, C(.dbd.NR.sup.i)NR.sup.cR.sup.d, NR.sup.cC(.dbd.NR.sup.i)NR.sup.cR.sup.d, S(O)R.sup.b, S(O)NR.sup.cR.sup.d, S(O).sub.2R.sup.b, NR.sup.cS(O).sub.2R.sup.b, C(.dbd.NOH)R.sup.b, C(.dbd.NO(C.sub.1-6 alkyl)) R.sup.b, and S(O).sub.2NR.sup.cR.sup.d; R.sup.a is H, Cy.sup.1, --(C.sub.1-6 alkyl)-Cy.sup.1, C.sub.1-6 alkyl, C.sub.1-6 haloalkyl, C.sub.2-6 alkenyl, C.sub.2-6 alkynyl, wherein said C.sub.1-6 alkyl, C.sub.1-6 haloalkyl, C.sub.2-6 alkenyl, or C.sub.2-6 alkynyl is optionally substituted with 1, 2, or 3 substituents independently selected from OH, CN, amino, halo, C.sub.1-6 alkyl, C.sub.1-6 haloalkyl, halosulfanyl, aryl, arylalkyl, heteroaryl, heteroarylalkyl, cycloalkyl and heterocycloalkyl; R.sup.b is H, Cy.sup.1, --(C.sub.1-6 alkyl)-Cy.sup.1, C.sub.1-6 alkyl, C.sub.1-6 haloalkyl, C.sub.2-6 alkenyl, C.sub.2-6 alkynyl, wherein said C.sub.1-6 alkyl, C.sub.1-6 haloalkyl, C.sub.2-6 alkenyl, or C.sub.2-6 alkynyl is optionally substituted with 1, 2, or 3 substituents independently selected from OH, CN, amino, halo, C.sub.1-6 alkyl, C.sub.1-6 haloalkyl, C.sub.1-6 haloalkyl, halosulfanyl, aryl, arylalkyl, heteroaryl, heteroarylalkyl, cycloalkyl and heterocycloalkyl; R.sup.a' and R.sup.a'' are independently selected from H, C.sub.1-6 alkyl, C.sub.1-6 haloalkyl, C.sub.2-6 alkenyl, C.sub.2-6 alkynyl, aryl, cycloalkyl, heteroaryl, heterocycloalkyl, arylalkyl, heteroarylalkyl, cycloalkylalkyl_and heterocycloalkylalkyl, wherein said C.sub.1-6 alkyl, C.sub.1-6 haloalkyl, C.sub.2-6 alkenyl, C.sub.2-6 alkynyl, aryl, cycloalkyl, heteroaryl, heterocycloalkyl, arylalkyl, heteroarylalkyl, cycloalkylalkyl or heterocycloalkylalkyl is optionally substituted with 1, 2, or 3 substituents independently selected from OH, CN, amino, halo, C.sub.1-6 alkyl, C.sub.1-6 haloalkyl, halosulfanyl, aryl, arylalkyl, heteroaryl, heteroarylalkyl, cycloalkyl and heterocycloalkyl; R.sup.b' and R.sup.b'' are independently selected from H, C.sub.1-6 alkyl, C.sub.1-6 haloalkyl, C.sub.2-6 alkenyl, C.sub.2-6 alkynyl, aryl, cycloalkyl, heteroaryl, heterocycloalkyl, arylalkyl, heteroarylalkyl, cycloalkylalkyl and heterocycloalkylalkyl, wherein said C.sub.1-6 alkyl, C.sub.1-6 haloalkyl, C.sub.2-6 alkenyl, C.sub.2-6 alkynyl, aryl, cycloalkyl, heteroaryl, heterocycloalkyl, arylalkyl, heteroarylalkyl, cycloalkylalkyl or heterocycloalkylalkyl is optionally substituted with 1, 2, or 3 substituents independently selected from OH, CN, amino, halo, C.sub.1-6 alkyl, C.sub.1-6 haloalkyl, C.sub.1-6 haloalkyl, halosulfanyl, aryl, arylalkyl, heteroaryl, heteroarylalkyl, cycloalkyl and heterocycloalkyl; R.sup.c and R.sup.d are independently selected from H, Cy.sup.1, --(C.sub.1-6 alkyl)-Cy.sup.1, C.sub.1-10 alkyl, C.sub.1-6 haloalkyl, C.sub.2-6 alkenyl, C.sub.2-6 alkynyl, wherein said C.sub.1-10 alkyl, C.sub.1-6 haloalkyl, C.sub.2-6 alkenyl, or C.sub.2-6 alkynyl, is optionally substituted with 1, 2, or 3 substituents independently selected from Cy.sup.1, --(C.sub.1-6 alkyl)-Cy.sup.1, OH, CN, amino, halo, C.sub.1-6 alkyl, C.sub.1-6 haloalkyl, C.sub.1-6 haloalkyl, and halosulfanyl; or R.sup.c and R.sup.d together with the N atom to which they are attached form a 4-, 5-, 6- or 7-membered heterocycloalkyl group optionally substituted with 1, 2, or 3 substituents independently selected from Cy.sup.1, --(C.sub.1-6 alkyl)-Cy.sup.1, OH, CN, amino, halo, C.sub.1-6 alkyl, C.sub.1-6 haloalkyl, C.sub.1-6 haloalkyl, and halosulfanyl; R.sup.c' and R.sup.d' are independently H, C.sub.1-10 alkyl, C.sub.1-6 haloalkyl, C.sub.2-6 alkenyl, C.sub.2-6 alkynyl, aryl, heteroaryl, cycloalkyl, heterocycloalkyl, arylalkyl, heteroarylalkyl, cycloalkylalkyl and heterocycloalkylalkyl, wherein said C.sub.1-10 alkyl, C.sub.1-6 haloalkyl, C.sub.2-6 alkenyl, C.sub.2-6 alkynyl, aryl, heteroaryl, cycloalkyl, heterocycloalkyl, arylalkyl, heteroarylalkyl, cycloalkylalkyl or heterocycloalkylalkyl is optionally substituted with 1, 2, or 3 substituents independently selected from OH, CN, amino, halo, C.sub.1-6 alkyl, C.sub.1-6 haloalkyl, C.sub.1-6 haloalkyl, halosulfanyl, aryl, arylalkyl, heteroaryl, heteroarylalkyl, cycloalkyl and heterocycloalkyl; or R.sup.c' and R.sup.d' together with the N atom to which they are attached form a 4-, 5-, 6- or 7-membered heterocycloalkyl group optionally substituted with 1, 2, or 3 substituents independently selected from OH, CN, amino, halo, C.sub.1-6 alkyl, C.sub.1-6 haloalkyl, C.sub.1-6 haloalkyl, halosulfanyl, aryl, arylalkyl, heteroaryl, heteroarylalkyl, cycloalkyl and heterocycloalkyl; R.sup.c'' and R.sup.d'' are independently selected from H, C.sub.1-10 alkyl C.sub.1-6 haloalkyl, C.sub.2-6 alkenyl, C.sub.2-6 alkynyl, aryl, heteroaryl, cycloalkyl, heterocycloalkyl, arylalkyl, heteroarylalkyl, cycloalkylalkyl and heterocycloalkylalkyl, wherein said C.sub.1-10 alkyl, C.sub.1-6 haloalkyl, C.sub.2-6 alkenyl, C.sub.2-6 alkynyl, aryl, heteroaryl, cycloalkyl, heterocycloalkyl, arylalkyl, heteroarylalkyl, cycloalkylalkyl or heterocycloalkylalkyl is optionally substituted with 1, 2, or 3 substituents independently selected from OH, CN, amino, halo, C.sub.1-6 alkyl, C.sub.1-6 haloalkyl, halosulfanyl, C.sub.1-6 haloalkyl, aryl, arylalkyl, heteroaryl, heteroarylalkyl, cycloalkyl and heterocycloalkyl; or R.sup.c'' and R.sup.d'' together with the N atom to which they are attached form a 4-, 5-, 6- or 7-membered heterocycloalkyl group optionally substituted with 1, 2, or 3 substituents independently selected from OH, CN, amino, halo, C.sub.1-6 alkyl, C.sub.1-6 haloalkyl, C.sub.1-6 haloalkyl, halosulfanyl, aryl, arylalkyl, heteroaryl, heteroarylalkyl, cycloalkyl and heterocycloalkyl; R.sup.i is H, CN, NO.sub.2 or C.sub.1-6 alkyl; R.sup.e and R.sup.f are independently selected from H and C.sub.1-6 alkyl; R.sup.i is H, CN, or NO.sub.2:, m is 0 or 1; n is 0 or 1; p is 0, 1, 2, 3, 4, 5, or 6; q is 0, 1, 2, 3, 4, 5 or 6; r is 0 or 1; and s is 0 or 1. 31. The pharmaceutical composition of claim 30, wherein the reactivation agent is panobinostat. 32. A pharmaceutical composition for treating a viral disease comprising an effective, antiviral amount of a JAK inhibitor, and an additional antiviral agent selected from the group consisting of an interferon, a ribavirin, an interleukin, a NS3 protease inhibitor, a NS5A inhibitor, a cysteine protease inhibitor, a phenanthrenequinone, a thiazolidine derivative, a thiazolidine, a benzanilide, a helicase inhibitor, a polymerase inhibitor, a nucleotide analogue, a gliotoxin, a cerulenin, an antisense phosphorothioate oligodeoxynucleotide, an inhibitor of IRES-dependent translation, and a ribozyme, wherein the JAK inhibitor is a compound of Formula A: ##STR00071## wherein: or the pharmaceutically acceptable salt thereof; wherein R.sup.1 is a group of the formula ##STR00072## wherein y is 0, 1 or 2; R.sup.4 is selected from the group consisting of hydrogen, (C.sub.1-C.sub.6)alkyl, (C.sub.1-C.sub.6)alkylsulfonyl, (C.sub.2-C.sub.6)alkenyl, (C.sub.2-C.sub.6)alkynyl wherein the alkyl, alkenyl and alkynyl groups are optionally substituted by deuterium, hydroxy, amino, trifluoromethyl, (C.sub.1-C.sub.4)alkoxy, (C.sub.1-C.sub.6)acyloxy, (C.sub.1-C.sub.6)alkylamino, ((C.sub.1-C.sub.6)alkyl).sub.2amino, cyano, nitro, (C.sub.2C.sub.6)alkenyl, (C.sub.2-C.sub.6)alkynyl or (C.sub.1-C.sub.6)acylamino; or R.sup.4 is (C.sub.3-C.sub.10)cycloalkyl wherein the cycloalkyl group is optionally substituted by deuterium, hydroxy, amino, trifluoromethyl, (C.sub.1-C.sub.6)acyloxy, (C.sub.1-C.sub.6)acylamino, (C.sub.1-C.sub.6)alkylamino, ((C.sub.1-C.sub.6)alkyl).sub.2amino, cyano, cyano(C.sub.1-C.sub.6)alkyl, trifluoromethyl(C.sub.1-C.sub.6)alkyl, nitro, nitro(C.sub.1-C.sub.6)alkyl or (C.sub.1-C.sub.6)acylamino; R.sup.5 is (C.sub.2-C.sub.9)heterocycloalkyl wherein the heterocycloalkyl groups must be substituted by one to five carboxy, cyano, amino, deuterium, hydroxy, (C.sub.1-C.sub.6)alkyl, (C.sub.1-C.sub.6)alkoxy, halo, (C.sub.1-C.sub.6)acyl, (C.sub.1-C.sub.6)alkylamino, amino(C.sub.1-C.sub.6)alkyl, (C.sub.1-C.sub.6)alkoxy-CO--NH, (C.sub.1-C.sub.6)alkylamino-CO--, (C.sub.2-C.sub.6)alkenyl, (C.sub.2-C.sub.6)alkynyl, (C.sub.1-C.sub.6)alkylamino, amino(C.sub.1-C.sub.6)alkyl, hydroxy(C.sub.1-C.sub.6)alkyl, (C.sub.1-C.sub.6)alkoxy(C.sub.1-C.sub.6)alkyl, (C.sub.1-C.sub.6)acyloxy(C.sub.1-C.sub.6)alkyl, nitro, cyano(C.sub.1-C.sub.6)alkyl, halo(C.sub.1-C.sub.6)alkyl, nitro(C.sub.1-C.sub.6)alkyl, trifluoromethyl, trifluoromethyl(C.sub.1C.sub.6)alkyl, (C.sub.1-C.sub.6)acylamino, (C.sub.1-C.sub.6)acylamino(C.sub.1-C.sub.6)alkyl, (C.sub.1-C.sub.6)alkoxy(C.sub.1-C.sub.6)acylamino, amino(C.sub.1-C.sub.6)acyl, amino(C.sub.1-C.sub.6)acyl(C.sub.1-C.sub.6)alkyl, (C.sub.1-C.sub.6)alkylamino(C.sub.1-C.sub.6)acyl, ((C.sub.1-C.sub.6)alkyl).sub.2amino(C.sub.1-C.sub.6)acyl, R.sup.15R.sup.16N--CO--O--, R.sup.15R.sup.16N--CO--(C.sub.1-C.sub.6)alkyl, (C.sub.1-C.sub.6)alkyl-S(O).sub.m, R.sup.15R.sup.16NS(O).sub.m, R.sup.15R.sup.16NS(O).sub.m(C.sub.1-C.sub.6)alkyl, R.sup.15S(O).sub.mR.sup.16N, R.sup.15S(O).sub.mR.sup.16(C.sub.1-C.sub.6)alkyl wherein m is 0, 1 or 2 and R.sup.15 and R.sup.16 are each independently selected from hydrogen or (C.sub.1-C.sub.6)alkyl; or a group of the formula ##STR00073## wherein a is 0, 1, 2, 3 or 4; b, c, e, f and g are each independently 0 or 1; d is 0, 1, 2, or 3; X is S(O).sub.n wherein n is 0, 1 or 2; oxygen, carbonyl or --(C.dbd.N-cyano)-; Y is S(O).sub.n wherein n is 0, 1 or 2; or carbonyl; and Z is carbonyl, C(O)O--,C(O)NR-- or S(O).sub.n wherein n is 0, 1 or 2; R.sup.6, R.sup.7, R.sup.8, R.sup.9, R.sup.10 and R.sup.11 are each independently selected from the group consisting of hydrogen or (C.sub.1-C.sub.6)alkyl optionally substituted by deuterium, hydroxy, amino, trifluoromethyl, (C.sub.1-C.sub.6)acyloxy, (C.sub.1-C.sub.6)acylamino, (C.sub.1-C.sub.6)alkylamino, ((C.sub.1-C.sub.6)alkyl).sub.2amino, cyano, cyano(C.sub.1-C.sub.6)alkyl, trifluoromethyl(C.sub.1-C.sub.6)alkyl, nitro, nitro(C.sub.1-C.sub.6)alkyl or (C.sub.1-C.sub.6)acylamino; R.sup.12 is carboxy, cyano, amino, oxo, deuterium, hydroxy, trifluoromethyl, (C.sub.1-C.sub.6)alkyl, trifluoromethyl(C.sub.1-C.sub.6)alkyl, (C.sub.1-C.sub.6)alkoxy, halo, (C.sub.1-C.sub.6)acyl, (C.sub.1-C.sub.6)alkylamino, ((C.sub.1-C.sub.6)alkyl).sub.2amino, amino(C.sub.1-C.sub.6)alkyl, (C.sub.1-C.sub.6)alkoxy-CO--NH, (C.sub.1-C.sub.6)alkylamino-CO--, (C.sub.2-C.sub.6)alkenyl, (C.sub.2-C.sub.6) alkynyl, (C.sub.1-C.sub.6)alkylamino, hydroxy(C.sub.1-C.sub.6)alkyl, (C.sub.1-C.sub.6)alkoxy(C.sub.1-C.sub.6)alkyl, (C.sub.1-C.sub.6)acyloxy(C.sub.1-C.sub.6)alkyl, nitro, cyano(C.sub.1-C.sub.6)alkyl, halo(C.sub.1-C.sub.6)alkyl, nitro(C.sub.1-C.sub.6)alkyl, trifluoromethyl, trifluoromethyl, (C.sub.1-C.sub.6)alkyl, (C.sub.1-C.sub.6)acylamino, (C.sub.1-C.sub.6)acylamino(C.sub.1-C.sub.6)alkyl, (C.sub.1-C.sub.6)alkoxy(C.sub.1-C.sub.6)acylamino, amino(C.sub.1-C.sub.6)acyl, amino(C.sub.1-C.sub.6)acyl(C.sub.1-C.sub.6)alkyl, (C.sub.1-C.sub.6)alkylamino(C.sub.1-C.sub.6)acyl, ((C.sub.1-C.sub.6)alkyl).sub.2amino(C.sub.1-C.sub.6)acyl, R.sup.15R.sup.16N--CO--O--, R.sup.15R.sup.16N--CO--(C.sub.1-C.sub.6)alkyl, R.sup.15C(O)NH, R.sup.15OC(O)NH, R.sup.15NHC(O)NH, (C.sub.1-C.sub.6)alkyl-S(O).sub.m, (C.sub.1-C.sub.6)alkyl-S(O).sub.m--(C.sub.1-C.sub.6)alkyl, R.sup.15R.sup.16NS(O).sub.m, R.sup.15R.sup.16NS(O).sub.m(C.sub.1-C.sub.6)alkyl, R.sup.15S(O).sub.mR.sup.16N, R.sup.15S(O).sub.mR.sup.16N(C.sub.1-C.sub.6)alkyl wherein m is 0, 1 or 2 and R.sup.15 and R.sup.16 are each independently selected from hydrogen or (C.sub.1-C.sub.6)alkyl; R.sup.2 and R.sup.3 are each independently selected from the group consisting of hydrogen, deuterium, amino, halo, hydroxy, nitro, carboxy, (C.sub.1-C.sub.6)alkenyl, (C.sub.2-C.sub.6)alkynyl, trifluoromethyl, trifluoromethoxy, (C.sub.1-C.sub.6)alkyl, (C.sub.1-C.sub.6)alkoxy, (C.sub.3-C.sub.10)cyclo alkyl wherein the alkyl, alkoxy or cycloalkyl groups are optionally substituted by one to three groups selected from halo, hydroxy, carboxy, amino (C.sub.1-C.sub.6)alkylthio, (C.sub.1-C.sub.6)alkylamino, ((C.sub.1-C.sub.6)alkyl).sub.2amino, (C.sub.5-C.sub.9)heteroaryl, (C.sub.2-C.sub.9)heterocycloalkyl, (C.sub.3-C.sub.9)cycloalkyl or (C.sub.6-C.sub.10)aryl; or R.sup.2 and R.sup.3 are each independently (C.sub.3-C.sub.10)cycloalkyl, (C.sub.3-C.sub.10)cycloalkoxy, (C.sub.1-C.sub.6)alkylamino, ((C.sub.1-C.sub.6)alkyl).sub.2amino, (C.sub.6-C.sub.10)arylamino, (C.sub.1-C.sub.6)alkylthio (C.sub.6-C.sub.10)arylthio, (C.sub.1-C.sub.6)alkylsulfinyl, (C.sub.6-C.sub.10)arylsulfinyl, (C.sub.1-C.sub.6)alkylsulfonyl, (C.sub.6-C.sub.10)arylsulfonyl, (C.sub.1-C.sub.6)acyl, (C.sub.1-C.sub.6)alkoxy-CO--NH--, (C.sub.1-C.sub.6)alkylamino-CO--, (C.sub.5-C.sub.9)heteroaryl, (C.sub.2-C.sub.9)heterocycloalkyl or (C.sub.6-C.sub.10)aryl wherein the heteroaryl, heterocycloalkyl and aryl groups are optionally substituted by one to three halo, (C.sub.1-C.sub.6)alkyl, (C.sub.1-C.sub.6)alkyl-CO--NH--, (C.sub.1-C.sub.6)alkoxy-CO--NH--, (C.sub.1-C.sub.6)alkyl-CO--NH--(C.sub.1-C.sub.6)alkyl, (C.sub.1-C.sub.6)alkoxy-CO--NH--(C.sub.1-C.sub.6)alkoxy-CO--NH--(C.sub.1-- C.sub.6)alkoxy, carboxy, carboxy(C.sub.1-C.sub.6)alkyl, carboxy(C.sub.1-C.sub.6)alkoxy, benzyloxycarbonyl(C.sub.1-C.sub.6)alkoxy, (C.sub.1-C.sub.6)alkoxycarbonyl(C.sub.1-C.sub.6)alkoxy, (C.sub.6-C.sub.10)aryl, amino, amino(C.sub.1-C.sub.6)alkyl, (C.sub.1-C.sub.6)alkoxycarbonylamino, (C.sub.6-C.sub.10)aryl(C.sub.1-C.sub.6)alkoxycarbonylamino (C.sub.1-C.sub.6)alkylamino, ((C.sub.1-C.sub.6)alkyl).sub.2amino, (C.sub.1-C.sub.6)alkylamino(C.sub.1-C.sub.6)alkyl, ((C.sub.1-C.sub.6)alkyl).sub.2amino(C.sub.1-C.sub.6)alkyl, hydroxy, (C.sub.1-C.sub.6)alkoxy, carboxy, carboxy(C.sub.1-C.sub.6)alkyl, (C.sub.1-C.sub.6)alkoxycarbonyl, (C.sub.1-C.sub.6)alkoxycarbonyl(C.sub.1-C.sub.6)alkyl, (C.sub.1-C.sub.6)alkoxy-CO--NH--, (C.sub.1-C.sub.6)alkyl-CO--NH--, cyano, (C.sub.5-C.sub.9)heterocycloalkyl, amino-CO--NH--, (C.sub.1-C.sub.6)alkyalamino-CO--NH--, ((C.sub.1-C.sub.6)alkyl).sub.2alamino-CO--NH--, (C.sub.6-C.sub.10)arylamino-CO--NH--, (C.sub.5-C.sub.9)heteroarylamino-CO--NH--, (C.sub.1-C.sub.6)alkylamino-CO--NH--(C.sub.1-C.sub.6)alkyl, ((C.sub.1-C.sub.6) alkyl) .sub.2amino-CO--NH--(C.sub.1-C.sub.6)alkyl, (C.sub.6-C.sub.10)arylamino-CO--NH--(C.sub.1-C.sub.6)alkyl, (C.sub.5-C.sub.9)heteroarylamino-CO--NH--(C.sub.1-C.sub.6)alkyl, (C.sub.1-C.sub.6)alkylsulfonyl (C.sub.1-C.sub.6)alkylsulfonylamino, (C.sub.1-C.sub.6)alkylsulfonylamino(C.sub.1-C.sub.6)alkyl, (C.sub.6-C.sub.10)arylsulfonyl, (C.sub.6-C.sub.10)arylsulfonylamino, (C.sub.6-C.sub.10)arylsulfonylamino(C.sub.1-C.sub.6)alkyl, (C.sub.1-C.sub.6)alkylsulfonylamino, (C.sub.l-C.sub.6)alkylsulfonylamino(C.sub.1-C.sub.6)alkyl, (C.sub.5-C.sub.9)heteroaryl or (C.sub.2-C.sub.9)heterocycloalkyl, or of Formula B: ##STR00074## including pharmaceutically acceptable salt forms or prodrugs thereof, wherein: A.sup.1 and A.sup.2 are independently selected from C and N; T, U, and V are independently selected from O, S, N, CR.sup.5, and NR.sup.6; wherein the 5-membered ring formed by A.sup.1, A.sup.2, U, T, and V is aromatic; X is N or CR.sup.4; Y is C.sub.1-8 alkylene, C.sub.2-8 alkenylene, C.sub.2-8 alkynylene, (CR.sup.11R.sup.12).sub.p--(C.sub.3-10 cycloalkylene)-(CR.sup.11R.sup.12).sub.q, (CR.sup.11R.sup.12).sub.p(arylene)-(CR.sup.11R.sup.12).sub.q, (CR.sup.11R.sup.12).sub.\p--(C.sub.1-10 heterocycloalkylene)-(CR.sup.11R.sup.12).sub.q, (CR.sup.11R.sup.12).sub.p-(heteroarylene)-(CR.sup.11R.sup.12).sub.q, (CR.sup.11R.sup.12).sub.pO(CR.sup.11R.sup.12).sub.q, (CR.sup.11R.sup.12).sub.pS(CR.sup.11R.sup.12).sub.q, (CR.sup.11R.sup.12).sub.pC(O)(CR.sup.11R.sup.12).sub.q, (CR.sup.11R.sup.12).sub.pC(O)NR.sub.c(CR.sup.11R.sup.12).sub.q, (CR.sup.11R.sup.12).sub.pC(O)O(CR.sup.11R.sup.12).sub.q, (CR.sup.11R.sup.12).sub.pOC(O)(CR.sup.11R.sup.12).sub.q, (CR.sup.11R.sup.12).sub.pOC(O)NR.sup.c(CR.sup.11R.sup.12).sub.q, (CR.sup.11R.sup.12).sub.pNR.sup.c(CR.sup.11R.sup.12).sub.q, (CR.sup.11R.sup.12).sub.pNR.sup.cC(O)NR.sup.d(CR.sup.11R.sup.12).sub.q, (CR.sup.11R.sup.12).sub.pS(O)(CR.sup.11R.sup.12).sub.q, (CR.sup.11R.sup.12).sub.pS(O)NR.sup.c(CR.sup.11R.sup.12).sub.q, (CR.sup.11R.sup.12).sub.pS(O).sub.2(CR.sup.11R.sup.12).sub.q, or (CR.sup.11R.sup.12).sub.pS(O).sub.2NR.sup.c(CR.sup.11R.sup.12).sub.q, wherein said C.sub.1-8 alkylene, C.sub.2-8 alkenylene, C.sub.2-8 alkynylene, cycloalkylene, arylene, heterocycloalkylene, or heteroarylene, is optionally substituted with 1, 2, or 3 substituents independently selected from -D.sup.1-D.sup.2-D.sup.3-D.sup.4; Z is H, halo, C.sub.1-4 alkyl, C.sub.2-4alkynyl, C.sub.2-4 alkynyl, C.sub.1-4 haloalkyl, halosulfanyl, C.sub.1-4 hydroxyalkyl, C.sub.1-4 cyanoalkyl, .dbd.C--R.sup.i, .dbd.N--R.sup.i, Cy.sup.1, CN, NO.sub.2, OR.sup.a, SR.sup.a, C(O)R.sup.b, C(O)NR.sup.cR.sup.d, C(O)OR.sup.a, OC(O)R.sup.b, OC(O)NR.sup.cR.sup.d, NR.sup.cR.sup.d, NR.sup.cC(O)R.sup.b, NR.sup.cC(O)NR.sup.cR.sup.d, NR.sup.cC(O)OR.sup.a, C(.dbd.NR.sup.i)NR.sup.cR.sup.d, NR.sup.cC(.dbd.NR.sup.i)NR.sup.cR.sup.d, S(O)R.sup.b, S(O)NR.sup.cR.sup.d, S(O).sub.2R.sup.b, NR.sup.cS(O).sub.2R.sup.b, C(.dbd.NOH)R.sup.b, C(.dbd.NO(C.sub.1-6alkyl)R.sup.b, and S(O).sub.2NR.sup.cR.sup.d, wherein said C.sub.1-8 alkyl, C.sub.2-8 alkenyl, or C.sub.2-8 alkynyl, is optionally substituted with 1, 2, 3, 4, 5, or 6 substituents independently selected from halo, C.sub.1-4 alkyl, C.sub.2-4 alkenyl, C.sub.2-4 alkynyl, C.sub.1-4 haloalkyl, halosulfanyl, C.sub.1-4 hydroxyalkyl, C.sub.1-4 cyanoalkyl, Cy.sup.1, CN, N.sub.2, OR.sup.a, SR.sup.a, C(O)R.sup.b, C(O)NR.sup.cR.sup.d, C(O)OR.sup.a, OC(O)R.sup.b, OC(O)NR.sup.cR.sup.d, NR.sup.cR.sup.d, NR.sup.cC(O)R.sup.b, NR.sup.cC(O)NR.sup.cR.sup.d, NR.sup.cC(O)OR.sup.a, C(.dbd.NR.sup.i)NR.sup.cR.sup.d, NR.sup.cC(.dbd.NR.sup.i)NR.sup.cR.sup.d, S(O)R.sup.b, S(O)NR.sup.cR.sup.d, S(O).sub.2R.sup.b, NR.sup.cS(O).sub.2R.sup.b, C(.dbd.NOH)R.sup.b, C(.dbd.NO(C.sub.1-6 alkyl))R.sup.b, and S(O).sub.2NR.sup.cR.sup.d; wherein when Z is H, n is 1; or the --(Y).sub.n--Z moiety is taken together with i) A.sup.2 to which the moiety is attached, ii) R.sup.5 or R.sup.6 of either T or V, and iii) the C or N atom to which the R.sup.5 or R.sup.6 of either T or V is attached to form a 4- to 20-membered aryl, cycloalkyl, heteroaryl, or heterocycloalkyl ring fused to the 5-membered ring formed by A.sup.1 A.sup.2, U, T, and V, wherein said 4- to 20-membered aryl, cycloalkyl, heteroaryl, or heterocycloalkyl ring is optionally substituted by 1, 2, 3, 4, or 5 substituents independently selected from --(W).sub.m-Q; W is C.sub.1-8 alkylenyl, C.sub.2-8 alkenylenyl, C.sub.2-8 alkynylenyl, O, S, C(O), C(O)NR.sup.c', C(O)O, OC(O), OC(O)NR.sup.c', NR.sup.c', NR.sup.c'C(O)NR.sup.d, S(O), S(O)NR.sup.c', S(O).sub.2, or S(O)2NR.sup.c'; Q is H, halo, CN, NO.sub.2, C.sub.1-8 alkyl, C.sub.2-8 alkenyl, C.sub.2-8 alkynyl, C.sub.1-8 haloalkyl, halosulfanyl, aryl, cycloalkyl, heteroaryl, or heterocycloalkyl, wherein said C.sub.1-8 alkyl, C.sub.2-8 alkenyl, C.sub.2-8 alkynyl, C.sub.1-8 haloalkyl, aryl, cycloalkyl, heteroaryl, or heterocycloalkyl is optionally substituted with 1, 2, 3 or 4 substituents independently selected from halo, C.sub.1-4 alkyl, C.sub.2-4 alkenyl, C.sub.2-4 alkynyl, C.sub.1-4 haloalkyl, halosulfanyl, C.sub.1-4 hydroxyalkyl, C.sub.1-4 cyanoalkyl, Cy.sup.2, CN, NO.sub.2, OR.sup.a', SR.sup.a', C(O)R.sup.b', C(O)NR.sup.c'R.sup.d', C(O)OR.sup.a', OC(O)R.sup.b', OC(O)NR.sup.c'R.sup.d', NR.sup.c'R.sup.d', NR.sup.c'C(O)R.sup.b', NR.sup.c'C(O)NR.sup.c'R.sup.d', N R.sup.c'C(O)OR.sup.a', S(O)R.sup.b', S(O)N R.sup.c'R.sup.d', S(O).sub.2R.sup.b', NR.sup.c'S(O).sub.2R.sup.b', and S(O).sub.2N R'R.sup.d'; Cy.sup.1 and Cy.sup.2 are independently selected from aryl, heteroaryl, cycloalkyl, and heterocycloalkyl, each optionally substituted by 1, 2, 3, 4 or 5 substituents independently selected from halo, C.sub.1-4 alkyl, C.sub.2-4 alkenyl, C.sub.2-4 alkynyl, C.sub.1-4 haloalkyl, halosulfanyl, C.sub.1-4 hydroxyalkyl, C.sub.1-4 cyanoalkyl, CN, NO.sub.2, OR.sup.a'', SR.sup.a'', C(O)R.sup.b'', C(O)NR.sup.c''R.sup.d'', C(O)OR.sup.a'', OC(O)R.sup.b'', OC(O)N R.sup.c''R.sup.d'', NR.sup.c''R.sup.d'', NR.sup.c''C(O)R.sup.b'', NR.sup.c''C(O)OR.sup.a'', NR.sup.c''S(O)R.sup.b'', NR.sup.c''S(O).sub.2R.sup.b'', S(O)R.sup.b'', S(O)NR.sup.c''R.sup.d'', S(O).sub.2R.sup.b'', and S(O).sub.2NR.sup.c''R.sup.d; R.sup.1, R.sup.2, R.sup.3, and R.sup.4 are independently selected from H, halo, C.sub.1-4 alkyl, C.sub.2-4 alkenyl, C.sub.2-4 alkynyl, C.sub.1-4 haloalkyl, halosulfanyl, aryl, cycloalkyl, heteroaryl, heterocycloalkyl, CN, NO.sub.2, OR.sup.7, SR.sup.7, C(O)R.sup.8, C(O)NR.sup.9R.sup.10, C(O)OR.sup.7OC(O)R.sup.8, OC(O)NR.sup.9R.sup.10; NR.sup.9R.sup.10, NR.sup.9 C(O)R.sup.8, NR.sup.cC(O)OR.sup.7, S(O)R.sup.8, S(O)NR.sup.9R.sup.10, S(O).sub.2R.sup.8 , NR.sup.9S(O).sub.2R.sup.8, and S(O).sub.2NR.sup.9R.sup.10; R.sup.5 is H, halo, C.sub.1-4 alkyl, C.sub.2-4 alkenyl, C.sub.2-4 alkynyl, C.sub.1-4 haloalkyl, halosulfanyl, CN, NO.sub.2, OR.sup.7, SR.sup.7, C(O)R.sup.8, C(O)NR.sup.9R.sup.10, C(O)OR.sup.7, OC(O)R.sup.8, OC(O)NR.sup.9R.sup.10, NR.sup.9R.sup.10, NR.sup.9C(O)R.sup.8, NR.sup.9C(O)OR.sup.7, S(O)R.sup.8, S(O)NR.sup.9R.sup.10, S(O).sub.2R.sup.8, NR.sup.9S(O).sub.2R.sup.8, or S(O).sub.2NR.sup.9R.sup.10; R.sup.6 is H, C.sub.1-4 alkyl, C.sub.2-4 alkenyl, C.sub.2-4 alkynyl, C.sub.1-4 haloalkyl, OR.sup.7, C(O)R.sup.8 , C(O)NR.sup.9R.sup.10, C(O)OR.sup.7, S(O)R.sup.8, S(O)NR.sup.9R.sup.10, S(O).sub.2R.sup.8, or S(O).sub.2NR.sup.9R.sup.10; R.sup.7 is H, C.sub.1-6 alkyl, C.sub.1-6 haloalkyl, C.sub.2-6 alkenyl, C.sub.2-6 alkynyl, aryl, cycloalkyl, heteroaryl, heterocycloalkyl, arylalkyl, heteroarylalkyl, cycloalkylalkyl or heterocycloalkylalkyl; R.sup.8 is H, C.sub.1-6 alkyl, C.sub.1-6 haloalkyl, C.sub.2-6 alkenyl, C.sub.2-6 alkynyl, aryl, cycloalkyl, heteroaryl, heterocycloalkyl, arylalkyl, heteroarylalkyl, cycloalkylalkyl or heterocycloalkylalkyl; R.sup.9 and R.sup.10 are independently selected from H, C.sub.1-10 alkyl C.sub.1-6 haloalkyl, C.sub.2-6 alkenyl, C.sub.2-6 alkynyl, C.sub.1-6 alkylcarbonyl, arylcarbonyl, C.sub.1-6 alkylsulfonyl, arylsulfonyl, aryl, heteroaryl, cycloalkyl, heterocycloalkyl, arylalkyl, heteroarylalkyl, cycloalkylalkyl and heterocycloalkylalkyl; or R.sup.9 and R.sup.10 together with the N atom to which they are attached form a 4-, 5-, 6- or 7-membered heterocycloalkyl group; R.sup.11 and R.sup.12 are independently selected from H and -E.sup.1-E.sup.2-E.sup.3-E.sup.4; D.sup.1 and E.sup.1 are independently absent or independently selected from C.sub.1-6 alkylene, C.sub.2-6 alkenylene, C.sub.2-6 alkynylene, arylene, cycloalkylene, heteroarylene, and heterocycloalkylene, wherein each of the C.sub.1-6 alkylene, C.sub.2-6 alkenylene, C.sub.2-6 alkynylene, arylene, cycloalkylene, heteroarylene, and heterocycloalkylene is optionally substituted by 1, 2 or 3 substituents independently selected from halo, CN, NO.sub.2, N.sub.3, SCN, OH, C.sub.1-6 alkyl, C.sub.1-6 haloalkyl, C.sub.2-8 alkoxyalkyl, C.sub.1-6 alkoxy, C.sub.1-6 haloalkoxy, amino, C.sub.1-6 alkylamino, and C.sub.2-8 dialkylamino; D.sup.2 and E.sup.2 are independently absent or independently selected from C.sub.1-6 alkylene, C.sub.2-6 alkenylene, C.sub.2-6 alkynylene, (C.sub.1-6 alkylene).sub.r--O--(C.sub.1-6 alkylene).sub.s, (C.sub.1-6 alkylene).sub.r--S---(C.sub.1-6 alkylene).sub.s, (C.sub.1-6 alkylene).sub.r--NR.sup.c--(C.sub.1-6 alkylene).sub.s, (C.sub.1-6 alkylene).sub.r--CO--(C.sub.1-6 alkylene).sub.s, (C.sub.1-6 alkylene).sub.r--COO--(C.sub.1-6 alkylene).sub.s, (C.sub.1-6alkylene).sub.r--CONR.sup.c--(C.sub.1-6 alkylene).sub.s, (C.sub.1-6 alkylene).sub.r--SO--(C.sub.1-6 alkylene).sub.s, (C.sub.1-6 alkylene).sub.r--SO.sub.2--(C.sub.1-6 alkylene).sub.s, (C.sub.1-6 alkylene).sub.r--SONR.sup.c--(C.sub.1-6 alkylene).sub.s and (C.sub.1-6 alkylene).sub.r--NR.sup.cCONR.sup.f--(C.sub.1-6 alkylene).sub.s, wherein each of the C.sub.1-6 alkylene, C.sub.2-6 alkenylene, and C.sub.2-6 alkynylene is optionally substituted by 1, 2 or 3 substituents independently selected from halo, CN, NO.sub.2, N.sub.3, SCN, OH, C.sub.1-6 alkyl, C.sub.1-6 haloalkyl, C.sub.2-8 alkoxyalkyl, C.sub.1-6 alkoxy, C.sub.1-6 haloalkoxy, amino, C.sub.1-6 alkylamino, and C.sub.2-8 dialkylamino; D.sup.3and E.sup.3 are independently absent or independently selected from C.sub.1-6 alkylene, C.sub.2-6 alkenylene, C.sub.2-6 alkynylene, arylene, cycloalkylene, heteroarylene, and heterocycloalkylene, wherein each of the C.sub.1-6 alkylene, C.sub.2-6 alkenylene, C.sub.2-6 alkynylene, arylene, cycloalkylene, heteroarylene, and heterocycloalkylene is optionally substituted by 1, 2 or 3 substituents independently selected from halo, CN, NO.sub.2, N.sub.3, SCN, OH, C.sub.1-6 alkyl, C.sub.1-6 haloalkyl, C.sub.2-8 alkoxyalkyl, C.sub.1-6 alkoxy, C.sub.1-6 haloalkoxy, amino, C.sub.1-6 alkylamino, and C.sub.2-8 dialkylamino; E.sup.4 and E.sup.4 are independently selected from H, halo, C.sub.1-4 alkyl, C.sub.2-4 alkenyl, C.sub.2-4 alkynyl, C.sub.1-4 haloalkyl, halosulfanyl, C.sub.1-4 hydroxyalkyl, C.sub.1-4 cyanoalkyl, Cy.sup.1, CN, NO.sub.2, OR.sup.a, SR.sup.a, C(O)R.sup.b, C(O)NR.sup.cR.sup.a, C(O)OR.sup.a, OC(O)R.sup.bOC(O)NR.sup.cR.sup.d NR.sup.cR.sup.d, NR.sup.cC(O)R.sup.b, NR.sup.cC(O)NR.sup.cR.sup.d, NR.sup.cC(O)OR.sup.a, C(.dbd.NR.sup.i)NR.sup.cR.sup.d, NR.sup.cC(.dbd.NR.sup.i)NR.sup.cR.sup.d, S(O)R.sup.b, S(O)NR.sup.cR.sup.d, S(O).sub.2R.sup.b, NR.sup.cS(O).sub.2R.sup.b, C(.dbd.NOH)R.sup.b, C(.dbd.NO(C.sub.1-6 alkyl)R.sup.b, and S(O).sub.2NR.sup.cR.sup.d, wherein said C.sub.1-8 alkyl, C.sub.2-8 alkenyl, or C.sub.2-8 alkynyl, is optionally substituted with 1, 2, 3, 4, 5, or 6 substituents independently selected from halo, C.sub.1-4 alkyl, C.sub.2-4 alkenyl, C.sub.2-4 alkynyl, C.sub.1-4 haloalkyl, halosulfanyl, C.sub.1-4 hydroxyalkyl C.sub.1-4 cyanoalkyl, Cy.sup.1, CN, NO.sub.2, OR.sup.a, SR.sup.a, C(O)R.sup.b, C(O)NR.sup.cR.sup.d, C(O)OR.sup.a, OC(O)R.sup.b, OC(O)NR.sup.cR.sup.d, NR.sup.cR.sup.d, NR.sup.cC(O)R.sup.b, NR.sup.cC(O)NR.sup.cR.sup.d, NR.sup.cC(O)OR.sup.a, C(.dbd.NR.sup.i)NR.sup.cR.sup.d, NR.sup.cC(.dbd.NR.sup.i)NR.sup.cR.sup.d, S(O)R.sup.b, S(O)NR.sup.cR.sup.d, S(O).sub.2R.sup.b, NR.sup.cS(O).sub.2R.sup.b, C(.dbd.NOH)R.sup.b, C(.dbd.NO(C.sub.1-6 alkyl))R.sup.b, and S(O).sub.2NR.sup.cR.sup.d; R.sup.a is H, Cy.sup.1, --(C.sub.1-6 alkyl)-Cy.sup.1, C.sub.1-6 alkyl, C.sub.1-6 haloalkyl, C.sub.2-6 alkenyl, C.sub.2-6 alkynyl, wherein said C.sub.1-6 alkyl, C.sub.1-6 haloalkyl, C.sub.2-6 alkenyl, or C.sub.2-6 alkynyl is optionally substituted with 1, 2, or 3 substituents independently selected from OH, CN, amino, halo, C.sub.1-6 alkyl, C.sub.1-6 haloalkyl, halosulfanyl, aryl, arylalkyl, heteroaryl, heteroarylalkyl, cycloalkyl and heterocycloalkyl; R.sup.b is H, Cy.sup.1, --(C.sub.1-6 alkyl)-Cy.sup.1, C.sub.1-6 alkyl, C.sub.1-6 haloalkyl, C.sub.2-6 alkenyl, C.sub.2-6 alkynyl, wherein said C.sub.1-6 alkyl, C.sub.1-6 haloalkyl, C.sub.2-6 alkenyl or C.sub.2-6 alkynyl is optionally substituted with 1, 2, or 3 substituents independently selected from OH, CN, amino, halo, C.sub.1-6 alkyl, C.sub.1-6 haloalkyl, C.sub.1-6 haloalkyl, halosulfanyl, aryl, arylalkyl, heteroaryl, heteroarylalkyl, cycloalkyl and heterocycloalkyl; R.sup.a' and R.sup.a'' are independently selected from H, C.sub.1-6 alkyl, C.sub.1-6 haloalkyl, C.sub.2-6 alkenyl, C.sub.2-6 alkynyl, aryl, cycloalkyl, heteroaryl, heterocycloalkyl, arylalkyl, heteroarylalkyl, cycloalkylalkyl and heterocycloalkylalkyl, wherein said C.sub.1-6 alkyl, C.sub.1-6 haloalkyl, C.sub.2-6 alkenyl, C.sub.2-6 alkynyl, aryl, cycloalkyl, heteroaryl, heterocycloalkyl, arylalkyl, heteroarylalkyl, cycloalkylalkyl or heterocycloalkylalkyl is optionally substituted with 1, 2, or 3 substituents independently selected from OH, CN, amino, halo, C.sub.1-6 alkyl, C.sub.1-6 haloalkyl, halosulfanyl, aryl, arlalkyl heteroaryl, heteroarylalkyl, cycloalkyl and heterocycloalkyl; R.sup.b' and R.sup.b'' are independently selected from H, C.sub.1-6 alkyl, C.sub.1-6 haloalkyl, C.sub.2-6 alkenyl, C.sub.2-6 alkynyl, aryl, cycloalkyl, heteroaryl, heterocycloalkyl, arylalkyl, heteroarylalkyl, cycloalkylalkyl and heterocycloalkylalkyl, wherein said C.sub.1-6 alkyl, C.sub.1-6 haloalkyl, C.sub.2-6 alkenyl, C.sub.2-6 alkynyl, aryl, cycloalkyl, heteroaryl, heterocycloalkyl, arylalkyl, heteroarylalkyl, cycloalkylalkyl or heterocycloalkylalkyl is optionally substituted with 1, 2, or 3 substituents independently selected from OH, CN, amino, halo, C.sub.1-6 alkyl, C.sub.1-6 haloalkyl, C.sub.1-6 haloalkyl, halosulfanyl, aryl, arylalkyl, heteroaryl, heteroarylalkyl, cycloalkyl and heterocycloalkyl; R.sup.c and R.sup.d are independently selected from H, Cy.sup.1, --(C.sub.1-6 alkyl)-Cy.sup.1, C.sub.1-10 alkyl, C.sub.1-6 haloalkyl, C.sub.2-6 alkenyl, C.sub.2-6 alkynyl, wherein said C.sub.1-10 alkyl, C.sub.1-6 haloalkyl, C.sub.2-6 alkenyl, or C.sub.2-6 alkynyl, is optionally substituted with 1, 2, or 3 substituents independently selected from Cy.sup.1, --(C.sub.1-6 alkyl)-Cy.sup.1, OH, CN, amino, halo, C.sub.1-6 alkyl, C.sub.1-6 haloalkyl, C.sub.1-6 haloalkyl, and halosulfanyl; or R.sup.c and R.sup.d together with the N atom to which they are attached form a 4-, 5-, 6- or 7-membered heterocycloalkyl group optionally substituted with 1, 2, or 3 substituents independently selected from Cy.sup.1, --(C.sub.1-6 alkyl)-Cy.sup.1, OH, CN, amino, halo, C.sub.1-6 alkyl, C.sub.1-6 haloalkyl, C.sub.1-6 haloalkyl, and halosulfanyl; R.sup.c' and R.sup.d' are independently selected from H, C.sub.1-10 alkyl, C.sub.1-6 haloalkyl, C.sub.2-6 alkenyl, C.sub.2-6 alkynyl, aryl, heteroaryl, cycloalkyl, heterocycloalkyl, arylalkyl, heteroarylalkyl, cycloalkylalkyl and heterocycloalkylalkyl, wherein said C.sub.1-10 alkyl, C.sub.1-6 haloalkyl, C.sub.2-6 alkenyl, C.sub.2-6 alkynyl, aryl, heteroaryl, cycloalkyl, heterocycloalkyl, arylalkyl, heteroarylalkyl, cycloalkylalkyl or heterocycloalkylalkyl is optionally substituted with 1, 2, or 3 substituents independently selected from OH, CN, amino, halo, C.sub.1-6 alkyl, C.sub.1-6 haloalkyl, C.sub.1-6 haloalkyl, halosulfanyl, aryl, arylalkyl, heteroaryl, heteroarylalkyl, cycloalkyl and heterocycloalkyl; or R.sup.c' and R.sup.d' together with the N atom to which they are attached form a 4-, 5-, 6- or 7-membered heterocycloalkyl group optionally substituted with 1, 2, or 3 substituents independently selected from OH, CN, amino, halo, C.sub.1-6 alkyl, C.sub.1-6 haloalkyl, C.sub.1-6 haloalkyl, halosulfanyl, aryl, arylalkyl, heteroaryl, heteroarylalkyl, cycloalkyl and heterocycloalkyl; R.sup.c'' and R.sup.d'' are independently selected from H, C.sub.1-10 alkyl, C.sub.1-6 haloalkyl, C.sub.2-6 alkenyl, C.sub.2-6 alkynyl, aryl, heteroaryl, cyloalkyl heterocycloalkyl, arylalkyl, heteroarylalkyl, cycloalkylalkyl and heterocycloalkylalkyl, wherein said C.sub.1-10 alkyl, C.sub.1-6 haloalkyl, C.sub.2-6alkenyl, C.sub.2-6 alkynyl, aryl, heteroaryl, cycloalkyl, heterocycloalkyl, arylalkyl, heteroarylalkyl, cycloalkylalkyl or heterocycloalkylalkyl is optionally substituted with 1, 2, or 3 substituents independently selected from OH, CN, amino, halo, C.sub.1-6 alkyl, C.sub.1-6 haloalkyl, halosulfanyl, C.sub.1-6 haloalkyl, aryl, arylalkyl, heteroaryl, heteroarylalkyl, cycloalkyl and heterocycloalkyl; or R.sup.C'' and R.sup.d'' together with the N atom to which they are attached form a 4-, 5-, 6- or 7-membered heterocycloalkyl group optionally substituted with 1, 2, or 3 substituents independently selected from OH, CN, amino, halo, C.sub.1-6 alkyl, C.sub.1-6 haloalkyl, C.sub.1-6 haloalkyl, halosulfanyl, aryl, arylalkyl, heteroaryl, heteroarylalkyl, cycloalkyl and heterocycloalkyl; R.sup.i is H, CN, NO.sub.2, or C.sub.1-6 alkyl; R.sup.e and R.sup.f are independently selected from H and C.sub.1-6 alkyl; R.sup.i is H, CN, or NO.sub.2; m is 0 or 1; n is 0 or 1; p is 0, 1, 2, 3, 4, 5, or 6; q is 0, 1, 2, 3, 4, 5 or 6; r is 0 or 1; and s is 0 or 1. 33. The pharmaceutical composition of claim 32, wherein the second agent is selected from the group consisting of pegylated interferon alpha 2a, interferon alphacon-1, natural interferon, albuferon, interferon beta-la, omega interferon, interferon alpha, interferon gamma, interferon tau, interferon delta and interferon .gamma.-lb. 34. A pharmaceutical composition for treating or eradicating an HIV infection comprising a combination of HAART, a JAK inhibitor, and an anti-HIV vaccine and/or an immunostimulatory agent, and a pharmaceutically acceptable carrier or excipient, wherein the JAK inhibitor is a compound of Formula A: ##STR00075## wherein: or the pharmaceutically acceptable salt thereof; wherein R.sup.1 is a group of the formula ##STR00076## wherein y is 0, 1 or 2; R.sup.4 is selected from the group consisting of hydrogen, (C.sub.1-C.sub.6)alkyl, (C.sub.1-C.sub.6)alkylsulfonyl, (C.sub.2-C.sub.6)alkenyl, (C.sub.2-C.sub.6)alkynyl wherein the alkyl, alkenyl and alkynyl groups are optionally substituted by deuterium, hydroxy, amino, trifluoromethyl, (C.sub.1-C.sub.4)alkoxy, (C.sub.1-C.sub.6)acyloxy, (C.sub.1-C.sub.6)alkylamino, ((C.sub.1-C.sub.6)alkyl).sub.2amino, cyano, nitro, (C.sub.2-C.sub.6)alkenyl, (C.sub.2-C.sub.6)alkynyl or (C.sub.1-C.sub.6)acylamino; or R.sup.4 is (C.sub.3-C.sub.10)cycloalkyl wherein the cycloalkyl group is optionally substituted by deuterium, hydroxy, amino, trifluoromethyl, (C.sub.1-C.sub.6)acyloxy, (C.sub.1-C.sub.6)acylamino, (C.sub.1-C.sub.6)alkylamino, ((C.sub.1-C.sub.6)alkyl).sub.2amino, cyano, cyano(C.sub.1-C.sub.6)alkyl, trifluoromethyl(C.sub.1-C.sub.6)alkyl, nitro, nitro(C.sub.1-C.sub.6)alkyl or (C.sub.1-C.sub.6)acylamino; R.sup.5 is (C.sub.2-C.sub.9)heterocycloalkyl wherein the heterocycloalkyl groups must be substituted by one to five carboxy, cyano, amino, deuterium, hydroxy, (C.sub.1-C.sub.6)alkyl, (C.sub.1-C.sub.6)alkoxy, halo, (C.sub.1-C.sub.6)acyl, (C.sub.1-C.sub.6)alkylamino, amino(C.sub.1-C.sub.6)alkyl, (C.sub.1-C.sub.6)alkoxy-CO--NH, (C.sub.1-C.sub.6)alkylamino-CO--, (C.sub.2-C.sub.6)alkenyl, (C.sub.2-C.sub.6) alkynyl, (C.sub.1-C.sub.6)alkylamino, amino(C.sub.1-C.sub.6)alkyl, hydroxy(C.sub.1-C.sub.6)alkyl, (C.sub.1-C.sub.6)alkoxy, (C.sub.1-C.sub.6)acyloxy(C.sub.1-C.sub.6)alkyl, nitro, cyano(C.sub.1-C.sub.6)alkyl, halo(C.sub.1-C.sub.6)alkyl, nitro(C.sub.1-C.sub.6)alkyl, trifluoromethyl, trifluoromethyl(C.sub.1-C.sub.6)alkyl, (C.sub.1-C.sub.6)acylamino, (C.sub.1-C.sub.6)acylamino(C.sub.1-C.sub.6)alkyl, (C.sub.1-C.sub.6)alkoxy(C.sub.1-C.sub.6)acylamino, amino(C.sub.1-C.sub.6)acyl, amino(C.sub.1-C.sub.6)acyl(C.sub.1-C.sub.6)alkyl, (C.sub.1-C.sub.6) alkylamino(C.sub.1-C.sub.6)acyl, ((C.sub.1-C.sub.6)alkyl).sub.2amino(C.sub.1-C.sub.6) acyl, R.sup.15R.sup.16N--CO--O--, R.sup.15R.sup.16N--CO--(C.sub.1-C.sub.6)alkyl, (C.sub.1-C.sub.6)alkyl-S(O).sub.m, R.sup.15R.sup.16NS(O).sub.m, R.sup.15R.sup.16NS(O).sub.m(C.sub.1-C.sub.6)alkyl, R.sup.15S(O).sub.mR.sup.16N, R.sup.15S(O).sub.mR.sup.16(C.sub.1-C.sub.6)alkyl wherein m is 0, 1 or 2 and R.sup.15 and R.sup.16 are each independently selected from hydrogen or (C.sub.1-C.sub.6)alkyl; or a group of the formula ##STR00077## wherein a is 0, 1, 2, 3 or 4; b, c, e, f and g are each independently 0 or 1; d is 0, 1, 2, or 3; X is S(O).sub.n wherein n is 0, 1 or 2; oxygen, carbonyl or --C(.dbd.N-cyano)-; Y is S(O).sub.n wherein n is 0, 1 or 2; or carbonyl; and Z is carbonyl, C(O)O--, C(O)NR-- or S(O).sub.n wherein n is 0, 1 or 2; R.sup.6, R.sup.7, R.sup.8, R.sup.9, R.sup.10 and R.sup.11 are each independently selected from the group consisting of hydrogen or (C.sub.1-C.sub.6)alkyl optionally substituted by deuterium, hydroxy, amino, trifluoromethyl, (C.sub.1-C.sub.6)acyloxy, (C.sub.1-C.sub.6)acylamino, (C.sub.1-C.sub.6)alkylamino, ((C.sub.1-C.sub.6)alkyl).sub.2amino, cyano, cyano(C.sub.1-C.sub.6)alkyl, trifluoromethyl(C.sub.1-C.sub.6)alkyl, nitro, nitro(C.sub.1-C.sub.6)alkyl or (C.sub.1-C.sub.6)acylamino; R.sup.12 is carboxy, cyano, amino, oxo, deuterium, hydroxy, trifluoromethyl, (C.sub.1-C.sub.6)alkyl, trifluoromethyl(C.sub.1-C.sub.6)alkyl, (C.sub.1-C.sub.6)alkoxy, halo, (C.sub.1-C.sub.6)acyl, (C.sub.1-C.sub.6)alkylamino, ((C.sub.1-C.sub.6)alkyl).sub.2amino, amino(C.sub.1-C.sub.6)alkyl, (C.sub.1-C.sub.6)alkoxy-CO--NH, (C.sub.1-C.sub.6)alkylamino-CO--, (C.sub.2-C.sub.6)alkenyl, (C.sub.2-C.sub.6) alkynyl, (C.sub.1-C.sub.6)alkylamino, hydroxy (C.sub.1-C.sub.6)alkyl, (C.sub.1-C.sub.6)alkoxy(C.sub.1-C.sub.6)alkyl, (C.sub.1-C.sub.6)acyloxy(C.sub.1-C.sub.6)alkyl, nitro, cyano(C.sub.1-C.sub.6)alkyl, halo(C.sub.1-C.sub.6)alkyl, nitro(C.sub.1-C.sub.6)alkyl, trifluoromethyl, trifluoromethyl(C.sub.1-C.sub.6)alkyl, (C.sub.1-C.sub.6)acylamino, (C.sub.1-C.sub.6)acylamino(C.sub.1-C.sub.6)alkyl, (C.sub.1-C.sub.6)alkoxy(C.sub.1-C.sub.6)acylamino, amino(C.sub.1-C.sub.6)acyl, amino(C.sub.1-C.sub.6)acyl(C.sub.1-C.sub.6)alkyl, (C.sub.1-C.sub.6) alkylamino(C.sub.1-C.sub.6)acyl, ((C.sub.1-C.sub.6)alkyl).sub.2amino(C.sub.1-C.sub.6)acyl, R.sup.15R.sup.16N--CO--O--, R.sup.15R.sup.16N--CO--(C.sub.1-C.sub.6)alkyl, R.sup.15C(O)NH, R.sup.15OC(O)NH, R.sup.15NHC(O)NH, (C.sub.1-C.sub.6)alkyl-S(O).sub.m, (C.sub.1-6)alkyl-S(O).sub.m--(C.sub.1-C.sub.6)alkyl, R.sup.15R.sup.16NS(O).sub.m, R.sup.15R.sup.16NS(O).sub.m(C.sub.1-C.sub.6)alkyl, R.sup.15S(O).sub.mR.sup.16N, R.sup.15S(O).sub.mR.sup.16N(C.sub.1-C.sub.6)alkyl wherein m is 0, 1 or 2 and R.sup.15 and R.sup.16 are each independently selected from hydrogen or (C.sub.1-C.sub.6)alkyl; R.sup.2 and R.sup.3 are each independently selected from the group consisting of hydrogen, deuterium, amino, halo, hydroxy, nitro, carboxy, (C.sub.2-C.sub.6)alkenyl, (C.sub.2-C.sub.6)alkynyl, trifluoromethyl, trifluoromethoxy, (C.sub.1-C.sub.6)alkyl, (C.sub.1-C.sub.6)alkoxy, (C.sub.3-C.sub.10)cycloalkyl wherein the alkyl, alkoxy or cycloalkyl groups are optionally substituted by one to three groups selected from halo, hydroxy, carboxy, amino (C.sub.1-C.sub.6)alkylthio, (C.sub.1-C.sub.6)alkylamino, ((C.sub.1-C.sub.6)alkyl).sub.2amino, (C.sub.5-C.sub.9)heteroaryl, (C.sub.2-C.sub.9)heterocycloalkyl, (C.sub.3-C.sub.9)cycloalkyl or (C.sub.6-C.sub.10)aryl; or R.sup.2 and R.sup.3 are each independently (C.sub.3-C.sub.10)cycloalkyl, (C.sub.3-C.sub.10)cycloalkoxy, (C.sub.1-C.sub.6)alkylamino, ((C.sub.1-C.sub.6)alkyl).sub.2amino, (C.sub.6-C.sub.10)arylamino, (C.sub.1-C.sub.6)alkylthio, (C.sub.6-C.sub.10)arylthio, (C.sub.1-C.sub.6)alkylsulfinyl, (C.sub.6-C.sub.10)arylsulfinyl, (C.sub.1-C.sub.6)alkylsulfonyl, (C.sub.6-C.sub.10)arylsulfonyl, (C.sub.1-C.sub.6)acyl, (C.sub.1-C.sub.6)alkoxy-CO--NH--, (C.sub.1-C.sub.6)alkylamino-CO--, (C.sub.5-C.sub.9)heteroaryl, (C.sub.2-C.sub.9)heterocycloalkyl or (C.sub.6-C.sub.10)aryl wherein the heteroaryl, heterocycloalkyl and aryl groups are optionally substituted by one to three halo, (C.sub.1-C.sub.6)alkyl, (C.sub.1-C.sub.6)alkyl-CO--NH--, (C.sub.1-C.sub.6)alkoxy-CO--NH--, (C.sub.1-C.sub.6)alkyl-CO--NH--(C.sub.1-C.sub.6)alkyl, (C.sub.1-C.sub.6)alkoxy-CO--NH--(C.sub.1-C.sub.6)alkyl, (C.sub.1-C.sub.6)alkoxy-CO--NH--(C.sub.1-C.sub.6)alkoxy, carboxy, carboxy(C.sub.1-C.sub.6)alkyl, carboxy(C.sub.1-C.sub.6)alkoxy, benzyloxycarbonyl(C.sub.1-C.sub.6)alkoxy, (C.sub.1-C.sub.6)alkoxycarbonyl(C.sub.1-C.sub.6)alkoxy, (C.sub.6-C.sub.10)aryl, amino, amino(C.sub.1-C.sub.6)alkyl, (C.sub.1-C.sub.6)alkoxycarbonylamino, (C.sub.6-C.sub.10)aryl(C.sub.1-C.sub.6)alkoxycarbonylamino, (C.sub.1-C.sub.6)alkylamino, ((C.sub.1-C.sub.6)alkyl).sub.2amino, (C.sub.1-C.sub.6)alkylamino (C.sub.1-C.sub.6)alkyl, ((C.sub.1-C.sub.6)alkyl).sub.2amino(C.sub.1-C.sub.6)alkyl, hydroxy, (C.sub.1-C.sub.6)alkoxy, carboxy, carboxy(C.sub.1-C.sub.6)alkyl, (C.sub.1-C.sub.6)alkoxycarbonyl, (C.sub.1-C.sub.6)alkoxycarbonyl(C.sub.1-C.sub.6)alkyl, (C.sub.1-C.sub.6)alkoxy-CO--NH--, (C.sub.1-C.sub.6)alkyl-CO--NH--, cyano, (C.sub.5-C.sub.9)heterocycloalkyl, amino-CO--NH--, (C.sub.1-C.sub.6)alkyamino-CO--NH--, ((C.sub.1-C.sub.6)alkyl).sub.2amino-CO--NH--, (C.sub.6-C.sub.10)arylamino-CO--NH--, (C.sub.5-C.sub.9)heteroarylamino-CO--NH--, (C.sub.1-C.sub.6)alkylamino-CO--NH--(C.sub.1-C.sub.6)alkyl, ((C.sub.1-C.sub.6)alkyl).sub.2amino-CO--NH--(C.sub.1-C.sub.6)alkyl, (C.sub.6-C.sub.10)arylamino-CO--NH--(C.sub.1-C.sub.6)alkyl, (C.sub.5-C.sub.9)heteroarylamino-CO--NH--(C.sub.1-C.sub.6)alkyl, (C.sub.1-C.sub.6)alkylsulfonyl, (C.sub.1-C.sub.6)alkylsulfonylamino, (C.sub.1-C.sub.6)alkylsulfonylamino(C.sub.1-C.sub.6)alkyl, (C.sub.6-C.sub.10)arylsulfonyl, (C.sub.6-C.sub.10)arylsulfonylamino, (C.sub.6-C.sub.10)arylsulfonylamino(C.sub.1-C.sub.6)alkyl, (C.sub.1-C.sub.6)alkylsulfonylamino, (C.sub.1-C.sub.6)alkylsulfonylamino(C.sub.1-C.sub.6)alkyl, (C.sub.5-C.sub.9)heteroaryl or (C.sub.2-C.sub.9)heterocycloalkyl, or of Formula B: ##STR00078## including pharmaceutically acceptable salt forms or prodrugs thereof, wherein: A.sup.1 and A.sup.2 are independently selected from C and N; T, U, and V are independently selected from O, S, N, CR.sup.5, and NR.sup.6; wherein the 5-membered ring formed by A.sup.1, A.sup.2, U, T, and V is aromatic; X is N or CR.sup.4; Y is C.sub.1-8 alkylene, C.sub.2-8 alkenylene, C.sub.2-8 alkynylene, (CR.sup.11R.sup.12).sub.p--(C.sub.3-10 cycloalkylene)-(CR.sup.11R.sup.12).sub.q, (CR.sup.11R.sup.12).sub.p-(arylene)-(CR.sup.11R.sup.12).sub.q, (CR.sup.11R.sup.12).sub.\p--(C.sub.1-10 heterocycloalkylene)-(CR.sup.11R.sup.12).sub.q, (CR.sup.11R.sup.12).sub.p-(heteroarylene)-(CR.sup.11R.sup.12).sub.q, (CR.sup.11R.sup.12).sub.pO(CR.sup.11R.sup.12).sub.q, (CR.sup.11R.sup.12).sub.pS(CR.sup.11R.sup.12).sub.q, (CR.sup.11R.sup.12).sub.pC(O)(CR.sup.11R.sup.12).sub.q, (CR.sup.11R.sup.12).sub.pC(O)NR.sub.c(CR.sup.11R.sup.12).sub.q, (CR.sup.11R.sup.12).sub.pC(O)O(CR.sup.11R.sup.12).sub.q, (CR.sup.11R.sup.12).sub.pOC(O)(CR.sup.11R.sup.12).sub.q, (CR.sup.11R.sup.12).sub.pOC(O)NR.sup.c(CR.sup.11R.sup.12).sub.q, (CR.sup.11R.sup.12).sub.pNR.sup.c(CR.sup.11R.sup.12).sub.q, (CR.sup.11R.sup.12).sub.pNR.sup.cC(O)NR.sup.d(CR.sup.11R.sup.12).sub.q, (CR.sup.11R.sup.12).sub.pS(O)(CR.sup.11R.sup.12).sub.q, (CR.sup.11R.sup.12).sub.pS(O)NR.sup.c(CR.sup.11R.sup.12).sub.q, (CR.sup.11R.sup.12).sub.pS(O).sub.2(CR.sup.11R.sup.12).sub.q, or (CR.sup.11R.sup.12).sub.pS(O).sub.2NR.sup.c(CR.sup.11R.sup.12).sub.q, wherein said C.sub.1-8 alkylene, C.sub.2-8 alkenylene, C.sub.2-8 alkynylene, cycloalkylene, arylene, heterocycloalkylene, or heteroarylene, is optionally substituted with 1, 2, or 3 substituents independently selected from -D.sup.1-D.sup.2-D.sup.3-D.sup.4; Z is H, halo, C.sub.1-4 alkyl, C.sub.2-4 alkenyl, C.sub.2-4 alkynyl, C.sub.1-4 haloalkyl, halosulfanyl, C.sub.1-4 hydroxyalkyl, C.sub.1-4 cyanoalkyl, .dbd.C--R.sup.i, .dbd.N--R.sup.i, Cy.sup.1, CN, NO.sub.2, OR.sup.a, SR.sup.a, C(O)R.sup.b, C(O)NR.sup.cR.sup.d, C(O)OR.sup.a, OC(O)R.sup.b, OC(O)NR.sup.cR.sup.d, NR.sup.cR.sup.d, NR.sup.cC(O)R.sup.b, NR.sup.cC(O)NR.sup.cR.sup.d, NR.sup.cC(O)OR.sup.a, C(.dbd.NR.sup.i)NR.sup.cR.sup.d, NR.sup.cC(.dbd.NR.sup.i)NR.sup.cR.sup.d, S(O)R.sup.b, S(O)NR.sup.cR.sup.d, S(O).sub.2R.sup.b, NR.sup.cS(O).sub.2R.sup.b, C(.dbd.NOH)R.sup.b, C(.dbd.NO(C.sub.1-6alkyl)R.sup.b, and S(O).sub.2NR.sup.cR.sup.d, wherein said C.sub.1-8 alkyl, C.sub.2-8 alkenyl, or C.sub.2-8 alkynyl, is optionally substituted with 1, 2, 3, 4, 5, or 6 substituents independently selected from halo, C.sub.1-4 alkyl, C.sub.2-4 alkenyl, C.sub.2-4 alkynyl, C.sub.1-4 haloalkyl, halosulfanyl, C.sub.1-4 hydroxyalkyl, C.sub.1-4 cyanoalkyl, Cy.sup.1, CN, N.sub.2, OR.sup.a, SR.sup.a, C(O)R.sup.b, C(O)NR.sup.cR.sup.d, C(O)OR.sup.a, OC(O)R.sup.b, OC(O)NR.sup.cR.sup.d, NR.sup.cR.sup.d, NR.sup.cC(O)R.sup.b, NR.sup.cC(O)NR.sup.cR.sup.d, NR.sup.cC(O)OR.sup.a, C(.dbd.NR.sup.i)NR.sup.cR.sup.d, NR.sup.cC(.dbd.NR.sup.i)NR.sup.cR.sup.d, S(O)R.sup.b, S(O)NR.sup.cR.sup.d, S(O).sub.2R.sup.b, NR.sup.cS(O).sub.2R.sup.b, C(.dbd.NOH)R.sup.b, C(.dbd.NO(C.sub.1-6 alkyl))R.sup.b, and S(O).sub.2NR.sup.cR.sup.d; wherein when Z is H, n is 1; or the --(Y).sub.n--Z moiety is taken together with i) A.sup.2 to which the moiety is attached, ii) R.sup.5 or R.sup.6 of either T or V, and iii) the C or N atom to which the R.sup.5 or R.sup.6 of either T or V is attached to form a 4- to 20-membered aryl, cycloalkyl, heteroaryl, or heterocycloalkyl ring fused to the 5-membered ring formed by A.sup.1 A.sup.2, U, T, and V, wherein said 4- to 20-membered aryl, cycloalkyl, heteroaryl, or heterocycloalkyl ring is optionally substituted by 1, 2, 3, 4, or 5 substituents independently selected from --(W).sub.m-Q; W is C.sub.1-8 alkylenyl, C.sub.2-8 alkenylenyl, C.sub.2-8 alkynylenyl, O, S, C(O), C(O)NR.sup.c', C(O)O, OC(O), OC(O)NR.sup.c', NR.sup.c', NR.sup.c'C(O)NR.sup.d', S(O), S(O)NR.sup.c', S(O).sub.2, or S(O)2NR.sup.c'; Q is H, halo, CN, NO.sub.2, C.sub.1-8 alkyl, C.sub.2-8 alkenyl, C.sub.2-8 alkynyl, C.sub.1-8 haloalkyl, halosulfanyl, aryl, cycloalkyl, heteroaryl, or heterocycloalkyl, wherein said C.sub.1-8 alkyl, C.sub.2-8 alkenyl, C.sub.2-8 alkynyl, C.sub.1-8 haloalkyl, aryl, cycloalkyl, heteroaryl, or heterocycloalkyl is optionally substituted with 1, 2, 3 or 4 substituents independently selected from halo, C.sub.1-4 alkyl, C.sub.2-4 alkenyl, C.sub.2-4 alkynyl, C.sub.1-4 haloalkyl, halosulfanyl, C.sub.1-4 hydroxyalkyl, C.sub.1-4 cyanoalkyl, Cy.sup.2, CN, NO.sub.2, OR.sup.a', SR.sup.a', C(O)R.sup.b', C(O)NR.sup.c'R.sup.d', C(O)OR.sup.a', OC(O)R.sup.b', OC(O)NR.sup.c'R.sup.d', NR.sup.c'R.sup.d', NR.sup.c'C(O)R.sup.b', NR.sup.c'C(O)N R.sup.c'R.sup.d', N R.sup.c'C(O)OR.sup.a', S(O)R.sup.b', S(O)N R.sup.c'R.sup.d', S(O).sub.2R.sup.b.degree., NR.sup.c'S(O).sub.2R.sup.b', and S(O).sub.2N R.sup.c'R.sup.d'; Cy.sup.1 and Cy.sup.2 are independently selected from aryl, heteroaryl, cycloalkyl, and heterocycloalkyl, each optionally substituted by 1, 2, 3, 4 or 5 substituents independently selected from halo, C.sub.1-4 alkyl, C.sub.2-4 alkenyl, C.sub.2-4 alkynyl, C.sub.1-4 haloalkyl, halosulfanyl, C.sub.1-4 hydroxyalkyl, C.sub.1-4 cyanoalkyl, CN, NO.sub.2, OR.sup.a'', SR.sup.a'', C(O)R.sup.b'', C(O)NR.sup.c''R.sup.d'', C(O)OR.sup.a'', OC(O)R.sup.b'', OC(O)N R.sup.c''R.sup.d'', NR.sup.c''R.sup.d'', NR.sup.c'C(O)R.sup.b'', NR.sup.c''C(O)OR.sup.a'', NR.sup.c''S(O)R.sup.b'', NR.sup.c''S(O).sub.2R.sup.b'', S(O)R.sup.b'', S(O)NR.sup.c''R.sup.d'', S(O).sub.2R.sup.b'', and S(O).sub.2NR.sup.c''R.sup.d''; R.sup.1, R.sup.2, R.sup.3, and R.sup.4 are independently selected from H, halo, C.sub.1-4 alkyl, C.sub.2-4 alkenyl, C.sub.2-4 alkynyl, C.sub.1-4 haloalkyl, halosulfanyl, aryl, cycloalkyl, heteroaryl, heterocycloalkyl, CN, NO.sub.2, OR.sup.7, SR.sup.7, C(O)R.sup.8, C(O)NR.sup.9R.sup.10, C(O)OR.sup.7OC(O)R.sup.8, OC(O)NR.sup.9R.sup.10, NR.sup.9R.sup.10, NR.sup.9C(O)R.sup.8, NR.sup.cC(O)OR.sup.7, S(O)R.sup.8, S(O)NR.sup.9R.sup.10, S(O).sub.2R.sup.8 NR.sup.9S(O).sub.2R.sup.8, and S(O).sub.2NR.sup.9R.sup.10; R.sup.5 is H, halo, C.sub.1-4 alkyl, C.sub.2-4 alkenyl, C.sub.2-4 alkynyl, C.sub.1-4 haloalkyl, halosulfanyl, CN, NO.sub.2, OR.sup.7, SR.sup.7, C(O)R.sup.8, C(O)NR.sup.9R.sup.10, C(O)OR.sup.7, OC(O)R.sup.8, OC(O)NR.sup.9R.sup.10, NR.sup.9R.sup.10, NR.sup.9C(O)R.sup.8, NR.sup.9C(O)OR.sup.7, S(O)R.sup.8, S(O)NR.sup.9R.sup.10, S(O).sub.2R.sup.8, NR.sup.9S(O).sub.2R.sup.8, or S(O).sub.2NR.sup.9R.sup.10; R.sup.6 is H, C.sub.1-4 alkyl, C.sub.2-4 alkenyl, C.sub.2-4 alkynyl, C.sub.1-4 haloalkyl, OR.sup.7, C(O)R.sup.8, C(O)NR.sup.9R.sup.10, C(O)OR.sup.7, S(O)R.sup.8, S(O)NR.sup.9R.sup.10, S(O).sub.2R.sup.8, or S(O).sub.2NR.sup.9R.sup.10; R.sup.7 is H, C.sub.1-6 alkyl, C.sub.1-6 haloalkyl, C.sub.2-6 alkenyl, C.sub.2-6 alkynyl, aryl, cycloalkyl, heteroaryl, heterocycloalkyl, arylalkyl, heteroarylalkyl, cycloalkylalkyl or heterocycloalkylalkyl; R.sup.8 is H, C.sub.1-6 alkyl, C.sub.1-6 haloalkyl, C.sub.2-6 alkenyl, C.sub.2-6 alkynyl, aryl, cycloalkyl, heteroaryl, heterocycloalkyl, arylalkyl, heteroarylalkyl, cycloalkylalkyl or heterocycloalkylalkyl; R.sup.9 and R.sup.10 are independently selected from H, C.sub.1-10 alkyl, C.sub.1-6 haloalkyl, C.sub.2-6 alkenyl, C.sub.2-6 alkynyl, C.sub.1-6 alkylcarbonyl, arylcarbonyl, C.sub.1-6 alkylsulfonyl, arylsulfonyl, aryl, heteroaryl, cycloalkyl, heterocycloalkyl, arylalkyl, heteroarylalkyl, cycloalkylalkyl and heterocycloalkylalkyl; or R.sup.9 and R.sup.10 together with the N atom to which they are attached form a 4-, 5-, 6- or 7-membered heterocycloalkyl group; R.sup.11 and R.sup.12 are independently selected from H and -E.sup.1-E.sup.2-E.sup.3-E.sup.4. D.sup.1 and E.sup.1 are independentl absent or independently selected from C.sub.1-6 alkylene, C.sub.2-6 alkenylene, C.sub.2-6 alkynylene, arylene cycloalkylene, heteroarylene, and heterocycloalkylene, wherein each of the C.sub.1-6 alkylene, C.sub.2-6 alkenylene, C.sub.2-6 alkynylene, arylene, cycloalkylene, heteroarylene, and heterocycloalkylene is optionally substituted by 1, 2 or 3 substituents independently selected from halo, CN, NO.sub.2, N.sub.3, SCN, OH, C.sub.1-6 alkyl, C.sub.1-6 haloalkyl, C.sub.2-8 alkoxyalkyl, C.sub.1-6 alkoxy, C.sub.1-6 haloalkoxy, amino, C.sub.1-6 alkylamino, and C.sub.2-8 dialkylamino; D.sup.2 and E.sup.2 are independently absent or independently selected from C.sub.1-6 alkylene, C.sub.2-6 alkenylene, C.sub.2-6 alkynylene, (C.sub.1-6 alkylene).sub.r--O--(C.sub.1-6 alkylene).sub.s, (C.sub.1-6 alkylene).sub.r--S--(C.sub.1-6 alkylene).sub.s, (C.sub.1-6 alkylene).sub.r--NR.sup.c--(C.sub.1-6 alkylene).sub.s, (C.sub.1-6 alkylene).sub.r--CO--(C.sub.1-6 alkylene).sub.s, (C.sub.1-6 alkylene).sub.r--COO--(C.sub.1-6 alkylene).sub.s, (C.sub.1-6 alkylene).sub.r--CONR.sup.c--(C.sub.1-6 alkylene).sub.s, (C.sub.1-6 alkylene).sub.r--SO--(C.sub.1-6 alkylene).sub.s, (C.sub.1-6 alkylene).sub.r--SO.sub.2--(C.sub.1-6 alkylene).sub.s, (C.sub.1-6 alkylene).sub.r--SONR.sup.c--(C.sub.1-6 alkylene).sub.s, and (C.sub.1-6 alkylene).sub.r--NR.sup.cCONR.sup.f--(C.sub.1-6 alkylene).sub.s, wherein each of the C.sub.1-6 alkylene, C.sub.2-6 alkenylene, and C.sub.2-6 alkynylene is optionally substituted by 1, 2 or 3 substituents independently selected from halo, CN, NO.sub.2, N.sub.3, SCN, OH, C.sub.1-6 alkyl, C.sub.1-6 haloalkyl, C.sub.2-8 alkoxyalkyl, C.sub.1-6 alkoxy, C.sub.1-6 haloalkoxy, amino, C.sub.1-6 alkylamino, and C.sub.2-8 dialkylamino; D.sup.3and E.sup.3 are independently absent or independently selected from C.sub.1-6 alkylene, C.sub.2-6 alkenylene, C.sub.2-6 alkynylene, arylene, cycloalkylene, heteroarylene, and heterocycloalkylene, wherein each of the C.sub.1-6 alkylene, C.sub.2-6 alkenylene, C.sub.2-6 alkynylene, arylene, cycloalkylene, heteroarylene, and heterocycloalkylene is optionally substituted by 1, 2 or 3 substituents independently selected from halo, CN, NO.sub.2, N.sub.3, SCN, OH, C.sub.1-6 alkyl, C.sub.1-6 haloalkyl, C.sub.2-8 alkoxyalkyl, C.sub.1-6 alkoxy, C.sub.1-6 haloalkoxy, amino, C.sub.1-6 alkylamino, and C.sub.2-8 dialkylamino; E.sup.4 and E.sup.4 are independently selected from H, halo, C.sub.1-4 alkyl, C.sub.2-4 alkenyl, C.sub.2-4 alkynyl, C.sub.1-4 haloalkyl, halosulfanyl, C.sub.1-4 hydroxyalkyl, C.sub.1-4 cyanoalkyl, Cy.sup.1, CN, NO.sub.2, OR.sup.a, SR.sup.a, C(O)R.sup.b, C(O)NR.sup.cR.sup.a, C(O)OR.sup.a, OC(O)R.sup.bOC(O)NR.sup.cR.sup.d NR.sup.cR.sup.d, NR.sup.cC(O)R.sup.b, NR.sup.cC(O)NR.sup.cR.sup.d, NR.sup.cC(O)OR .sup.a, C(.dbd.NR.sup.i)NR.sup.cR.sup.d, NR.sup.cC(.dbd.NR.sup.i)NR.sup.cR.sup.d, S(O)R.sup.b, S(O)NR.sup.cR.sup.d, S(O).sub.2R.sup.b, NR.sup.cS(O).sub.2R.sup.b, C(.dbd.NOH)R.sup.b, C(.dbd.NO(C.sub.1-6 alkyl)R.sup.b, and S(O).sub.2NR.sup.cR.sup.d, wherein said C.sub.1-8 alkyl, C.sub.2-8 alkenyl, or C.sub.2-8 alkynyl, is optionally substituted with 1, 2, 3, 4, 5, or 6 substituents independently selected from halo, C.sub.1-4 alkyl, C.sub.2-4 alkenyl, C.sub.2-4 alkynyl, C.sub.1-4 haloalkyl, halosulfanyl, C.sub.1-4 hydroxyalkyl, C.sub.1-4 cyanoalkyl, Cy.sup.1, CN, NO.sub.2, OR.sup.a, SR.sup.a, C(O)R.sup.b, C(O)NR.sup.cR.sup.d, C(O)OR.sup.a, OC(O)R.sup.b, OC(O)NR.sup.cR.sup.d, NR.sup.cR.sup.d, NR.sup.cC(O)R.sup.b, NR.sup.cC(O)NR.sup.cR.sup.d, NR.sup.cC(O)OR.sup.a, C(.dbd.NR.sup.i)NR.sup.cR.sup.d, NR.sup.cC(.dbd.NR.sup.i)NR.sup.cR.sup.d, S(O)R.sup.b, S(O)NR.sup.cR.sup.d, S(O).sub.2R.sup.b, NR.sup.cS(O).sub.2R.sup.b, C(.dbd.NOH)R.sup.b, C(.dbd.NO(C.sub.1-6 alkyl))R.sup.b, and S(O).sub.2NR.sup.cR.sup.d; R.sup.a is H, Cy.sup.1, --(C.sub.1-6 alkyl)-Cy.sup.1, C.sub.1-6 alkyl, C.sub.1-6 haloalkyl, C.sub.2-6 alkenyl, C.sub.2-6 alkynyl, wherein said C.sub.1-6 alkyl, C.sub.1-6 haloalkyl, C.sub.2-6 alkenyl, or C.sub.2-6 alkynyl is optionally substituted with 1, 2, or 3 substituents independently selected from OH, CN, amino, halo, C.sub.1-6 alkyl, C.sub.1-6 haloalkyl, halosulfanyl, aryl, arylalkyl, heteroaryl, heteroarylalkyl, cycloalkyl and heterocycloalkyl; R.sup.b is H, Cy.sup.1, --(C.sub.1-6 alkyl)-Cy.sup.1, C.sub.1-6 alkyl, C.sub.1-6 haloalkyl, C.sub.2-6 alkenyl, C.sub.2-6 alkynyl, wherein said C.sub.1-6 alkyl, C.sub.1-61-6 haloalkyl, C.sub.2-6 alkenyl, or C.sub.2-6 alkynyl is optionally substituted with 1, 2, or 3 substituents independently selected from OH, CN, amino, halo, C.sub.1-6 alkyl, C.sub.1-6 haloalkyl, C.sub.1-6 haloalkyl, halosulfanyl, aryl, arylalkyl, heteroaryl, heteroarylalkyl, cycloalkyl and heterocycloalkyl; R.sup.a' and R.sup.a'' are independently selected from H, C.sub.1-6 alkyl, C.sub.1-6 haloalkyl, C.sub.2-6 alkenyl, C.sub.2-6 alkynyl, aryl, cycloalkyl, heteroaryl, heterocycloalkyl, arylalkyl, heteroarylalkyl, cycloalkylalkyl, and heterocycloalkylalkyl, wherein said C.sub.1-6 alkyl, C.sub.1-6 haloalkyl, C.sub.2-6 alkenyl, C.sub.2-6 alkynyl, aryl, cycloalkyl, heteroaryl, heterocycloalkyl, arylalkyl, heteroarylalkyl, cycloalkylalkyl or heterocycloalkylalkyl is optionally substituted with 1, 2, or 3 substituents independently selected from OH, CN, amino, halo, C.sub.1-6 alkyl, C.sub.1-6 haloalkyl, halosulfanyl, aryl, arylalkyl, heteroaryl, heteroarylalkyl, cycloalkyl and heterocycloalkyl; R.sup.b' and R.sup.b'' are independently selected from H, C.sub.1-6 alkyl C.sub.1-6 haloalkyl, C.sub.2-6 alkenyl, C.sub.2-6 alkynl, aryl, cycloalkyl, heteroaryl, heterocycloalkyl, arylalkyl, heteroarylalkyl, cycloalkylalkyl and heterocycloalkylalkyl, wherein said C.sub.1-6 alkyl, C.sub.1-6 haloalkyl, C.sub.2-6 alkenyl, C.sub.2-6 alkynyl, aryl, cycloalkyl, heteroaryl, heterocycloalkyl, arylalkyl, heteroarylalkyl, cycloalkylalkyl or heterocycloalkylalkyl is optionally substituted with 1, 2, or 3 substituents independently selected from OH, CN, amino, halo, C.sub.1-6 alkyl, C.sub.1-6 haloalkyl, C.sub.1-6 haloalkyl, halosulfanyl, aryl, arylalkyl, heteroaryl, heteroarylalkyl, cycloalkyl and heterocycloalkyl; R.sup.c and R.sup.d are independently selected from H, Cy.sup.1, --(C.sub.1-6 alkyl)-Cy.sup.1, C.sub.1-10 alkyl, C.sub.1-6 haloalkyl, C.sub.2-6 alkenyl, C.sub.2-6 alkynyl, wherein said C.sub.1-10 alkyl, C.sub.1-6 haloalkyl, C.sub.2-6 alkenyl, or C.sub.2-6 alkynyl, is optionally substituted with 1, 2, or 3 substituents independently selected from Cy.sup.1, --(C.sub.1-6 alkyl)-Cy.sup.1, OH, CN, amino, halo, C.sub.1-6 alkyl, C.sub.1-6 haloalkyl, C.sub.1-6 haloalkyl, and halosulfanyl; or R.sup.c and R.sup.d together with the N atom to which they are attached form a 4-, 5-, 6- or 7-membered heterocycloalkyl group optionally substituted with 1, 2, or 3 substituents independently selected from Cy.sup.1, --(C.sub.1-6 alkyl)-Cy.sup.1, OH, CN amino halo C.sub.1-6 alkyl, C.sub.1-6 haloalkyl, C.sub.1-6 haloalkyl, and halosulfanyl; R.sup.c' and R.sup.d' are independently selected from H, C.sub.1-10 alkyl, C.sub.1-6 haloalkyl, C.sub.2-6 alkenyl, C.sub.2-6 alkynyl, aryl, heteroaryl, cycloalkyl, heterocycloalkyl, arylalkyl, heteroarylalkyl, cycloalkylalkyl and heterocycloalkylalkyl, wherein said C.sub.1-10 alkyl, C.sub.1-6 haloalkyl, C.sub.2-6 alkenyl, C.sub.2-6 alkynyl, aryl, heteroaryl, cycloalkyl, heterocycloalkyl, arylalkyl, heteroarylalkyl, cycloalkylalkyl or heterocycloalkylalkyl is optionally substituted with 1, 2, or 3 substituents independently selected from OH, CN, amino, halo, C.sub.1-6 alkyl, C.sub.1-6 haloalkyl, C.sub.1-6 haloalkyl, halosulfanyl, aryl, arylalkyl, heteroaryl, heteroarylalkyl, cycloalkyl and heterocycloalkyl; or R.sup.c' and R.sup.d' together with the N atom to which they are attached form a 4-, 5-, 6- or 7-membered heterocycloalkyl group optionally substituted with 1, 2, or 3 substituents independently selected from OH, CN, amino, halo, C.sub.1-6 alkyl, C.sub.1-6 haloalkyl, C.sub.1-6 haloalkyl, halosulfanyl, aryl, arylalkyl, heteroaryl, heteroarylalkyl, cycloalkyl and heterocycloalkyl; R.sup.c'' and R.sup.d'' are independently selected from H, C.sub.1-10 alkyl, C.sub.1-6 haloalkyl, C.sub.2-6 alkenyl, C.sub.2-6 alkynyl, aryl,heteroaryl, cycloalkyl heterocycloalkyl, arylalkyl, heteroarylalkyl, cycloalkylalkyl and heterocycloalkylalkyl, wherein said C.sub.1-10 alkyl, C.sub.1-6 haloalkyl, C.sub.2-6 alkenyl, C.sub.2-6 alkynyl, aryl, heteroaryl, cycloalkyl, heterocycloalkyl, arylalkyl, heteroarylalkyl, cycloalkylalkyl or heterocycloalkylalkyl is optionally substituted with 1, 2, or 3 substituents independently selected from OH, CN, amino, halo, C.sub.1-6 alkyl, C.sub.1-6 haloalkyl, halosulfanyl, C.sub.1-6 haloalkyl, aryl, arylalkyl, heteroaryl, heteroarylalkyl, cycloalkyl and heterocycloalkyl; or R.sup.c'' and R.sup.d'' together with the N atom to which they are attached form a 4-, 5-, 6- or 7-membered heterocycloalkyl group optionally substituted with 1, 2, or 3 substituents independently selected from OH, CN, amino, halo, C.sub.1-6 alkyl, C.sub.1-6 haloalkyl, C.sub.1-6 haloalkyl, halosulfanyl, aryl, arylalkyl, heteroaryl, heteroarylalkyl, cycloalkyl and heterocycloalkyl; R.sup.i is H, CN, NO.sub.2, or C.sub.1-6 alkyl; R.sup.e and R.sup.f are independently selected from H and C.sub.1-6 alkyl; R.sup.i is H, CN, or NO.sub.2; m is 0 or 1; n is 0 or 1; p is 0, 1, 2, 3, 4, 5, or 6; q is 0, 1, 2, 3, 4, 5 or 6; r is 0 or 1; and s is 0 or 1. 35. The pharmaceutical composition of claim 34, wherein the HAART comprises: a) at least one each of an adenine, cytosine, thymidine, and guanine nucleoside antiviral agent, or b) at least one additional antiviral agent selected from the group consisting of non-nucleoside reverse transcriptase inhibitors (NNRTI), protease inhibitors, fusion inhibitors, entry inhibitors, attachment inhibitors, and integrase inhibitors. 36. A method for treating an HIV infection, comprising administering to a patient in need thereof an effective antiviral amount of a JAK inhibitors selected from the group consisting of: CEP-701 (Lestaurtinib), AZD1480, LY3009104/INCB28050 Pacritinib/SB1518, VX-509, GLPG0634, INC424, R-348, CYT387, TG 10138, AEG 3482, 7-iodo-N-(4-morpholinophenyl)thieno[3,2-d]pyrimidin-2-amine, 7-(4-aminophenyl)-N-(4-morpholinophenyl)thieno[3,2-d]pyrimidin-2-amine, N-(4-(2-(4-morpholinophenylamino)thieno[3,2-d]pyrimidin-7-yl)phenyl)acryl- amide, 7-(3-aminophenyl)-N-(4-morpholinophenyl)thieno[3,2-d]pyrimidin-2ami- ne, N-(3-(2-(4-morpholinophenylamino)thieno[3,2-d]pyrimidin-7-yl)phenyl)ac- rylamide, N-(4-morpholinophenyl)thieno[3,2-d]pyrimidin-2-amine, methyl 2-(4-morpholinophenylamino)thieno[3,2-d]pyrimidine-7-carboxylate, N-(4-morpholinophenyl)-5H-pyrrolo[3,2-d]pyrimidin-2-amine, 7-(4-amino-3-methoxyphenyl)-N-(4-morpholinophenyl)thieno[3,2-d]pyrimidin-- 2-amine, 4-(2-(4-morpholinophenylamino)thieno[3,2-d]pyrimidin-7-yl)benzene- sulfonamide, N,N-dimethyl-3-(2-(4-morpholinophenylamino)thieno[3,2-d]pyrimidin-7-yl)be- nzenesulfonamide, 1-ethyl-3-(2-methoxy-4-(2-(4-morpholinophenylamino)thieno[3,2-d]pyrimidin- -7-yl)phenyl)urea, N-(4-(2-(4-morpholinophenylamino)thieno[3,2-d]pyrimidin-7-yl)phenyl)metha- nesulfonamide, 2-methoxy-4-(2-(4-morpholinophenylamino)thieno[3,2-d]pyrimidin-7-yl)pheno- l, 2-cyano-N-(3-(2-(4-morpholinophenylamino)thieno[3,2-d]pyrimidin-7-yl)ph- enyl)acetamide, N-(cyanomethyl)-2-(4-morpholinophenylamino)thieno[3,2-d]pyrimidine-7-carb- oxamide, N-(3-(2-(4-morpholinophenylamino)thieno[3,2-d]pyrimidin-7-yl)phen- yl)methanesulfonamide, 1-ethyl-3-(4-(2-(4-morpholinophenylamino)thieno[3,2-d]pyrimidin-7-yl)-2-(- -trifluoromethoxy)phenyl)urea, N-(3-nitrophenyl)-7-phenylthieno[3,2-d]pyrimidin-2-amine, 7-iodo-N-(3-nitrophenyl)thieno[3,2-d]pyrimidin-2-amine, N1-(7-(2-ethylphenyl)thieno[3,2-d]pyrimidin-2-yl)benzene-1,3-diamine, N-tert-butyl-3-(2-(4-morpholinophenylamino)thieno[3,2-d]pyrimidin-7-yl)be- nzenesulfonamide, N1-(7-iodothieno[3,2-d]pyrimidin-2-yl)benzene-1,3-diamine, 7-(4-amino-3-(tri fluoromethoxy)phenyl)-N-(4-morpholinophenyl)thieno[3,2-d]pyrimidin-2-amin- e, 7-(2-ethylphenyl)-N-(4-morpholinophenyl)thieno[3,2-d]pyrimidin-2-amine, N-(3-(2-(4-morpholinophenylamino)thieno[3,2-d]pyrimidin-7-yl)phenyl) acetamide, N-(cyanomethyl)-N-(3-(2-(4-morpholinophenylamino)thieno[3,2-d]pyrimidin-7- -yl)phenyl)methanesulfonamide, N-(cyanomethyl)-N-(4-(2-(4-morpholinophenylamino)thieno[3,2-d]pyrimidin-7- -yl)phenyl)methanesulfonamide, N-(3-(5-methyl-2-(4-morpholinophenylamino)-5H-pyrrolo[3,2-d]pyrimidin-7-y- l)phenyl)methanesulfonamide, 4-(5-methyl-2-(4-morpholinophenylamino)-5H-pyrrolo[3,2-d]pyrimidin-7-yl)b- enzenesulfonamide, N-(4-(5-methyl-2-(4-morpholinophenylamino)-5H-pyrrolo[3,2-d]pyrimidin-7-y- l)phenyl)methanesulfonamide, 7-iodo-N-(4-morpholinophenyl)-5H-pyrrolo[3,2-d]pyrimidin-2-amine, 7-(2-isopropylphenyl)-N-(4-morpholinophenyl)thieno[3,2-d]pyrimidin-2-amin- e, 7-bromo-N-(4-morpholinophenyl)thieno[3,2-d]pyrimidin-2-amine, N7-(2-isopropylphenyl)-N2-(4-morpholinophenyl)thieno[3,2-d]pyrimidine-2,7- -diamine, N7-(4-isopropylphenyl)-N2-(4-morpholinopheny)thieno[3,2-d]pyrimi- dine-2,7-diamine, 7-(5-amino-2-methylphenyl)-N-(4-morpholinophenyl)thieno[3,2-d]pyrimidin-2- -amine, N-(cyanomethyl)-4-(2-(4-morpholinophenylamino)thieno[3,2-d]pyrimid- in-7-yl)benzamide, 7-iodo-N-(3-morpholinophenyl)thieno[3,2-d]pyrimidin-2-amine, 7-(4-amino-3-nitrophenyl)-N-(4-morpholinophenyl)thieno[3,2-d]pyrimidin-2-- amine, 7-(2-methoxypyridin-3-yl)-N-(4-morpholinophenyl)thieno[3,2-d]pyrimi- din-2-amine, (3-(7-iodothieno[3,2-d]pyrimidin-2-ylamino)phenyl)methanol, N-tert-butyl-3-(2-(3-morpholinophenylamino)thieno[3,2-d]pyrimidin-7-yl)be- nzenesulfonamide, N-tert-butyl-3-(2-(3-(hydroxymethyl)phenylamino)thieno[3,2-d]pyrimidin-7-- yl)benzenesulfonamide, N-(4-morpholinophenyl)-7-(4-nitrophenylthio)-5H-pyrrolo[3,2-d]pyrimidin-2- -amine, N-tert-butyl-3-(2-(3,4,5-trimethoxyphenylamino)thieno[3,2-d]pyrimi- din-7-yl)benzenesulfonamide, 7-(4-amino-3-nitrophenyl)-N-(3,4-dimethoxyphenyl)thieno[3,2-d]pyrimidin-2- -amine, N-(3,4-dimethoxyphenyl)-7-(2-methoxypyridin-3-yl)thieno[3,2-d]pyri- midin-2-amine, N-tert-butyl-3-(2-(3,4-dimethoxyphenylamino)thieno[3,2-d]pyrimidin-7-yl)b- enzenesulfonamide, 7-(2-aminopyrimidin-5-yl)-N-(3,4-dimethoxyphenyl)thieno[3,2-d]pyrimidin-2- -amine, N-(3,4-dimethoxyphenyl)-7-(2,6-dimethoxypyridin-3-yl)thieno[3,2-d]- pyrimidin-2-amine, N-(3,4-dimethoxyphenyl)-7-(2,4-dimethoxypyrimidin-5-yl)thieno[3,2-d]pyrim- idin-2-amine, 7-iodo-N-(4-(morpholinomethyl)phenyl)thieno[3,2-d]pyrimidin-2-amine, N-tert-butyl-3-(2-(4-(morpholinomethyl)phenylamino)thieno[3,2-d]pyrimidin- -7-yl)benzenesulfonamide, 2-cyano-N-(4-methyl-3-(2-(4-morpholinophenylamino)thieno[3,2-d]pyrimidin-- 7-yl)phenyl)acetamide, ethyl 3-(2-(4-morpholinophenylamino)thieno[3,2-d]pyrimidin-7-yl)benzoate, 7-bromo-N-(4-(2-(pyrrolidin-1-yl)ethoxy)phenyl)thieno[3,2-d]pyrimidin-2-a- mine, N-(3-(2-(4-(2-(pyrrolidin-1-yl)ethoxy)phenylamino)thieno[3,2-d]pyrim- idin-7-yl)phenyl)acetamide, N-(cyanomethyl)-3-(2-(4-morpholinophenylamino)thieno[3,2-d]pyrimidin-7-yl- )benzamide, N-tert-butyl-3-(2-(4-morpholinophenylamino)thieno[3,2-d]pyrimidin-7-yl)be- nzamide, N-tert-butyl-3-(2-(4-1-ethylpiperidin-4-yloxy)phenylamino)thieno[- 3,2-d]pyrimidin-7-yl)benzenesulfonamide, tert-butyl-4-(2-(4-(morpholinomethyl)phenylamino)thieno[3,2-d]pyrimidin-7- -yl)-1H-pyrazole-1-carboxylate, 7-bromo-N-(4-((4-ethylpiperazin-1-yl)methyl)phenyl)thieno[3,2-d]pyrimidin- -2-amine, N-tert-butyl-3-(2-(4-((4-ethylpiperazin-1-yl)methyl)phenylamino)- thieno[3,2-d]pyrimidin-7-yl)benzenesulfonamide, N-(4-((4-ethylpiperazin-1-yl)methyl)phenyl)-7-(1H-pyrazol-4-yl)thieno[3,2- -d]pyrimidin-2-amine, N-(cyanomethyl)-3-(2-(4-(morpholinomethyl)phenylamino)thieno[3,2-d]pyrimi- din-7-yl)benzamide, N-tert-butyl-3-(2-(4-(2-(pyrrolidin-1-yl)ethoxy)phenylamino)thieno[3,2-d]- -pyrimidin-7-yl)benzenesulfonamide, tert-butyl pyrrolidin-1-yl)ethoxy)phenylamino)thieno[3,2-d]pyrimidin-7-yl)benzylcarb- amate, 3-(2-(4-(2-(pyrrolidin-1-yl)ethoxy)phenylamino)thieno[3,2-d]pyrimid- in-7-yl)benzenesulfonamide, 7-(3-chloro-4-fluorophenyl-N-(4-(2-(pyrrolidin-1-yl) ethoxy)phenyl)thieno-[3,2-d]pyrimidin-2-amine, tert-butyl 4-(2-(4-(1-ethylpiperidin-4-yloxy)phenylamino)thieno[3,2-d]pyrimidin-7-yl- -)-1H-pyrazole-1-carboxylate, 7-(benzo[d][1,3]dioxol-5-yl)-N-(4-(morpholinomethyl)phenyl)thieno[3,2-d]p- yrimidin-2-amine, tert-butyl 5-(2-(4-(morpholinomethyl)phenylamino)thieno[3,2-d]pyrimidin-7-yl)-1H-ind- ole-1-carboxylate, 7-(2-aminopyrimidin-5-yl)-N-(4-(morpholinomethyl)phenyl)thieno[3,2-d]pyri- midin-2-amine, tert-butyl 4-(2-(4-(morpholinomethyl)phenylamino)thieno[3,2-d]pyrimidin-7-yl)-5,6-di- -hydropyridine-1(2H)-carboxylate, tert-butyl morpholinomethyl)phenylamino)thieno[3,2-d]pyrimidin-7-yl)benzylcarbamate, N-(3-(2-(4-(morpholinomethyl)phenylamino)thieno[3,2-d]pyrimidin-7-yl)-phe- nyl)acetamide, N-(4-(2-(4-(morpholinomethyl)phenylamino)thieno[3,2-d]pyrimidin-7-yl)phen- yl)acetamide, N-(3-(2-(4-(morpholinomethyl)phenylamino)thieno[3,2-d]pyrimidin-7-yl)phen- yl)methanesulfonamide, 7-(4-(4-methylpiperazin-1-yl)phenyl)-N-(4-(morpholinomethyl)phenyl)thieno- -[3,2-d]pyrimidin-2-amine, N-(2-methoxy-4-(2-(4-(morpholinomethyl)phenylamino)thieno[3,2-d]pyrimidin- -7-yl)phenyl)acetamide, 7-bromo-N-(3,4,5-trimethoxyphenyl)thieno[3,2-d]pyrimidin-2-amine, (3-(2-(3,4,5-trimethoxyphenylamino)thieno[3,2-d]pyrimidin-7-yl)phenyl)met- hanol, (4-(2-(3,4,5-trimethoxyphenylamino)thieno[3,2-d]pyrimidin-7-yl)phen- yl)methanol, (3-(2-(4-morpholinophenylamino)thieno[3,2-d]pyrimidin-7-yl)phenyl)methano- l, (4-(2-(4-morpholinophenylamino)thieno[3,2-d]pyrimidin-7-yl)phenyl)metha- nol, N-(pyrrolidin-1-yl)ethoxy)phenylamino)thieno[3,2-d]pyrimidin-7-yl)ben- zyl)methanesulfonamide, tert-butyl morpholinomethyl)phenylamino)thieno[3,2-d]pyrimidin-7-yl)benzylcarbamate, N-(4-(morpholinomethyl)phenyl)-7-(3-(piperazin-1-yl)phenyl)thieno[3,2-d]p- yrimidin-2-amine, 7-(6-(2-morpholinoethylamino)pyridin-3-yl)-N-(3,4,5-trimethoxyphenyl)thie- no[3,2-d]pyrimidin-2-amine, 7-(2-ethylphenyl)-N-(4-(2-(pyrrolidin-1-yl)ethoxy)phenyl)thieno[3,2-d]pyr- imidin-2-amine, 7-(4-(aminomethyl)phenyl)-N-(4-(morpholinomethyl)phenyl)thieno[3,2-d]pyri- midin-2-amine, N-(4-(1-ethylpiperidin-4-yloxy)phenyl)-7-(1H-pyrazol-4-yl)thieno[3,2-d]py- rimidin-2-amine, N-(2,4-dimethoxyphenyl)-7-phenylthieno[3,2-d]pyrimidin-2-amine, 7-bromo-N-(3,4-dimethoxyphenyl)thieno[3,2-d]pyrimidin-2-amine, N-(3,4-dimethoxyphenyl)-7-phenylthieno[3,2-d]pyrimidin-2-amine, and pharmaceutically acceptable salts and prodrugs thereof. 37. The method of claim 36, wherein the JAK inhibitors are selected from the group consisting of: CEP-701 (Lestaurtinib), AZD1480, LY3009104/INCB28050 Pacritinib/SB1518, VX-509, GLPG0634, INC424, R-348, CYT387, TG 10138, AEG 3482, 7-iodo-N-(4-morpholinophenyl)thieno[3,2-d]pyrimidin-2-amine, 7-(4-aminophenyl)-N-(4-morpholinophenyl)thieno[3,2-d]pyrimidin-2-amine, N-(4-(2-4-morpholinophenylamino)thieno[3,2-d]pyrimidin-7-yl)pheny)acrylam- ide, 7-(3-aminophenyl)-N-(4-morpholinophenyl)thieno[3,2-d]pyrimidin-2-amin- e, N-(3-(2-(4-morpholinophenylamino)thieno[3,2-d]pyrimidin-7-yl)phenyl)acr- ylamide, N-(4-morpholinophenyl)thieno[3,2-d]pyrimidin-2-amine, methyl 2-(4-morpholinophenylamino)thieno[3,2-d]pyrimidine-7-carboxylate, N-(4-morpholinophenyl)-5H-pyrrolo[3,2-d]pyrimidin-2-amine, 7-(4-amino-3-methoxyphenyl)-N-(4-morpholinophenyl)thieno[3,2-d]pyrimidin-- 2-amine, 4-(2-(4-morpholinophenylamino)thieno[3,2-d]pyrimidin-7-yl)benzene- sulfonamide, N,N-dimethyl-3-(2-(4-morpholinophenylamino)thieno[3,2-d]pyrimidin-7-yl)be- nzenesulfonamide, 1-ethyl-3-(2-methoxy-4-(2-(4-morpholinophenylamino)thieno[3,2-d]pyrimidin- -7-yl)phenyl)urea, N-(4-(2-(4-morpholinophenylamino)thieno[3,2-d]pyrimidin-7-yl)phenyl)metha- nesulfonamide, 2-methoxy-4-(2-(4-morpholinophenylamino)thieno[3,2-d]pyrimidin-7-yl)pheno- l, 2-cyano-N-(3-(2-(4-morpholinophenylamino)thieno[3,2-d]pyrimidin-7-yl)ph- enyl)acetamide, N-(cyanomethyl)-2-(4-morpholinophenylamino)thieno[3,2-d]pyrimidine-7-carb- oxamide, N-(3-(2-(4-morpholinophenylamino)thieno[3,2-d]pyrimidin-7-yl)phen- yl)methanesulfonamide, 1-ethyl-3-(4-(2-(4-morpholinophenylamino)thieno[3,2-d]pyrimidin-7-yl)-2-(- -trifluoromethoxy)phenyl)urea, N-(3-nitrophenyl)-7-phenylthieno[3,2-d]pyrimidin-2-amine, 7-iodo-N-(3-nitrophenyl)thieno[3,2-d]pyrimidin-2-amine, N1-(7-(2-ethylphenyl)thieno[3,2-d]pyrimidin-2-yl)benzene-1,3-diamine, N-tert-butyl-3-(2-(4-morpholinophenylamino)thieno[3,2-d]pyrimidin-7-yl)be- nzenesulfonamide, N1-(7-iodothieno[3,2-d]pyrimidin-2-yl)benzene-1,3-diamine, 7-(4-amino-3-(trifluoromethoxy)phenyl)-N-(4-morpholinophenyl)thieno[3,2-d- ]pyrimidin-2-amine, 7-(2-ethylphenyl)-N-(4-morpholinophenyl)thieno[3,2-d]pyrimidin-2-amine, N-(3-(2-(4-morpholinophenylamino)thieno[3,2-d]pyrimidin-7-yl)phenyl)aceta- mide, N-(cyanomethyl)-N-(3-(2-(4-morpholinophenylamino)thieno[3,2-d]pyrimi- din-7-yl)phenyl)methanesulfonamide, N-(cyanomethyl)-N-(4-(2-(4-morpholinophenylamino)thieno[3,2-d]pyrimidin-7- -yl)phenyl)methanesulfonamide, N-(3-(5-methyl-2-(4-morpholinophenylamino)-5H-pyrrolo[3,2-d]pyrimidin-7-y- l)phenyl)methanesulfonamide, 4-(5-methyl-2-(4-morpholinophenylamino)-5H-pyrrolo[3,2-d]pyrimidin-7-yl)b- enzenesulfonamide, N-(4-(5-methyl-2-(4-morpholinophenylamino)-5H-pyrrolo[3,2-d]pyrimidin-7-y- l)phenyl)methanesulfonamide, 7-iodo-N-(4-morpholinophenyl)-5H-pyrrolo[3,2-d]pyrimidin-2-amine, 7-(2-isopropylphenyl)-N-(4-morpholinophenyl)thieno[3,2-d]pyrimidin-2-amin- e, 7-bromo-N-(4-morpholinophenyl)thieno[3,2-d]pyrimidin-2-amine, N7-(2-isopropylphenyl)-N2-(4-morpholinophenyl)thieno[3,2-d]pyrimidine-2,7- -diamine, N7-(4-isopropylphenyl)-N2-(4-morpholinophenyl)thieno[3,2-d]pyrim- idine-2,7-diamine, 7-(5-amino-2-methylphenyl)-N-(4-morpholinophenyl)thieno[3,2-d]pyrimidin-2- -amine, N-(cyanomethyl)-4-(2-(4-morpholinophenylamino)thieno[3,2-d]pyrimid- in-7-yl)benzamide, 7-iodo-N-(3-morpholinophenyl)thieno[3,2-d]pyrimidin-2-amine, 7-(4-amino-3-nitrophenyl)-N-(4-morpholinophenyl)thieno[3,2-d]pyrimidin-2-- amine, 7-(2-methoxypyridin-3-yl)-N-(4-morpholinophenyl)thieno[3,2-d]pyrimi- din-2-amine, (3-(7-iodothieno[3,2-d]pyrimidin-2-ylamino)phenyl)methanol, N-tert-butyl-3-(2-(3-morpholinophenylamino)thieno[3,2-d]pyrimidin-7-yl)be- nzenesulfonamide, N-tert-butyl-3-(2-(3-(hydroxymethyl)phenylamino)thieno[3,2-d]pyrimidin-7-- yl)benzenesulfonamide, N-(4-morpholinophenyl)-7-(4-nitrophenylthio)-5H-pyrrolo[3,2-d]pyrimidin-2- -amine, N-tert-butyl-3-(2-(3,4,5-trimethoxyphenylamino)thieno[3,2-d]pyrimi- din-7-yl)benzenesulfonamide, 7-(4-amino-3-nitrophenyl)-N-(3,4-dimethoxyphenyl)thieno[3,2-d]pyrimidin-2- -amine, N-(3,4-dimethoxyphenyl)-7-(2-methoxypyridin-3-yl)thieno[3,2-d]pyri- midin-2-amine, N-tert-butyl-3-(2-(3,4-dimethoxyphenylamino)thieno[3,2-d]pyrimidin-7-yl)b- enzenesulfonamide, 7-(2-aminopyrimidin-5-yl)-N-(3,4-dimethoxyphenyl)thieno[3,2-d]pyrimidin-2- -amine, N-(3,4-dimethoxyphenyl)-7-(2,6-dimethoxypyridin-3-yl)thieno[3,2-d]- pyrimidin-2-amine, N-(3,4-dimethoxyphenyl)-7-(2,4-dimethoxypyrimidin-5-yl)thieno[3,2-d]pyrim- idin-2-amine, 7-iodo-N-(4-(morpholinomethyl)pheny)thieno[3,2-d]pyrimidin-2-amine, N-tert-butyl-3-(2-(4-(morpholinomethyl)phenylamino)thieno[3,2-d]pyrimidin- -7-yl)benzenesulfonamide, 2-cyano-N-(4-methyl-3-(2-(4-morpholinophenylamino)thieno[3,2-d]pyrimidin-- 7-yl)phenyl)acetamide, ethyl 3-(2-(4-morpholinophenylamino)thieno[3,2-d]pyrimidin-7-yl)benzoate, 7-bromo-N-(4-(2-(pyrrolidin-1-yl)ethoxy)phenyl)thieno[3,2-d]pyrimidin-2-a- mine, N-(3-(2-(4-(2-(pyrrolidin-1-yl)ethoxy)phenylamino)thieno[3,2-d]pyrim- idin-7-yl)phenyl)acetamide, N-(cyanomethyl)-3-(2-(4-morpholinophenylamino)thieno[3,2-d]pyrimidin-7-yl- )benzamide, N-tert-butyl-3-(2-(4-morpholinophenylamino)thieno[3,2-d]pyrimidin-7-yl)be- nzamide, N-tert-butyl-3-(2-(4-(1-ethylpiperidin-4-yloxy)phenylamino)thieno- [3,2-d]pyrimidin-7-yl)benzenesulfonamide, tert-butyl-4-(2-(4-(morpholinomethyl)phenylamino)thieno[3,2-d]pyrimidin-7- -yl)-1H-pyrazole-1-carboxylate, 7-bromo-N-(4-((4-ethylpiperazin-1-yl)methyl)phenyl)thieno[3,2-d]pyrimidin- -2-amine, N-tert-butyl-3-(2-(4-((4-ethylpiperazin-1-yl)methyl)phenylamino)- thieno[3,2-d]pyrimidin-7-yl)benzenesulfonamide, N-(4-((4-ethylpiperazin-1-yl)methyl)phenyl)-7-(1H-pyrazol-4-yl)thieno[3,2- -d]pyrimidin-2-amine, N-(cyanomethyl)-3-(2-(4-(morpholinomethyl)phenylamino)thieno[3,2-d]pyrimi- din-7-yl)benzamide, N-tert-butyl-3-(2-(4-(2-(pyrrolidin-1-yl)ethoxy)phenylamino)thieno[3,2-d]- -pyrimidin-7-yl)benzenesulfonamide, tert-butyl pyrrolidin-1-yl)ethoxy)phenylamino)thieno[3,2-d]pyrimidin-7-yl)benzylcarb- amate, 3-(2-(4-(2-(pyrrolidin-1-yl)ethoxy)phenylamino)thieno[3,2-d]pyrimid- in-7-yl)benzenesulfonamide, 7-(3-chloro-4-fluorophenyl)-N-(4-(2-(pyrrolidin-1-yl)ethoxy)phenyl)thieno- -[3,2-d]pyrimidin-2-amine, tert-butyl 4-(2-(4-(1-ethylpiperidin-4-yloxy)phenylamino)thieno[3,2-d]pyrimidin-7-yl- -)-1H-pyrazole-1-carboxylate, 7-(benzo[d][1,3]dioxo1-5-yl)-N-(4-(morpholinomethyl)phenyl)thieno[3,2-d]p- yrimidin-2-amine, tert-butyl 5-(2-(4-(morpholinomethyl)phenylamino)thieno[3,2-d]pyrimidin-7-yl)-1H-ind- ole-1-carboxylate, 7-(2-aminopyrimidin-5-yl)-N-(4-(morpholinomethyl)phenyl)thieno[3,2-d]pyri- midin-2-amine, tert-butyl 4-(2-(4-(morpholinomethyl)phenylamino)thieno[3,2-d]pyrimidin-7-yl)-5,6-di- -hydropyridine-1(2H)-carboxylate, tert-butyl morpholinomethyl)phenylamino)thieno[3,2-d]pyrimidin-7-yl)benzylcarbamate, N-(3-(2-(4-(morpholinomethyl)phenylamino)thieno[3,2-d]pyrimidin-7-yl)-phe- nyl)acetamide, N-(4-(2-(4-(morpholinomethyl)phenylamino)thieno[3,2-d]pyrimidin-7-yl)phen- yl)acetamide, N-(3-(2-(4-(morpholinomethyl)phenylamino)thieno[3,2-d]pyrimidin-7-yl)phen- yl)methanesulfonamide, 7-(4-(4-methylpiperazin-1-yl)phenyl)-N-(4-(morpholinomethyl)phenyl)thieno- -[3,2-d]pyrimidin-2-amine, N-(2-methoxy-4-(2-(4-(morpholinomethyl)phenylamino)thieno[3,2-d]pyrimidin- -7-yl)phenyl)acetamide, 7-bromo-N-(3,4,5-trimethoxyphenyl)thieno[3,2-d]pyrimidin-2-amine, (3-(2-(3,4,5-trimethoxyphenylamino)thieno[3,2-d]pyrimidin-7-yl)phenyl)met- hanol, (4-(2-(3,4,5-trimethoxyphenylamino)thieno[3,2-d]pyrimidin-7-yl)phen- yl)methanol, (3-(2-(4-morpholinophenylamino)thieno[3,2-d]pyrimidin-7-yl)phenyl)methano- l, (4-(2-(4-morpholinophenylamino)thieno[3,2-d]pyrimidin-7-yl)phenyl)metha- nol, N-(pyrrolidin-1-yl)ethoxy)phenylamino)thieno[3,2-d]pyrimidin-7-yl)ben- zyl)methanesulfonamide, tert-butyl morpholinomethyl)phenylamino)thieno[3,2-d]pyrimidin-7-yl)benzylcarbamate, N-(4-(morpholinomethyl)phenyl)-7-(3-(piperazin-1-yl)phenyl)thieno[3,2-d]p- yrimidin-2-amine, 7-(6-(2-morpholinoethylamino)pyridin-3-yl)-N-(3,4,5-trimethoxyphenyl)thie- no[3,2-d]pyrimidin-2-amine, 7-(2-ethylphenyl)-N-(4-(2-(pyrrolidin-1-yl)ethoxy)phenyl)thieno[3,2-d]pyr- imidin-2-amine, 7-(4-(aminomethyl)phenyl)-N-(4-(morpholinomethyl)phenyl)thieno[3,2-d]pyri- midin-2-amine, N-(4-(1-ethylpiperidin-4-yloxy)phenyl)-7-(1H-pyrazol-4-yl)thieno[3,2-d]py- rimidin-2-amine, N-(2,4-dimethoxyphenyl)-7-phenylthieno[3,2-d]pyrimidin-2-amine, 7-bromo-N-(3,4-dimethoxyphenyl)thieno[3,2-d]pyrimidin-2-amine, N-(3,4-dimethoxyphenyl)-7-phenylthieno[3,2-d]pyrimidin-2-amine, and pharmaceutically acceptable salts and prodrugs thereof. 38. A pharmaceutical composition comprising an effective antiviral amount of a JAK inhibitor selected from the group consisting of: CEP-701 (Lestaurtinib), AZD1480, LY3009104/INCB28050 Pacritinib/SB1518, VX-509, GLPG0634, INC424, R-348, CYT387, TG 10138, AEG 3482, 7-iodo-N-(4-morpholinophenyl)thieno[3,2-d]pyrimidin-2-amine, 7-(4-aminophenyl)-N-(4-morpholinophenyl)thieno[3,2-d]pyrimidin-2-amine, N-(4-(2-(4-morpholinophenylamino)thieno[3,2-d]pyrimidin-7-yl)phenyl)acryl- amide, 7-(3-aminophenyl)-N-(4-morpholinophenyl)thieno[3,2-d]pyrimidin-2-am- ine, N-(3-(2-(4-morpholinophenylamino)thieno[3,2-d]pyrimidin-7-yl)phenyl)a- crylamide, N-(4-morpholinophenyl)thieno[3,2-d]pyrimidin-2-amine, methyl 2-(4-morpholinophenylamino)thieno[3,2-d]pyrimidine-7-carboxylate, N-(4-morpholinophenyl)-5H-pyrrolo[3,2-d]pyrimidin-2-amine, 7-(4-amino-3-methoxyphenyl)-N-(4-morpholinophenyl)thieno[3,2-d]pyrimidin-- 2-amine, 4-(2-(4-morpholinophenylamino)thieno[3,2-d]pyrimidin-7-yl)benzene- sulfonamide, N,N-dimethyl-3-(2-(4-morpholinophenylamino)thieno[3,2-d]pyrimidin-7-yl)be- nzenesulfonamide, 1-ethyl-3-(2-methoxy-4-(2-(4-morpholinophenylamino)thieno[3,2-d]pyrimidin- -7-yl)phenyl)urea, N-(4-(2-(4-morpholinophenylamino)thieno[3,2-d]pyrimidin-7-yl)phenyl)metha- nesulfonamide, 2-methoxy-4-(2-(4-morpholinophenylamino)thieno[3,2-d]pyrimidin-7-yl)pheno- l, 2-cyano-N-(3-(2-(4-morpholinophenylamino)thieno[3,2-d]pyrimidin-7-yl)ph- enyl)acetamide, N-(cyanomethyl)-2-(4-morpholinophenylamino)thieno[3,2-d]pyrimidine-7-carb- oxamide, N-(3-(2-(4-morpholinophenylamino)thieno[3,2-d]pyrimidin-7-yl)phen- yl)methanesulfonamide, 1-ethyl-3-(4-(2-(4-morpholinophenylamino)thieno[3,2-d]pyrimidin-7-yl)-2-(- -trifluoromethoxy)phenyl)urea, N-(3-nitrophenyl)-7-phenylthieno[3,2-d]pyrimidin-2-amine, 7-iodo-N-(3-nitrophenyl)thieno[3,2-d]pyrimidin-2-amine, N1-(7-(2-ethylphenyl)thieno[3,2-d]pyrimidin-2-yl)benzene-1,3-diamine, N-tert-butyl-3-(2-(4-morpholinophenylamino)thieno[3,2-d]pyrimidin-7-yl)be- nzenesulfonamide, N1-(7-iodothieno[3,2-d]pyrimidin-2-yl)benzene-1,3-diamine, 7-(4-amino-3-(trifluoromethoxy)phenyl)-N-(4-morpholinophenyl)thieno[3,2-d- ]pyrimidin-2-amine, 7-(2-ethylphenyl)-N-(4-morpholinophenyl)thieno[3,2-d]pyrimidin-2-amine, N-(3-(2-(4-morpholinophenylamino)thieno[3,2-d]pyrimidin-7-yl)phenyl)aceta- mide, N-(cyanomethyl)-N-(3-(2-(4-morpholinophenylamino)thieno[3,2-d]pyrimi- din-7-yl)phenyl)methanesulfonamide, N-(cyanomethyl)-N-(4-(2-(4-morpholinophenylamino)thieno[3,2-d]pyrimidin-7- -yl)phenyl)methanesulfonamide, N-(3-(5-methyl-2-(4-morpholinophenylamino)-5H-pyrrolo[3,2-d]pyrimidin-7-y- l)phenyl)methanesulfonamide, 4-(5-methyl-2-(4-morpholinophenylamino)-5H-pyrrolo[3,2-d]pyrimidin-7-yl)b- enzenesulfonamide, N-(4-(5-methyl-2-(4-morpholinophenylamino)-5H-pyrrolo[3,2-d]pyrimidin-7-y- l)phenyl)methanesulfonamide, 7-iodo-N-(4-morpholinophenyl)-5H-pyrrolo[3,2-d]pyrimidin-2-amine, 7-(2-isopropylphenyl)-N-(4-morpholinophenyl)thieno[3,2-d]pyrimidin-2-amin- e, 7-bromo-N-(4-morpholinophenyl)thieno[3,2-d]pyrimidin-2-amine, N7-(2-isopropylphenyl)-N2-(4-morpholinophenyl)thieno[3,2-d]pyrimidine-2,7- -diamine, N7-(4-isopropylphenyl)-N2-(4-morpholinophenyl)thieno[3,2-d]pyrim- idine-2,7-diamine, 7-(5-amino-2-methylphenyl)-N-(4-morpholinophenyl)thieno[3,2-d]pyrimidin-2- -amine, N-(cyanomethyl)-4-(2-(4-morpholinophenylamino)thieno[3,2-d]pyrimid- in-7-yl)benzamide, 7-iodo-N-(3-morpholinophenyl)thieno[3,2-d]pyrimidin-2-amine, 7-(4-amino-3-nitrophenyl)-N-(4-morpholinophenyl)thieno[3,2-d]pyrimidin-2-- amine, 7-(2-methoxypyridin-3-yl)-N-(4-morpholinophenyl)thieno[3,2-d]pyrimi- din-2-amine, (3-(7-iodothieno[3,2-d]pyrimidin-2-ylamino)phenyl)methanol, N-tert-butyl-3-(2-(3-morpholinophenylamino)thieno[3,2-d]pyrimidin-7-yl)be- nzenesulfonamide, N-tert-butyl-3-(2-(3-(hydroxymethyl)phenylamino)thieno[3,2-d]pyrimidin-7-- yl)benzenesulfonamide, N-(4-morpholinophenyl)-7-(4-nitrophenylthio)-5H-pyrrolo[3,2-d]pyrimidin-2- -amine, N-tert-butyl-3-(2-(3,4,5-trimethoxyphenylamino)thieno[3,2-d]pyrimi- din-7-yl)benzenesulfonamide, 7-(4-amino-3-nitrophenyl)-N-(3,4-dimethoxyphenyl)thieno[3,2-d]pyrimidin-2- -amine, N-(3,4-dimethoxyphenyl)-7-(2-methoxypyridin-3-yl)thieno[3,2-d]pyri- midin-2-amine, N-tert-butyl-3-(2-(3,4-dimethoxyphenylamino)thieno[3,2-d]pyrimidin-7-yl)b- enzenesulfonamide, 7-(2-aminopyrimidin-5-yl)-N-(3,4-dimethoxyphenyl)thieno[3,2-d]pyrimidin-2- -amine, N-(3,4-dimethoxyphenyl)-7-(2,6-dimethoxypyridin-3-yl)thieno[3,2-d]- pyrimidin-2-amine, N-(3,4-dimethoxyphenyl)-7-(2,4-dimethoxypyrimidin-5-yl)thieno[3,2-d]pyrim- idin-2-amine, 7-iodo-N-(4-(morpholinomethyl)phenyl)thieno[3,2-d]pyrimidin-2-amine, N-tert-butyl-3-(2-(4-(morpholinomethyl)phenylamino)thieno[3,2-d]pyrimidin- -7-yl)benzenesulfonamide, 2-cyano-N-(4-methyl-3-(2-(4-morpholinophenylamino)thieno[3,2-d]pyrimidin-- 7-yl)phenyl)acetamide, ethyl 3-(2-(4-morpholinophenylamino)thieno[3,2-d]pyrimidin-7-yl)benzoate, 7-bromo-N-(4-(2-(pyrrolidin-1-yl)ethoxy)phenyl)thieno[3,2-d]pyrimidin-2-a- mine, N-(3-(2-(4-(2-(pyrrolidin-1-yl)ethoxy)phenylamino)thieno[3,2-d]pyrim- idin-7-yl)phenyl)acetamide, N-(cyanomethyl)-3-(2-(4-morpholinophenylamino)thieno[3,2-d]pyrimidin-7-yl- )benzamide, N-tert-butyl-3-(2-(4-morpholinophenylamino)thieno[3,2-d]pyrimidin-7-yl)be- nzamide, N-tert-butyl-3-(2-(4-(1-ethylpiperidin-4-yloxy)phenylamino)thieno- [3,2-d]pyrimidin-7-yl)benzenesulfonamide, tert-butyl-4-(2-(4-(morpholinomethyl)phenylamino)thieno[3,2-d]pyrimidin-7- -yl)-1H-pyrazole-1-carboxylate, 7-bromo-N-(4-((4-ethylpiperazin-1-yl)methyl)phenyl)thieno[3,2-d]pyrimidin- -2-amine, N-tert-butyl-3-(2-(4-((4-ethylpiperazin-1-yl)methyl)phenylamino)- thieno[3,2-d]pyrimidin-7-yl)benzenesulfonamide, N-(4-((4-ethylpiperazin-1-yl)methyl)phenyl)-7-(1H-pyrazol-4-yl)thieno[3,2- -d]pyrimidin-2-amine, N-(cyanomethyl)-3-(2-(4-(morpholinomethyl)phenylamino)thieno[3,2-d]pyrimi- din-7-yl)benzamide, N-tert-butyl-3-(2-(4-(2-(pyrrolidin-1-yl)ethoxy)phenylamino)thieno[3,2-d]- -pyrimidin-7-yl)benzenesulfonamide, tert-butyl pyrrolidin-1-yl)ethoxy)phenylamino)thieno[3,2-d]pyrimidin-7-yl)benzylcarb- amate, 3-(2-(4-(2-(pyrrolidin-1-yl)ethoxy)phenylamino)thieno[3,2-d]pyrimid- in-7-yl)benzenesulfonamide, 7-(3-chloro-4-fluorophenyl)-N-(4-(2-(pyrrolidin-1-yl)ethoxy)phenyl)thieno- -[3,2-d]pyrimidin-2-amine, tert-butyl 4-(2-(4-(1-ethylpiperidin-4-yloxy)phenylamino)thieno[3,2-d]pyrimidin-7-yl- -)-1H-pyrazole-1-carboxylate, 7-(benzo[d][1,3]dioxol-5-yl)-N-(4-(morpholinomethyl)phenyl)thieno[3,2-d]p- yrimidin-2-amine, tert-butyl 5-(2-(4-(morpholinomethyl)phenylamino)thieno[3,2-d]pyrimidin-7-yl)-1H-ind- ole-1-carboxylate, 7-(2-aminopyrimidin-5-yl)-N-(4-(morpholinomethyl)phenyl)thieno[3,2-d]pyri- midin-2-amine, tert-butyl 4-(2-(4-(morpholinomethyl)phenylamino)thieno[3,2-d]pyrimidin-7-yl)-5,6-di- -hydropyridine-1(2H)-carboxylate, tert-butyl morpholinomethyl)phenylamino)thieno[3,2-d]pyrimidin-7-yl)benzylcarbamate, N-(3-(2-(4-(morpholinomethyl)phenylamino)thieno[3,2-d]pyrimidin-7-yl)-phe- nyl)acetamide, N-(4-(2-(4-(morpholinomethyl)phenylamino)thieno[3,2-d]pyrimidin-7-yl)phen- yl)acetamide, N-(3-(2-(4-(morpholinomethyl)phenylamino)thieno[3,2-d]pyrimidin-7-yl)phen- yl)methanesulfonamide, 7-(4-(4-methylpiperazin-1-yl)phenyl)-N-(4-(morpholinomethyl)phenyl)thieno- -[3,2-d]pyrimidin-2-amine, N-(2-methoxy-4-(2-(4-(morpholinomethyl)phenylamino)thieno[3,2-d]pyrimidin- -7-yl)phenyl)acetamide, 7-bromo-N-(3,4,5-trimethoxyphenyl)thieno[3,2-d]pyrimidin-2-amine, (3-(2-(3,4,5-trimethoxyphenylamino)thieno[3,2-d]pyrimidin-7-yl)phenyl)met- hanol, (4-(2-(3,4,5-trimethoxyphenylamino)thieno[3,2-d]pyrimidin-7-yl)phen- yl)methanol, (3-(2-4-morpholinophenylamino)thieno[3,2-d]pyrimidin-7-yl)phenyl)methanol- , (4-(2-(4-morpholinophenylamino)thieno[3,2-d]pyrimidin-7-yl)phenyl)methan- ol, N-(pyrrolidin-1-yl)ethoxy)phenylamino)thieno[3,2-d]pyrimidin-7-yl)benz- yl)methanesulfonamide, tert-butyl morpholinomethyl)phenylamino)thieno[3,2-d]pyrimidin-7-yl)benzylcarbamate, N-(4-(morpholinomethyl)phenyl)-7-(3-(piperazin-1-yl)phenyl)thieno[3,2-d]p- yrimidin-2-amine, 7-(6-(2-morpholinoethylamino)pyridin-3-yl)-N-(3,4,5-trimethoxyphenyl)thie- no[3,2-d]pyrimidin-2-amine, 7-(2-ethylphenyl)-N-(4-(2-(pyrrolidin-1-y1)ethoxy)phenyl)thieno[3,2-d]pyr- imidin-2-amine, 7-(4-(aminomethyl)phenyl)-N-(4-(morpholinomethyl)phenyl)thieno[3,2-d]pyri- midin-2-amine, N-(4-(1-ethylpiperidin-4-yloxy)phenyl)-7-(1H-pyrazol-4-yl)thieno[3,2-d]py- rimidin-2-amine, N-(2,4-dimethoxyphenyl)-7-phenylthieno[3,2-d]pyrimidin-2-amine, 7-bromo-N-(3,4-dimethoxyphenyl)thieno[3,2-d]pyrimidin-2-amine, N-(3,4-dimethoxyphenyl)-7-phenylthieno[3,2-d]pyrimidin-2-amine, and pharmaceutically acceptable salts and prodrugs thereof, a pharmaceutically acceptable carrier or excipient, and an additional anti-HIV compound. 39. The composition of claim 38, wherein the JAK inhibitors are selected from the group consisting of: CEP-701 (Lestaurtinib), AZD1480, LY3009104/INCB28050 Pacritinib/SB1518, VX-509, GLPG0634, INC424, R-348, CYT387, TG 10138, AEG 3482, 7-iodo-N-(4-morpholinophenyl)thieno[3,2-d]pyrimidin-2-amine, 7-(4-aminophenyl)-N-(4-morpholinophenyl)thieno[3,2-d]pyrimidin-2-amine, N-(4-(2-(4-morpholinophenylamino)thieno[3,2-d]pyrimidin-7-yl)phenyl) acrylamide, 7-(3-aminophenyl)-N-(4-morpholinophenyl)thieno[3,2-d]pyrimidin-2-amine, N-(3-(2-(4-morpholinophenylamino)thieno[3,2-d]pyrimidin-7-yl)phenyl) acrylamide, N-(4-morpholinophenyl)thieno[3,2-d]pyrimidin-2-amine, methyl 2-(4-morpholinophenylamino)thieno[3,2-d]pyrimidine-7-carboxylate, N-(4-morpholinophenyl)-5H-pyrrolo[3,2-d]pyrimidin-2-amine, 7-(4-amino-3-methoxyphenyl)-N-(4-morpholinophenyl)thieno[3,2-d]pyrimidin-- 2-amine, 4-(2-(4-morpholinophenylamino)thieno[3,2-d]pyrimidin-7-yl)benzene- sulfonamide, N,N-dimethyl-3-(2-(4-morpholinophenylamino)thieno[3,2-d]pyrimidin-7-yl)be- nzenesulfonamide, 1-ethyl-3-(2-methoxy-4-(2-(4-morpholinophenylamino)thieno[3,2-d]pyrimidin- -7-yl)phenyl)urea, N-(4-(2-(4-morpholinophenylamino)thieno[3,2-d]pyrimidin-7-yl)phenyl)metha- nesulfonamide, 2-methoxy-4-(2-(4-morpholinophenylamino)thieno[3,2-d]pyrimidin-7-yl)pheno- l, 2-cyano-N-(3-(2-(4-morpholinophenylamino)thieno[3,2-d]pyrimidin-7-yl)ph- enyl)acetamide, N-(cyanomethyl)-2-(4-morpholinophenylamino)thieno[3,2-d]pyrimidine-7-carb- oxamide, N-(3-(2-(4-morpholinophenylamino)thieno[3,2-d]pyrimidin-7-yl)phen- yl)methanesulfonamide, 1-ethyl-3-(4-(2-(4-morpholinophenylamino)thieno[3,2-d]pyrimidin-7-yl)-2-(- -trifluoromethoxy)phenyl)urea, N-(3-nitrophenyl)-7-phenylthieno[3,2-d]pyrimidin-2-amine, 7-iodo-N-(3-nitrophenyl)thieno[3,2-d]pyrimidin-2-amine, N1-(7-(2-ethylphenyl)thieno[3,2-d]pyrimidin-2-yl)benzene-1,3-diamine, N-tert-butyl-3-(2-(4-morpholinophenylamino)thieno[3,2-d]pyrimidin-7-yl)be- nzenesulfonamide, N1-(7-iodothieno[3,2-d]pyrimidin-2-yl)benzene-1,3-diamine, 7-(4-amino-3-(trifluoromethoxy)phenyl)-N-(4-morpholinophenyl)thieno[3,2-d- ]pyrimidin-2-amine, 7-(2-ethylphenyl)-N-(4-morpholinophenyl)thieno[3,2-d]pyrimidin-2-amine, N-(3-(2-(4-morpholinophenylamino)thieno[3,2-d]pyrimidin-7-yl)phenyl)aceta- mide, N-(cyanomethyl)-N-(3-(2-(4-morpholinophenylamino)thieno[3,2-d]pyrimi- din-7-yl)phenyl)methanesulfonamide, N-(cyanomethyl)-N-(4-(2-(4-morpholinophenylamino)thieno[3,2-d]pyrimidin-7- -yl)phenyl)methanesulfonamide, N-(3-(5-methyl-2-(4-morpholinophenylamino)-5H-pyrrolo[3,2-d]pyrimidin-7-y- l)phenyl)methanesulfonamide, 4-(5-methyl-2-(4-morpholinophenylamino)-5H-pyrrolo[3,2-d]pyrimidin-7-yl)b- enzenesulfonamide, N-(4-(5-methyl-2-(4-morpholinophenylamino)-5H-pyrrolo[3,2-d]pyrimidin-7-y- l)phenyl)methanesulfonamide, 7-iodo-N-(4-morpholinophenyl)-5H-pyrrolo[3,2-d]pyrimidin-2-amine, 7-(2-isopropylphenyl)-N-(4-morpholinophenyl)thieno[3,2-d]pyrimidin-2-amin- e, 7-bromo-N-(4-morpholinophenyl)thieno[3,2-d]pyrimidin-2-amine, N7-(2-isopropylphenyl)-N2-(4-morpholinophenyl)thieno[3,2-d]pyrimidine-2,7- -diamine, N7-(4-isopropylphenyl)-N2-(4-morpholinophenyl)thieno[3,2-d]pyrim- idine-2,7-diamine, 7-(5-amino-2-methylphenyl)-N-(4-morpholinophenyl)thieno[3,2-d]pyrimidin-2- -amine, N-(cyanomethyl)-4-(2-(4-morpholinophenylamino)thieno[3,2-d]pyrimid- in-7-yl)benzamide, 7-iodo-N-(3-morpholinophenyl)thieno[3,2-d]pyrimidin-2-amine, 7-(4-amino-3-nitrophenyl)-N-(4-morpholinophenyl)thieno[3,2-d]pyrimidin-2-- amine, 7-(2-methoxypyridin-3-yl)-N-(4-morpholinophenyl)thieno[3,2-d]pyrimi- din-2-amine, (3-(7-iodothieno[3,2-d]pyrimidin-2-ylamino)phenyl)methanol, N-tert-butyl-3-(2-(3-morpholinophenylamino)thieno[3,2-d]pyrimidin-7-yl)be- nzenesulfonamide, N-tert-butyl-3-(2-(3-(hydroxymethyl)phenylamino)thieno[3,2-d]pyrimidin-7-- yl)benzenesulfonamide, N-(4-morpholinophenyl)-7-(4-nitrophenylthio)-5H-pyrrolo[3,2-d]pyrimidin-2- -amine, N-tert-butyl-3-(2-(3,4,5-trimethoxyphenylamino)thieno[3,2-d]pyrimi- din-7-yl)benzenesulfonamide, 7-(4-amino-3-nitrophenyl)-N-(3,4-dimethoxyphenyl)thieno[3,2-d]pyrimidin-2- -amine, N-(3,4-dimethoxyphenyl)-7-(2-methoxypyridin-3-yl)thieno[3,2-d]pyri- midin-2-amine, N-tert-butyl-3-(2-(3,4-dimethoxyphenylamino)thieno[3,2-d]pyrimidin-7-yl)b- enzenesulfonamide, 7-(2-aminopyrimidin-5-yl)-N-(3,4-dimethoxyphenyl)thieno[3,2-d]pyrimidin-2- -amine, N-(3,4-dimethoxyphenyl)-7-(2,6-dimethoxypyridin-3-yl)thieno[3,2-d]- pyrimidin-2-amine, N-(3,4-dimethoxyphenyl)-7-(2,4-dimethoxypyrimidin-5-yl)thieno[3,2-d]pyrim- idin-2-amine, 7-iodo-N-(4-(morpholinomethyl)phenyl)thieno[3,2-d]pyrimidin-2-amine, N-tert-butyl-3-(2-(4-(morpholinomethyl)phenylamino)thieno[3,2-d]pyrimidin- -7-yl)benzenesulfonamide, 2-cyano-N-(4-methyl-3-(2-(4-morpholinophenylamino)thieno[3,2-d]pyrimidin-- 7-yl)phenyl)acetamide, ethyl 3-(2-(4-morpholinophenylamino)thieno[3,2-d]pyrimidin-7-yl)benzoate, 7-bromo-N-(4-(2-(pyrrolidin-1-yl)ethoxy)phenyl)thieno[3,2-d]pyrimidin-2-a- mine, N-(3-(2-(4-(2-(pyrrolidin-1-yl)ethoxy)phenylamino)thieno[3,2-d]pyrim- idin-7-yl)phenyl)acetamide, N-(cyanomethyl)-3-(2-(4-morpholinophenylamino)thieno[3,2-d]pyrimidin-7-yl- )benzamide, N-tert-butyl-3-(2-(4-morpholinophenylamino)thieno[3,2-d]pyrimidin-7-yl)be- nzamide, N-tert-butyl-3-(2-(4-(1-ethylpiperidin-4-yloxy)phenylamino)thieno- [3,2-d]pyrimidin-7-yl)benzenesulfonamide, tert-butyl-4-(2-(4-(morpholinomethyl)phenylamino)thieno[3,2-d]pyrimidin-7- -yl)-1H-pyrazole-1-carboxylate, 7-bromo-N-(4-((4-ethylpiperazin-1-yl)methyl)phenyl)thieno[3,2-d]pyrimidin- -2-amine, N-tert-butyl-3-(2-(4-((4-ethylpiperazin-1-yl)methyl)phenylamino)- thieno[3,2-d]pyrimidin-7-yl)benzenesulfonamide, N-(4-((4-ethylpiperazin-1-yl)methyl)phenyl)-7-(1H-pyrazol-4-yl)thieno[3,2- -d]pyrimidin-2-amine, N-(cyanomethyl)-3-(2-(4-(morpholinomethyl)phenylamino)thieno[3,2-d]pyrimi- din-7-yl)benzamide, N-tert-butyl-3-(2-(4-(2-(pyrrolidin-1-yl)ethoxy)phenylamino)thieno[3,2-d]- -pyrimidin-7-yl)benzenesulfonamide, tert-butyl pyrrolidin-1-yl)ethoxy)phenylamino)thieno[3,2-d]pyrimidin-7-yl)benzylcarb- amate, 3-(2-(4-(2-(pyrrolidin-1-yl)ethoxy)phenylamino)thieno[3,2-d]pyrimid- in-7-yl)benzenesulfonamide, 7-(3-chloro-4-fluorophenyl)-N-(4-(2-(pyrrolidin-1-yl)ethoxy)phenyl)thieno- -[3,2-d]pyrimidin-2-amine, tert-butyl 4-(2-(4-(1-ethylpiperidin-4-yloxy)phenylamino)thieno[3,2-d]pyrimidin-7-yl- -)-1H-pyrazole-1-carboxylate, 7(benzo[d][1,3]dioxol-5-yl)-N-(4-(morpholinomethyl)phenyl)thieno[3,2-d]py- rimidin-2-amine, tert-butyl 5-(2-(4-(morpholinomethyl)phenylamino)thieno[3,2-d]pyrimidin-7-yl)-1H-ind- ole-1-carboxylate, 7-(2-aminopyrimidin-5-yl)-N-(4-(morpholinomethyl)phenyl)thieno[3,2-d]pyri- midin-2-amine, tert-butyl 4-(2-(-4-(morpholinomethyl)phenylamino)thieno[3,2-d]pyrimidin-7-yl)-5,6-d- i-hydropyridine-1(2H)-carboxylate, tert-butyl morpholinomethyl)phenylamino)thieno[3,2-d]pyrimidin-7-yl)benzylcarbamate, N-(3-(2-(4-(morpholinomethyl)phenylamino)thieno[3,2-d]pyrimidin-7-yl)phen- yl)acetamide, N-(4-(2-(4-(morpholinomethyl)phenylamino)thieno[3,2-d]pyrimidin-7-yl)phen- yl)acetamide, N-(3-(2-(4-(morpholinomethyl)phenylamino)thieno[3,2-d]pyrimidin-7-yl)phen- yl)methanesulfonamide, 7-(4-(4-methylpiperazin-1-yl)phenyl)-N-(4-(morpholinomethyl)phenyl)thieno- [3,2-d]pyrimidin-2-amine, N-(2-methoxy-4-(2-(4-(morpholinomethyl)phenylamino)thieno[3,2-d]pyrimidin- -7-yl)phenyl)acetamide, 7-bromo-N-(3,4,5-trimethoxyphenyl)thieno[3,2-d]pyrimidin-2-amine, (3-(2-(3,4,5-trimethoxyphenylamino)thieno[3,2-d]pyrimidin-7-yl)phenyl)met- hanol, (4-(2-(3,4,5-trimethoxyphenylamino)thieno[3,2-d]pyrimidin-7-yl)phen- yl)methanol, (3-(2-(4-morpholinophenylamino)thieno[3,2-d]pyrimidin-7-yl)phenyl)methano- l, (4-(2-(4-morpholinophenylamino)thieno[3,2-d]pyrimidin-7-yl)phenyl)metha- nol, N-(pyrrolidin-1-yl)ethoxy)phenylamino)thieno[3,2-d]pyrimidin-7-yl)ben- zyl)methanesulfonamide, tert-butyl morpholinomethyl)phenylamino)thieno[3,2-d]pyrimidin-7-yl)benzylcarbamate, N-(4-(morpholinomethyl)phenyl)-7-(3-(piperazin-1-yl)phenyl)thieno[3,2-d]p- yrimidin-2-amine, 7-(6-(2-morpholinoethylamino)pyridin-3-yl)-N-(3,4,5-trimethoxyphenyl)thie- no[3,2-d]pyrimidin-2-amine, 7-(2-ethylphenyl)-N-(4-(2-(pyrrolidin-1-yl)ethoxy)phenyl)thieno[3,2-d]pyr- imidin-2-amine, 7-(4-(aminomethyl)phenyl)-N-(4-(morpholinomethyl)phenyl)thieno[3,2-d]pyri- midin-2-amine, N-(4-(1-ethylpiperidin-4-yloxy)phenyl)-7-(1H-pyrazol-4-yl)thieno[3,2-d]py- rimidin-2-amine, N-(2,4-dimethoxyphenyl)-7-phenylthieno[3,2-d]pyrimidin-2-amine, 7-bromo-N-(3,4-dimethoxyphenyl)thieno[3,2-d]pyrimidin-2-amine, N-(3,4-dimethoxyphenyl)-7-phenylthieno[3,2-d]pyrimidin-2-amine, and pharmaceutically acceptable salts and prodrugs thereof. 40. The pharmaceutical composition of claim 30, wherein the JAK inhibitor is ##STR00079## LY3009104/INCB28050, ##STR00080## or a pharmaceutically acceptable salt or prodrug thereof. 41. The method of claim 5, wherein the Jak inhibitor is Jakafi, Tofacitinib, or LY3009104/INCB28050. 42. The method of claim 8, wherein the Jak inhibitor is Jakafi, Tofacitinib, or LY3009104/INCB28050. 43. The method of claim 11, wherein the Jak inhibitor is Jakafi, Tofacitinib, or LY3009104/INCB28050. 44. The method of claim 16, wherein the Jak inhibitor is Jakafi, Tofacitinib, or LY3009104/INCB28050. 45. The pharmaceutical composition of claim 30, wherein the Jak inhibitor is Jakafi, Tofacitinib, or LY3009104/INCB28050. 46. The pharmaceutical composition of claim 32, wherein the Jak inhibitor is Jakafi, Tofacitinib, or LY3009104/INCB28050.